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This is an umbrella term used to encompass the specific 
roles of nurses who practice at a more advanced level 




An incident that results in harm to a patient 
 
An adverse drug event refers to any injury occurring at 
the time a drug is used, whether or not it is identified 




A Bord Altranais is the regulatory body for the nursing 
profession in Ireland. Following the signing of 
Commencement Order S.I. No. 385 in 2012, the name 
of An Bord Altranais changed to Nursing and Midwifery 
Board of Ireland (NMBI) in 2011.  
 
Audit An independent, objective assurance and consulting 
activity designed to add value and improve an 
organisation’s operations. It helps an organisation to 
accomplish its objectives by bringing a systematic, 
disciplined approach to evaluate and improve the 






Written agreement between the Registered Nurse 
prescriber and specific Consultant medical 
practitioner(s), agreeing the prescription of medicinal 
products by the registered nurse or midwife within 
their scope of practice at their place of employment. 
The medicinal product listing is approved by the Drugs 
and Therapeutics Committee and authorised by the 
director of nursing/midwifery/public health or relevant 
nurse and midwife manager on behalf of the health 
service provider. 
Competence The ability of the registered nurse or midwife to 
practice safely and effectively, fulfilling his or her 









The Department of Health and Children Ireland is our 
shared framework for improving the health and 
wellbeing through the harmonisation of policy and 
provision across Government and with a wide range of 
stakeholders to improve outcomes for children, young 




Research studies that have as their main objective the 
accurate portrayal of the characteristics of persons, 
situations, or group, and/or the frequency with which 





This is a multidisciplinary advisory committee which is a 
subcommittee of the Medical Board. Terms of 
reference include advising hospital staff on all matters 
pertaining to the use of drugs and medicines and 
ensuring that prescribing and administration of drugs is 





The Health Service Executive is responsible for the 
provision of health and personal social services with 




The Health Service Executive, a hospital, a nursing 
home, a clinic or person whose sole or principal activity 
or business is the provision of health services or a class 





The Higher Education Authority is the statutory 
planning and policy development body for higher 




Inappropriate prescribing is defined as a situation 
where risk from the adverse effects of a prescribed 
medication outweighs the desired clinical benefits of 




A consultant medical practitioner or general 
practitioner who has committed to act as a mentor and 
provide instruction and supervision within the specific 
clinical practice area for the duration of the education 
programme 
Midwife A person whose name is entered in the midwife 












Board of Ireland 
 
Nurse 
In Ireland, monitoring of nurse prescribing is achieved 
through inputting data directly to a database managed 
by the Health Service Executive.  The official title of the 




The regulatory body for the nursing and midwifery 
profession in Ireland. 
 
 
A woman or man whose name is entered into the 








Medicinal products which are exempt from prescription 
control under SI 540-the medicinal products 
((Prescription and Control of Supply) Regulations 2003) 
 
 
A way of looking at natural phenomena which 
encompasses a set of philosophical assumptions and 
which guides one’s approach to enquiry. 
 
Prescribe To authorise in writing the dispensing, supply and 
administration of a named medicinal product (typically 
a prescription-only medicine, but may include over the 
counter medicines) for a specific patient. 
 
Prescription A prescription issued by a registered medical 
practitioner for the medical treatment of an individual, 
by a registered dentist for the dental treatment of an 
individual, or by a registered veterinary surgeon for the 
purpose of animal treatment or a registered nurse for 
the medical treatment of an individual subject to article 






The person nominated by the Director of Nursing on 
behalf of the health service provider to be the 
prescribing link. This person takes responsibility for the 
initiative locally, liaises with the education provider and 







The investigation of phenomena, typically in an in-
depth and holistic fashion, through the collection of 







Qualitative descriptive research design is a scientific 
method which involves observing and describing the 
behaviour of a subject without influencing it in any 
way. 
The investigation of phenomena that lends itself to 
precise measurement and quantification, often 




A nurse/midwife who is registered in the division of the 




Acted as an advisory resource to the Department of 
Health and Children to develop and implement a plan 




The range of roles, functions, responsibilities and 
activities which a registered nurse/midwife is educated, 
competent and has authority to perform. 
Workarounds Locally constructed paper based alternatives to 











ABA An Bord Altranais 
ACT 
ADE 
Anatomical Therapeutic Chemical 
Adverse drug event 
ANP Advanced Nurse Practitioner  
APRN 
CDSS 
Advanced Practice Registered Nurses 
Clinical Decision Support System 
CNS Central Nervous System 
CPA Collaborative Practice Agreement 
CPD 
CREC 
Continuing Professional Development 
Clinical Research Ethics Committee 
DoH Department of Health 
DoHC Department of Health and Children 
HCP Healthcare professionals 
HEI Higher Education Institutes 
HIQA Health Information Quality Authority 
HIT Health Information Technology 
HSE Health Service Executive 
HSP Health Service Provider 
ICD International Classification of Diseases 
IQR Interquartile Range 
MAI Medication Appropriate Index 
MDS Minimum Data Set 
MRN 
NMBI 
Medical Record Number 




Over the counter 
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PA Physician Assistants 
PIM Potential Inappropriate Medications 
PIP Potential Inappropriate Prescriptions 
PPO Potential Prescribing Omissions 
PRN Pro re nata (as required) 
RCSI Royal College of Surgeons in Ireland 
RIG Resource and Implementation Group 
RNP Registered Nurse Prescriber 
SD Standard Deviation 
SPSS Statistical Package for the Social Sciences 
START Screening Tool to Alert doctors to Right 
Prescriptions 
STOPP Screening Tool of Older Persons Prescriptions 
UCC University College Cork 
UK United Kingdom 
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CHAPTER 1 INTRODUCTION, 
BACKGROUND AND 
OVERVIEW OF METHODS 
USED IN THIS THESIS 
 
Chapter 1 introduces the reader to the research area of nurse prescribing 
which outlines the background and introduction of nurse prescribing to the 
Irish and international setting. The Chapter also gives an overview of the 
legislation and educational framework together with the involvement of the 
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 'Introducing nurse prescribing: an Irish perspective'. Creedon, R. & O'Connell, E. (2009) 
Nurse Prescribing, 7 (11):507-511. 
2
 Introducing Nurse Prescribing to Ireland: challenges and solutions. Creedon, R. & 





Nurse and midwife prescribing is one of a number of significant changes 
to the Irish nurses’ professional role over the past 10 years.  Prescriptive 
authority for nurses was introduced as a direct response to patients’ needs 
that were identified through The Commission on Nursing - A Blueprint for the 
Future (Department of Health and Children, 1998b). It is a significant change 
to the nursing role because it substantially expands the traditional function of 
nurses and, as a result, considerably extends the horizons for the future of the 
nursing profession in Ireland. Although nurse prescribers entered the Irish 
health service in 2008 it continues to expand and challenges professional 
boundaries that are already being redefined with nursing roles having an ever 
increasing responsibility (Creedon, 2010b). Nurse prescribers are now seen as 
more approachable by patients, and doctors are no longer engaged in the 
risky practice of signing off prescriptions for patients they have not recently 
seen (Robinson, 2009). Research regarding nurse prescribing to date 
acknowledges the role expansion but, more importantly, identifies the 
relationship between the nurse and the patient in providing reassurance, 
continuity of care, information, provision of health promotion, and being 
approachable as the most positive aspects of nurse prescribing (Naughton et 
al., 2012). The nurse’s ability to identify barriers when offering lifestyle advice 
because of their holistic approach to patient care enables them to consider 
the social context of patients’ lives and the impact it may have on the 
management of each individual patients’ medication regime (Bradley et al., 
2005). This mirrors the findings of international research where nurse 
prescribers have been identified as safe and effective practitioners resulting 
in increased patient satisfaction (Shum et al., 2000, Pritchard and Kendrick, 
2001, Haidar, 2007) and a more cost-effective service. However, in 2011 Irish 
nurse prescribers began to contest nurse prescribing structures as somewhat 
restrictive and needing review or change if they were to continue assisting 
3 
 
the advancement of the initiative. Therefore, this thesis was undertaken to 
explore and identify nurse prescriber’s issues and concerns in clinical practice.   
 
1.2 International perspective of nurse prescribing 
 
Internationally, several healthcare systems now include some form of 
prescribing by non-medical healthcare professionals, offering potential 
benefits in terms of increasing patients’ continuity of care and access to 
medicines, better utilisation of economic and human resources, reduction in 
patient waiting times and less fragmented care (Emmerton, 2005, Cooper et 
al., 2008). Prescribing medications has traditionally been the domain of 
doctors, but nurse prescribing has been introduced in response to changing 
service needs and the increasing specialisation of nurses and midwives as 
they expand and advance their scope of practice. However, international 
differences between legislative procedures and the professional bodies 
responsible for the regulation of nursing practice has resulted in the 
implementation of several models of prescribing worldwide (An Bord 
Altranais and NMPDU, 2005). The different approaches to the development of 
nurse prescribing in other countries have arisen from the differing needs of 
health services.  In the developed world, advances in technology, a desire by 
medical providers to reduce costs and increase services, and the demands of 
service users, have influenced the evolution of nurse prescribing.  Within the 
context of these changes and advances in nursing and midwifery practice, 
prescriptive authority has become an essential component of nursing in many 
countries (Buchan & Calman, 2004). 
In the United States of America (USA), Advanced Practice Registered 
Nurses (APRNs) have had prescriptive privileges since 1969, although the level 
of prescriptive authority varies from State to State in terms of the degree of 
independence given and the ability to prescribe controlled drugs (Phillips, 
2008). Even though APRN prescribing has been authorised in the USA for over 
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30 years, there are limited data regarding the evolution of the APRN 
prescriber role. Two types of non-physician clinicians write prescriptions in 
order to fill a growing demand for medications: physician assistants (PAs) and 
nurse practitioners. This fragmentation of prescribing practice is due to 
opposition from the medical profession and the diverse registration 
regulations in different States of the USA (Plonczynski, 2003). In addition, the 
limited data regarding the evolution of the APRN prescriber role has resulted 
in the USA lacking evidence-based guidelines that can be used by educators 
and regulators. Other issues that have been identified as barriers to 
prescribing in the USA include restrictive formularies imposed by the medical 
insurance companies, lack of support from health providers and the refusal of 
pharmacists to recognise prescriptions administered by the APRN 
(Plonczynski, 2003). The study also identified the lack of uniformity in 
‘language, laws and regulations’ among States that limited effective 
professional practice and mobility for the nurse prescriber (NP), causing 
confusion for the public.  The introduction of prescribing competencies could 
serve as a basis for national guidelines (standards) in the USA that could be 
used to support autonomous prescribing in all States, thereby addressing the 
variations in prescriptive authority that continues to exists between States 
today (Ross, 2012). 
Nurse prescribing in the United Kingdom (UK) has been developing 
significantly since it was first referred to in the Cumberledge Report 
(Department of Health and Social Security, 1986). In The NHS Plan 
(Department of Health and Children, 2000) the modernisation agenda for the 
health service was set out, and clearly stated that the key to the success of 
the plan rested on changing health worker/professional roles (Pontin and & 
Jones, 2007). Since the introduction of nurse prescribing to the UK in 1992, 
extended prescribing and supplementary prescribing have been reviewed and 
extended to all registered nurses, midwives, pharmacists and other 
healthcare professionals (HCP) following appropriate training and 
examination (Berry et al., 2006). A dual system continues to be employed. 
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Independent prescribers, since 2006, are fully autonomous and wholly 
accountable for the medications they prescribe whereas supplementary 
prescribers have the authority to prescribe certain medications that are 
agreed upon following collaboration with a medical practitioner (Health 
Service Executive, 2008b). 
In a review undertaken by An Bord Altranais (ABA) in 2005, it was 
identified that legislative developments in a number of other countries (e.g. 
Sweden, Canada, Australia, USA and Finland) allow nurses to prescribe 
medicines but are not as progressive as the UK in extended prescribing rights 
for nurses. Nurse prescribing has been developed as part of nurse practitioner 
roles in Canada, New Zealand and Australia, while in Sweden, prescriptive 
authority has been limited to health care settings outside of hospitals (An 
Bord Altranais and NMPDU, 2005). Similarly, in Finland, nurse prescribing, has 
been introduced because of doctor shortages in remote areas experienced 
over the past 10 years, and developed through the Primary Health Care 
Services (Government Act 433/2010, (Ministry of Social Affairs and Health 
Finland, 2010p. 10-12)). 
The international experience of nurse prescribing has demonstrated 
benefits in terms of increased patient satisfaction and concordance with 
medication regimes (Drennan et al., 2011). The role of the NP also continues 
to expand in the healthcare setting as it increases in prominence and 
significance (Cipher et al., 2006). International research has increasingly put 
the role of the non-medical prescriber at the centre of health policies to meet 





1.3 The introduction of nurse prescribing in Ireland3 
 
For decades, prescribing medications was the doctor’s prerogative. It 
signified knowledge, authority, and the exercise of a power sanctioned by 
social and professional consent (An Bord Altranais and NMPDU, 2005). The 
introduction of nurse prescribing to Ireland in 2007 was in response to 
changing service needs and the increasing specialisation of nurses and 
midwives as they expanded and advanced their scope of practice 
(Department of Health and Children, 1998b). It was expected that the 
introduction of nurse prescribing would lead to better integrated care for 
patients, improved delivery in the acute sector, and earlier intervention in the 
community and primary care settings. This significant initiative in the Irish 
Health Service had implications not only for nurses and midwives, but for the 
health system as a whole, and patients and service users in particular. As 
mentioned in section 1.1. the international differences between legislative 
procedures and the professional bodies responsible for the regulation of 
nursing practice worldwide has given the governing bodies considerable 
information to draw on in order to develop the most appropriate nurse 
prescribing model for the Irish Health Service (An Bord Altranais and NMPDU, 
2005). 
 
1.3.1 National perspective 
 
The present focus of nurse prescribing in Ireland emerged from two 
documents; (1) the Report of the Commission on Nursing – A Blueprint for 
the Future (Department of Health and Children, 1998a) and (2) the Review 
of Scope of Practice for Nursing and Midwifery: Final Report (An Bord 
Altranais, 2000).  During the consultative process employed for both of 
                                                             
3
 Following the signing of Commencement Order S.I. No. 385 of 2012, the name of An Bord 
Altranais changed to Nursing and Midwifery Board of Ireland (NMBI). This change of name 
reflects the recognition of midwifery as a separate and distinct profession to that of nursing. 
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these reports, it emerged that ‘nurses or midwives might need to 
administer non-prescribed drugs or medicated dressings in the interest of 
the patient, but in the absence of medical support’ (Department of Health 
and Children, 1998b, p. 58). In addition, The Commission of Nursing (1998a) 
also highlighted that nurses and midwives experienced challenges in their 
current roles concerning medication management and the impact it had on 
the delivery of care. The rationale for these recommendations stemmed 
from a view within the profession that an inability to prescribe was 
resulting in the delivery of fragmented care that was negatively impacting 
on the quality of care delivered to patients. Therefore, in 2001, Ireland 
commenced a review of the role of the nurses and midwives regarding 
prescribing and administration of medicinal products which highlighted that 
involvement of nurses and midwives in medication management would 
improve patient care delivery (An Bord Altranais and NMPDU, 2005). In 
response, ABA and the National Council for the Professional Development 
of Nursing and Midwifery jointly established ‘The Review of Nurses and 
Midwives in the Prescribing & Administration of Medicinal Products Project’ 
in September 2001 to examine expansion of practice by nurses and 
midwives specifically in relation to prescribing and medication 
management. The Steering Committee of this project comprised of 
representatives from ABA, the National Council4 for the Professional 
Development of Nursing and Midwifery, and the Department of Health and 
Children. Other areas of nursing and midwifery were represented, as were 
patient and service-user groups, the medical and pharmacy professions, 
and various agencies and nursing unions (National Council for the 
Professional Development of Nursing Midwifery, 2003). Their overriding 
consideration for the extension of prescribing rights to nurses and midwives 
was to improve services to patients and deploy the education and expertise 
of nurses and midwives more efficiently. The initiative also addressed 
                                                             
4
 National Council for the Professional Development of Nursing Midwifery was dissolved 
in 2011 with the responsibility for nursing role development transferred to An Bord Altranais 
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changes in configuration and delivery of care which were identified by the 
Department of Health and Children (2001) and the European Working Time 
Directive for non-consultant hospital doctors (Department of Health and 
Children, 2003). While obtaining value for money for the Governments 
increased spending on nurse education and training, it was hoped that 
nurse prescribing would lead to better integrated care for patients, 
improved delivery in the acute sector, and earlier intervention in the 
community settings (Health Service Executive, 2008a). 
In October 2005, the Minister for Health and Children identified the 
introduction of nurse prescribing as a priority that became a reality in 2007 
(An Bord Altranais, 2007b). To support the introduction of nurse 
prescribing, the Health Service Executive (HSE) established the Office of the 
Nursing Services Director in September 2006. This support acknowledged 
the vital role of nurses and midwives in the delivery of health services and 
demonstrated its commitment to the future development of these 
professions.  In addition, to guide the introduction of nurse prescribing, the 
Resource and Implementation Group (RIG) was established in November 
2006 was charged with the task of drafting the necessary regulatory 
changes and overseeing in two phases the implementation of the initiative 
nationally. Phase one, consisted of advising on the Regulations to be 
drafted, and phase two, was to oversee the roll-out of the initiative on a 
national basis (Health Service Executive, 2008b). Prescriptive authority for 
nurses and midwives had the ability to impact directly on all services to 
enhance and improve the health service infrastructure and capability to 
provide and support innovative, responsive and appropriate service 
delivery (An Bord Altranais, 2009). Therefore, the Office of the Nursing 






1. practice development 
2. education and training  
3. governance 
4. quality and standards  
5. capacity building and leadership 
(Health Service Executive, 2008b) 
  
International models were reviewed by ABA to inform the 
development of prescriptive authority in the Irish setting. However, 
drawing on evidence–based practice internationally was somewhat 
challenging as different legislative procedures resulted in the 
implementation of several models of prescribing worldwide (An Bord 
Altranais and NMPDU, 2005). These reviews did, however, inform the 
regulatory, legislative and implementation structures for the development 
of nurse/midwife prescribing in Ireland and identified the benefits for 
patients and service users as: 
• Appropriate and safe prescribing 
• Patient satisfaction 
• Convenience and greater accessibility for patients 
• Nurses as providers of information 
• Patients having improved compliance with their medications 
• Fewer pharmacological interventions considered 
• Appropriate clinical decision making 
• Cost effectiveness 
 
Subsequently, a committee for prescriptive authority was established 
within ABA in February 2007.  Its main aim was to advise the Board on its 
regulatory functions within the proposed draft Regulations with regard to 




1.3.2 Overview of legislation framework 
 
To facilitate nurse prescribing, changes to the legislation were required.  
The Minister for Health and Children was instrumental in introducing primary 
legislation to allow prescriptive authority for nurses and midwives in the form 
of the Irish Medicines Board (Miscellaneous Provisions) Act, 2006 
(Department of Health and Children, 2006).  The Minister’s rationale for the 
extension of prescriptive authority to nurses and midwives was to improve 
services to patients. This was supported by strong international evidence 
from the USA and the UK. Subsequently, on the 1st of May 2007, the Minister 
for Health and Children signed into law the following Orders/Regulations: 
• The Irish Medicines Board (Miscellaneous Provisions) Act 2006 
(Commencement) Order 2007. 
• The Medicinal Products (Prescription and Control of supply) 
(Amendment) Regulations 2007. 
• The Misuse of Drugs (Amendment) Regulations 2007. 
• Nurses Rules, 2007. 
 
This regulatory framework for prescriptive authority provided for in the 
legislation covered four main parameters; 1) education, 2) registration, 3) 
clinical competence and 4) clinical governance. Furthermore, the Regulations 
state information that must be contained on a prescription by the prescriber 
including the name and registration number assigned to the registered nurse 
prescriber (An Bord Altranais, 2007d).  
The Misuse of Drugs (Amended) Regulations (2007) was introduced 
specifically to identify the drugs and route of administration for which 
Schedule 2 or Schedule 3 drugs could be prescribed by a Nurse Prescriber 
(NP). The Schedule is divided into three parts. Part 1 includes morphine 
sulphate and codeine phosphate for pain relief in hospitals and includes pain 
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associated with a probable myocardial infarction, and pain following trauma 
or post-operative pain. Part 2 includes morphine sulphate, hydromorphine, 
oxycodone, buprenorphine, fentanyl, methylphenidate, and codeine 
phosphate for use in palliative care. Part 3 includes the use of pethidine in 
midwifery, and morphine sulphate and fentanyl for neonatal care in hospitals 
(Drennan et al., 2009). 
The Nurse Rules 2007 (An Bord Altranais, 2007a) created a separated 
division of the Register for NPs and allows the prescriber to practice as an 
RNP.  The Rules also stated that the education programme for nurses and 
midwives should be in accordance with a curriculum approved by ABA. 
 
1.4 Education programme 
 
A pilot education programme for nurse prescribing commenced in the 
Royal College of Surgeons in Ireland (RCSI) at the end of March 2003 and 
concluded in September 2003. However, whilst the pilot educational 
programme was successful, empowering legislation and clinical areas were 
not sufficiently developed for the full implementation of nurse/midwife 
prescribing at this time. It was not until April 2007 that the present nurse 
prescribing education programme commenced. In its development and 
delivery, the education programme built on the established regulatory 
documents from ABA, the National Council for the Professional Development 
of Nursing and Midwifery and relevant current legislation pertaining to 
medicinal products. It was initially offered as a stand-alone programme by the 
School of Nursing, RCSI, Dublin and the School of Nursing and Midwifery, 
University College Cork. It is now delivered by several additional colleges 
around the country in response to the needs of the health service provider.  
The purpose of this education programme for prescriptive authority is to 
ensure that, upon successful completion, the nurse/midwife is equipped with 
the knowledge, skills and competence to prescribe safely and effectively. The 
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education programme was designed in response to a direct request from ABA 
which changed in 2012 also at the request of the HSE as a result of a 
tendering process.  This may change again in the future, depending on best 
practice and requirements that are determined by the Irish governing body 
ABA and the HSE. 
The programme originally consisted of 26 days of theory on three core 
modules (An Bord Altranais, 2007b) with an additional 12 days of practical 
training. In 2012 the theory component was reduced to eleven days at the 
request of the HSE. The twelve-day (96 hour) practical clinical element of the 
programme has not changed and is supervised in clinical practice by a medical 
mentor/practitioner. This practitioner is a Consultant in the nurse or 
midwives’ area of clinical practice or a General Practitioner who will have 
previously entered into a collaborative practice agreement (CPA) with the 
nurse and their health service provider (An Bord Altranais, 2007d). In 
response to the needs of service providers, the programme has developed to 
include blended learning strategies that facilitate the delivery at regional 
sites.  A more flexible approach to the educational programme delivery has 
emerged in some colleges to facilitate candidates (Adams et al., 2010) by 
reducing the requirement of face to face teaching at a central site.  
Within the requirements and standards, the education programme must 
enable the nurse/midwife to (An Bord Altranais, 2007b): 
1. Demonstrate a systemic understanding of the regulatory 
framework associated with prescribing, including the legislation 
and professional guidelines supporting nurse prescribing. 
2. Critically utilise evidence-based knowledge and skill of 
patient/client assessment and consultation to achieve a holistic 
approach to patient/client care in the prescribing of medicinal 
products. 
3. Apply expert skills in clinical decision-making in relation to 
prescribing medicinal products. 
13 
 
4. Demonstrate a critical understanding of the 
pharmacotherapeutics, pharmacodynamics and pharmacokinetics. 
5. Demonstrate knowledge of the role of the multidisciplinary team 
and effective communication process involved in safe medication 
management. 
 
The aim of the competency framework is to ensure that the participants 
acquire skills of critical analysis, problem-solving, decision-making and 
reflective skills. To complement these professional standards, five domains of 
competencies are assessed in clinical practice by the medical 
mentor/practitioner. These are: 
 
1. Professional/ethical practice 
2. Holistic approach and integration of knowledge 
3. Interpersonal skills 
4. Organisation and management of care 
5. Personal and professional development   
(An Bord Altranais, 2009)                              
 
Support is provided by the educational institution through a lecturer who 
visits the student’s area of practice where the clinical practicum is 
undertaken.  
 
1.5 The role of the Health Service Executive 
 
The introduction of the nurse prescribing initiative to Ireland had at its 
core the potential to contribute to the change required under the HSE six 
transformation policies which were: 
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1. Develop integrated services across all stages of the care journey 
2. Configure primary community and continuing services so that they 
deliver optimal and cost effective results 
3. Configure hospital services to deliver optimal and cost effective 
results 
4. Implement a model for the prevention and management of 
chronic illness 
5. Implement standards based on performance measurement and 
management throughout the HSE 
6. Ensure all staff enable in transforming health and social care in 
Ireland 
 
(Health Service Executive, 2008b) 
 
Following the introduction of legislation to allow prescriptive authority 
for nurses and midwives in May 2007, there were nine core principles for the 
implementation of nurse prescribing; 1) accountability, 2) collaboration, 3) 
consistency, 4) governance, 5) maximising benefits to patients and service 
users, 6) patient-centeredness, 7) quality, 8) safety, and 9) sustainability. In 
addition to the guidance provided by the Resource and Implementation group 
(RIG), a Director and four Assistant Directors of Nurse Prescribing were 
appointed within the HSE in 2007-08 to oversee the implementation of the 
prescribing initiative within the four health service divisions nationally. With 
guidance provided by RIG, four key objectives underlined the implementation 
of the prescribing initiative by the HSE were identified: 
• Development and implementation of a plan to roll out nurse and midwife 
prescribing. 
• Identification of clinical governance structures to support appropriate 
and safe nurse and midwife prescribing. 
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• Development of a mechanism for the evaluation of nurse and midwife 
prescribing. 
• The development of an inclusive communication strategy. 
(Health Service Executive, 2008b) 
 
Essential criteria were identified which had to be met by all health service 
providers (HSP) in order to participate in the prescribing initiative. 
Participating HSPs are required to have organisational policies which support 
the safe management of nurse prescribing and access to a Drugs and 
Therapeutics Committee. They are also required to develop robust CPA with a 
named medical practitioner as well as a mechanism to audit and evaluate 
nurse prescribing practices which is considered  ‘essential in order to support 
best practice’ (Health Service Executive, 2008b p. 59) 
The RIG identified the need for a standardised approach to monitoring 
the implementation of nurse prescribing. To facilitate this, the HSE introduced 
the National Prescribing Minimum Dataset (MDS) in 2008 to record and 
monitor the prescribing activities of the each nurse/midwife prescriber. This 
database allows prescribers to enter details of each prescription issued which 
can then be collated and accessed by directors of nursing/midwifery/public 
health, prescribing site coordinators and nurse/midwife prescribers.  The 
system contains 12 distinct pieces of information (see screen shot in Figure 
1.1):  
1. The prescriber’s clinical site and area of practice  
2. Personal identification number 
3. Clinical Area 
4. Date 
5. Shift on which the prescription was prescribed 
6. The patient’s medical record number (MRN) 
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7. The mode of prescription (medication record, prescription pad or 
electronic) 
8. Clinical Indication (prophylaxis, diagnosis, treatment) 
9. The medication prescribed  
10. Medication dose 
11. Medication frequency  
12. Route of administration of the medication prescribed   
 
 
FIGURE 0.1 NEW PRESCRIBING INPUT SCREEN 
 
In November 2008, the office of the Nursing Services Director, HSE 
published a ‘Guiding Framework for the Implementation of Nurse and Midwife 
Prescribing in Ireland.’ This document sourced its data from the National 
Nurse and Midwife Prescribing MDS and provided comprehensive information 
on the on-going development of the prescribing initiative for the health 
service providers on a two-monthly basis initially and more recently has 
extended to bi-annually.   
Additional requirements for the nurses’ and midwives’ place of 
employment include confirmation of an organisational policy for nurse 
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prescribing, appropriate risk management systems, access to a Drugs and 
Therapeutics Committee and a commitment by the employer to the 
facilitation of continuing education for the Registered Nurse Prescriber 
(Health Service Executive, 2008b). More recently, continuing professional 
development (CPD) has been included in the Nurses Act of 2011 and is the 
responsibility of the professional to provide proof of same if required. 
Originally, the initiative was restricted to nurses and midwives working within 
the health service however, in 2009 prescriptive authority was extended to 
nurse and midwives in the private sector (Health Service Executive, 2009). 
 
1.6 The Role of An Bord Altranais (ABA) 
 
ABA is the regulatory body for the nursing profession in Ireland and has 
played a key role in the regulation, education, clinical governance and 
professional guidance in the area of prescriptive authority for nurses and 
midwives. In 2007, ABA established a new division of the Register for nurse 
and midwife prescribers. It also provided approval of Higher Education 
Institutes (HEI) and HSPs to collaboratively deliver education programmes to 
prepare nurse prescribers for their expanded role (An Bord Altranais, 2007b). 
The development of the Decision-Making Framework for Nurse and Midwife 
Prescriptive Authority (An Bord Altranais, 2007c) provided guidance for HSPs 
with regard to the context and appropriateness of prescribing for their service 
needs. The decision-making processes within the framework included 
references to the readiness of local policies supporting nurse/midwife 
prescribing, and the development of a collaborative practice agreement 
(CPA). A decision on whether the prescribing was within the nurses/midwives’ 
scope of practice and an assessment on whether there is a need to prescribe 
was also outlined. The decision-making framework provided a basis for 
determining the extent to which the nurse/midwife has sufficient information 
to determine the treatment plan for a patient, and the extent to which they 
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can make a decision on the need to initiate pharmacological treatment. 
Finally, the discussion and implementation of the treatment in consultation 
with the patient and their families was defined.   
Practice Standards for Nurses and Midwives with Prescriptive Authority 
(An Bord Altranais, 2007b), on the other hand, gave nine directives on 
professional guidance for prescriptive authority and medication management. 
However, in 2010, ABA revised the practice standards to include an extra two 
directives (An Bord Altranais, 2010a). The Practice Standards include: 
1. Clinical decision-making process - A systematic clinical decision-
making process should inform the decision to prescribe and is 
underpinned by the Decision-Making Framework for Nurse and 
Midwife Prescribing (An Bord Altranais, 2007c) 
2. Communication and history taking - The responsibility of 
prescriptive authority requires the NP to effectively and efficiently 
communicate with the patient/service-user and to complete an 
accurate and comprehensive medication history. 
3. Documentation - All episodes of nurse and midwife prescribing 
should normally be recorded in the patient’s/service-user’s case notes. 
The rationale for this is to ensure that there is clear communication 
regarding treatment with medical and other healthcare professionals. 
4. Prescription writing - Specific standards for prescription writing 
must be adhered to as required by legislation and the health service 
provider/employer (including Drugs and Therapeutics committee) 
policy. This also pertains to the safe keeping and accountability 
associated with prescription pads. 
5. Prescribing for self, family and significant others - Prescribing must 
take place in the context of providing nursing/midwifery care to an 
identified patient/service user requiring the services of the health 
service provider. The medicines regulations - Medicinal Products 
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(Prescription and Control of Supply) (Amendment) Regulations, 2007 
and Misuse of Drugs (Amendment) Regulations, 2007 - provide specific 
requirements for nurses to issue a prescription which must be 
adhered to in the provision of health care. A RNP prescribing for self, 
family and significant others is in violation of these Regulations. 
6. Repeat prescribing - There should be regular review and 
appropriate clinical assessment of the patient’s/service-user’s 
condition for continuing a specific medication in accordance with the 
overall treatment plan.  
7. Prescribing of unauthorised and off-label medications - The 
prescribing of unauthorised medications by the RNP is not provided 
for in the current medicines regulations. 
8. Prescribing by means of verbal/telephone, email or fax - The 
Medicines Regulations of 2007 for both prescription and MDA drugs 
do not authorise the RNP to prescribe medications employing means 
of communication other than in writing. ABA does not support the use 
of verbal, telephone, email or fax medication orders as routine 
medication management practice for communication of an individual 
patient/service-user prescription. 
9. Separation of responsibilities in the medication management cycle - 
Distinct separation of responsibilities and activities in the medication 
management cycle provides for greater patient/service-user safety 
and error prevention. 
10. Influence of outside interests (relationships with pharmaceutical 
representation or similar organisations) - The RNP should prescribe in 
an appropriate, ethical manner, based on the best interests of the 
patient/service user only. She or he should not be influenced by 




11. Continuing professional development and continued competency - 
The RNP accepts personal responsibility for professional development 
and the maintenance of professional competence. This is achieved by 
engaging in CPD, audit of practice, and peer review.  
 
(An Bord Altranais, 2010a) 
 
Finally, a guideline for the development of a CPA was provided for with 
the publication of the ‘CPA for Nurses and Midwives with Prescriptive 
Authority’ (An Bord Altranais, 2007d and, An Bord Altranais, 2007e). The CPA 
guides the clinical supervision of nurses and midwives in relation to 
prescriptive authority and outlines the parameters of the nurses and 
midwives prescribing functions and agreements of their role with the 
employer/organisation. The CPA must be signed by the registrant, 
collaborating medical practitioner and HSP, which provides ABA with 
evidence that clinical governance and communication structures are in place 
to support the nurse prescriber. The introduction of this document by ABA 
has restricted prescribing in Ireland from what was initially described as an 
open formulary to that of a limited formulary, one which is controlled by the 
Drugs and Therapeutics Committee within each clinical organisation. 
However, it is not as restrictive as the supplementary prescribing that was 
initially introduced in the UK in the late 1990s. The function of the CPA is to 
outline the specific medications that the nurse can prescribe and the health 
care setting in which prescribing is to take place within their scope of practice. 
A copy of the CPA is initially submitted to ABA within five days of the 
nurse/midwife commencing prescribing. The responsibility for this document 
has now been transferred to the nurse prescriber’s organisation and it 
becomes null and void if the prescriber changes clinical area or type of 
employment for a period of one year. The document may be revisited as 
necessary to include or remove medication depending on the service 
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requirements or changes in the clinical area in which the nurse prescriber is 




This Chapter gives an overview of nurse prescribing from an international 
perspective and how nurse prescribing was introduced to Ireland including 
the legislative changes required. The Chapter also discussed the education 
programme, together with the role of the HSE and ABA in the initiative. 
 




CHAPTER 2 OVERVIEW OF 
METHODOLOGIES USED IN 
THIS THESIS  
 
Chapter 2 gives an overview of the mixed methodologies utilised in this 
Thesis, including the research design which guided the researcher’s decision-



















 The term methodology refers to the methods of obtaining, organising 
or analysing data (Polit and Beck, 2012). The methods used in this Thesis were 
influenced by current thought on evaluation theory and the move to use both 
quantitative and qualitative approaches in evaluating initiatives. All 
researchers have different beliefs and ways of viewing and interacting with 
their surroundings resulting in a variety of ways that studies are undertaken. 
However, there are certain principles available to guide a researcher’s actions 
and beliefs. Such values or principles can be referred to as a paradigm and can 
be viewed as a lens that helps to sharpen our focus on a phenomenon of 
interest (Weaver and Olson, 2006). The studies were conducted across three 
countries Ireland, UK and Canada an overview of which can be viewed in 
Table 2.1. Stage 1, 3, and 4 were conducted in Ireland and explored different 
issues specifically relating to clinical practice.  Stage 2 was conducted in 
Ireland and the UK to gain an understanding of how Irish nurse prescribers 
compared with their counterparts in the UK. Stage 5 of the research was 
undertaken in Canada to understand how nurse prescribing evolved and if 
there were comparisons or differences to the Irish setting.  All three countries 
had similar educational, registration and assessment criteria for their nurse 
















Assessment criteria to 
become a nurse 
prescriber 
 





the Nursing and 
Midwifery Board of 
Ireland 
Written assignment 
Observed structured long 
examination record Observed 
Structured Long Examination 
(OSLER)  
Pharmacy Presentation and 
Multiple Choice Questions 
(MCQ) examination 
Clinical placement logbooks and 
practicum advancement records 
United Kingdom Prescribing courses 
are taught at 
undergraduate and 
postgraduate levels 




with the National 
Prescribing Centre 
(NPC), have defined 





A portfolio or learning log that 
demonstrates application of 
theory to practice 
Objective Structured Clinical 
Examination (OSCE) 
Satisfactory completion of the 
period of practice experience, 
including sign off by the 
designated medical practitioner 
A written final pharmacology 
examination, Students must 
achieve a minimum 80% pass 
Numerical assessment within 
the context of prescribing 
practice. Students must achieve 
a 100% pass 
Canada Masters level 
degree 
Registration is 
required with the 
national regulatory 
nursing bodies of 
the region within 







Critical appraisal paper 
Final examination 
 
To gain a better understanding of why and how the researcher chose a 
mixed method approach in this Thesis, an overview of the research is set out 
in detail, with the underpinning methods for each stage of the research 
discussed separately within individual chapter. However, individual methods 
can only make sense if they are anchored to their methodological and 
epistemological frameworks (Staller, 2013). In order to describe the variety of 
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research activities undertaken during this study, the data collection activities 
and associated analysis methods an overview can be viewed in Table 2.2  
 
TABLE 0-2 METHODOLOGY FLOW DIAGRAM 
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2.2 Research Paradigm 
 
 Guba and Lincoln (1994, p. 105) define paradigms as ‘the basic belief 
system or worldview’ which influence the researcher’s choice of 
epistemology, ontology, and methodology of the research. These choices 
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provides a way of looking at a natural phenomenon ‘that incorporates a set of 
philosophical assumptions that guides one’s approach to enquiry’ (Polit & 
Beck, 2012, p. 761). Additionally, the Weaver and Olson’s (2006, p. 460) 
definition of a paradigm reveals how research can be affected and directed by 
a specific paradigm by stating, ‘paradigms are patterns of beliefs and 
practices that regulate inquiry within a discipline by providing lenses, frames 
and processes through which investigation is accomplished’. Therefore, to 
clarify the researcher’s structure of inquiry and methodological choices, an 
exploration of the inclusive mixed methods approach adopted for this study 
was discussed in advance of any discussion about the specific methods 
utilised in the individual studies. 
Utilising a mixed method research approach permits the researchers to 
view problems from multiple perspectives to enhance and enrich the meaning 
of a singular perspective (Michel, 2008). Therefore, a mixed method was 
undertaken to encompass the different aspects of nurse prescribing relative 
to patient care and practice. This allowed the researcher the ability to 
statistically analyse the scientific data whilst also recognizing the complex 
psychosocial and emotional factors that influence nurse prescribing. In 
particular, this Thesis utilised a triangulation of surveys, semi-structured 
interviews and document analysis to better understand the research 
question. Triangulation also facilitated comparison of quantitative and 
qualitative data sets to produce well-validated conclusions that tested the 
consistency of findings obtained though different instruments used (Migiro 
and Magangi, 2011).  
There are a number of theoretical perspectives from which all research 
stem, including positivism, post positivism, interpretivism, critical enquiry, 
feminism, postmodernism and post-structuralism (Crotty, 1998). Adhering to 
only one paradigm or its associated theories limits the understanding of a 
phenomenon because contextual factors and influences may not be explored 
as widely (Leddy, 2000). The proposed mixed methods approach to this Thesis 
was underpinned by the pragmatic paradigm which recognised the diverse, 
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yet equally valid opinions of research participants. This perspective evaluates 
an idea not by the criterion ‘is it true?’ but rather by the question ‘what 
difference does it make?’ (Warms and Schroeder, 2012). This is an important 
concept because the issues experienced by nurse prescribers are so diverse 
that multiple approaches to problem-solving are necessary (Monti and 
Tingen, 1999). Furthermore the pragmatic paradigm is also informed by the 
‘Complexity Theory’ that attempts to explain complex phenomenon not 
explainable by traditional theories and provides a theoretical base for the 
nurse prescriber who functions in a dynamic healthcare system intertwined 
within other complex systems. Science flows into art as the nurse prescriber 
draws on a broad knowledge base, interpersonal abilities, communication, 
competencies, hands-on skills, and the numerous other components that are 
imbedded in the practice of nursing (Hidalgo-Kehoe, 2012). With complexity 
theory, nurse prescribing is recognized as a process, a state of becoming that 
is never repeated (Gleick, 1987). The researchers are not occupied with an 
objective pursuit of truth, but rather working towards finding suitable 
strategies for dealing with complex phenomena. 
Designing a mixed methods study involves a similar structure to those 
taken in traditional research methods but requires three additional steps. 
These include, 1) deciding whether to use an explicit theoretical lens, 2) 
identifying the data collection procedures together with the data analysis and 
3) integration procedures (Tashakkori and Teddlie, 1998, Morgan, 1998, 
Creswell, 1999, Greene and Caracelli, 1993). Those steps occur more or less 
sequentially in mixed method research, with one informing and influencing 
the other (Migiro and Magangi, 2011). Therefore, to clarify the researcher’s 
structure of inquiry the methodological choices will be further discussed 





2.3 Research Design 
 
In this Thesis, both quantitative and qualitative research methods were 
used where quantitative methods included the collection, analysis and 
interpretation of data in numerical forms and qualitative methods consisted 
of the collection, analysis and interpretation of narrative forms of data (Polit 
and Beck, 2010). These terms perhaps oversimplify what are rich and complex 
traditions, ideas, approaches, and techniques of research. However, the 
terms are utilised globally to indicate that the research emanates from a 
single perspective or set of related techniques (Dellinger and Leech, 2007).  
 Pragmatism has gained considerable support as a carriage for mixed 
methods research (Morgan, 2007, Feilzer, 2010) because of its orientation 
toward ‘solving practical problems in the ‘real world’ (Feilzer, 2010, p. 8) 
rather than on assumption about the nature of knowledge.  It is derived from 
the writings of Pierce, Dewey and James in the 19th and 20th centuries 
together with Rorty and Davidson in the late 20th century.  Pragmatism as a 
philosophy includes the use of induction, deduction and abduction: induction 
(or discovery of patterns or gaining an understanding of the meanings 
humans attach to events, a closer understanding of the research context, and 
collection of qualitative data), deduction (moving from theory to data, the 
collection of quantitative data, testing of theories and hypotheses, 
explanation of causal relationships between variables, application of controls 
to ensure validity of data and the selection of sufficient sample sizes in order 
to generalise conclusions), and abduction (uncovering and relying on the best 
of a set of explanations for understanding one’s result) (de Waal, 2004).  
Varied opinions are held regarding the most appropriate paradigm to 
underpin mixed methods research; to deal with this problem, a range of 
alternative approaches have been developed (Teddlie and Tashakkori, 2003, 
Creswell and Plano Clark, 2007). These approaches can be classified into three 
basic categories: a‐paradigmatic stance, multiple paradigm approach and the 
single paradigm approach. The first of these simply ignores paradigmatic 
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issues altogether; the second asserts that alternative paradigms are not 
incompatible and can be used in the one research project and the third claims 
that both quantitative and qualitative research can be accommodated under 
a single paradigm (Hall, 2011). The latter claim and approach followed in this 
research is also supported by Teddlie and Tashakkori (2009) and Migiro and 
Magangi (2011). However, one must be cognisant that the study research 
questions are considered central to the research and it is important that the 
appropriate methods are used to answer them, including the philosophical 
views underlying each method (Maxcy, 2003). The researcher is encouraged 
to expand their thinking to acknowledge the even broader patterns that 
affect people and communities such as the environment, the economy, and 
the political system. Nevertheless, Morgan (2007) observed that ‘the 
pragmatic approach reminds us that our values and our politics are always a 
part of who we are and how we act’ (p. 69-70) rejecting any crude notion of 
pragmatism that simply claims the ends justify the means.  
The convergent design was utilised in this Thesis and involved collecting, 
analysing, and merging quantitative and qualitative data and results at one 
time; this can raise issues regarding the philosophical assumptions behind the 
research. Instead of trying to ‘mix’ different paradigms, ‘it is recommended 
that researchers who use this design work from a paradigm such as 
pragmatism to provide an ‘umbrella’ paradigm for the research study’ 
(Creswell and Plano Clark, 2007p. 78). The assumptions of pragmatism are 
well suited for guiding the work of merging qualitative and quantitative 
approaches into a larger understanding drawing on ‘what works,’ thereby, 
giving primacy to the importance of the research problem and question, and 
valuing both objective and subjective knowledge (Morgan, 2007). As a 
philosophical movement, pragmatism maintains that the claims about the 
truth of one view or another must be connected to the practical 




2.3.1 Convergent design procedure 
 
There are four major steps in the convergent design; these steps can be 
viewed in Figure 2.1. Firstly, the researcher collects both quantitative data 
and qualitative data about the topic of interest. These two types of data 
collection are concurrent but separate—that is, one does not depend on the 
results of the other. They also typically have equal importance for addressing 
the study’s research questions. Secondly, the researcher analyses the two 
data sets independently of each other using typical quantitative and 
qualitative analytic procedures. Once the two sets of initial results are in 
hand, the researcher reaches the point of interface and works to merge the 
results of the two data sets in the third step. This merging step may include 
directly comparing the separate results or transforming results to facilitate 
relating the two data types during additional analysis. In the final step, the 
researcher interprets to what extent and in what ways the two sets of results 
converge, diverge from each other, relate to each other, and/or combine to 
create a better understanding in response to the study’s overall purpose. The 
findings are integrated during the interpretation/discussion phase of the 






























FIGURE 0.1 DIAGRAM OF THE RESEARCH PROCESS 
(Hall and Howard, 2008)
Design the quantitative strand 
 
State quantitative research questions 
and determine the quantitative approach 
Collect the Quantitative Data 
 Obtain permissions 
 Identify the quantitative sample 
 Collect closed-ended data with 
instruments 
Design the qualitative strand 
 
State qualitative research questions 
and determine the quantitative approach 
Collect the Qualitative Data 
 Obtain permissions 
 Identify the qualitative sample 
 Collect open-ended data with 
protocols  
 Collect closed-ended data with  
instruments 
Analyse the Quantitative Data: 
Analyse the quantitative data using 
descriptive statistics, inferential statistics, 
and effect sizes. 
Analyse the Qualitative Data: 
Analyse the qualitative data using 
procedures of theme development and 
those specific to the qualitative approach. 
Use Strategies to Merge the Two Sets of Results: 
Identify content areas represented in data sets and compare, 
contrast, and/or synthesize the results in a discussion. Identify 
differences within one set of results based on dimensions within the 
other set and examine the differences within a display organized by 
the dimensions.  
Interpret the Merged Results: 
Summarize and interpret the separate results  
Discuss to what extent and in what ways 
results from the two types of data converge, 
diverge, relate to each other, and/or produce 




The purpose of the convergent design is ‘to obtain different but 
complementary data on the same topic’ (Morse, 1991 p. 122), to gain a more 
complete understanding of the research topic or phenomenon and to cross-
validate or corroborate findings (Curry et al., 2009). The intent in using this 
design is to bring together the differing strengths and non-overlapping 
weaknesses of quantitative methods (large sample size, trends, 
generalization) with those of qualitative methods (small sample, details, in 
depth) (Patton, 1990) to synthesis and strengthen complementary 
quantitative and qualitative results. Qualitative and quantitative data 
collection techniques include; questionnaire, semi-structured interviews, 
chart/medication reviews, application of an evaluation tool, researcher’s field 
notes of personal observations and conversations. As the understanding of 




Triangulation was utilised in this research, the aim being to enhance the 
process of empirical research by using a combination of multiple methods in a 
study of the same object or event to depict more accurately the phenomenon 
being investigated (Watson et al., 2008). In addition, Polit and Beck (2012) 
present a more embracing description of triangulation as the use of multiple 
sources of data to draw conclusions about what constitutes the truth, so to 
converge on an accurate representation of reality.   
 There are four common types of triangulation discussed within the 
literature including: 1) data triangulation that involves time, space, and 
persons; 2) investigator triangulation which uses more than one researcher to 
collect and analyse data; 3) theory triangulation that uses more than one 
theoretical perspective to interpret the study phenomenon; and 4) 
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methodological triangulation that involves the combination of approaches 
from the same research tradition/paradigm in the same study to measure the 
same variable(s) (Watson et al., 2008). In terms of validity and interpretation, 
Silverman (2004) suggests that drawing data from different contexts allows a 
true state of affairs to emerge increasing the studies validity and in addition, 
the depth and quality of the results, has the capacity to provide valuable 
understanding for the NPs’ practice. Therefore, a survey study, interviews and 
chart reviews were utilised to reveal the phenomenon of nurse prescribing in 
practice.  
 
2.3.2.1 Methodological triangulation  
 
Methodological triangulation, according to Perlesz and Lindsay (2001) 
involves the use of more than one research method in one study, which 
occurs at the level of design or data collection technique and is an approach 
commonly utilised in nursing studies. One of the main strengths of 
methodological triangulation is to serve as a means of overcoming the 
methodological divide between quantitative and qualitative paradigms. In this 
study, data from the implementation of a prescribing evaluation tool 
involving chart reviews was complemented with data from interviews to 
explore the many dimensions of the complex concepts contained therein.  
Revealing the phenomena and facilitating an understanding at its different 
levels will make a more valid contribution to the theory and knowledge of 
nurse prescribing.  
 
2.3.2.2 Data triangulation 
 
Data triangulation according to Watson et al. (2008) involves the 
collection of data from multiple sources for analysis in the same study with 
each source focused upon the phenomenon of interest. For example in this 
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study data were collected from multiple sources; questionnaire, interviews, 
field notes, chart reviews, and application of a prescribing evaluation tool. 
These multiple data sources help validate the findings by viewing the 
phenomena under investigation from different perspectives that are divided 
into categories of time, space and person.   
Time triangulation represents the collection of data on the same 
phenomena at different points in time e.g. hours, days or weeks with the 
purpose of validating the occurrence of the phenomena across time. In this 
study the goal was not to compare participants’ knowledge or experiences at 
different points in time. Therefore, for this study, only two types of data 
triangulation were utilised: space and person.    
Space triangulation is the collection of data on the same phenomenon at 
different sites (two or more settings) to test multiple site consistency and rule 
out site variations.  
Person triangulation implies that data were collected from more than 
one level of person, or collectives. Given the broad range of individual 
backgrounds, experience and the importance of varied data sources by 
persons, the socialisation process and experiences and interactions of these 
individuals have been highlighted in the literature (Knafl and Breitmayer, 
1991). The use of various levels of nurse prescribers provided greater insight 
into a variety of issues including: competence, support, professional 
development requirements, workload issues, financial concerns, level of 
appropriate and inappropriate prescribing, and inputting data to the national 
monitoring system. These data were utilised to support, supplement, and 
validate the information gained from published material on the topic as well 
as the research data. 
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2.3.3.3 Unit of analysis triangulation 
 
Kimcbi et al. (1991) cited in Begley (1996 p. 125) describe unit of analysis 
triangulation as 'the use of two or more approaches to the analysis of the 
same set of data for the purpose of validation'. This study incorporated more 
than one level of analysis by ensuring different grades of nurse prescribers in 
different clinical sites participated in the study, thereby, facilitating the 
diverse levels within the unit of NPs.  
 
2.4 Method  
 
2.4.1 Quantitative method 
 
Two overarching quantitative research methods were used in this study; 
a) that of survey research that utilised a questionnaire and b) outcome 
research that was supported by the application of a prescribing evaluation 
tool.  
 
2.4.2 Survey Objective   
 
The objective of the survey was to discover if there were differences or 
similarities in the prescribing process undertaken by Irish and UK nurse 
prescribers.  
 
2.4.2.1 Survey Research 
 
A questionnaire survey was used to obtain information about the 
prevalence, distribution and interrelations of variables within the nurse 
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prescribing population.  The surveys obtained information from NPs by means 
of a self-reporting questionnaire. In this study the questionnaire was divided 
into three distinct sections: a) demographics, b) information relating to 
prescribing and competence and c) advancement of nurse prescribing and 
requirements. 
 
2.4.2.2 Outcome research  
 
Outcomes research has been defined as ‘the study of the end results of 
health services that takes patients’ experiences, preferences, and values into 
account—is intended to provide scientific evidence relating to decisions made 
by all who participate in health care.’ (Clancy and Eisenberg, 1998, p.245). 
Therefore, outcomes research focuses on the end results of patient care. In 
order to explain the end result, the researcher must also understand the 
processes used to provide patient care. In this Thesis descriptive statistics 
were utilised.  
 
2.4.3 Qualitative method  
 
Qualitative descriptive research using Colaizzi’s framework for guidance 
was the qualitative research method of choice because it facilitated the best 
understanding of NPs’ experiences in practice and how they interpret those 
experiences (Todres and Holloway, 2006). The objective of this method was 
the direct investigation and description of the phenomenon as consciously 
experienced in a natural rather than experimental setting while emphasising 
the experiences, attitudes and views of the participants rather than providing 
quantified answers to a question (Nieswiadomy, 2008). This gave an 
additional perspective to the research from evidence that emerged through 




2.5 Integration of qualitative and quantitative methods 
 
Capitalising on the strengths of mixed methods, the data from the 
qualitative and quantitative methods were analysed to determine whether 
the results were convergent, complimentary or contradictory (Erzberger and 
Kelle, 2003). The aim in the analysis of a study using a triangulation model is 
to determine the extent to which the findings from the different methods 
used in the study either support or contradict each other. When the findings 
from the method used in the study lead to the same conclusion, the findings 
are said to be convergent: this is the classic definition of triangulation. 
Findings that do not necessarily lead to the same conclusion but rather 
augment and supplement the understanding advanced in the study are 
complementary. It is based on an assumption that different methods uncover 
different aspects of the phenomenon under investigation. Contradictory 
results stand in opposition but divergent findings are not necessarily 
indicative of a problem with the method used. Rather, contradictory results 
may provide new insight into the focus of the enquiry.  
 
2.6 Ethics Approval 
 
Ethics refers to the correct rules of conduct necessary when carrying out 
research and as researchers we have a moral responsibility to protect 
research participants from harm. Moral issues rarely yield a simple explicit 
right or wrong answer. It is therefore often a matter of judgement whether 
research is justified or not and researchers need to remember that they have 
a duty to respect the rights and dignity of research participants. This means 
that they must abide by certain moral principles and rules of conduct. 
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There are a number of key phrases that describe the system of ethical 
protections that the contemporary social and medical research establishment 
have created to try to better protect the rights of their research participants 
(Trochim, 2006). These include voluntary participation, informed consent, risk 
of harm and privacy and confidentiality. Even when clear ethical standards 
and principles exist, no set of standards can possibly anticipate every ethical 
circumstance. Therefore, there needs to be a procedure that assures 
researchers will consider all relevant ethical issues in formulating research 
plans.  
Considering that the research project was clinical in nature, it was 
referred to the Clinical Research Ethics Committee for Cork Teaching 
Hospitals (CREC) to secure Ethics approval. Evidence of Ethics approval for 
each section of the study appears under the relevant chapter.  
 
2.6.1 Voluntary participation and consent 
 
One of the fundamental ethical requirements of research with humans is 
that informed consent must be obtained in advance of the research 
commencing. In practice this means it is not sufficient to simply get potential 
participants to say ‘yes’. They also need to know to what it is that they are 
agreeing. In other words the researcher should, so far as is practicable explain 
in advance, what is involved and obtain the informed consent of participants.  
However, giving information is only half the process. Participants need to be 
capable of understanding this information and have the power of free choice 
thereby enabling them to voluntarily consent or decline participation.  
To provide potential participants with accurate information for this study, 
it was necessary to develop several information sheets, each relevant to a 
particular section of the study and distributed at the appropriate time to the 
potential participants. Each participant information sheet drew attention to 
the voluntary nature of the research and that they had the right to withdraw 
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at any stage without prejudice. They were also informed that such decisions 
were kept confidential and not reported to organisation.  
The consent form used was approved by CREC and consistent with the 
guidelines set out by the Committee that ensure all relevant elements are 
included in the form. Prior to commencement of any research activities, the 
researcher secured a signed consent form from each participant or verbal 
consent for telephone interviews. In addition, each participant was given a 
duplicate copy of their signed consent form for their records.  
 
2.6.2 Privacy and confidentiality 
 
Researchers have a responsibility to safeguard the privacy and the 
personal information of participants. Sometimes research involves the use of 
highly sensitive personal data. Misuse or inadequate protection of such data 
violates participants’ rights and may have legal consequences for the 
researcher. 
Therefore, in Ireland the requirements of the Data Protection Acts, 1988 
and 2003 and Freedom of Information Act, 1998 and 2014 must be fulfilled. In 
particular, identifiable data must be rendered irreversibly anonymous 
wherever practical. Where such actions are not possible, stringent measures 
in relation to data protection must be taken, such as security of records, 
encryption, coding, use of pseudonyms and removal of identifying contextual 
information. 
 
2.6.3 Risk of harm 
 
The risks to which research subjects may be exposed to have been 
classified as ‘physical, psychological, social, and economic’ (Levine, 1988 p. 
42). The general guideline according to Polit & Beck (2012 p. 146) is that the 
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‘degree of risk to be taken by those participating in the research should never 
exceed the potential humanitarian benefits of knowledge to be gained’. All 
research involves some risk but in many cases, the risk is minimal and should 
not be greater than those ordinarily encounters in daily life. In this study the 
main types of data collected that included personal details about the research 
participants; were interview, nursing documentation, and participant 
responses to a questionnaires. Although demographic data were collected 
from all participants, none of the participants could be identified from this 
information. Therefore, data collected in this study were deemed as having a 
minimal risk to the participant.  
 
2.6.4 Security of data 
   
Creating a secure environment for all data relating to the study was 
important to ensure the integrity of research data since it addressed concerns 
relating to confidentially, security, and preservation/retention of research 
data. For security purposes, the only persons who had access to the research 
data were the researcher and research supervisors. All data generated were 
stored in locked files, identification numbers and codes were allocated, 
names replaced with pseudonyms in accordance with university policy 
following completion of data analysis and the associated Thesis chapter. 
Copies of the audio tapes or corresponding transcripts were not made. 
Digital research data were store on a computer that was not connected 
to any network and was encrypted should any unauthorized person try to 
access it. Ensuring that up-to-date anti-virus software was installed on the 
office and home computer was also part of the process. On completion of the 
study, the data were transferred from the computer and stored securely and 
archived in accordance with University College Cork Regulations. Paper copies 
will be shredded and hard drives/databases will be wiped clean following the 





This Chapter gives an overall description of the course the methodology 
followed. A summary of which is detailed in table 2.1. This is followed by a 
detailed description of the research design which highlights elements of the 
researcher’s decisions on sampling, data collection and analysis. Finally, 
ethical issues were addressed.  Further discussion on research methods used 








CHAPTER 3 SYSTEMATIC 
SEARCH AND NARRATIVE 
REVIEW OF THE LITERATURE 
 
Chapter 3 consists of a systematic search and narrative review of the 
literature on nurse prescribing both nationally and internationally. The review 
investigates the impact nurse prescribing has on the organisation, patient and 
healthcare professional, with the aim of identifying factors associated with 











                                                             
5
The impact of nurse prescribing on the clinical setting: A literature review. Creedon, R., 
Byrne, S., Kennedy, J. & McCarthy, S. (2015) British Journal of Nursing. 24(17) 878-885. 
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3.1 Introduction  
 
Prescribing medications has traditionally been the domain of doctors, but 
nurse prescribing has been introduced in response to changing service needs 
and the increasing specialisation of nurses and midwives as they expand and 
advance their scope of practice. This has resulted in two schools of thought 
about the potential impact of nurse prescribing; the first is as a backward step, 
prioritizing ‘cure’ over ‘care’ (Cutcliffe and Campbell, 2002) and the second as 
formalizing the ‘informal’ prescribing that nurses already undertake (Nolan et 
al., 2001). The international experience of nurse prescribing has demonstrated 
the associated benefits in terms of increased patient satisfaction and 
concordance with medication regimes (Berry et al., 2008), cost effectiveness 
(Drennan et al., 2009) and increased nurse competence (Courtenay et al., 
2007c). Additionally, patients interviewed about the most positive aspects of 
nurse prescribing identified the approachability of the NP, the relationship 
between the nurse and the patient in providing reassurance, continuity of care, 
information and health promotion details (Russell, 2003, Courtenay et al., 
2010b). The role of the NP continues to grow in the healthcare setting 
internationally, increasing in both prominence and significance (Cipher et al., 
2006). However, international differences between legislative procedures and 
the professional bodies responsible for the regulation of nurse prescribing have 
resulted in the implementation of several models of prescribing worldwide (An 
Bord Altranais and NMPDU, 2005, Kroezen et al., 2012). Nonetheless, NPs both 
nationally and internationally continue to publicise that extending prescribing 
rights has allowed nurses to make better use of their skills (Wilhelmsson and 
Foldevi, 2003, Drennan et al., 2009), gain recognition as a profession (While & 
Biggs, 2004, Latter et al., 2012), increase professional development and 
enhance self-esteem (Courtney and Butler, 1999, Cashin et al., 2009). 
The continued expansion of nurse prescribing according to Naughton et al. 
(2012) and Scrafton et al. (2012), is motivated by an intricate mix of internal and 
external forces, together with changes in societal values and technology. Recent 
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studies have indicated that the introduction of nurse prescribing has blurred 
professional boundaries with jurisdictional control between the medical and 
nursing profession now changing (Bowskill et al., 2012, Ben Natan et al., 2013, 
Kroezen et al., 2013, Kroezen et al., 2014). The consequences of these changes 
has had an impact on the patient (Courtenay et al., 2011), organisation (Banicek, 
2012), and healthcare professional (Latter et al., 2012). However, additional 
concerns have been identified regarding therapeutic relationships, role conflict, 
and lack of support, causing concern for the progress of nurse prescribing (Ross 
and Kettles, 2012).  Building on a literature review conducted in 2009 and 
published in two parts by the author and colleagues (Creedon et al., 2009c, O' 
Connell et al., 2009), it is now timely to systematically identify and evaluate 
available evidence with regard to the impact of nurse prescribing from an 




The aim of this Chapter was to identify and analyse the results of studies on 
nurse prescribing to examine the impact it has had in the clinical setting from the 
patient, healthcare professional and organisational perspective and identify 




A systematic search and narrative review was undertaken to address the 
impact of nurse prescribing in the clinical setting from the perspective of the 
patient, health care professional and organisation.  For such a broad question, 
this review combined the search strategies and inclusion/exclusion criteria 
associated with systematic reviews as well as the analytical synthesis of a critical 
review (Twycross et al., 2015) to provide ‘best evidence synthesis’ available 
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(Grant and Booth, 2009). Multiple study designs were incorporated in the review 
rather than focusing on a single study design with the intention of providing a 
more complete picture of the research on the topic. Its primary purpose was to 
offer the reader a comprehensive background for understanding current 
knowledge and highlighting the significance of new research. To provide insight 
into the strengths and weaknesses of the studies included, Caldwell’s et al. 
(2011) framework was applied although it was not necessary to subject the 
articles included to a methodological critique when using a systematic search 
and review (Grant and Booth, 2009).  
 
3.3.1 Methodological design 
 
The framework consisted of an overall approach to study critique using 
specific items based on the methodology and provided a list of criteria for 
qualitative, quantitative, and mixed methods research to assist the reader in 
assessing the reliability of the study to its stated design and determine the 
dependability of the results (Twycross et al., 2015). The items included such 
elements as: is there an hypothesis?; are key variables defined?; is the selection 
of participants described and sample method defined?; and are major concepts 
defined? Although, initially the framework did not produce a single numerical 
score to represent quality, for the purpose of this review the Caldwell 
framework that consists of 18 questions was awarded a numerical value 
(Bettany-Saltikov, 2012). Specifically, the application of each question has three 
possible answers, an answer to which scores were applied. An answer of no = 0, 
partly =1, and yes =2, were assigned, with the maximum value any study could 
achieve being 36. The structure of the framework and application of numerical 





3.3.2 Search method  
 
To identify relevant research studies, the following literature databases and 
websites were searched: CINAHL, PubMed, Online Computer Library Centre 
(OCLC) and Science Direct. Websites included were the Irish Department of 
Health and Children (www.dohc.ie), the UK Department of Health 
(http://tinyurl.com/c8cqtdj) and Google Scholar (www.scholar.google.com). The 
search terms (prescribing OR “prescriptive authority”) AND (nurse OR nursing OR 
non-medical) were repeated across databases. Articles selected were dated from 
January 2009 to September 2014 with no restriction on the type of patient group 
for whom medications were prescribed. Further studies were included if they 
had a comparative design, e.g. comparing nurse prescribing with physician 
prescribing or comparing nurse prescribing overall. The results from the different 
databases revealed 443 studies of potential interest after duplicates had been 
removed. 
 
3.3.3 Inclusion criteria 
 
Original research designs applying qualitative, quantitative and mixed 
method that had nurses, healthcare professionals and service users as 
participants and published in English between September 2009 and August 2014 
were eligible for inclusion in the systematic review. 
 
3.3.4 Exclusion criteria 
 
Studies that did not meet the inclusion criteria above were commentaries, 
editorials, and letters and review papers. In addition, studies focusing only on 
educational institutions, evaluations of theoretical frameworks, practice models, 






The titles and abstracts were reviewed and assessed against the inclusion 
and exclusion criteria; 414 studies were eliminated. The full-text papers for the 
29 studies were obtained. The reference lists of these papers were then 
searched together with grey material. This process revealed an additional eight 
papers that met the inclusion criteria, resulting in a total of 37 papers eligible for 
inclusion in the review: A flow diagram (Moher et al., 2009) was used to 
illustrate the different phases and identification of relevant studies between 
September 2009 and August 2014 for inclusion in the review: Figure 3.1 shows 
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FIGURE 0.1 DIAGRAM OF STUDIES IDENTIFIED 
Titles identified after 
elimination of duplicates 443 
Papers reviewed by 
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information required to 
make assessment n= 23 
144 papers excluded did not 




Studies identified from 
search in reference list and 
websites. n= 8 
 
247 papers excluded- not 
related to topic 
 





3.4.1 Data extraction and synthesis 
 
 Data extracted from each study took the following format: study, country, 
study design, aim, sample (participants and setting), data collection method, 
main results (Table 3.1). Findings were organised into the following categories: 
implementation of nurse prescribing (prescribing arrangement, work force 
planning, treatment protocols, and infrastructure) CPD, jurisdiction, and 
remuneration. Information was tabulated allowing identification of prominent 
themes and offering structured ways of dealing with the data in each item. 
 
3.4.2 Quality of studies 
 
 Systematic search and reviews are undertaken to summarise the activity in 
the field, identify gaps, determine the need for a systematic review and to 
summarise the findings for dissemination (Davis et al., 2009). The qualities of 
the final 37 studies were further assessed using a framework designed by 
Caldwell et al. (2011). On completion of this process, all studies scored between 
20-35 scores are identified in Table 3.1. Studies were not excluded based on the 
assessment quality as preconceptions are inherent in the wide range of 




TABLE 0-1 SUMMARY OF STUDIES INCLUDED IN THE REVIEW 
 







Main findings Quality according to 
Caldwell’s Framework 
Banicek (2012) UK 
Survey design 
To examine the attitudes of 
postoperative patients toward 




patients in the 
hospital setting 
 
Questionnaire The majority of patient had confidence in NPs however, some reported 
concerns regarding the qualification and training of NPs. 
Factors that may impact on this relationship are increased workloads 
and responsibilities, fear of litigation, inter-professional conflict moving 









To explore the application and 
safe non-medical prescribing 
in an accident and emergency 
and sexual health department 
n=409 






comparison of 409 
case notes was 
undertaken. 
Over 53.5% of NPs’ patients required medication, with 99.8% being 
clinically appropriate. Analgesics were the commonly prescribed class of 
medication in the emergency setting (31%) and antibiotics in sexual 
health setting (55%). 
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Bowskill et al. 
(2012) UK 
Case study 
To investigate how nurse NPs 
integrate prescribing in clinical 
practice 
n=26 NPs were 
chosen from a 
convenience 








conducted by the 
principle 
investigator 
The most significant finding to emerge from these case studies of nurse 




Carey et al. (2009) 
UK 
Case study 
To explores stakeholders views 
on the impact of nurse 
prescribing on dermatology 
services 
n=10. Findings from 
a larger study 
informed the 
purposively 














conducted with NPs 
(n=11) and 
members of the 
health care team 





Findings identified two themes relating to the contribution of NPs to the 
delivery of dermatological services. 
1 Participants identified several areas where NPs had enhanced the 
provision of dermatological services. However, 2 participants identified 






and a dermatology 
nurse consultant 
(n=1). 




To examine the CPD needs of 
nurses who prescribe 
medicines to patients with 
diabetes. 
n=439 NPs in 
Diabetic care 
Questionnaire Over 80% reported CPD was available and they had accessed it to 
support their prescribing role. Over 40% of nurses had CPD needs in the 
area of prescribing policy, pharmacology for diabetes and the 
management and treatment of diabetes related conditions. Senior 
nurses reported fewer CPD needs. 
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To explore the practices of 
nurses who prescribe 
medication for patients with 
skin conditions. 
n=186  NP in the 
area of 
dermatology 
Questionnaire The diverse range of medicines management activities in which NPs are 
involved needs to be recognised by those responsible in service 
planning. 
A lack of specialist training is associated with lower rates of prescribing 
and reduction in the numbers of ways in which nurses use the 
prescribing qualification. 
Specific issues identified were lack of appropriate CPD, access, 
availability and time to undertake CPD. 
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Carey et al. (2014) 
UK 
Interviews 
To explore how nurse 
prescribing is used for patients 
with respiratory conditions in 
different care settings across 
one strategic health authority, 
n=40. A purposive 
sample of 138 
respondents were 












The main findings related to 1Access (Frail and housebound patients, 
gaps in routine care, access to treatment in hospital) 2Adherence and 
risk management (managing comorbidity, prescribing and patient 
consultation, managing emergency or preventive medicine) and 3Impact 
on nurses (job satisfaction, knowledge and confidence, anxieties and 
concerns for patients with respiratory conditions) 
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Cashin et al. (2009) 
Australia 
Survey 
To report the perceptions of 
Australian NPs and NP 
candidates in regard to their 
confidence and practice in 
providing medicine 





n=64 NP candidates 
Electronic survey High levels of confidence were reported in relation to providing client 
education regarding medications. 25 
Cooper et al. 
(2013) UK 
Interviews 
To comprehensively address 
both the question of whether 
non-medical prescribing 
presents a challenge to 
medical dominance, and more 
general experiences and 
perceptions of this form of 
n=40 (n=11 
doctors/nurses/pha
rmacists and n=28 
patients) 
10 case study sites 




Five key themes emerged in relation to medical authority. 
1Doctors role in legitimating supplementary prescribing 
2Patients and supplementary prescribers; perceptions of doctors as 
hierarchically superior 
3Advice seeking and ‘knock on door’ policies 
4Doctors’ perceived control over access to prescribing training 






in primary and 
secondary care 
 
In focusing on the dependent supplementary prescribing model in this 
study the findings of continued medical authority is perhaps not so 
unexpected, given that supplementary prescribing involves the doctor in 
the initial diagnosis, the agreement of clinical management plans and 
continued overall care of patients. 
The claim that doctors appear to be making is that prescribing is an act 
they are happy to relinquish due to its increasingly rationalised nature 
which appears to be consistent with vertical substitution of healthcare 
professional work, where there is an ‘active discarding of unwanted 
tasks to another provider’ 
The independent non-medical prescribing model involves potentially 
less close medical involvement and a diagnostic role for nurses. 
 




To evaluate the extension of 






delivered to 3700 
registered NPs. The 
response rate was 
26% NP (n=948) 
/public (n=1016 in 










conducted face to 




The benefits of extending nurse prescribing include: improved patient 
access to treatment; enhanced patient care; enabled more effective use 
of medical staff time and greater professional satisfaction for nurses 








To provide an overview of the 
therapy area in which nurses 




NP members of the 
ANP 
Questionnaire 44% reported they had CPD needs in relation to knowledge of 
conditions. 75.2% required CPD for pharmacology of medicines and 
52.8% in the area of assessment and diagnosis. 
59.9% indicated their preference for e-learning, 19.9% for evening 





Courtney et al. 
(2010) UK 
Case study 
To explore the views of 
patients with diabetes about 
nurse prescribing and the 
perceived advantages and 
disadvantages 
n=41 Diabetic 






Findings identified the following themes: 
1Benefits of efficiency and access 
2Confidence in nurse prescribing 
3Disadvantages and conditions 




Courtney et al. 
(2011) UK 
Case study 
To explore the views of 
dermatology patients about 
nurse prescribing and its 
impact on medicine 
management and concordance 
n=42 patients. 
Participants were 






Findings refer to 1Access to services and efficiency (patients reported 
that the NP improved access to services by increasing the number of 
available appointments, offering telephone access, providing local 
services, and improving efficiency) 
2Information giving and continuity of care (greater alignment between 








adherence) 3 Improvement in confidence and concordance 
4Differences between doctors and nurses (Nurses are reported to be 
more approachable than doctors, to have better listening skills and to 
adopt a more supportive role) 
5Patient concerns (it was important for patients to have continuity of 
care). 
 





To aggregate and interpret 
existing literature and 
systematic studies to obtain an 
insight on nurse prescription. 
 
n= 11 studies 
included in the 
review 
Primary care 
Review Specific findings include:  1Leading countries in prescribing (Quality and 
safety of practice). 2Views of stakeholders (Mainly stakeholders views of 
NP are positive there were negative views of physicians reported which 
may be due to lack of knowledge). 3Feature of nurse prescribing (longer 
consultations that can lead to patient centred care linking back to 
holistic care). Benefits (improved care delivery, increased patient 
satisfaction, better use of personnel, and reduction in costs). 
Disadvantages (could be corrected by managerial planning). 
Infrastructure (some of the issues are linked specifically to political and 
economic environment however, educational preparation, competency 








To explore patients attitudes 
to and experiences of nurse 
prescribing in inner-city 









Participants viewed NP as a positive experience which was convenient 
and quicker to arrange a consultation. Participants also felt that nurse 
prescribers had knowledge and skills to diagnose and prescribe safely 
and efficiently. Overall participants identified patient-centred care, 
information/explanation provision, and benefits of NP, quality 








To evaluate the utilisation of 
formularies and barriers to the 
full implementation of 
independent prescribing and 












primary care over 
six clinical sites. 
 
Interviews: 
10 interviews were 
carried out before 
reaching data 
saturation 
Findings identifies 1Clear boundaries and information provided by the 
formularies 
2Formularies were considered helpful with the transition from 
supplementary prescriber to independent prescriber 
3Reservation were voiced about matching the formularies accurately 
with the clinical area and needs of the prescriber. Comments suggested 








The sums of the evaluation 
were to 1Measure patients’ 
satisfaction with education 
and advice received from 
nurse or midwifes with a 
prescribing remit. 
2Measure patients’ satisfaction 






Questionnaire In the study the whole consultation process between the nurse or 
midwife and patient was explored. 
The only element of education and advice received from the prescriber 
that fell below ninety per cent agreement related to information about 
their medication. 
The highest level of satisfaction was associated with the level of 
professional care received followed by the overall satisfaction with the 





3Measure patients’ self-reports 
of their intention to comply 
with the nurse or midwife 
prescribers’ prescriptions and 
advice. 
4Identify the variables that 
predict patients’ intention to 
comply with the prescriptions 
and advice provided by nurses 
or  midwifes with prescriptive 
authority 
 
Overall levels of satisfaction with the consultation process was high with 
the majority of patients surveyed of the opinion nurse prescribers were 
comprehensive in their care delivery, listened to their concerns and 
treated them as individuals. 
Compliance was associated with satisfaction and time spent with the 
patient during the prescribing consultation, overall satisfaction with the 
consultation process and patients health status. 
Dunn et al. (2010) 
Australia 
Survey 
To conduct the first national 











Electronic survey Over two thirds of Australian NPs identified prescribing as part of their 
practice. 
A substantial proportion of prescribers face insurmountable barriers to 
prescribing in practice. These barriers include inconsistencies in State 





Earle et al. (2011a) 
UK 
Single case study 
(Interpretive 
phenomenology) 
1. To explore and compare the 
experiences and views of 
practicing and non-practicing 
nurse prescribers working in 
one mental health trust. 
2. To explore the views of 
service users in receipt of this 
care. 
3. To consider some of the 
issues regarding how nurse 
prescribing is implemented in 
teams based on the 











used for each group 
Overall service users appeared to be very satisfied with their care and 
receiving their medication from a nurse. In particular convenience, 
therapeutic relationship, reduced stress, information, choice and 
autonomy were suggested improvements. However, more complex 
prescribing would still require a doctor. 
NPs issues included training and in particular, recognised they had a 
great deal to learn and this would continue. Marrying their previous 
workload with prescribing was a concern and nurses struggle to balance 
the role of prescriber and nurse. Furthermore, the lack of pay incentive 
could slow the growth of the initiative. Benefits identified included 
improved concordance and compliance and a trusting and more open 
relationship with clients. The prescribers also wanted the organisation 
to be supportive of the role and that colleagues recognise the 




Earle et al. (2011b) 
UK 
Interviews 
To explore at the views of 
mental health professionals, 
and specifically psychiatrists, 
regarding their experiences 
and beliefs related to mental 
health nurse prescribing 
specifically. 









n=1 social worker 
Interviews: 
psychiatrists 
interviewed did not 
participate in the 
focus group (n=9) 
interviews. 
Psychiatrists – highlighted that the organisation lacked a clear 
management structure to support the process of nurse prescribing. 
1Doctors had no training to support in their supervisory role. 
2Psychiatirsts had some choice as to whether or not to supervise a 
particular individual prescriber. 3 One saw treatment protocols as 
positive and helpful whereas another saw danger because of protocols 
could be followed blindly when inappropriate to do so 
 









To investigate the real world 















There is a suggestion that in some nurse prescriber/GP relationships 
there is a struggle for dominance and control which might be 
considered at best unproductive, and at worst, to undermining 
collaborative working relationships. The potential for change within 
professional roles and relationships within the wider primary care team 
has implications for all involved as roles and boundaries become blurred 
and unclear. 
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Gielen et al. (2014) 
Netherlands 
Systematic review 
To identify, appraise and 
synthesise the evidence of the 
effects of nurse prescribing 
when compared with 
physician prescribing on the 
quality and type of 
medications prescribed and on 
patient outcomes. 





that does not 
include  qualitative 
study design 
Patients are generally more or equally satisfied with the care provided 
by nurses compared with the traditional care provided by physicians. 
Based on the results it appears that nurse prescribing is of similar 
quality to physicians prescribing, and worries about whether nurses 
have the competence to prescribe appear to be unfounded. 
Nurse prescribing is embedded in tasks such as consultation, diagnosis 
and treatment, making it difficult to distinguish the effects of nurse 
prescribing. Raising the question are patients satisfied with nurse 
prescribing because of their prescribing practice or because of the time 
nurses invest in the prescribing process? 
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Green et al. (2009) 
UK 
Mixed method 
Reports on the training needs 
for non-medical prescribers by 










1The nature and academic level of pharmacology within curricula of pre-
registered and post-registered nursing programmes should be reviewed. 
2Formal specific CPD recognising the variety of multi-professional 
activity in nurse prescribing needs to be recognised. Study days and 
training updates need to be local to the work base and easily accessible 
during work time. 3The involvement of medical, pharmacy, senior nurses 
and university colleagues should be sought to develop areas where 
clinical specialties are new to medical and diagnostic skill development 
as part of non-medical prescribing. 4A clear evaluation framework and 
process should be put in place to provide data relating to all ongoing 
CPD activity for non-medical prescribers including the informal 
arrangements at organisational level. 
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To explore the opinions of 
patients on the development 






In-depth interviews Participants had a preference for nurses as prescribers because nurses 
were considered to be trustworthy, caring and from a devoted 
profession with which patients’ relationships are established. 
Participants expressed concern about clinical governance, privacy and 





n=11 male and n=7 
female 
community pharmacies. Participants also acknowledged the expert drug 
knowledge of pharmacists and their accessibility. Nurses are highly 
regarded, accepted and preferred as prescribers with few concerns. 
 
Jones et al. (2010) 
UK 
Mixed method 
single case study 
To report on an evaluation of 
the implementation of nurse 
prescribing in an acute care 
hospital in England. 
n=140 NP/Patients 
Acute care hospital 
 
Observation n=2 








Nurse prescribing was found to benefit patients through service delivery 
improvement and using staff skills differently. 
No differences were found between the way in which nurses and 
doctors performed prescribing roles but there was a statically significant 
difference between the medication-related information satisfaction 
ratings of patients who had seen a nurse prescriber, compared with 
those seen by a doctor. 
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To gain more insight into the 
forces that lead to the 
introduction of nurse 
prescribing and into legal, 
educational and organisational 
conditions under which nurse 
prescribing of medicines is 








Survey Prescribing rights in most countries are limited to certain categories of 
nurses.  In practically all countries that have granted nurses 
independent prescribing rights, nurse are allowed to prescribe 
prescriptions-only medicines, albeit often limited to medications that 
fall within their scope of practice. 
Independent and supplementary nurse prescribers bear the same 
responsibilities for the treatment process of patients, in which the 
prescription of medicines from just one element. The content of training 
programmes for independent and supplementary nurse prescribing 
seems rather similar. There is no remuneration for prescribers from the 
employing organisation. 
Jurisdictional control for prescribing between the medical and nursing 





Kroezen et al. 
(2013) Netherlands 
Survey study 
To gain insight into the views 
of Dutch registered nurse, 
nurse specialists (with a 
Master’s in Advanced Nursing 
Practice) and physicians on the 











Questionnaire Nurse specialists were more convinced than registered nurses and 
physicians that nurse prescribing improvement quality of care and are 
also more positive about the consequences of nurse prescribing. 
However, all groups agreed that nurse prescribing benefits nurses’ daily 
practice and the nursing profession as a whole. 
When asked about their views on the consequences of nurse prescribing 
on the relationship between the medical and nursing professions, all 
three professional groups agreed that nurse prescribing increases 




Kroezen et al. 
(2014) Netherlands 
A multiple case 
study 
To study how prescribing by 
nurse specialists is taking 
shape in the workplace and 
how jurisdictional control over 
prescribing is divided between 











Most nurse specialists worked from protocol that were almost always 
developed and/or approved by medical staff and hospital pharmacists. 
Across the work settings there was variety in both the extent and way in 
which nurse specialists’ legal prescriptive authority was implemented. 
Prescribing by nurse specialists as spoken about by policy makers, 
healthcare professionals and patients alike is nothing more than an 







it is in terms of what is understood by nurse prescribing, the status of 
the initiative itself may become ambiguous.  Internationally there is a 
need for detailed evaluation of the cost effectiveness of nurse 
prescribing considering cost effectiveness was cited one of the main 
reasons for introducing prescriptive authority for nurses initially. 
 
Latter et al. (2012) 
UK 
 
To evaluate the clinical 
appropriateness of prescribing 







Generally nurses and pharmacists tend to prescribe within specific 
clinical specialties. 
There was room for improvement in skills of either history-taking and 









To evaluate the clinical 
appropriateness and safety of 
nurse and midwife prescribing 
practice. 
 






95-96% of medications prescribed were indicted and effective for the 
diagnosed condition. Criteria related to dosage, directions, drug-drug or 
disease-condition interaction and duplication of therapy were judged 
appropriate in 87-92% of prescriptions. Duration of therapy received the 
lowest value at 76%. Overall reviewers indicated that between 69-80% 




Natan et al. (2012) 
Israel 
Correlational study 
To explore the attitudes of 
patients with chronic 
conditions toward the 
expansion of nurse authority 
with an emphasis on nurse 
prescribing of medications for 
chronic conditions 
n=230 Patients.  
 
Questionnaire Nurse prescribing shortens waiting lists for medical care, improves 
adherence to treatment and ensures a rapid medial response. 
The image of nursing was identified as important for respondents – the 
more positive the image the more positive their attitudes to prescribing. 
Public attitudes affect the decisions of policy makers and their 
institutions of improved courses of action. 





Rana et al. (2009) 
UK 
Survey study 
To explore the attitudes of all 
grades of psychiatrists working 
in two mental health trusts in 





Questionnaire The minority of participants, mainly non-consultant, stated that 
although nurses were capable of prescribing some medication, they 
should not be granted full independent prescribing rights.  The majority, 
largely senior doctors, felt that no distinction should be made about 
where nurses should prescribe and should do so independently 
Despite resistance from junior doctors to nurses prescribing 
independently, they felt that nurses should be able to prescribe out of 









The aim of the study was to 
ascertain mental health NPs 
views of the barriers to their 
prescribing independently but 
also include perceptions of 
barriers to supplementary 
prescribing. 










There is an ongoing problem with the implementation of nurse 
prescribing. This relates to both lack of recognition for the additional 
responsibility that prescribing entails and lack of support for the role. 
The issue of apparent lack of clear prescribing policy and guidance left 
respondents in confusion and unsurprisingly unwilling to prescribe. 
Findings specifically indicate when nurse prescribers did not feel 
supported they were less likely to prescribe 










To explore the experiences of 
secondary care NP to establish 
how prescribing is employed 
and what its benefits and 
disadvantages are perceived to 
be. 
n=6 NP secondary 
care 
 
Interviews. Overall participants viewed nurse prescribing as a valuable addition to 
existing roles and having prescribing rights promoted greater 
accountability and patient safety. Respondents suggested workforce 
planning and review needs to take into account the additional time 
required to make prescribing decisions, if other aspects of care are not 




Snowden et al. 
(2010) UK 
Grounded Theory 
To explore the impact of 
prescribing rights on mental 






n=6  mental health 
nurse prescribers 
n=2 service users of 










Interviews. The research shows that there is a possibility clinical mentors may be 
overestimating their own understanding of medication management. 
There is, therefore, a case for structural education in medicines 
management to be introduced into pre and post registration mental 
health nursing. 1Critically evaluate the concept of concordance in 
medication management. 2Analyse the potential conflict between 
modern nursing ideology and legal and ethical issues pertaining to 
medication management. 3In psychopharmacological terms 
demonstrate critical understanding of likely adverse events. 4Justify an 
individual approach to medication management. 
There is therefore a case for structured education in medicines 
management to be introduced into pre- and post-registration mental 









To provide information on the 
profile and practice of nurses 
in the UK who prescribe 
medication for pain. 
 






Questionnaire The survey describes in detail the profile and practice of UK nurses who 
prescribe for patients in pain. The majority of treatments are related to 
minor injuries and illnesses and are seen within general practice, 
emergency care, walk in centres and out-of-hours clinics. 
Access to CPD is particularly important where nurses are developing 
new areas of practice. 







To ascertain the aspirations, 
priorities and preferred mode 








Anxiety and lack of confidence in non-medical prescribing pose a 
significant challenge for CPD resulting from contrasting professional 






Note: NP =Nurse Prescriber 
CPD continuing professional development  
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3.5 Findings  
 
 The literature originated from UK (27), Scotland (1), Australia (2), The 
Netherlands (4), Israel (1), Iran (1) and Ireland (1). All data extracted from the 
studies were based on the results and discussion sections of papers, not the 
study conclusion. Outcomes were classified according to the categories 
identified. Categories were then grouped according to the research question 
to reveal the effects of nurse prescribing on the patient, and healthcare 
professional and organisation for discussion.   
 
Study details 
Of the 37 studies reviewed, 31 included data on prescribing in practice, 
frequently from the viewpoint of prescribers and clients/patients. Seven 
studies included data about CPD, four directly and three indirectly. Five 
reported on issues of jurisdiction with two focusing specifically on this issue. 
Although there were no studies that reported specifically on financial issues 
although four studies did mentioned financial incentives as significant.  
There were a mixture of quantitative (n=15), qualitative (n=20) and mixed 
methods (n=2) studies sourced using a range of data collection methods. 
Details of specific methodological issues are set out in Table 3.1  
 
3.5.1 Prescribing in practice  
 
Variations in the way nurse prescribing translates into practice have been 
identified. Even though nurses in most countries are allowed to prescribe 
medicines on an independent basis, their scope of practice varied 
considerably depending on whether or not protocols or formularies are in 
place and how restrictive they are (Kroezen et al., 2012). This directly 
impacted on the extent to which nurse specialists made use of their 
60 
prescriptive authority in everyday practice (Kroezen et al., 2014). Although 
the majority of studies referred to issues about prescribing in practice, seven 
studies focused specifically on this area. Overall findings agreed that nurse 
prescribing increases effectiveness and autonomy in practice which in turn 
raises many issues concerning confidence, workload (Earle et al., 2011a), 
access to ongoing or specialist training (Stenner et al., 2012, Courtenay, 
2013), appropriate clinical decision-making (Latter et al., 2012), self-
restriction (Bowskill et al., 2012), and safety (Naughton et al., 2012, Black, 
2013). NPs in general are aware of their limitations and regularly consult with 
medical colleagues in an informal way that was agreeable to both nurses and 
doctors (Kroezen et al., 2014). 
3.5.2 Workforce planning 
 There was a strong feeling that service development must take into 
account the additional work entailed in prescribing. Having the ability to 
prescribe increased workloads for the NP (Earle et al., 2011a) who appear to 
struggle with balancing their new role, particularly where boundaries of the 
nursing work and prescribing roles are unclear (Bowskill et al., 2012). Earle et 
al. (2011a) suggests that this can be overcome through local negotiation. 
However, Carey et al. (2013, p. 20) has a more specific approach stating that 
those responsible for service planning need to recognise ‘the diverse range of 
medicines management activities in which NPs are involved’ to address the 
hidden workload. Additional issues of concern identified were budgetary 
constraints that impacted negatively in terms of prescribing itself, numbers 
accessing training and the ability to demonstrate the effectiveness of nurse 
prescribing (Scrafton, 2012). Workforce planning in some instances did not 
support funding arrangements and agreements were not always in place to 
support nurse prescribing thereby creating potential inequalities in service 
provision for patients (Carey et al., 2014). 
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3.5.3 Continuing Professional Development (CPD) 
 
 NPs expressed anxiety that they were ‘not keeping up to date’. There was 
also a fear of making incorrect decisions if they could not recall theory 
learned during the prescribing course (Weglicki et al., 2014). This anxiety and 
lack of confidence by nurses in their prescribing ability poses a significant 
challenge for CPD. Contrasting professional backgrounds, individual skill 
levels, work-place expectations and demands are but some of the concerns to 
be addressed when focusing on CPD needs for NPs. Four studies reported 
specifically on CPD for NPs (Courtenay and Gordon, 2009, Green et al., 2009, 
Carey and Courtenay, 2010, Weglicki et al., 2014). The number is low 
considering the importance placed on CPD by governing bodies and 
organisations to ensure NPs’ knowledge remains current. However, additional 
studies included CPD in their findings or discussion as an important element 
of nurse prescribing to be addressed (Scrafton, 2012, Stenner et al., 2012). 
The pace of change in the area of prescribing presents educators with a new 
challenge as professionals from a broad range of disciplines pursue ongoing 
development to prescribe in their specialty area of practice.  
 
 Specific difficulties with respect to the provision and access of CPD 
included cost, time, workload pressure, staffing levels, and workload patterns 
(Courtenay and Gordon, 2009). Pressure to satisfy mandatory updates (Green 
et al., 2009), lack of organisational support (Carey and Courtenay, 2010), 
patient safety, workforce planning and education of line managers, were 
identified as issues impacting on CPD.  In addition, Weglicki et al. (2014) 
identified reduced education budgets, and lack of support from employers or 
the professional body for CPD as contributing to anxiety and lack of 
confidence in non-medical prescribing, and individual skill development. From 
a more encouraging perspective, studies also identified positive outcomes of 
CPD. Consolidation of learning, information on new skills, an opportunity to 
share with colleagues (Green et al., 2009); organisational benefits, improved 
patient care, knowledge and confidence (Carey and Courtenay, 2010), 
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networking between practice settings, colleagues learning from informal 
debate,  and reduced anxiety (Weglicki et al., 2014) were all identified. The 
main barriers to CPD were summarised by Stenner et al. (2012) as financial, 
time/staff shortage, availability of training at an appropriate level, and lack of 
organisational support for role development.  
 
 Pharmacology knowledge is the most important CPD need identified by 
NPs, a situation that Carey & Courtney (Lacobucd. G, 2006) acknowledged as 
warranting further investigation. However, additional studies identified 
assessment and diagnostic skills up-dates as taking priority (Courtenay and 
Gordon, 2009, Green et al., 2009, Carey and Courtenay, 2010). Weglicki et al. 
(2014) did, however, voice concern that an adequate CPD strategy is not yet 




 The expansion of prescriptive authority has affected professional 
boundaries and in some relationships there is a struggle for dominance 
(Fisher, 2010). The consequences of this can impact on the relationship 
between the nursing and medical professions and jurisdictional control over 
prescribing (Kroezen et al., 2014). The attitudes of doctors to the initiative 
and, in particular, the differences between junior and senior doctors toward 
nurse prescribing may represent concerns about their future role (Rana et al., 
2009). However, findings from Kroezen et al. (2013) emphasise that once 
healthcare professionals have experience with nurse prescribing their views 
become more positive toward the initiative. This is an important finding 
because a ‘lack of peer support and/or objections from physicians can hamper 
progress’ (Kroezen et al., 2012, p. 1010) despite there being evidence since 
the 1960’s in the USA supporting the nurse prescribing initiative. Healthcare 
professionals are now renegotiating these blurred boundaries by addressing 
the issues through formal workplace policies (Kroezen et al., 2013) that 
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require clear organisational structures (Earle et al., 2011b). For NPs, the 
acquisition of prescribing rights is not considered a challenge to medicine but 
the ‘evolution’ of nursing to meet practice demands (Kroezen et al., 2013). 
Only in the UK, where nurses prescribe independently from the national 
formulary, is jurisdiction over prescribing considered equal to that of the 
medical profession (Kroezen et al., 2012). 
3.5.5 Prescribing arrangements and treatment protocols 
 Protocols and formularies for prescribing developed and approved by 
medical staff causes restriction to the process and places NPs in a subordinate 
position to the medical staff. Even though medical specialists are confident 
about nurse prescribing, they still feel that they have ‘final responsibility for 
the nurse and the patient’ (Kroezen et al., 2012, p. 1009). The impact of nurse 
prescribing on professional relationships may differ depending on whether 
supplementary or independent prescribing is practised. Continued medical 
authority is expected with supplementary prescribing given that the doctor 
makes the initial diagnosis and is involved in agreeing a clinical management 
plan for the patient (Cooper et al., 2013). The independent prescribing model 
is more autonomous allowing NPs to diagnose and prescribe without direct 
medical involvement. Independent prescribing therefore poses a different 
challenge to medical authority and the role associated with prescribing 
(Fisher, 2010, Earle et al., 2011b). More recently, nurses and other healthcare 
professionals were granted the same prescribing rights as doctors in the UK. 
3.5.6 Financial incentive 
NPs were of the opinion that recognition and support should take the 
form of financial incentives for taking on additional non-medical prescribing 
responsibilities (Green et al., 2009). In reality, nurses struggle with balancing 
their role as prescriber and may harbour resentment about extra work and 
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responsibility without extra pay (Earle et al., 2011a). Kroezen et al. (2012) did 
find that NPs in most countries who earned more than nurses without 
prescribing qualifications did so because of advanced qualifications unrelated 
to prescribing qualifications. A lack of pay incentive was also recognised by 
Earle et al. (2011a) as an issue that may slow the development of nurse 
prescribing. 
 
3.5.7 Factors relating to the patient 
 
 The patients’ perspective of nurse prescribing was at the core of six 
studies; two studies used the term ‘views of patients’, three studies used the 
term ‘patients’ attitude’ and one study ‘patients’ satisfaction’ of nurse 
prescribing (Courtenay et al., 2010b, Drennan et al., 2011, Dhalivaal, 2011, 
Courtenay et al., 2011, Banicek, 2012, Ben Natan et al., 2013). 
 
 Patients viewed NPs positively with regard to convenience, accessibility, 
timeliness, knowledge, safety, holistic care approach and a good relationship 
with the nurse. However, an interesting concern identified by Banicek (2012) 
and Dhalivaal (2011) was patients’ apprehension related to the qualifications 
and training of NPs. This is significant because patients confidence is inspired 
by the nurse’s level of knowledge (Cashin et al., 2009, Courtenay et al., 2011, 
Drennan et al., 2011, Coull et al., 2013) and is associated with increased levels 
of patient satisfaction and adherence to medication regimens and a good 
relationship with the patient (Courtenay et al., 2010b). Incidents were also 
identified where patients compared the NP with the physicians whom they 
perceived as having more extensive knowledge due to their lengthy training 
(Courtenay et al., 2011) with some patients continuing to think that the role 
of the nurse is to help the physician (Ben Natan et al., 2013).  Initial patient 
impressions according to Ben Natan et al. (2013) change and became more 
positive the more exposure patients have to nurse prescribing. Overall, 
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findings indicated that patients welcomed the addition of NP to the 
healthcare team. 
3.5.8 Factors relating to the healthcare professional 
The healthcare professional perspective highlighted benefits such as 
increased recognition of abilities, professional autonomy, accountability, 
increased job satisfaction, improved multidisciplinary communication, 
monitoring and reporting of adverse drug events (Coull et al., 2013, 
Darvishpour et al., 2014). In addition, the development of confidence and 
competence in practice were significant factors identified by the healthcare 
professional (Cashin et al., 2009, Snowden and Martin, 2010, Dunn et al., 
2010, Dobel-Ober et al., 2013). In particular, Snowden and Martin (2010), 
emphasised that confidence and competence is dependent upon 
pharmacology knowledge and the quality of the nurse/patient relationship. 
Cashin (2009) found that through the provision of patient information, 
education, discussion, and assisting clients in making informed decisions, 
confidence and competence were also advanced. Many countries use 
formularies to support nurse prescribing and competence development. 
However, Dobel-Ober et al. (2013) found that using formularies was 
cumbersome, and needed regular review to take into account prescribers’ 
needs and confidence development. There are positive aspects to using 
formularies such as reviewing progress in terms of critical evaluation, analysis 
of potential conflict, demonstration of critical understanding and justification 
of the NPs approach to medication management (Dobel-Ober et al., 2013). In 
contrast, Dunn et al. (2010) cautions over reliance on protocols or personal 
formularies, as they may decrease opportunities to independently prescribe 
in practices which in turn reduces confidence levels (Cashin et al., 2009). 
Developing peer and interdisciplinary relationships enables integration of 
nurse prescribing and promotes safety in patient assessment, clinical 
decision-making and documentation (Bowskill et al., 2012, Naughton et al., 
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2012, Black, 2013). Overall, it was found that nurses provide a prescribing 
service for patients comparable in quality and safety with prescribing by 
doctors (Latter et al., 2012). 
 
3.5.9 Factors relating to the organisation 
 
 Lack of support within the organisation was identified as three fold: 1) 
lack of supervision, 2) lack of support within the role, and 3) lack of support 
from other healthcare professionals (Ross and Kettles, 2012). In addition, 
organisational implementation of practice protocols is restrictive and should 
not be confused with best practice (Dunn et al., 2010). Organisational 
confidence is required to ensure the role is recognised and valued otherwise 
nurse prescribers do not feel supported and are less likely to prescribe (Ross 
and Kettles, 2012).   
 
 The benefits identified from an organisational level include – improved 
access and care delivery, faster and more efficient service, better patient 
satisfaction, cost-effectiveness and streamlining of staffing skills (Carey et al., 
2009a, Darvishpour et al., 2014). Patient benefits were convenience, better 
patient education, enhanced patient care, easier access to medicines, 
reduced waiting times, improve safety, improved satisfaction (Carey et al., 
2009a, Ross and Kettles, 2012, Darvishpour et al., 2014).  
 
The barriers to prescribing from an organisational perspective were 
identified by Carey et al. (2009a) as local restrictions, lack of CPD and formal 
support. At present prescribers are working to capacity and further benefits 
will not be evident unless resources are put in place. Similar difficulties with 
infrastructure were identified by Coull et al. (2013). In addition, Ross & Kettle 
(2012) also highlighted that organisations required greater commitment to 
nurse prescribing than appearing to do what was cost effective and 
appropriate from the political and policy makers’ perspective. A broader 
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perspective of nurse prescribing is required to ensure an appropriate 
infrastructure supports the continued evolution of the role (Coull et al., 
2013). 
 
Healthcare professionals, particularly nurses, have anxieties and concerns 
related to prescribing that have been identified as barriers or potential 
barriers to prescribing. For instance, remuneration was identified by Ross & 
Kettles (2012) as a continuing barrier for nurses considering that additional 
responsibility and increased workload did not equate to financial reward. To 
date, this situation has not changed with Carey et al. (2014) highlighting that 
structural reorganisation in the health service is now looking at GPs and 





Despite differences in prescriptive authority for nurse prescribing in 
different countries, a review of the literature shows many similarities in 
relation to the benefits that it provides for patients, carers, nurses, doctors 
and the overall delivery of healthcare. Compelling advantages for nurse 
prescribing across health care settings include a nurse’s continuous contact 
with patients that facilitate the patients’ needs in more detail, giving more 
options for patients, holistic care, time saving, use of advanced nurse 
practicing skills and cost saving for the health care system. The advantages 
come hand in hand with the concerns about patient care, inappropriate 
prescribing, inter-professional relationships, cost of CPD and jurisdiction of 
prescribing. It is important to note that studies included in this review meet 
specific inclusion and exclusion criteria which may not allow full exploration 
of nurse prescribing process that is embedded in other tasks such as 
consultation, assessment and revision of treatment. One should note that the 
majority of the studies are undertaken from a UK perspective which is more 
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progressive in advancing nurse prescribing than other countries. Other 
countries with a larger geographical area have nurse prescribing practice 
spread across state and separate governing jurisdictions, and is often 
inconsistent, complex and in some cases restrictive (Dunn et al., 2010). 
 
3.6.1 The impact of nurse prescribing on the patient  
 
 Improved speed and convenience of access to medicines have been 
consistently reported as key benefits of nurse prescribing by patients 
(Drennan et al., 2009). Increasing the number of NPs has two-fold effect a) 
improved patient access to services and b) relieved pressure on doctors 
thereby preserving limited medical resources for the most seriously ill 
patients. However, these efficiency changes are supported with limited 
evidence from research using case studies.  
 The nurse-patient relationship is one of the central factors contributing 
to the success of nurse prescribing because the continuity of care that the NP 
provides has a positive effect on the patient’s level of satisfaction. The 
literature further reveals that patients are highly satisfied and confident in the 
NPs ability to prescribe because of their specialist knowledge, experience and 
a belief that nurses know their own limitations (Courtenay et al., 2011). 
Patients also consider nurses to be more approachable than doctors, better at 
communication and more likely to include them in discussion about their 
medications. This approach to prescribing makes it easier for patients to 
share information, ask questions, and address problems and as a result, they 
understand their condition and treatment better. In promoting a good 
prescribing relationship with the patient, it is important to avoid confusion 
because there may be limitations imposed on prescribing certain medications 
depending upon the country in which the NP is practising. This can present 
problems when treating patient with multiple comorbidities. To overcome 
this, when embarking on the prescribing relationship, NPs must be clear with 
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patients about what they can and cannot prescribe. Such clarity is important 
if the prescribing role is to be developed purposefully.  
 
3.6.2 The impact of nurse prescribing on healthcare professionals 
 
Nurse prescribing is viewed as a valuable addition to existing roles, and 
expansion of prescribing rights was believed to be a positive step that 
promotes greater accountability and patient safety (Cashin et al., 2009, Earle 
et al., 2011a, Latter et al., 2012, Naughton et al., 2012, Carey et al., 2014). 
This increase in responsibility was not undertaken lightly but was welcomed, 
as long as it was for patient benefit and not just to fill gaps left by staffing 
shortfalls. The main factors identified that facilitated effective prescribing in 
practice include teamwork, peer support and doctor support that is accessible 
and positive regarding nurse prescribing. Having such support can facilitate 
prescribing when present but limit nurse prescribing when absent. Therefore, 
the education of medical practitioners on prescribing and the role of the NPs 
is of paramount importance to ensure a collegial relationship. Addressing this 
issue at the education level may be an option for the future. Using an 
interdisciplinary educational approach to preparing both doctors and nurses 
for prescribing would improve relationships and understanding of both roles. 
 
 Supplementary prescribing was credited with improved understanding 
between the professions because the doctor taking responsibility for the 
diagnosis however, this is depended on individual attitudes. It was Rana et al. 
(2009) who stressed the importance of Health Trusts (organisations) to help 
make the transition toward new roles for prescribers with the intention of 
reducing conflict. A comparison of nurses and doctors prescribing practices 
would also be useful to compare the decision making process by both nurses 
and doctors, ideally incorporating patient outcomes and cost effectiveness in 
the clinical setting. 
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3.6.3 The impact of nurse prescribing on the organisation 
The healthcare environment has changed significantly over the last decade 
driven by changing demographics and epidemiology with organisations now 
requiring the services of NPs more and more to help provide a streamlined and 
timely service for patients. Clinical governance and overall organisational 
support have been identified repeatedly as important factors for the success of 
nurse prescribing. Having organisational structures in place also support NPs to 
fully integrate into the healthcare team. Current knowledge is an essential 
element for NPs to work as part of the healthcare team because prescribing 
knowledge extends beyond the act of consultations for issuing prescriptions to 
also encompass education, titration and discontinuation of medication. 
Inadequate support in the face of heavy work commitments reduces the 
opportunity for development (Green et al., 2009). Having access to a supportive 
environment encourages NPs to attend updates and opportunities to 
networking between the different healthcare settings however, a clear 
evaluation framework is required to obtain a robust picture of the CPD that 
works for NPs. The challenge of providing appropriate CPD for experienced NPs 
is pharmacology education which, if appropriately focused, relates to their 
specialty making it applicable to a small number of prescribers. This focused 
education creates challenges for providers of CPD who may find it difficult to 
deliver at an affordable cost. In addressing these issues, the organisation needs 
to consider workforce planning and review needs to take into account the 
additional time required to make prescribing decisions, if other aspects of care 
are not to be compromised. 
Having the time to prescribe is also a concern for NPs who suggest they 
sometimes have to satisfy unrealistic expectations imposed by the organisation. 
Assessing and meeting the more complex needs of patient medication requires 
time and the components of stress and workload balance identified by Creedon 
et al. (2014) tend to relate to excessive workloads rather than challenging care 
situations. The progressive, dynamic nature of nurse prescribing requires shared 
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responsibility with health service providers to develop robust systems to 
support competence, assurance and safe clinical governance. This requires that 
the health service expand their narrow view of prescribing which tends to be 
focused on a consultation that results in a medication being prescribed (Health 
Service Executive, 2014c). Education, titration and discontinuation of 
medications are equally important in the cost-conscious and prescribing 
optimisation environment of today’s health service. Understanding the true 
cost-effectiveness of the NPs contributions within the organisation needs to be 
undertaken through robust research. Where cost savings were identified, 
redirection of these savings to address issues such as protected study time and 
financial support that hinder the access of CPD could be made. 
The issue of remuneration, or lack thereof, was mentioned in several 
papers and could be identified as a barrier to the implementation of nurse 
prescribing. This may explain why nurses do not prescribe although 
remuneration does not factor highly in reported findings on the topic. 
Nevertheless, it does seem unrealistic to expect nurses to undertake such a 
skilled independent role that is cost effective for the organisation without 
recompense. 
 
3.7 Conclusion  
 
It is evident from the literature that nurse prescribing is beneficial for the 
patient, organisation and healthcare professional and could also be viewed as 
one of the most exciting initiatives in the recent history of nursing. Nurses 
clearly understand the requirements of the role, however, it is important that 
they continue to make the role explicit within the multidisciplinary team to 
ensure that collaboration is optimal and misunderstanding minimal. The 
results also reveal that there are issues of concern such as workloads, 
remuneration, support, CPD, and workplace jurisdiction need to be addressed 
if NP is to continue evolving. 
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To understand the issues concerning workloads, a broader view of nurse 
prescribing needs to be considered to capture the true impact of the 
initiative. To ensure barriers do not develop, future research should consider 
the inclusion of all nurse prescribing consultations in evaluations and not just 
those that end in a medication being prescribed. In addition, understanding 
and remaining up-dated on the key principles of nurse prescribing will allow 
nurses to remain instrumental in the development of this role over the next 
decade. 
 
Publication for this chapter can be viewed in appendix 3. 
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CHAPTER 4 QUALITATIVE 
INVESTIGATION OF NURSE 
PRESCRIBERS’ EXPERIENCE OF 
THE MINIMUM DATA SET IN 
CLINICAL PRACTICE 
Chapter 4 – describes how in Ireland, monitoring of nurse prescribing 
is achieved through inputting data directly to a database called the Minimum 
Data Set (MDS) that is managed by the Health Service Executive (HSE). This 
chapter explores NPs’ experiences of using the MDS in clinical practice using a 





 Nurse prescribers’ experiences of recording prescribing data to the Minimum Data Set 
in Ireland. Creedon R., McCarthy S. & Kennedy J. (2014) British Journal of Community 
Nursing, 19(12) 594-600. 
7
 The Impact the Minimum Dataset has on the Nurse prescribing process. Creedon R., 
McCarthy S. & Kennedy J. All Ireland School of Pharmacy 34th research Seminar (2013) Poster 
presentation 
8
 The 2014 paper was used as part of a national review of nurse prescribing in Ireland 




Nurse prescribing has been introduced nationally and internationally in 
response to changing service needs and the increasing specialisation of nurses 
and midwives as they expand and advance their scope of practice (McKenna 
et al., 2008, Kroezen et al., 2012). However, international differences 
between legislative procedures and the professional bodies responsible for 
the regulation of nursing practice has resulted in the implementation tailored 
models of prescribing to meet the specific demands of health services  
worldwide (An Bord Altranais and NMPDU, 2005, Kroezen et al., 2012). 
Nurse prescribing in Ireland follows the model of independent nurse 
prescribing that utilises a limited formulary extending to those medicinal 
products normally used in a named clinical area. More specifically, the 
identified medications are ‘listed in a collaborative practice agreement (CPA) 
and approved by the collaborating medical practitioner and authorised by The 
Director’  (Health Service Executive, 2012a, p. 1). Encouragingly, nurse 
prescribing in Ireland has continued to grow over the past five years with the 
role of the NP in the healthcare setting increasing in prominence and 
significance in keeping with international development (Cipher et al., 2006, 
Latter et al., 2010). As a result, nurse prescribing is generating an ever-
increasing amount of rich clinical and patient information that needs 
appropriate management and analysis. Collecting and utilising nurse 
prescribing data correctly is, therefore, of major significance (Munsch, 2002) 
and considered by Dr. June Crown (Personal correspondence, 2010) as a 
significant opportunity that was missed in the UK. 
Nurse prescribing activity in Ireland is monitored using data recorded in 
the National Nurse and Midwife Prescribing Minimum Data Set (MDS) which 
was funded and introduced to Ireland by the Health Service Executive (HSE) in 
February 2008, (Adams et al., 2010). The MDS is an electronic system that 
was specifically developed to collect nurse prescribing data and is a web-
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based application used for the recording of prescribing information. The main 
purpose of the system is to allow ‘each individual nurse and/or midwife 
prescriber to report on the number of prescriptions written by them and for 
which principal clinical indication over any specified time period’ (Health 
Service Executive, 2008b, p. 49). Each registered NP in clinical practice is 
required to use the system. The MDS contains data on 12 items that are listed 
below Table 4.1 screenshot of which can be viewed in Figure 1.1. 
 
TABLE 0-1 ITEMS CONTAINED IN THE MDS 
1. Prescribing site 
2. Registered nurse prescriber (RNP) – personal identification number 
3. Clinical area 
4. Date 
5. Shift 
6. Patient- medical record number (MRN) 
7. Prescribing mode 
8. Clinical indication (prophylaxis, diagnosis or treatment) 






However, it should be noted that the HSE states ‘it is not a prescribing 
system nor is it used to record clinical or patient information’ (Health Service 
Executive, 2008b, p. 51) even though patient medical record numbers and 
specific clinical sites are recorded. The benefits of introducing this system are 






TABLE 0-2 BENEFITS OF THE MDS IDENTIFIED BY THE HSE 
 Accessibility in any location with web access. 
 The fact that the system is centrally administered and funded 
thereby, ensuring that there are no additional requirements on 
local information communication technology departments. 
 Security and confidentiality of the system. 
 Ability to retrieve any aspect of the information entered in the 
system using the search function. 
 Ability to run standard reports on prescribing activity over a given 
time period. 
 Transparency and comparability in relation to activity of 
prescribers. 
 Functionality to prepare, print, export, save or email reports 
immediately when required. 
 Capacity to export information, pre-formatted for analysis and 
research. 
 A key resource for registered nurse prescribers to demonstrate 
their continuing competence within their area of prescriptive 
authority. 
 An important mechanism for clinical supervision among registered 
nurse prescribers and the interdisciplinary team. 
 Access to resources – journal articles and texts, related to 
prescribing including links to key websites 
 A tool for use as the basis for undertaking an audit of prescribing 
activity. 
 Links to other Registered Nurse Prescribers and the Office of the 
Nursing Services Director through the notice board section of the 
system. 
 
(Health Service Executive, 2008b) 
The system was also designed to allow for immediate answering of 
questions in relation to the prescribing practice ‘either by using standard 
reports or the search and export function’ (Health Service Executive, 2008b, p. 
55). However, one of the primary challenges to the effective use of health 
information technology (HIT) in the health care setting remains its adaptation 
and successful implementation (Sequist et al., 2008). HIT may have limitations 
in its effectiveness because the management of clinical data for supporting 
patient care/direction is a complex endeavour that is highly dependent on 
appropriate management and accurate input of information to any new 
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system developed (Bose, 2003). Lapane et al, (2008) highlight the importance 
of careful attention to the details when implementing HIT, including active 
promotion of the benefits of these technologies, setting the appropriate 
sensitivity and specificity of the interventions and incorporating them into 
workflow and clinical activities in practice. This structured approach to the 
introduction of HIT in the form of the MDS was not followed by the HSE. 
Instead, a directive was issued to the clinical areas that the MDS would be 
introduced and was a compulsory part of the prescribing process.   This was 
perhaps a somewhat restricted view of HIT, considering appropriate 
collection and management of such data can be useful to the health service. 
In order to track increasing consumer demands for quality care services that 
are cost effective and guides health services toward the potential of HIT to 
help ‘lower health care cost, improve efficiency, quality and safety of medical 
care’ (Jamal et al., 2009, p. 35). These optimistic expectations are predicated 
based on the substantial role HIT already plays in improving health care 
internationally along with evidence from research undertaken (Ortiz and 
Clancy, 2003, Chaudhry et al., 2006, Bates and Bitton, 2010). 
Anecdotal evidence was presented at a meeting with ABA in November 
2011 that the MDS was having a negative impact on prescribing in the clinical 
setting and many NPs had stopped inputting data while others were inputting 
limited data to the system.  In light of this, research was then undertaken to 




 The purpose of this qualitative descriptive study was to gain a better 





There are different research designs within qualitative research which 
include phenomenology, grounded theory, exploratory and descriptive (Burns 
and Grove, 2011) In this study, a qualitative descriptive approach was used to 
explore the research question as it was best suited to the study of human 
experiences and aimed to gain an understanding of nurse prescribers 
experiences of the MDS. Using this research method researchers describe 
phenomena about which little is known. From the data collected, patterns or 
trends that may emerge and possible links between variables can be observed 
but the emphasis is on the description of the phenomenon (Parahoo, 2006) 
The researcher stays closer to their data and the surface of the words and 
events than researchers conducting phenomenological, ethnographic, or 
narrative research (Sandelowski, 2000). Specifically, the goal of the research 
was to establish a comprehensive summary of events in the everyday terms 
of nurse prescriber’s use and understanding of the MDS. This approach is well 
suited for researching topics about which little is known and yielding practical 




A descriptive, qualitative design was adopted, which aims to provide a 
rich straight description of a phenomenon (Neergaard MA et al., 2009). In line 
with this study’s  objective of providing a truthful account of the nurse 
prescribers experiences, this design is less theoretical than some, which can 
be considered an advantage, as it allows for findings to emerge from the raw 
data without being restricted by imposed methodologies or predetermined 
theories (Thomas, 2003). The aimed was to stay as close as possible to the 
participants’ descriptions of their experiences of the MDS with minimal 
interpretation (Sandelowski, 2010). Given that this was a descriptive study, 
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the interpretation was low inference, in that the findings were not described 
in terms of a conceptual or philosophical framework (Sandelowski, 2000). 
However, it did involve a degree of interpretation, as this cannot be avoided 
based on the underlying assumptions of interpretivism as a basis for 
qualitative research. 
 
Qualitative descriptive research aims to help understand social 
phenomena in a natural rather than an experimental setting while 
emphasising the experience, attitudes, and views of the participants rather 
than providing measured answers to a question (Nieswiadomy, 2008). 
Qualitative descriptive research obtains data usually in the form of words, 
based on interviews that is focused on obtaining deep and meaningful 
information from small groups which fulfil certain criteria set out by the 
researcher (McCarthy G. O'Sullivan, 2008) and has the ability to assist with 
guiding future nursing practice (Barroso, 2010). A qualitative descriptive study 
was selected to allow the investigator to come to know and understand the 
experience of MDS, within the ‘life world’ of the nurse prescribers perspective 
The value of qualitative descriptive research lies not only in the knowledge it 
can produce, but the establishing of ‘facts’ about the MDS which ultimately 
rendered a summary and a ‘straight description’ of the events experienced 
from the nurse prescribers perspective in practice (Sandelowski, 2000). 
  
To ensure the researcher addressed personal bias, a reflexive journal was 
started in which preconceptions were identified throughout the research 
process (Ahern, 1999). There were still ‘grey areas,’ and as the researcher 
discovered, professional judgement was required to make decisions for which 
there were no clear guidelines or rules. The aim is to make the process of data 
analysis as visible and transparent as possible (Ortlipp, 2008). A strategy that 
can facilitate reflexivity, whereby researchers use their journal to examine 
‘personal assumptions and goals” and clarify “individual belief systems and 
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subjectivities’ (Ahern, 1999 p. 409) claiming to create transparency through 
knowing and exposing the self through reflective journal, is also subjective. 
This research project was primarily interview-based and therefore it was the 
main ‘instrument’ of data collection. Reading about the role of the researcher 
was thus in relation to the role of the researcher as interviewer. 
 
Qualitative studies almost always use small, non-random samples. The 
basis for sampling in phenomenology is that participants have experienced 
the phenomenon under investigation and are willing and able to articulate 
their experiences (Corben, 1999). According to Polit and Becks (2012) 
qualitative researchers begin the process with a specific sampling question in 
mind: Who would be an information rich data source for my study? With this 
in mind a purposive sampling strategy was employed in this study to ensure 
experiences of the phenomenon to be researched (O'Rielly and Kiyimba, 
2015) and a representation of the different levels of nurse prescribers 
experiencing the phenomenon were also included in the sample. 
 
4.3.2 Inclusion exclusion criteria 
 
Inclusion criteria - participants were required to have completed the 
nurse prescribing programme, have registered with the Nursing and 
Midwifery Board of Ireland, currently working for the Health Service Executive 
(HSE) which mandated all prescriptions be entered onto the minimum data 
set. 
Exclusion criteria – nurse prescribers not registered with the Nursing and 




4.3.3 Ethics considerations 
 
A research proposal was submitted for examination by the Regional 
Clinical Research Ethics Committee (CREC) Cork. The study met the research 
governance criteria and approval to undertake the study was granted 




Purposive sampling was utilised to recruit participants who had 
experience of the phenomenon of interest in order that a rich and dense text 
might be generated (van Manen, 1990). In particular, the participants were 
accessed through the practice development coordinators across a number of 
organisations in the HSE throughout the south of Ireland. The twelve 
participants interviewed were of different age groups, from different clinical 
backgrounds, and held positions from staff nurse to advanced nurse 
practitioner that permitted an in-depth understanding of the lived experience 
of inputting data to the MDS in clinical practice.  
 
4.3.5 Data collection 
 
The interviews were conducted in February-April 2012 with NPs who met 
the inclusion criteria of having experience of the phenomena. During the 
interview, a broad opening question requested the participants to ‘reflect on 
their knowing-in-practice’ (Schon, 1991, p. 61) of the MDS. From this initial 






Semi-structured interviews facilitated data gathering with the process 
informed by a single open-ended question ‘What is your experience of using 
the MDS in practice?’ to commence the interview.  This provided a starting 
point but additional questions were allowed to emerge naturally from the 
dialogue. A list of core questions was utilised if the participant did not address 
specific areas in revealing their experience of using the MDS in practice 
(Appendix 5). The researcher also availed of the opportunity to probe the 
meaning of the experience for that individual, thereby facilitating a deeper 
understanding of the experiences, thoughts and emotions of the participant. 
In addition, the researcher needed to be flexible during the interview process 
to account for additional topics and a dynamic conversational exchange. It 
needed to be borne in mind that the interview is reciprocal with both 
researcher and research subject engaged in the dialogue. 
 
The use of semi-structured interviews is believed to provide a 'deeper' 
understanding of social phenomena than would be obtained from purely 
quantitative data gathering methods, such as questionnaires (Silverman, 
2004). There are three fundamental types of research interviews: structured, 
semi-structured and unstructured. The choice between different interview 
methods is often dictated by fundamental concerns such as whether the 
premise of the research is inductive or deductive (O'Rielly and Kiyimba, 2015). 
Semi-structured interviews used in this study consisted of one key question 
that helped to define the areas to be explored, but also allowed the 
interviewer or interviewee the latitude to diverge in order to pursue an idea 
or response in more detail (Britten, 1999). This flexibility, particularly 
compared with structured interviews, allowed for the discovery or 
elaboration of information that is important to participants but may not have 
previously been thought of as pertinent by the research team. In this way 
interviews are not natural tools for gathering data but are active interactions 
(Fontana and Frey, 2003) and therefore it is important to appreciate the 
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researchers place in the production of the data (Potter, 2002). The type of 
questions asked, the way in which those questions are asked and the 
relationship between the interviewer and interviewee shaped the outcome 
(O'Rielly and Kiyimba, 2015). However, one needed to bear in mind the 
comments of Fontana & Frey (2005) who highlighted that ambiguity is 
imbedded in the spoken and written word no matter how carefully questions 
are worded, asking questions and getting answers is a much harder task than 
it may at first seem.  
 
The interview process incorporated the principles that aimed to reduce 
the traditional, hierarchal relationship between the researcher and research 
participant by such means as mutuality, dialogue (Lather, 1991) and building 
trust (Oakley, 2013). To maintain consistency, all of the interviews were 
conducted by one researcher. 
 
4.3.5.2 Pilot interviews  
 
Two NPs (one from primary and one from secondary care) were invited to 
take part in the pilot interviews as it was important to have representation 
from both sectors Gerrish and Lacey (2006) suggested pilot studies provide a 
valuable opportunity to see if the proposed overarching interview question is 
relevant and appropriate. Therefore, the question was used to commence the 
interview was ‘Tell me your experience of using the MDS in practice’. Talk 
developed naturally, leading from one topic to the next in the participant’s 
response. As the interview continued, the information revealed by the 
participant addressed the specific areas of interest on the topic to the 
researcher. A final check of the question schedule towards the end of the 
interview picked up just one topic that had not arisen from the interview. At 
the second pilot interview, the interview began once again with the 
overarching question, ‘Tell me your experience of using the MDS in practice’. 
It was soon apparent that the subsequent questions to be asked by the 
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interviewer were addressed automatically by the interviewees once they 
began  discussing their experiences of the MDS in practice in fact, all the areas 
included in the interview schedule were at some point discussed during the 
interview by the participant without additional prompts. This approach felt 
comfortable and the pilot interviews gave the researcher a valuable 
opportunity to practice their interview skills in advance of conducting the 
formal interviews. However, the researcher needed to be aware that 
questions may evolve as interviews progressed.  
The pilot interviews for the MDS study lasted 35 and 40 minutes 
respectively. There was an interruption to one interview because the bleep 
was activated. This raised the researcher’s awareness to ensure time 
allocated to interviews was adequate and flexible to accommodate the 
possibility of such an incidence with the remaining interviews to be 
undertaken.  
Prior to the interviews, all participants were provided with information 
sheets detailing the purpose and nature of the research and had the 
opportunity to ask the researcher any questions. Informed consent was 
obtained and forms were signed in addition the possibility of re-negotiating 
consent was discussed. Consent form and the participant information sheet 
have been included in appendix 6.  Confidentiality was assured and the right 
to withdraw at any time during the investigation, without prejudice, was 
guaranteed.  The interviews were digitally recorded and later transcribed 
verbatim by the researcher to ensure the experience as described by the 
participant was accurately captured. The strength of emotion regarding some 






4.3.6 Data analysis  
 
 Sandelowski (2000, 2010) noted that in a qualitative descriptive design 
there may be overtones from other methods. While this is a qualitative 
descriptive study there are elements of phenomenological overtones as 
noted in the use of Colaizzi's (1978) method of data analysis. This method 
‘remains with the human experience as it is experienced, one which tries to 
sustain contact with the experience as it is given’ (p. 53). Colaizzi's method 
does seek to describe the phenomenon of interest but facilitated an account 
of the facts of the experience (Sandelowski, 2000, Truglio-Londrigan, 2013). A 
series of steps was employed to accomplish this (see table 4.3). Each 
participant's transcript was read as a whole to gain a sense of the experience. 
Meaning statements were clustered into common themes and again referred 
back to the original commentary for validation, thus ensuring that only the 
participant’s perception was captured. In following the principles of data 
reduction, all themes were included until a description of the experiences of 
the nurse prescribers as a whole was obtained. Significant phrases were 
extracted. These phrases revealed categories, themes and subthemes. 
Individual findings were presented to participants for validation, leading to 
confirmation and/or additional questions at the end of the process. In 
addition, checks with my research supervisor were also conducted which 
determined agreement about categories, themes and subthemes. Throughout 
the analysis the investigator also returned to the literature to clarify and 
expand upon findings. The investigator, however, had no preconceived 
notions as to specific facts of this experience or the events and stayed with 






TABLE 0-3 COLAIZZI’S FRAMEWORK   
1. Each transcript should be read and re-read in order to obtain a general 
sense about the whole content.  
2. For each transcript, significant statements that pertain to the phenomenon 
under study should be extracted. These statements must be recorded on a 
separate sheet noting their pages and lines numbers.  
3. Meanings should be formulated from these significant statements.  
4. The formulated meanings should be sorted into categories, clusters of 
themes, and emergent themes.  
5. The findings of the study should be integrated into an exhaustive 
description of the phenomenon under study.  
6. The fundamental structure of the phenomenon should be described.  
7. Finally, validation of the findings should be sought from the research 





Thematic analysis allowed the researcher to report the experiences of the 
study participants which were captured during the interview process. 
Specifically, thematic analysis is a method for “identifying, analysing and 
reporting patterns (themes) within data. It minimally organises and describes 
the data set in (rich) detail’. However, frequently it goes further than this, and 
‘interprets various aspects of the research topic.” (Braun and Clarke, 2006 p. 
79). Thematic analysis is flexible and what researchers do with the themes once 
they uncover them differ based on the intentions of the research and the 
process of analysis. While researchers debate whether thematic analysis is a 
complete ‘method’ per se, it is a process that can be used with many kinds of 
qualitative data, and with many goals in mind. The aptness being it does not 
ascribe to any particular epistemology or discipline (Braun and Clarke, 2006). 
Therefore, the researcher considers it would be suitable and beneficial for 
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inclusion in this study. To direct the thematic analysis Colaizzi’s framework was 
used. It included understanding the data and identifying significant statements 
which in turn were converted into formulated meanings. The results were then 
integrated and exhaustive description reduced giving a fundamental 
description which was returned to the participants for validation. An overview 











FIGURE 0.1 OVERVIEW OF COLAIZZI'S PROCESS 
(Abu Shosha, 2012) 
The framework entailed following the steps that represent Colaizzi’s 
process for qualitative descriptive data analysis (Sanders, 2003, Speziale and 





Step 1- Gaining a sense of the transcript 
The researcher conducted and transcribed each of the interviews 
personally which helped gain a sense of the experience of each participant. As 
suggested by Colaizzi (1978) the narrative was listened to and re-read several 
times to gain a sense of the whole content. During this stage any thoughts, 
feelings and ideas that arose by the researcher due to previous work with NPs 
were added to the reflective journal. This helped the researcher maintain 
focus on the participants lived experience. To ensure accuracy the 
transcriptions was checked by a second researcher.  
 
Step 2 – Extraction of significant statements 
Transcripts were read and re-read to identify the participant’s experience 
of using the MDS in clinical practice. Undertaking this process according to 
Colaizzi (1978) helped identify and extract significant statements from the 
transcripts that detect each participant’s knowledge of the lived experience. 
Significant statements were highlighted on each page of the transcript and 
colour coded depending on the statement and how it related to the 
phenomenon. Following this each statement was extracted from the 
transcript retaining the transcript, page and line number and pasted to a 
separate document. Although there are a number of computer programmes 
available to analyse qualitative data the researcher chose to analyse and 
extract the significant statements manually with the help of MS word.  This 
process also facilitated further immersion in the data. The 12 transcripts 
revealed 273 significant statements. Table 4.4 provides examples that were 




Step 3 – Formulation of meanings form significant statements 
At this stage Colaizzi’s process (1978) endorses that the researcher 
formulate a more general summary of meanings for each significant 
statement extracted from the transcripts. It is essential to bracket when 
analysing phenomenology data using a Husserlian approach who states that it 
is only when this has been accomplished that more specific investigations can 
begin (Husserl, 1960). In addition to maintaining a reflective journal the 
researcher engaged in discussion with an outside source to ensure there were 
not harmful effects of unacknowledged preconceptions related to the 
research (Rolls and Relf, 2006). Once presuppositions had been stated and set 
aside in so far as is possible each significant statement relating to the 
phenomenon was studied carefully to determine a sense of its meaning. This 
required working back and forth between significant statements and original 
transcripts to ensure there was no misinterpretation of the information. 
 
Step 4 - Sorting formulated meanings into categories 
Once the meanings were formulated for each of the significant 
statements the next step was to organise the meanings into clusters of 
themes. From the description of the phenomenon 273 statements of 
significance were identified and arranged into 54 theme clusters which were 
then collapsed into eight emergent themes. At this stage groups of cluster 
themes were grouped together to form a distinctive construct of themes. 
 
Step 5 – Exhaustive description of the phenomenon 
The fifth stage of Colaizzi’s Process (1978) advises the researcher to 
integrate all the emergent themes into an exhaustive description of the 
phenomenon. After merging all study themes, the whole structure of the 
phenomenon ‘The impact the MDS has on the nurse prescribing processes’ 
had been extracted. The narrative analysis was described and returned to the 
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researcher supervisor who double checked the exhaustive description for 
validation. 
 
Step 6 – Describe the fundamental structure of the phenomenon 
In this step Colaizzi (1978) advises that the exhaustive description be 
reduced to an essential structure. A reduction of finding was performed in 
which redundant, misused or overestimated descriptions (Abu Shosha, 2012) 
were eliminated from the overall structure. Overall themes identified 
together with the discovery of challenging comments refined the data on the 
NPs experience of the MDS. 
 
Step 7 – Validation of findings by participants. 
The final validation of the data analysis involved returning to the 
participants for review to ensure the content represents their experiences. It 
was not physically possible to interview all participants again therefore a hard 
copy of the findings was sent to each individual for comment. Initially 
feedback obtained via email from two participants indicated that the 
information contained in the transcripts was accurate and reflected their 
experience of the phenomenon. Reminders were sent to the remaining 
participants however, only one additional comment was received. All three 
comments identified satisfaction with the study findings as reflective of their 
feelings and experiences of using the MDS.  
An example of the significant statement, formulated meaning, theme 
clusters and emergent themes have been derived from the transcripts of raw 
data and are presented in Table 4.4. The overview offers a perspective for 
understanding the complex, variant and changing ways in which nurse 
prescribers experience the MDS in practice.  
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TABLE 0-4 SAMPLE OF WRITTEN DESCRIPTORS AND THEMES  
Significant statements 
(Random selection from interviews) 







Interview 3 (86-95) I don’t really know why we 
have the MDS because as I was saying I only put in 
what tablet I prescribed I never record what I have 
done before that. Say if there was a kidney 
infection you would have the urinalysis, you know 
you might have an awful lot of work done before 
you decide to prescribe. Then you just write down 
the tablet you never say…I never write down why I 
am giving a particular medication. Or I might 
assess the patient and discontinue a medication 
and that’s not recorded anywhere. Even if you are 
recharging PRN drugs the patient has to be 
assessed and that’s not recorded either. 
 
Interview 7 (59-61) Just to make a long story short 
I fine the MDS totally of no use to me personally 
and I suppose this sounds awful but we often 
wonder what it’s for. I tried contacting the HSE but 
got no satisfaction  
 
Interview 2 (54-57) It (the MDS) works well but I 
don’t feel that the HSE data base captures the 







 Lack of information regarding 
the MDS provided to the nurse 
prescribers 
 Unable to input the data 
considered appropriate 
because of choice limitations.  
 Specialty requirements not 
facilitated by the database or 
recognised by the HSE. 
 Discontinued meds cannot be 
recorded. 
 The rationale and decision 
making for prescribing not 
captured. 


















































the MDS has 





Interview 7 (54-59) At the moment the MDS is 
absolutely of no value for audit purposes to me.  I 
absolutely do not input all the data and I cannot 
say that the information is accurate or up to date.  
I think the last time I inputted data was nearly 8 
months ago. I’m embarrassed to say. Also access 
to a computer is limited here in our hospital and 
very slow so entering prescriptions takes so much 
time. 
 
Interview 6 (78-82) There is a lot in prescribing 
and the MDS does not reflect that workload. As I 
said you just input the patient’s name, date the 
drug you prescribe, dosage and the reason why 
which is very limited choice and that’s all that is on 
the database. Everything I do for the patient is 




 The MDS is a bottleneck for 
prescribing. 
 Access to computers is limited 
and infrastructure poor 
 Duplication of information 
increases workloads. 




 The MDS is an inaccurate 
reflection of workload. 
 Nurses do not have an issues 
with prescribing, just the MDS 
 Prescribing is very beneficial 









































the MDS has 




Interview 3 (55-58) There are four prescribers here 
and one I know does not input any data to the 
MDS but I don’t know about the others. So the 
MDS is not a true representation of the 
prescriptions written here.  
 
Interview 3 (74-80) There is an awful lot of 
repetition do you know between the nursing notes 
and the medical notes…it’s just time consuming. I 
don’t have time to input the prescriptions I write 





 Not all prescriptions written 
are inputted onto the 
database. 
 The MDS is an unreliable 
source of information for staff 

































the MDS has 
on the nurse 
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what I prescribe, date and time. I could have about 
5 or 10 of them in my pocket or they could be 
gathering for two or three weeks or more in my 
locker.  I know they say make time but it’s hard. I 
don’t input all of the information to the MDS. May 
be down the line if they are doing an audit or 
something but, like I say it won’t reflect what we 
are prescribing on the wards and I don’t know why 
we have it at all.  
 
Interview 7 (25-28) My prescription record is 
better viewed through the records kept here in 
this hospital, so if anyone wanted to look back or 
ask about a certain prescription I would have a 





 Separate recording systems are 
developed in practice to meet 
clinical needs. 
 Relevance of MDS information 



















Qualitative studies need to demonstrate different standards of rigour 
than quantitative studies. According to Lincoln and Guba (1985) the criteria 
for rigour in qualitative research are to be expressed as trustworthiness and 
their credibility, transferability, dependability, and confirmability. Techniques 
used to meet criteria for trustworthiness were (1) peer debriefing, which ‘ is a 
process of exposing oneself to a disinterested peer in a manner paralleling an 
analytical session and for the purpose of exploring aspects of the inquiry that 
might otherwise remain only implicit within the inquirer's mind’ (Lincoln & 
Guba, 1985 p 308); (2) when the researcher derives themes from one 
interview, the themes will be checked against other transcripts to ensure they 
also appropriately indicated within the content of these interviews; (3) 
member checks, in which participant are asked to validate emerging themes 
and confirm accuracy of findings (Colaizzi, 1978 (Step 7), Lincoln & Guba, 
1985); and (4) an audit trail of the systematic process were made to allow 
transparency of decision-making. Similar steps are identified in Ryan et al. 




Three main themes emerged from the analysis of the data, each of which 
is elaborated on in this section. While the themes are distinctive and 
demonstrate that the NPs recognise and identify benefits and challenges to 
inputting data, they also had reservations about the effectiveness of the MDS 





4.4.1 Theme 1 - Communication  
 
The most immediately apparent issue for all participants was 
communication that was perceived as inadequate between the HSE (decision-
makers) and the NPs (participants), and which seemed to be controlled by the 
HSE. In particular, nurse prescribers explained how the lack of communication 
regarding the MDS caused frustration because the challenges experienced 
with inputting data in the clinical setting were not acknowledged or 
recognised. The situation was further compounded by the fact that when the 
HSE introduced the MDS in 2008, NPs were clearly informed that the initiative 
would be revisited after one year. When this did not transpire, participants 
sought guidance from colleagues, Nurse Practice Development Coordinators 
and Directors of Nursing on how to manage the issues encountered with the 
MDS. 
‘...so I was under the impression from the first ehmm...nurse prescribing 
course (2007) that it would be a year that we would have to input the 
information on the MDS then it would be reviewed...and I or my colleagues 
never heard anything about it being reviewed since then…So, I stopped 
inputting data in 2010. I did contact the HSE via email and tried to make 
phone contact but I got no reply. ….the nurse practice development 
coordinator fed it back nationally that there were issues with the minimum 
data set and prescribers in her site were stopping inputting data for that 
reason…we heard nothing’. 
(Nurse Prescriber 1) 
 
‘I made phone calls and sent email to the HSE regarding issues I had with the 
MDS but I got no reply…I just didn’t have the time to keep contacting them’.  
 






In addition, participants reported that a properly structured 
communication system was a priority for NPs to facilitate them in foreseeing 
and adjusting their responses to the prescribing process including the data 
monitoring system. The lack of response to emails and phone call queries by 
the HSE raised even more questions by the nurse prescribers.  
 ‘…why be monitored so closely…we are autonomous in our practice 
and we are able to make decisions that we can stand by and there are no 
mistakes being made by nurse prescribers?’ 
(Nurse Prescriber 8) 
 
 ‘…I have no other issue with prescribing just the MDS and the 
restrictiveness of it’. 
(Nurse Prescriber 1) 
 
Failure by the HSE to respond to direct queries by the participants was 
interpreted by participants as the HSE having a limited understanding of the 
NPs role and additional workload which means their contributions appeared 
to be unrecognised and undervalued. The task of reporting on each 
prescription written by inputting the information into the MDS is now 
questioned by the majority of participants to its value and accuracy, 
considering four of the participants do not input any data and five of the 
participants only input data on a proportion of prescriptions written. In fact, 
NPs voiced concerns that the end user and technology did not interact to 
achieve a common goal and having the means to record nurse prescribing 





‘I discussed it (MDS) with colleagues and other advanced nurse 
practitioners everybody had the same gripe that it was of little value to the 
clinical area and patient’.  
(Nurse Prescriber 2) 
 
‘Prescribing is really valuable to my work…I absolutely don't input data 
to the MDS and I cannot say it’s even accurate, or up to date I think the last 
time I inputted data on it was nearly eight months ago…I know from talking to 
other nurse prescribers I am not the only one not inputting data’. 
(Nurse Prescriber 7) 
 
It was important for NPs that they felt able to trust and have confidence 
in the nurse prescribing structures, particularly communication managed by 
the HSE.  As the role of nurse prescribing develops, it has become clear to 
participants that the absence of established structures for exchanging 
information constitutes a one-way communication structure that does not 
facilitate the communication of clinical issues which impacts on nurse 
prescribing back to the HSE. 
 ‘…the MDS is causing a terrible bottleneck …the unfortunate thing 
about it is that it is actually affecting patients and prescribing’. 








4.3.2 Theme 2 - Workload and time  
 
Having the time to prescribe was a concern for all participants because of 
the impact of the moratorium on recruitment employed by the HSE in 2009. 
Resulting problems identified by the participants included frontline disorder, 
staff shortages, rising patient waiting lists, ward and bed closures, and 
increased trolley numbers in emergency departments. The research 
participants’ views suggested that they have to satisfy unrealistic 
expectations by coping with an unacceptable working environment to meet 
the HSE’s financial targets. Assessing and meeting the more complex health 
needs of patient medications requires time and participants reported 
difficulties because of increasing reductions in staffing levels and time 
available to complete their work in the clinical setting. 
 ‘…when I do prescribe it’s time is an issue… I can’t spend a whole lot of 
time with the patient because the next patient is waiting on a trolley’.  
(Nurse Prescriber 2) 
 
‘If I have 10 minutes to spare, inputting data to the MDS is not a 
priority by no means there is a way more to do and this (the MDS) is down at 
the bottom of the list really to be honest.’ 
(Nurse Prescriber 3) 
 
The components of stress and workload balance highlighted by 
participants tend to relate to excessive work, rather than challenging care 
situations. The participants’ cognisance of their workloads was defined in 





(documentation) patient communication and education. Several issues were 
identified as increasing workload problems.  The issue highlighted most was 
duplication of documented information regarding prescribing. 
 ‘There is a lot of repetition, like I would have to document in the 
medication chart first, then the nursing notes, then the medical notes and by 
the time you get to the MDS it comes down to whether or not I have time to 
input data’. 
(Nurse Prescriber 3) 
 
 ‘… the MDS is not a true representation of the prescriptions written 
here so we keep our own records of prescribing…I don’t like the MDS because I 
don’t use the information for anything’. 
(Nurse Prescriber 3) 
 
Because of time and workload constraints, narrow parameters of the 
data system and incomplete entry of data to the MDS, NPs now identify the 
MDS as inaccurate and time consuming with little benefit for practice, 
patients or audit purposes. This situation has resulted in the development of 
separate audit structures being put in place depending on the local 
requirements.  
 ‘the database provides you with none of the quality indicators I feel 
support best practice in relation to prescribing…I use an auditing tool we 
devised here in the hospital for auditing my prescribing now, not the MDS’.  





‘…I can imagine what ever data is pulled off it if it is looking at 
reflection of numbers of nurses prescribing I can tell you now it is not 
accurate…the data is absolutely skewed and flawed…I do not use it for 
auditing.’   
(Nurse Prescriber 7) 
 
 ‘the data on the MDS is flawed and does not capture information on 
diagnosis, comorbidities, or drug interaction and should not be used for 
reports or research’. 
(Nurse Prescriber 8) 
 
At present, NPs feel there is limited understanding of their role and the 
additional workload of the prescribing process that is taken on in addition to 
an already full clinical workload. Whilst some participants felt that having a 
means of identifying when NPs were becoming overburdened was important, 
others felt that there was the additional element of valuable data loss which 
contributed to the negative reaction to the MDS that needed to be 
addressed.   
 ‘…it is totally of no use to me personally (MDS)and I suppose 
ahmm...this sounds awful but we often wonder what it’s for I wonder what it's 
for…but I do feel there is valuable data that needs to be captured and used 
more appropriately’.                                                                                                          
(Nurse Prescriber 7) 
Now that participants are experiencing the MDS as an obstacle with little 





 ‘…I think the MDS is overkill and is not of any benefit to the prescriber 
or patient…if I didn’t have the MDS in place I would be more inclined to 
prescribe for patients’.   
(Nurse Prescriber 6) 
 
Comparisons were also made between the prescribing process in place 
for nurses and those for doctors. As doctors are not required to input their 
prescriptions onto a database, six respondents felt it was more time efficient 
to get the doctor to prescribe. 
 ‘The main problem I have is the time it takes and….doctors don’t have 
to do it (input data) so I just ask them to prescribe it’s easier’. 
(Nurse Prescriber 8) 
 
4.4.3 Theme 3 – Attitude and behaviour 
 
In general, participants’ attitudes to NP were very positive and they 
agreed that having prescribing rights improved continuity of care and delivery 
time for patients. However, the impact on their own workload did cause them 
concern because they did not experience any significant change to work 
arrangements to accommodate the prescribing process once registered as a 
NP. 
 ‘The extra work prescribing generates is always in the back of my 
mind…and controls my decision to prescribe or not, yes it’s a big element of 
my decision to prescribe’.  





The same participant avoided prescribing complex medications or taking 
on high-risk patients because of their inability to take on the extra workload. 
It’s (MDS) stopping patient care and that’s not what nurse prescribing was 
about in the first place. The MDS is defeating the purpose of prescribing for 
me’. 
(Nurse Prescriber 5) 
 
 
NPs appear to react to their environment in an evaluative fashion and, 
the structures of the prescribing process that are controlled by the use of 
standards, policies and improved patient outcomes. This was perceived by  
many participants as a reliable impetus for the administration of a medication 
in a safe, consistent and structured manner for clients/patients. 
 ‘…with nurse prescribing organisational policy in place we are within 
our own comfort zone and have the knowledge base… that’s good’. 
(Nurse Prescriber 4) 
 
It was important for participants that they continued to trust the 
structures in place that support NP. Consequently, they expressed concern 
regarding the process of evaluation and lack of representation from their 
clinical areas for such procedures. In particular, participants felt that NPs 
views on structures in place and relevance of these structures to patients and 
practice was central to the future development as nurse prescribing was 





‘... I am very happy to prescribe, I am very happy to do the 
assessments I just find the MDS is a complete waste of my time, I find very 
stressful…and you see there is no benefit in it for me.’ 
(Nurse Prescriber 10) 
 
However, participants found it is difficult to align their thoughts and 
actions with the expectations and change experiences within the HSE because 
of its state of continuous flux. In fact, each nurse prescriber’s unique 
understanding of what change is, or what change represents, seems to add to 
the formulation of attitudes and reactions to change in the clinical setting. 
This situation appears to be causing considerable frustration to the research 
participants and the prescribing process. 
 ‘Prescribing can be very frustrating because it’s such a good course 
and you learn so much…in fact it is the best course I have ever done …it’s just  
so frustrating when you can’t use it more…it (MDS) even stop you from 
extending your CPA (collaborative practice agreement)’.  
(Nurse Prescriber 11) 
 
 ‘I get very stressed out about it, I worry about not filling it, I just do not 
…absolutely not have any time in my working week even to consider putting 
data into the MDS’.                                                                                                                     
(Nurse Prescriber 7) 
 
Participants felt that role overload and expansion of duties without clear 
description was causing problems for them as prescribers. The extra time that 





its costs to patients, and participants would like to see role expansion and 
increased work load offset with sufficient support. In addition, participants 
felt that they were in a good position to identify and resolve underlying 
systemic issues and offer ideas for possible resolution to issues encountered 
with the MDS.  
‘…I thought the MDS was to be in place for one year and then it would 
be reviewed, but that was six years ago… and like any new initiative there are 
things that work and things that don’t but no one came back to the 
prescribers using the system(MDS) to find out what they were’.  
(Nurse Prescriber 6) 
 
Many participants felt that reassessment of the MDS in consultation with 
NPs is required in order to ensure that valuable nurse prescribing data does 
not continue to be lost.  
‘…I would say having the right to prescribe is very beneficial but the 
MDS stops me from prescribing’.  
(Nurse Prescriber 12) 
 
‘…nurse prescribing is the greatest thing I have experienced in years 
and years ...it's brilliant…but I have so many issues with the MDS’. 
    (Nurse Prescriber 10) 
 
These quotes demonstrate the importance of nurse prescribing and the 





clinical setting. The MDS appears to be creating a negative attitude to 
prescribing because the participants cannot see the benefit of results 
considering the time that is required to input the data onto the system. 
‘…the (MDS) information is not beneficial and the way I look at it now 
is …if I didn’t have the MDS in place I would be more inclined to prescribe for 
patients’. 





Findings indicate that participants believe prescribing rights for nurses is 
of significant benefit in the healthcare service, results that are comparable 
with those identified in other settings where nurses prescribe medicines 
(Avery, 2004, Latter et al., 2005, Courtenay and Berry, 2007a, Stenner and 
Courtenay, 2008, Courtenay et al., 2010b, Bowskill et al., 2012). However, 
findings also provide insight into some of the concerns and anxieties nurse 
prescribers had regarding data recording that has been described by the HSE 
as a ‘mandatory’ part of the prescribing process. Factors identified that 
contribute to these anxieties and concerns are. 
 
 The Minimum Data Set (Perceived value)  
 Communication  
 Staffing levels  






Since commencing this research the HSE has undertaken a review of the 
data collection system (Health Service Executive, 2014a)  the main challenges of 
the system were identified as time constraints, additional work, deterrent to 
prescribing, inaccurate statistics published, benefit of the database. Perhaps 
these challenges identified are better understood in the context of the HSE 
National Implementation Report (Health Service Executive, 2014b) which states 
1067 nurses and midwives have been funded to undertake the NP programme 
to date. However, the numbers of registered nurse prescribers in the country as 
of March 2014 was 772 equating to 72.3% of the nurses and midwives who 
have been funded and completed the education programme since April 2007. 
Significant repetition of information appears throughout this bi-monthly report 
(Health Service Executive, 2014b) and information gleaned from the data 
strategy provides little or no benefit to the prescriber, organisation or patient, 
considering the time and effort spent on inputting data.  More significantly, my 
results find that the database does not capture important data on diagnosis, 
patient age, co-morbidities, drug interactions or discontinuation of drugs that 
could be cross-referenced to inform practice and policy. Participants 
acknowledged this from their concern that the database end-user and 
technology do not interact to achieve a common goal. Perhaps the independent 
lists contained in the data and identified by O’Halloran (2010) as not 
structurally designed to generate queries need to be addressed before the data 
are viewed as valuable in the clinical setting. NPs have moved beyond the 
simplistic presentation of prescribing data in the National Implementation 
Report (Health Service Executive, 2014c) to now understanding that recorded 
prescribing data is information that could be valuable to inform their decision 
making and guide quality improvement. Perceived and real inefficiencies in the 
MDS encouraged the nurse prescribers to use ‘workarounds’ (Lawler et al., 
2011). These are locally-constructed paper-based alternatives that meet their 





‘workarounds’ may benefit the nurse prescriber they are also a manifestation of 
the incompatibility with the MDS and clinical requirements. Resolving 
competing demands by managing nurse prescribing data using ‘workarounds’ 
creates new pathways of documentation that must now be cross referenced 
with the MDS to fully understand the challenges of nurse prescribing in 
practice. NPs identified that their prescribing workload is under represented in 
the MDS, a fact that is supported by the National Implementation Report 
(2014c). Considering the source of the data, findings from this research would 
dispute the accuracy of these figures which are, in fact, a serious under-
reporting of the actual prescribing for this time period. The dramatically 
reduced HSE nursing staff levels by 5,197 in the last five years (O' Regan, 2013) 
further support concerns regarding unacknowledged workloads. These figures, 
together with my results, imply that clinical workloads have been increased 
substantially since the introduction of nurse prescribing to the clinical setting 
without consideration for altering existing arrangements or roles. Difficulties in 
adapting to such demands on time in the clinical setting appeared with nurse 
prescribers reducing the numbers of prescriptions written, asking the doctor to 
prescribe, not expanding their collaborative practice agreement to add new 
drugs or simply not prescribing. Whilst participants believe that prescribing is 
very beneficial, these difficulties have caused stress for the NP which is now 
becoming an inhibiting factor to the initiative making it unattractive, 
problematic and leading to a non-supportive attitude (Vakola and Nikolaou, 
2005).  However, participants were also aware that smart use of prescribing 
data and information is an important component of creating a responsive 
system that contributes positively to the nurse prescribing initiative and 
provides opportunity to improve health in terms of both quality and cost. 
Having access to good data that are accurate, reliable and consistent, reflects 
what is really happening in practice with nurse prescribing. Interpretation of 





issues/problem identified in the study. Participants have revealed an insightful 
understanding of the nurse prescribing processes and are well placed to select 
the most appropriate interventions to establish implementation strategies in 
collaboration with the HSE to improve workload issues in their particular clinical 
setting. 
Evidence from this research finds the MDS is designed to meet different 
needs than those of the local clinical areas, making it difficult to implement. 
This in turn results in reduced productivity and access to nurse prescribing 
information that is a critical component of future patient care and safety. The 
task for the HSE is to re-evaluate the design of the MDS to ensure benefits 
significantly outweigh the disadvantages clearly communicated by the 




The concept of the MDS has potential valuable and NPs recognise the 
integral connection of nurse prescribing data to evidence-based practice and 
the role both those components play in clinical decision making, nursing 
research, professional development, operational effectiveness, and 
ultimately, the patient-nurse relationship. However, nurses need to be 
actively involved in the MDS, so the right information and knowledge 
required to support care is targeted and the transition from informed patient 
care to patient informed care is developed to improve prescribing expertise. 
The role of the NP is clearly an important element of future healthcare, 
and issues surrounding workload management, and communication needs to 
be addressed by the HSE to guarantee appropriate and accurate management 





information management as demonstrated by international research in the 
long (term see section 4.1).  
The paradox for NPs at present is that on one hand they are a service that 
is valued by patients and, on the other, a disenfranchised, overworked and 
undervalued group of staff within the health organisation. Further 
investigation into the unregistered nurse prescribers who have successfully 
completed the education programme is required to understand if the 




The author would like to thank the nurse prescribers who generously 
gave of their time to participate in the interviews for this study. 
 







CHAPTER 5 IRISH/UK 
QUESTIONNAIRE: 
UNDERSTANDING THE 
PARALLELS BETWEEN NURSE 
PRESCRIBERS IN IRELAND 
AND THE UNITED KINGDOM 
USING A SURVEY STUDY 
DESIGN 
 
 Chapter 5 – describes a survey which was designed to understand how 
nurse prescribers in Ireland compare with their counterparts in the United 
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Since the introduction of nurse prescribing to the Irish healthcare setting 
in 2007 there has been significant changes experienced within the health 
service making the outcome of the initiative difficult to predict. Evidence from 
existing research is focused within the country (Drennan et al., 2009, 
Naughton et al., 2012) and does not give an indication of how nurse 
prescribers in Ireland compare with international counterparts.  
Following the introduction of prescribing authority to the Irish setting the 
nurses’ professional role has expanded considerably. In particular, prescribing 
authority has expanded the core function of nursing and, as a result, 
significantly extends the horizons for the future of the nursing profession in 
Ireland, (Creedon, 2010b). Today, nurse prescribing is considered an essential 
part of nursing practice in our health service nationally (Drennan et al., 2011) 
with 772 nurses and midwives registered to prescribe medications producing 
34,688 prescriptions for 27,405 patients during the year 2014 (Health Service 
Executive, 2014b).   
In the United Kingdom (UK) expansion of nursing practice to include 
prescribing authority began in 1994 and has developed steadily in the interim. 
During 2010, nurse prescribing across the UK produced 12.8 million 
prescriptions (RCN, 2010). Similar to Ireland, nurse prescribing in the UK is an 
independently registerable qualification that complements a more patient-
centred way of working that emphasises an integrative approach to care 
delivery at primary, secondary and tertiary levels within the health services. 
Emphasis is also placed on quality, standards, education and ongoing 
evaluation of the prescribing initiative which has challenged traditional 
approaches to nursing care (Bradley et al., 2007) that were previously based 
on tasks, rituals and workforce division (An Bord Altranais, 2012a, RCN, 2012). 
However, international differences between legislative procedures and 
professional bodies responsible for the regulation of nurse prescribing have 
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resulted in the implementation of several models of prescribing worldwide 
(An Bord Altranais and NMPDU, 2005, Kroezen et al., 2012). The two models 
most often discussed in the literature are independent and supplementary 
nurse prescribing with each role having clear directives (Courtenay et al., 
2007c, Kroezen et al., 2012). The independent prescribing model is 
autonomous allowing NPs to diagnose and prescribe without direct medical 
involvement in the process. The supplementary prescribing model is based on 
a voluntary prescribing partnership between the doctor and the nurse once 
the patient has been diagnosed by a doctor.  
In Ireland the independent nurse prescribing model is used to facilitate 
prescribing using a limited number of medicines that are listed in a 
collaborative practice agreement (CPA). Each NP develops their own CPA that 
specifically outlines the medicines for their practice area and which are 
approved by the Drugs and Therapeutics committee, medical consultant and 
representatives from the health care setting, usually the Director of Nursing 
or relevant manager. The CPA can be adjusted at any time depending on the 
service needs but as part of the national evaluation in 2009 (Drennan et al., 
2009) it was recommended to consider phasing out the CPA. The 
supplementary model of nurse prescribing utilised in the UK is not supported 
in the Irish setting because there was a concerted effort to move away from 
protocols already in place in practice. 
Outcomes of new nursing initiatives are often difficult to predict with 
certainty. While many nurses acknowledge that prescribing authority is fast 
becoming an essential part of clinical practice, there are others of the opinion 
that restrictive structures in place for nurse prescribing does not allow the 
role to reach its full potential (Ross and Kettles, 2012, Coull et al., 2013, 
Creedon et al., 2014). Many questions about the role of NPs remain 
unanswered (Kroezen et al., 2012) and, in addition to restrictive structures, 
support and autonomy have come to the fore requiring consideration. The 
uncertainty of evidence from existing research about such issues is made 
more obvious by the ongoing considerable challenge of engaging Irish NPs 
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who delay registration once the educational preparation for prescribing had 
been completed (Health Service Executive, 2014b). 
Given that the Health Service Executive (HSE) in Ireland is committed to 
increasing the number of prescribers, it is important to evaluate nurses’ 
experiences of this process and identify key issues that need to be addressed 
or amended to ensure improvement continues. Therefore, this study 
examined the perceptions of NPs in Ireland in relation to their counterparts in 





The aim of the study was to gain an understanding of how Irish NPs 
practice, their competence, perceptions of the role and future needs 




In order for the researcher to gain different perspectives and draw 
attention to different factors that affect NPs, descriptive research methods 
were employed in this study to provide a snapshot of prescribing in practice 
and surrounding issues. Descriptive research deals with questions that seek to 
explain what things are like and describe relationships but do not predict 
relationships between variables or the direction of the relationship (Michel, 
2008). The main objective is therefore ‘the accurate portrayal of the 
characteristics of persons, situations or groups and or the frequency with 
which certain phenomenon occurs’ (Polit and Beck, 2012, p. 752). The 
intention of this methodology is that descriptive research provides a relatively 
complete picture of what is occurring at a given time in the area of nurse 
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prescribing. The methods of collecting data for descriptive research can be 
employed singly or in various combinations, provisional to the research 
questions at hand. Depending on the methodology utilised, data can be 
tangible (quantitative) or abstract (qualitative). As each type of descriptive 
data provides different representations of the world, their integration widens 




A survey design was used; participants were asked to self-complete an 
online questionnaire that was distributed via Survey Monkey®. Whilst many 
people think of a questionnaire as the “survey”, the questionnaire is just one 
part of the survey process. Surveys also require selecting populations for 
inclusion, pre-testing instruments, determining delivery methods, ensuring 
validity, and analysing results (Gray, 2014). In general, questionnaires are 
relatively quick to collect information and offer the possibility for respondents 
to remain anonymous and are suitable for sensitive topics which people may 
be reluctant to talk about in person. Nonetheless, in some situations 
questionnaires can not only they take a long time to design but also to apply 
and analyse. 
The questionnaire was modified by the authors. A combination of open 
and closed questions was used in the questionnaire. Closed questions (apart 
from the demographic and CPD data) were in a format of five possible 
answers for each question (accepting only one right answer) according to the 
5-point Likert Scale a model that complemented data entry and statistical 
analysis (Appendix 8).  
The research evaluated the consistency and understanding of the 
completed questionnaires from the pilot group and, after modifying the 
wording of some questions, the final draft was created for the Irish 
participants (questions 1-43). This draft was then reviewed by an advanced 
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nurse practitioner with prescribing rights in the UK to ensure terminology 
used was appropriate. Before implementing the UK questionnaire, further 
adjustment to wording was required for clarity (Appendix 9). Similar to the 
Irish questionnaire, UK respondents were asked to tick a box to indicate their 
responses or comment on a negative answer to ensure qualitative data was 
also generated from this section of the research. 
 Validity of research is a complex concept that is broadly concerns with 
the soundness of the study evidence (Polit and Beck, 2012). Specifically, for 
questionnaires validity, one of the greatest risks in developing response sets 
is leaving out an important alternative or response (Burns and Grove, 2005). 
For the purpose of this research validity is the extent to which a test 
measures what it is supposed to measure and is raised in the context of the 
three perspectives, identified by Burns and Grove (2005) as the form of the 
test, the purpose of the test and the population for whom it is intended.   
Understanding the target audience for which the questionnaire was 
developed was important for the researcher to ensure the relevance and 
comprehensiveness of the questions were appropriately structured.  
In order to support face content validity, the questionnaire structure and 
format was based on a modified version of previous work undertaken for the 
national evaluation of nurse prescribing (Drennan et al., 2009). In addition to 
assure clarity, accuracy and consistency of the questions, the questionnaire 
was piloted with ten Irish NPs. After completing the questionnaire, 
respondents in the pilot sample were asked to comment on its ease of 
completion, and if they experienced any difficulties understanding what was 
required of them at any point throughout the questionnaire. It was evident 
from the completed questionnaires that both the format and content of the 
questions were appropriate. A pilot of the UK version of the questionnaire 
was undertaken with an advanced nurse practitioner.  However, to further 
enhance the face and content validity of the questionnaire it was reviewed in 
conjunction with the research supervisors to ensure questions were phrased 
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appropriately together with options for responding. As a result, for clarity, 
further adjustments incorporated amendments to language were 
subsequently made to the final version of the questionnaire.  
Unlike the original questionnaire, this study did not combine any items to 
form a scale therefore Cronbach's alpha was not reported.  
 
5.3.2 Ethics approval 
 
A proposal was submitted for examination to the Clinical Ethics Research 
Committee, University College Cork. The study met the research governance 




Convenient samples of NPs registered in Ireland and the UK were emailed 
extending an invitation to participate; this email contained information about 
the study and contact details for the researcher should the potential 
participant require further information (Appendix 11). In addition, the email 
informed the potential participants that the study was completely voluntary, 
responses were strictly confidential and privacy assured. Consent to 
participate in the survey was assumed on the basis of a returned and 
completed questionnaire. Those who wished to participate used the 
electronic link within the email to access the online survey and simple 
instructions were included on how to complete the questions. Data collected 
included demographic information, level of satisfaction experienced by NPs 
and possible need for continuing professional development. Data collection 




At the time of data collection, there were two educational institutions 
delivering the nurse prescribing education programme in Ireland, University 
College Cork (UCC) located in the HSE South and the Royal College of 
Surgeons in Ireland (RCSI) located in the HSE East. When approached, access 
to the students at the RCSI site was not facilitated. To counteract this access 
issue, the National Nursing and Midwifery Board Ireland (NMBI formally ABA) 
was also approached to accommodate broader access but the request was 
not facilitated. In order to ensure inclusion of the NPs from the HSE East, 
individual hospitals were contacted directly through site coordinators and 
Directors of Nursing requesting participants for the study. A total of 140 
potential participants were identified for the study at the end of this process. 
After two email reminders and delivery of a hardcopy of the questionnaires 
with a personalised letters to each potential participant by post, 70 (50%) 
completed questionnaires were returned by the Irish NPs (60 from the HSE 
South and 10 from the HSE East).  
UK NPs was accessed through the membership list of the Association of 
Nurse Prescribing database. This association is an independent organisation, 
providing support and education for nurses in their role as a prescriber. All 
members were sent an email invitation by the Association of Nurse 
Prescribers administrator to participate in the online survey. The Association 
of Nurse Prescribers members’ database was used to disseminate the 
questionnaire. A total of 346 (29%) completed questionnaires were returned 
from the UK. 
 
5.3.4 Data analysis  
 
Descriptive statistics were used to describe the characteristics of the Irish 
and UK respondents. Categorical data were described numerically using 
frequency (percentage) and graphically using bar charts. For comparisons 
between Irish and UK respondents, the chi-squared test or Fisher’s exact test 
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(in the case of small expected counts) were used for nominal categorical 
variables and the Mann-Whitney test was used for ordered categorical 
variables. All statistical analyses were performed using IBM SPSS Statistics 
22.0 (Illinois, Chicago) or Stata 9.2 (TX, USA). All tests were two-sided and a p-
value <0.05 was considered to be statistically significant. The purpose of this 
section of the research was not to prove a difference or identify a study 
hypothesis but a start point or baseline research that could generate a study 
hypothesis for future research on the topic as no previous studies have been 




Of the potential 140 nurse prescribing participants working in care of the 
elderly in Ireland a total of 70 (50%) returned completed questionnaires. In 
the UK 1,200 potential participants were invited to participate 346 (29%) 
returned completed questionnaires. 
 
5.4.1 Nurse prescribers’ profile and service provision 
 
The first section of the questionnaire reported on the demographic, 
professional and academic profile of the NPs in both Ireland and the UK 
(Table 5.1). Demographic data revealed that the highest concentration of NPs 
for both groups in the age range 40-54 years. Details of participants’ 
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Staff nurse 
District/primary care nurse 
Practice nurse   
Nurse practitioner 
Clinical nurse manager 
Advanced nurse practitioner 
Consultant 
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General hospital practice area 
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Participants from the UK were older (p<0.001) with 37% of them aged 50 
years and above compared with 20% of Irish participants. Similarly, 
participants from the UK had more years of clinical experience (p<0.001) with 
73% of them having greater than 20 years of experience compared with 37% 
for Irish participants. No differences were found between the UK and Irish 
participants regarding their academic qualifications (p=0.259). Respondents 
were asked to give details of their current employment position and area of 
clinical practice. A wide range of positions and area of practice were reported 
a summary of which is set out in Table 5.1 
 
5.4.2 Prescribing independence  
 
Participants were asked how independently they prescribed in practice.  
However, for the purpose of this question, a specified list equated to 
independently prescribing medications from a list of drugs agreed with the 
organisation and a predetermined list referred to supply and administration 
of medications using directives set by the organisation without input from the 
NP. Responses indicated that 88% of prescribers from the UK were more 
likely to prescribe independently from a national formulary whereas the 
majority of Irish participants (97%) prescribe from a specified list. In addition, 
51% Irish participants were also more likely to prescribe from a 
predetermined list sanctioned by the local health care organisation whereas 
only 38% of UK respondents follow this route of prescribing. None of the Irish 
participants had their prescriptions co-signed by a doctor compared with 8% 






TABLE 0-2 PRESCRIBING INDEPENDENCE 
 Ireland UK  










I independently prescribe from a 
national formulary 
 
I prescribe from a specialised list  
 
I prescribe from a predetermined 
list 
 
















































1 From chi-squared test unless otherwise stated; 2 From Fisher’s exact test 
 
In this section, respondents were asked to give details regarding the 
prescribing consultation process which facilitated a decision to prescribe or 
not.  
 
5.4.3 Workload within the prescribing process  
 
To gain a better understanding on the number of prescriptions written by 
NPs, respondents were asked to indicate the number of prescriptions they 
issued each month. Differences in prescription patterns between Ireland and 




FIGURE 0.1NUMBER OF PRESCRIPTIONS WRITTEN PER WEEK 
 
However, the time dedicated to prescribing each week was greater in the 
UK than Ireland (Table 5.3). 
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10(14.7) 




















































Perhaps a more accurate reflection of the consultations (workload) 
involved in prescribing medications can be viewed in Table 5.4 considering 
that not all consultations result in a medication being prescribed.  
Respondents were also asked to indicate if consultations were required 
for the purpose of education, titration, and discontinuation of medications 
depending on the specialty and/or patients’ health problems. Respondents 
indicated that consultations varied in duration depending on the patient’s 
needs. Irish participants (36%) had a higher ratio of consultation that resulted 
in the prescribing of a medication than UK participants (17%). However, UK 
participants had a higher ratio of consultations resulting in the 
discontinuation of medications compared with Irish participants (Table 5.4) 




TABLE 0-4 CONSULTATIONS UNDERTAKEN PER WEEK FOR PRESCRIBING/AMENDMENT OF MEDIATION 
  
Consultation resulting in the 
prescribing of a medication 
 
Consultation resulting in the 
amendment of a medication 
 
 
Consultation resulting in the 
discontinuation of a medication 





















1 in 2 
1 in 3 
1 in 4 
1 in 5 
1 in 6 
1 in 7 



























































On average, participants from Ireland had longer consultations than their 
counterparts in the UK with the majority of respondents in both Ireland and the 
UK requiring 15-30 minutes to complete the process of prescribing (figure 5.2).  
 
FIGURE 0.2 LENGTH OF CONSULTATIONS  
 
Considering the time involved in prescribing, respondents were asked how 
advantageous prescribing authority was to their practice. Both cohorts 
responded positively with 98% of UK respondents and 95.7% of Irish 
respondents answering ‘very positive’ nevertheless, there were concerns 
regarding increased workload with the majority of respondents from both 
Ireland and the UK affirming a significant increase in workloads. A more accurate 
reflection of the increased workload involved in prescribing medications can be 
























FIGURE 0.3 PARTICIPANTS PERCEPTIONS OF INCREASED WORKLOADS 
 
5.4.4 Satisfaction and autonomy 
 
Both cohorts of respondents identified that there were significant increases 
in their satisfaction, autonomy and confidence because of prescribing. Table 5.5 
gives specific details of prescribers’ perceptions with differences found between 
the Irish and UK participants for seven of the 22 statements regarding 
prescriber’s perceptions of their role. Support from doctors was enjoyed by 
100% of Irish NPs as opposed to 87% of UK NPs. Seventy nine percent of Irish 
participants felt they were less dependent on doctors compared with 90% of UK 
participants who agreed with this statement. However, a frustration with 
prescribing from a pre-approved list was experienced by 46% of Irish participants 
compared with 20% of UK participants.   
 
 
1 8 19 39 33
0 11 10 33 46






Neither agree nor disagree Agree
Strongly agree
Has the introduction of nurse prescribing to your role 
increased your workload? 
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TABLE 0-5 PRESCRIBERS’ PERCEPTION OF THEIR ROLE 
1 
From chi-squared test unless otherwise stated; 
2 
From Fisher’s exact test
 AGREE 








Nurse prescribing has made access to 
medications more convenient for patients 
70 65 (92.3) 346 329 (95.1) 0.393
2 




346 302 (87.3) 0.002 
The prescribing course prepared me 
adequately for my role 
70 58 (82.9) 345 288 (83.5) 0.899 
As a NP I am less dependent on doctors 70 55 (78.6) 345 311 (90.1) 0.006 
I have greater satisfaction and autonomy 70 64 (91.4) 345 326 (94.5) 0.405
2 
My professional status has improved 68 52 (76.5) 345 243 (70.4) 0.314 
The additional responsibility causes 
anxiety 
70 22 (31.4) 345 108 (31.3) 0.984 
I fear making an incorrect diagnosis 76 23 (33.3) 345 100 (29.0) 0.471 
I fear making a medication error 70 29(41.4) 342 150 (43.9) 0.709 
I am frustrated with limitations of 
prescribing from an approved list 
70 32 (45.7) 335 67 (20.0) <0.001 
I would feel confident prescribing a 
greater range of  drugs 
70 43 (61.4) 339 140 (41.3) 0.002 




339 334 (98.5) 0.593
2 
I am confident in my ability in this role 69 67(97.1) 346 333 (96.2) 1
2 
I am confident to communicate with 
patients 
        70 70 
(100.0) 
342 341 (99.7) 1
2
 
I am aware of the cost of drugs 69 50 (72.5) 345 319 (92.5) <0.001 
I treat patients/clients as partners in the 
consultation process 
70 65 (93) 341 334 (97.9) 0.037
2 
I address the principles of adherence with 
patients 
70 63 (90.0) 341 334 (97.9) 0.004
2 













342 341 (99.7) 1
2
 
I keep up to date with current prescribing 
practice 
 
69 66 (95.7) 340 332 (97.6) 0.406
2 
I can critically appraise relevant 
information and apply to practice 
70 68 (97.1) 346 333 (96.2) 1
2
 






The differences identified in seven of the 22 statements regarding NPs 
perceptions of their role are as follows: 
1. “The doctors I work with support nurse prescribing”: 100% of Irish 
participants compared with 87% of UK participants agreed with this 
statement (p=0.002). 
 
2. “As a NP I am less dependent on doctors”: 79% of Irish participants 
compared with 90% of UK participants agreed with this statement 
(p=0.006). 
 
3.  “I am frustrated with limitations of prescribing from an approved list”: 
46% of Irish participants compared with 20% of UK participants 
agreed with this statement (p<0.001). 
 
4. “I would feel confident prescribing a greater range of drugs”: 61% of 
Irish participants compared with 41% of UK participants agreed with 
this statement (p=0.002). 
 
 
5.  “I am aware of the cost of drugs”: 73% of Irish participants compared 
with 93% of UK participants agreed with this statement (p<0.001). 
 
6. “I treat patients/clients as partners in the consultation process”: 93% 
of Irish participants compared with 98% of UK participants agreed 
with this statement (p=0.037). 
 
 
7. “I address the principles of adherence with patients”: 90% of Irish 
participants compared with 98% of UK participants agreed with this 
statement (p=0.004). 
 
NPs were also asked if there were any disadvantages to their prescribing 
(Q 18) and asked to elaborate on a negative response which included 
‘I have difficulties in adapting to increased demands on my time’ 
‘The more prescriptions I write the more paperwork I have’ 
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‘The is no place to record the assessment, education and discontinuation 
or titration of drugs as part of my workload’ 
 
 
5.4.5 Continuing professional development and support  
 
Finally respondents were asked about the amount of support they received 
from their organisation/clinical area for continuing professional development 
(CPD). Seventy percent of Irish participants and 69.9% of UK participants 
indicated that they received adequate support. All respondents gave 
additional information with regards to CPD (Table 5.6). UK participants were 
more likely to have undertaken additional education since completing the 
prescribing programme from both a formal (linked to education programmes) 
and informal (study days, conferences) perspective, whereas a higher number 
of Irish respondents indicated additional CPD was required. 
 
TABLE 0-6 NPS' CPD REQUIREMENTS IN RELATION TO PRESCRIBING 







Undertaken informal CPD to date 
 
57 (81.4) 319 (92.2) 0.005 
Undertaken formal CPD to date 
 
32 (45.7) 221 (63.9) 0.005 
Additional CPD is required 
 
32 (45.7) 114 (32.9) 0.013 
Adequately supported to undertake 
CPD  
 
49 (70.0) 241 (69.7) 0.954 
 
Over 90% of Irish and UK participants would attend industry sponsored 
study days. There was no difference between Irish and UK respondents. UK 
participants were more likely to have undertaken additional education since 
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completing the prescribing programme (43% for UK vs 23% for Irish 
participants, p=0.001).  
 
TABLE 0-7 OTHER QUESTIONS ASKED   









I received support and supervision in 
practice  
 
Would you attend an industry sponsored 
study day?  
 
I have undertaken additional education 
since completing the prescribing 
education programme 
 
Have you changed your job title since 
completing the prescribing programme? 
 
Have you changed your practice area 














































UK participants were more likely to have changed their job title since 
completing the prescribing programme (27% for UK vs 12% for Irish 
participants, p=0.007). UK participants were more likely to have changed their 
practice area since completing the prescribing programme (16% for UK vs 3% 
for Irish participants, p=0.010). 
 
The Irish questionnaire only included additional questions on the 
minimum dataset which revealed the following. When asked if they use the 
minimum set data to inform practice changes there was a significant 
disagreement identified n=44 (62.9%). Participants were also asked if they 
used the data for audit purposes, review of prescribing history, to inform 
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studies and surveys and support discussion regarding prescribing. Results are 
set out in table 5.8 
 









I use the MDS to compile my audit 
reports 
 
I use the MDS to inform practice 
 
I use the MDS to review prescribing 
history 
 
I use the MDS to inform studies and 
surveys 
 







































Findings in relation to these additional questions will be further discussed 




This study is the first to compare Irish and UK NP across a number of areas 
related to prescribing.  Overall, participants have a positive attitude toward 
nurse prescribing (Table 5.5). In particular confidence in communication and 
establishing a partnership with patients returned very high scores which are 






5.5.1 Nurse prescriber’s profile  
 
The majority of participants were highly qualified with extensive 
experience and employed across a number of clinical specialties. The largest 
group of respondents for both settings were employed in the acute care 
setting. Findings are similar to those identified in previous studies (Latter et 
al., 2005, Courtenay and Carey, 2008b, Stenner et al., 2011) whose research 
also included a cross section of nurse prescriber’s from different areas of 
practice.   
 
5.5.2 Role Independence 
 
Responses from the UK can be viewed in the context of having two 
distinct types of prescribing, independent and supplementary, with each role 
having clear directives (Courtenay et al., 2007, Kroezen et al., 2012), whereas, 
the Irish NPs’ independence is negotiated at organizational level and the 
outcome is heavily dependent on the doctor and Drug and Therapeutic 
committee (An Bord Altranais, 2012a). Participants from the UK (88%) were 
more likely to prescribe independently from the national formulary as 
opposed to 18% of Irish nurse prescribers. This percentage returned by Irish 
nurse prescribers does not appear to reflect the Irish prescribing process 
considering all Irish nurses prescriber are governed by a CPA which specifically 
identifies the drugs each NP may prescribe. However, subject to individual 
situations, local structures in place for advanced NPs can vary and may allow 
a more independent prescribing practice hence the return of 18% (n=9). 
Recent work by this research group has identified that the CPA is hampering 
or preventing prescribing in the Irish setting (Creedon et al., 2014). This is a 
direct result of control of the Irish nurses and midwives who prescribe from a 
CPA which is approved by the Drug and Therapeutic Committee and medical 
consultants within the organisation. Having a CPA has led to a two tiered 
approach to prescriptive authority for nurses and doctors causing conflict 
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between nurses’ perceived prescribing role and the role that the organisation 
imposes on them. In addition, doctor’s co-signatures on nurse’s prescriptions 
identified by 8% of UK respondents may be due to a team approach to 
treating patients with multiple comorbidities a situation identified in studies 
by Courtenay et al. (2007) and Carey et al. (2014) as a position nurse 
prescribers may find challenging. No Irish NP identified this within their 
practice, suggesting the possibility that more complex cases are managed by 
doctors because of limitations imposed on NPs by the CPA which restrict the 
drugs available for prescribing. This finding requires further exploration. 
Moreover, the absence of a clear job description for Irish NPs allows further 





Findings provide additional insight into workloads and if prescribers’ 
workloads are to be measured correctly then the hidden workload identified 
in the research needs to be acknowledged considering not all consultations 
conclude with an action.  The range of prescriptions written by respondents in 
Ireland and the UK does not appear to reflect the number of 
consultations/workload undertaken by NPs. This discrepancy is outlined more 
clearly in Table 5.4 (page 120) where consultations resulting in the prescribing 
of a medication are outlined more accurately and represent only a portion of 
consultations undertaken. Similar findings of increased workloads have been 
identified by Coull et al. (2013) and a decision not to prescribe within a 
consultation should also be recognised and is distinct from titrating dosages, 
discontinuing medications and education. 
Identification of hidden workloads is important to NPs as confirmed by 
the response to the question on increased workloads (Figure 5.3). A 
significant number of respondents from Ireland (79%) and UK (73%) identified 
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increased workloads due to increased responsibilities as a result of 
prescribing and the dedicated time required for the prescribing process. 
Incomplete recognition of NPs ‘hidden’ workload in Ireland together with the 
effects of the moratorium has had a negative impact on the numbers of NPs 
in clinical practice (Health Service Executive, 2014c). Difficulties in adapting to 
such increased demands on time in the clinical setting surfaced when 
respondents were asked to expand on negative responses comments. For 
example, to manage the increased prescribing workload, NPs choose to 
reduce the number of prescriptions written, asked the doctor to prescribe or 
simply did not prescribe. Other factors such as assessment, education, 
titration and discontinuation of drugs were identified by participants in this 
study as important elements of the prescribing process considering the cost-
conscious nature of the health service today.   
Acknowledgement of workloads is important to ensure nurse prescribing 
is not regarded as an add-on to the nurses’ role. Respondents must 
sometimes contend with understaffed clinical environment that contribute to 
the responsibilities and at times stressful nature of nurse prescribing. 
However, Carey et al. (2013) was more specific in stating that those 
responsible for service planning need to recognise ‘the diverse range of 
medicines management activities in which nurse prescribers are involved’ (p. 
2073).  This strong response for identification of increased workloads is also 
supported by research undertaken by Coull et al. (2013). 
 
5.5.4 Competence and confidence 
 
Both cohorts of respondents identified that there were significant 
increases in satisfaction autonomy and confidence because of prescribing. 
However, differences were found between the Irish and UK participants for 
seven (of the 22 statements) regarding prescribers perceptions of their role. 
Support for nurse prescribing from doctors was experienced by all of the Irish 
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participants compared with 87% of UK participants. This finding is supported 
by Kerozen et al. (2014) with the exception of some junior doctors who are 
perhaps not as familiar with nurse prescribing in practice. However, a small 
number of nurse prescribers remain dependent on doctors with 79% of Irish 
participants indicating they were less dependent on doctors compared with 
90% of UK participants. These numbers can perhaps be explained by the less 
experienced NPs continuing to need guidance until confidence and 
competence develops in practice.  
Irish participants (46%) also indicated they were frustrated with the 
limitations of prescribing from an approved list as opposed to 20% of UK 
participants. Participants from both cohorts 61% of the Irish and 41% of the 
UK participants also indicated they would feel confident prescribing a greater 
range of medicines.  
UK respondents (93%) were more aware of the cost of medicines 
compared with their Irish counterparts (73%). This is an important factor to 
be investigated further considering a major proportion of the health budget is 
spent on medications each year in both Ireland and the UK. 
 
5.5.5 Continuing Professional Development (CPD) 
 
Respondents reported CPD needs across the majority of clinical areas. 
The role of CPD in nurse prescribing has repeatedly been identified as a 
crucial element in maintaining competence (Otway, 2001, Courtenay et al., 
2007c, Carey and Courtenay, 2010, Dobel-Ober et al., 2013, Weglicki et al., 
2014) and is intrinsic to the nurse prescribing role (Courtenay et al., 2007d, 
Green et al., 2009). UK respondents (92%) were more likely to have 
undertaken CPD compared with (81%) of Irish participants. The majority of 
respondents from both cohorts (70%) believed that they received adequate 
support and supervision in practice similar to findings by Carey et al. (2013). 
However, difficulties identified from free text comments precisely identify a 
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lack of appropriate pharmacology CPD as an ongoing issue which needs 
further investigation. 
In comparison with previous findings (Latter et al., 2005, Carey and 
Courtenay, 2010)  this study divided CPD into formal and informal 
development. Findings identified for formal CPD are similar to Latter et al. 
(2005) who reported that just under 60% of the participants in their study had 
undertaken formal CPD, whereas Carey & Courtenay (2010) reported that 
over 80% of participants had undertaken CPD but did not identify if CPD was 
formal or informal. Courtney et al. (2007d) identified the lack of opportunity 
in maintaining CPD resulted in nurses having less confidence to prescribe in 
comparison with those who engage in CPD on a regular basis but, once 
qualified, the CPD needs of NPs are frequently unmet (Courtenay and Gordon, 
2009). For instance, a specific rationale given for requiring an assessment 
skills revision course were attributed to working in highly specialised areas. 
Respondents identified that assessment skills utilised tended to focus on 
specific systems thereby not allowing the opportunity for continued practice 
on remaining systems which were not specifically linked to the clinical 
specialty of the NP or patient condition. The discrepancy in the responses for 
this question on formal and informal CPD between cohorts of respondents 
may be influenced by the ongoing recruitment moratorium in place in Ireland 
that has resulted in limited opportunity to undertake CPD. Even though 
acquisition of the necessary knowledge to prescribe has been positively 
evaluated (Drennan et al., 2009, Latter et al., 2012) nurses require support 
(Carey et al., 2009b). Nevertheless, individual responsibility for CPD has been 
written into the Nurses Act stating that ‘a registered nurse and registered 
midwife shall maintain professional competence on an ongoing basis’ 
(Oireachtas and Department of Health, 2011 Nurse and Midwives Act, part 1. 
88-(1)). Introducing such a change firmly puts the onus on the nurse not the 






Although nurse prescribing has only been in existence in Ireland for eight 
years, the majority of Irish NPs are as confident in their ability to prescribe as 
their counterparts in the UK. However, a considerably large portion of the 
respondents in both Ireland and the UK have issues with increased and 
hidden workload within the prescribing role. This has serious implications for 
the progress of NPs in the Irish setting particularly considering the 
moratorium on recruitment in place at the time of the study. With this survey, 
an understanding has been gained of what nurses require of organisations to 
meet their commitment to the prescribing process. The issues specifically 
identified as warranting attention were adequate acknowledgement of the 
workload involved in daily practice along with supportive organisational 
structures for implementation related aspects such as CPD. In the Irish setting 
having such support may help to overcome the perceived barriers appearing 
in the form of reduced applications for the education programme and lack of 
commitment to register as a prescriber once the education programme has 
been completed. 
Furthermore, a review of the Irish collaborative practice agreement 
which was also highlighted in the National Evaluation Report (Drennan et al., 
2009) is timely to address the medical dominance of NP. The system must 
learn to trust the education process and the NPs ability to prescribe safely 
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Chapter 6 – focuses on the application of the STOPP/START evaluation 
tool to the prescribing of nurse prescribers. Quantitative and qualitative data 
are presented and discussed in this Chapter as follows: 
Stage 1: A prospective study was conducted to evaluate the prescribing 
of NPs working in care of the elderly. Using information from the nursing and 
medical notes along with the medication kardex, the researcher applied the 
STOPP/START criteria to nurses’ prescriptions to identify potential 
inappropriate prescriptions (PIP) or potential prescriptions of omission (PPO). 
Feedback letters were placed in the patients’ chart for the NP to review. 
Stage 2: Explored the NPs’ utilisation of the feedback letters issued 
following stage 1 of the study. The qualitative approach sought to understand 
the motivations and perceptions of the research participants allowing the 
researcher to gain rich knowledge about the participants, their emotions, 
perceptions and actions, regarding the feedback letters. 
 





Nurse prescribing in Ireland have grown nationally over the past six years 
with a large concentration of nurse prescribers now working in care of the 
elderly. To date approximately 9.8% (n=76) of the 772 nurse prescribers 
registered to work with the HSE prescribe directly for older adults with an 
additional number working in other specialties areas that also cater for elderly 
patients (Health Service Executive, 2014c). Despite the improved access to 
medications following the introduction of nurse prescribing, the need for 
improved medication management in older adults continues to remain a 
priority (Fick and Selme, 2011). 
Internationally, the acceptance of the nurse prescribing role by 
stakeholders such as peers, doctors and patients is essential if nurse prescribing 
is to continue evolving (Stenner et al., 2010a, Earle et al., 2011b). Extensive 
research has been undertaken in the area of nurse prescribing in relation to the 
patient’s perspective (Courtenay et al., 2010b, Drennan et al., 2011, Dhalivaal, 
2011, Courtenay et al., 2011, Banicek, 2012, Ben Natan et al., 2013), benefits 
and barriers (Carey et al., 2009a, Ross and Kettles, 2012, Coull et al., 2013, 
Darvishpour et al., 2014, Carey et al., 2014), professional relationships (Dunn et 
al., 2010, Fisher, 2010, Earle et al., 2011b, Kroezen et al., 2012, Kroezen et al., 
2013), and competence development (Cashin et al., 2009, Snowden and Martin, 
2010, Dobel-Ober et al., 2013). The literature further discloses that patients are 
happy to consult with NPs but also wish to reserve the right to see a doctor 
when they feel it is necessary (Luker et al., 1998a, Brooks et al., 2001, Latter 
and Courtenay, 2004, Berry et al., 2006, Drennan et al., 2011). Such 
reservations may be addressed through comparative analysis of prescribing 
practices and clinical outcomes for patients treated by medical and non-
medical prescribers. 
Within the Irish setting, nurse prescribing research has mainly focused on 
implementation (Creedon and O'Connell, 2009, Adams et al., 2010), cost 
 
effectiveness (Drennan et al., 2009), the need for CPD (Creedon, 2010a), and 
clinical appropriateness and safety (Naughton et al., 2012). Considering 
inappropriate prescribing is a growing public health problem (Spinewine et al., 
2007) with the cost of medications to the health service rising annually (Barry, 
2013), it is surprising that there is limited published research on prescribing 
practices for NPs and particularly if prescribing is appropriate or inappropriate. 
Older adult patients are the largest consumers of prescribed medications  and 
considering the projected rise in this sector of the population from 532,000 in 
2011 to almost 1.4 million by 2046 (Age Action, 2013) emphasis on nursing 
research needs to shift. 
Older adult patients suffering from multiple conditions consume a large 
range of medications and the occurrence of potentially inappropriate 
prescribing (PIP) is a well-documented problem (Spinewine et al., 2007, 
Gallagher and O'Mahony, 2008a). However, the appropriateness of nurses’ 
prescriptions has not been investigated, leaving a void in the understanding of 
the impact it has in practice. In general, medicines in older people are 
considered appropriate when they have a clear evidence-based indication, are 
well tolerated in the majority and are cost-effective (O'Mahony and Gallagher, 
2008). In contrast, medications that are potentially inappropriate have no 
evidence-based indication, carry a substantially higher risk of potential side 
effects  compared with use in younger people or are not cost effective 
(Gallagher and O'Mahony, 2008a). In addition, older adult patients are more 
likely to have multiple comorbidities, a higher risk of adverse drug events 
(ADEs) and to have more than one prescriber involved in their care (Ryan et al., 
2012). Risks to prescribing are further augmented by age-related changes in 
physiology and body composition that affect the pharmacokinetics and 
pharmacodynamics of medications prescribed (Barry, 2008). These factors, 
combined with the increasing availability of new medications potentially 
contribute to polypharmacy and PIP. Optimal prescribing is critical to the goal 
of older adult care in order to cure disease, eliminate or reduce symptoms and 
improve functioning (Gallagher and O'Mahony, 2008a). Prescribing medications 
 
is therefore, one of the most powerful tools available to NPs in the prevention 
and treatment of disease and alleviation of symptoms.  
The national evaluation of nurse prescribing undertaken in 2009 gave a 
snapshot of prescribing by reviewing the accuracy and clarity of drug details in 
208 prescriptions using the following seven headings: 
 Name of prescribed item, 
 Dosage, 
 Frequency, 
 Quantity (in number of dose units or days of treatment), 
 Instructions, 
 Signature, 
 Registered nurse prescriber PIN 
(Drennan et al., 2009) 
 
Medication safety and appropriateness was also assessed using eight items 
from the modified Medication Appropriateness Index (MAI) tool (Fitzgerald et 
al., 1997). 
 Medications indicated, 
 Medications effective for condition,  
 Dosage correct, 
 Directions correct, 
 Clinically significant medication interactions, 
 Clinically significant medication disease/condition interactions, 
 Unnecessary duplication with other medications, 
 Duration of therapy acceptable, 
 
All indicators returned an appropriate score of between 76-96%. A small 
number of prescriptions required attention to detail in terms of prescription 
instructions because of potential medication or disease interactions. This 
 
reflected the reality of clinical practice where prescribing for the elderly can be 
influenced by risk benefit assessment (Steinman and Hanlon, 2010).  
Understanding the role of medication management by NPs in older adult 
care is valuable considering the ageing Irish population and present published 
figures that 12.7% of the population is aged 65 years or older (CSO, 2014), 3.5% 
of whom require long-term care. Specifically understanding the influence of 
nurse prescribing is crucial in view of 1) the increasing volume of prescriptions 
written by nurse prescribers, 2) how inappropriate prescribing is common in 
older patients (Spinewine et al., 2007), 3) how inappropriate prescribing is 
associated with ADEs (Lund et al., 2010), hospitalisation (Klarin et al., 2005), 
and wasteful utilisation of resources (Cahir et al., 2010a). More recently, 
concerns regarding PIP practices in the older adult population have come under 
considerable scrutiny (Gallagher and O'Mahony, 2008b, Barry, 2008, Ryan et al., 
2009a, Ryan et al., 2012, O'Sullivan et al., 2013). In particular, the use of 
medicines that have clinically significant drug-drug, drug-disease and the 
underuse of beneficial medicines (Gallagher and O'Mahony, 2008b) that can 
pose more risk than benefits to patients are being reviewed. 
It is therefore timely to conduct a detailed evaluation of NPs’ prescriptions 
to understand their prescribing practices for patients. If nurses are to truly 
become independent prescribers then their practices must be benchmarked 
with their medical counterparts. The exploration of nurse prescribing through 
the application of the Screening Tool of Older Persons Prescriptions (STOPP) 
and Screening Tool to Alert doctors to Right Treatments (START) offers a 
reasonably inexpensive and time-efficient method of exploring prescriptions 





6.1.1 Screening tool 
 
 There are a number of medication screening tools that can be used to 
measure the appropriateness of prescribing. For instance, the Beers criteria 
tool is widely used in the United States of America however, its application in 
Europe is limited owing to differences in prescribing patterns, drug availability 
and transferability of criteria (Spinewine et al., 2007). Recognising the 
deficiencies of the Beers criteria, newer explicit screening criteria have been 
devised and validated, with the aim of improving applicability and usefulness. 
These include the STOPP/START criteria by Gallagher et al. (2008c). A review 
undertaken by Laroche et al. (2009) examined the strengths and weaknesses of 
inappropriate prescribing screening tools and endorsed the use of 
STOPP/START as the more appropriate tool in the European context. In 
addition, a number of studies undertaken by Gallagher and O’Mahony (2008b), 
Ryan et al. (2009c), Kruse et al. (2010), O’Sullivan et al. (2010) and Gallagher et 
al. (2011) have used the STOPP/START criteria to assess prescribing 
appropriateness and addressed perceived deficiencies of the Beer’s criteria in 
relation to European prescribing patterns. 
STOPP comprises of 65 criteria; each criterion is accompanied by a concise 
explanation why the prescription is potentially inappropriate. START consists of 
22 evidence-based prescribing indicators that highlight prescribing omissions 
for commonly encountered diseases in older people (Gallagher et al., 2008c) 
(Appendix 12). STOPP/START criteria were validated by a panel of experts in 
geriatric pharmacology from Ireland and the United Kingdom. However, 
O’Mahony (2010) advised that STOPP/ START criteria should be used in unison 
on the basis that the inclusion of inappropriate medicines and omission of 
essential medicines are interconnected problems in geriatric pharmacotherapy.  
STOPP/START is current and relevant to Irish practice as it focuses on 
medicines routinely prescribed to older patients in Ireland. It links the 
prescription of these medicines to potential problems associated with their use 
in the context of patients’ co-morbidity and medical history. As well as referring 
 
to drug-disease interactions, it also considers drug-drug interactions, 
therapeutic duplication and drugs that increase the risk of falls. The criteria are 
arranged in accordance with physiological systems and will be set out 
accordingly in the results.  
The prevalence of potential inappropriately prescribed drugs for older 
adult patients by NPs was determined using the START/STOPP screening 
criteria. However, information regarding feedback from healthcare 
professionals following the use of the STOPP/START and its application in 
routine clinical practice has not as yet been sufficiently captured in the 
published research (O'Sullivan et al., 2013). Even though detection of PIP can 
provide a valuable insight into unsafe practices and help identify opportunities 





















The aim of the study was to determine the prevalence and nature of nurse 
prescribers’ potential inappropriate prescriptions (PIP) and potential 




The STOPP/START tool (Gallagher et al., 2008c) was applied to 
prescriptions written by NPs for patients aged ≥65 years. The STOPP/START 
indicators facilitated the researcher to screen medication regimes prescribed 
within daily clinical practice from patient records and medication charts. 
 
6.3.1 Participants  
 
In this study a purposive sample of forty potential registered NPs working 
with older patients’ ≥ 65years in the southern region of Ireland (HSE South) and 
spanning 17 different clinical sites were eligible to participate in the research. 
Each nurse was contacted individually to establish their willingness to 
participate in the research and also asked if they could identify ten patients in 
their care for whom they had written prescriptions for independently.  
 
Inclusion criteria – participants were required to have completed the nurse 
prescribing programme, have registered with the Nursing and Midwifery Board 
of Ireland, were prescribing medications independently for patients ≥65 years, 
currently working for the Health Service Executive (HSE) and had a) written at 
least 10 different prescriptions for b) ten separate patients. 
 
 
Exclusion criteria - nurses who have undertaken the nurse prescribing 
programme but who have not registered with the Nursing and Midwifery Board 
Ireland to prescribe.  Nurses with fewer than ten prescriptions written for ten 
individual patients. 
 
6.3.2 Research sites 
 
The participating sites in this study 
spanned the HSE South represented by the 
light green area on the map from Kerry in 
the West to Wexford in the East.  
Seventeen sites were included in the study 
covering all areas except Carlow. At the 
time of data collection this area did not 
have a nurse prescriber working in care of 




When the NPs were contacted individually there were issues that did not 
facilitate participation. Specifically, two NPs were not registered with the 
nursing governing body, one NP was unable to participate due to illness, eight 
had insufficient prescriptions (<10) written, two had moved to the private 
sector, one NP’s practice was on hold due to issues with clinical indemnity and 
one refused to participate. The remaining 25 nurse prescribers were informed 
of the two stage process of the study before agreeing to participate. This was 
important to ensure that participants having completed the first stage of the 
study were available to participate in the second stage. Each of the 25 
participants identified prescriptions written for ten individual patients equating 
 
to 250 patient records requiring review. Access to relevant documents was 
negotiated directly with the NP, organisation, and practice development 
coordinators. 
 
A pilot of the STOPP/START data collection database was undertaken in a 
pre-determined site using ten patients’ charts to ensure information obtained 
from the database was accurate and feedback generated for the NPs was 
appropriate. Two academic pharmacists who were experienced in 
STOPP/START criteria application reviewed the data from these ten patients. 
Each case/file was discussed in detail including the feedback letter generated 
from the data until agreement was reached regarding the nature of feedback 
information to be returned to the NP. The pilot data was included as part of  
the overall date collection. 
 
One month prior to commencing data collection, an information sheet 
containing the details of the study, along with a copy of the ethics approval 
letter was emailed to each participating NP.  Participating NPs received a 
supplementary telephone call to answer any questions and organise a mutually 
suitable date on which to gather the data. Participants were again contacted by 
phone seven days before the agreed visit date to answer any additional queries 
and ensure access to the relevant documents could be facilitated on the agreed 
date for data collection.  
 
 
6.3.3 Ethics approval 
 
A research proposal was submitted and approved by the Clinical Research 
Ethics Committee of the Cork Teaching Hospitals and University College Cork 




6.3.4 Data collection  
 
Data were collected from the nursing and medical records and medication 
kardexes of the patients identified. Data inputted to the database did not 
contain any information that would allow identification of research participants 
or patients. However, to ensure the feedback letters placed in the medical 
notes could be identified appropriately patient’s name and medical record 
number were included. One copy of the feedback letter was printed and 
returned to the file for the NP to review (Appendix 14). This letter was not used 




6.3.4.1 Chart review 
 
Data collected on medications prescribed by NPs from charts including 
medical, nursing and the medication kardex were managed using a 
modification of a specifically constructed database E-Pharma-Assist Clinical 
Decision Support System (CDSS) (Appendix 15), designed and validated by the 
Department of Geriatric Medicine, Cork University Hospital, and the School of 
Pharmacy at University College Cork (O'Sullivan et al., 2013). The database is 
structured to facilitate analysis and eventual usability of the findings. The 
database also enables collection of data in a format that keeps all individual 
records separate but allows for easy compiling and cross-referencing. 
Additional electronically stored data on Microsoft Word®, Excel®, Access® 
(Microsoft Corp.) 2007 and SPSS were done in accordance with the provisions 
of the Data Protection Act 2003. 
 
Collection of data took place over a twelve month period February 2013- 
January 2014 and took approximately 60 minutes per patient chart. Specific 
profile data were obtained from the medical and nursing notes and included 
 
the following details; patient’s age and gender, current diagnosis, relevant 
medical history, Barthel score, current medications, and biochemical data 
where available. Any additional query regarding information was discussed 
directly with the NP.  Each patient was assigned a number at the point of data 
entry to ensure anonymity. Medication data collected including name, dose, 
frequency, and the total number of medications was obtained from the most 
recent medication kardex. Both regular and ‘as required’/pro re nata (PRN) 
prescription medications were recorded to ensure a complete profile of 
medication data was collected. All medications were supplied by prescription 
and charted accordingly, non-prescription over the counter medications were 
not included in the data. Medications were coded according to the World 
Health Organisation’s Anatomical Therapeutic Chemical (ATC) classification 
system and all medical diagnoses were coded according to the International 
Classification of Diseases 10th edition (ICD-10) (WHO, 2010, WHO, 2011).   
 
Feedback letters generated from the application of the STOPP/START tool 
regarding PIP and PPO were placed in the patient’s file immediately following 
the review. Recognising that confidentiality was of paramount importance, any 
further issues regarding PIP and/or PPO was viewed directly from the 
appropriate section of the anonymised database. 
 
 
6.3.5 Data analysis 
 
Categorical data were described using frequency (percentage) and 
continuous data using mean and standard deviation (SD) or in the case of 
skewed data, the median and interquartile range (IQR).  The Chi–squared test 
was used to compare PIP and PPOs. Univariate and multivariate logistic 
regression analyses were performed to investigate factors associated with PIPs 
and PPOs. All statistical analyses were performed using IBM SPSS Statistics 22.0 
(NY, USA). All tests were two-sided and a p-value <0.05 was considered to be 
statistically significant.  
 
 
Once the data had been calculated for results, it was then necessary to 
compare these results with local or national benchmarks. The application of the 
STOPP/START criteria in care of the older adult has limited but sufficient studies 





All patients included in this study were inpatients in long term care nursing 
home and hospitals settings and prescribed for by NPs. The background 
demographic details and most prevalent disease states affecting patients are 




Due to unforeseen circumstances three patients’ records were not 
included in the data collection, (one patient died prior to data collection, the 
medical status of another patient deteriorated requiring transfer to palliative 
care facility and one patient was transferred to the acute care setting for 
treatment). Therefore, the study included 247 patients, of whom 58.7% (n=145) 
were female. Overall, the mean age of the patients was 81.3 years (SD±9.2) and 
when categorised by gender, the mean age (SD) was 77.7 (±8.6) years for males 
and 83.8 (±8.8) years for females. The five most prevalent diagnoses in the 
population studied was dementia (n=72; 29.1%), conditions causing reduced 
mobility (n=48; 19.4%), osteoarthritis/osteoporosis (n=25; 10.1%), diabetes 














Age (years) Mean (SD) 
                    Range 
 
Age group: n (%) 

























Falls in the past three months2 
Ongoing constpation2 
Recent ongoing nausea/vomiting 
 
Barthel activities of daily living 
Median (IQR) 
High dependency (0-4) 
Medium dependency (5-8) 
Low/medium  dependency (9-12) 
Low dependency (13-20) 
81.3 (9.2) 




















































































































1 n=239 (n=101 for males and n=138 for females); 2 n=237 (n=100 for males and n-137 for females); 3 n=223 (n=93 for males and 
n=130 for females) 
 
All 247 patients were prescribed a range of medications between 2 and 27 
the total number of medications prescribed being 2,463 (Table 6.2).   
 
TABLE 0-2 FREQUENCY OF MEDICATIONS PRESCRIBED FOR PATIENTS, OVERALL AND BY GENDER 
 Overall (n=247) Gender 
 























10 (7 to 12) 









9 (6 to 11) 




0 (0 to 2) 
0 to 6  
 
1007 
9 (7 to 12) 









9 (6 to 11) 




0 (0 to 2) 




10 (7 to 12) 









8 (6 to 11) 




0 (0 to 2) 
0 to 6 
 
 
Of the total medications identified, 2200 were regular medications and 263 
(12%) were PRN medications. Overall, the median number of medications per 
patient was 10 (IQR: 7 to 12). The fewest number of medications for a single 
patient was 2 while the highest was 27. 
 
 
6.4.2 STOPP criteria 
 
 The most frequently encountered STOPP criteria are detailed in table 6.3 
and 6.4. STOPP identified 204 instances of PIP in 136 (55.1%) patients. Of the 65 
criteria in STOPP, 28 (43.1%) were used to identify these PIP.  Eighty four 
(34.0%) patients were prescribed one PIP, 41 (16.6%), were prescribed two, 
nine (3.6%) were prescribed three and two (0.8%) were prescribed four or more 
PIPs (Table 6.3). The central nervous system (CNS) accounted for the highest 
proportion of PIP identified (n=84; 41.2%), followed by the gastrointestinal 
 
system (n=77; 37.7%), the cardiovascular system (n=18; 8.8%), and the 
endocrine system (n=11; 5.4%). 
 
In terms of drug class, proton pump inhibitors at extended full dose 
accounted for the highest proportion of PIP identified (n=76; 37.3%); the 
second most common instance was the prescribing of benzodiazepines (n=49; 
24.0%).  
 
TABLE 0-3 MOST FREQUENTLY ENCOUNTERED POTENTIAL INAPPROPRIATE PRESCRIBING (PIP) 
ACCORDING TO STOPP CRITERIA 






Loop diuretic as first-line monotherapy for hypertension (safer, more effective 
alternatives available) 
2 (0.8%) 
Calcium channel blockers with chronic constipation (may exacerbate constipation) 1 (0.4%) 
Aspirin with no history of coronary, cerebral or peripheral vascular symptoms or 
occlusive event 
9 (3.6%) 
Warfarin for first uncomplicated pulmonary embolus for longer than 12 months 
duration 
1 (0.4%) 
NSAID with moderate-severe hypertension (risk of exacerbation of hypertension) 3 (1.2%) 
NSAID with heart failure (risk of exacerbation of heart failure) 1(0.4%) 
Alpha-blockers with long-term urinary catheter in situ i.e. more than 2 months  1(0.4%) 
 
Central Nervous System 
Tricyclic antidepressant with cardiac conductive abnormalities 1(0.4%) 
Tricyclic antidepressant with an opiate or calcium channel blocker  1(0.4%) 
Long-term (i.e. ≥ 1 month), long-acting benzodiazepines  22 (8.9%) 
Long-term (i.e. ≥1 month) neuroleptics as long-term hypnotics  16 (6.5%) 
Long-term neuroleptics (≥ 1 month) in those with Parkinsonism  2 (0.8%) 
 
Prolonged use (≥ 1 week) of first generation antihistamines  1(0.4%) 
Bladder antimuscarinic drugs with dementia  2 (0.8%) 
Benzodiazepines (sedative, may cause reduced sensorium, impair balance) 27(10.9%) 
Neuroleptic drugs (may cause gait dyspraxia) 1(0.4%) 
First generation antihistamines (sedative, may impair sensorium) 3 (1.2%) 
Long-term opiates in those with recurrent falls  4 (1.6%) 
Use of long-term powerful opiates e.g. morphine or fentanyl as first line therapy for 
mild-moderate pain 
1(0.4%) 
Long-term opiates in those with dementia unless indicted for palliative care or 




Aspirin with a past history of peptic ulcer disease without histamine H2 receptor 
antagonist or proton pump inhibitor  
1(0.4%) 






Long-term use of NSAIDS (>3 months) for symptom relief of mild osteoarthritis  2 (0.8%) 
 
Genitourinary System 
Alpha-blockers in males with frequent incontinence   1(0.4%) 
 
Endocrine System 
Glibenclamide or chlorpropamide with type 2 diabetes mellitus  1(0.4%) 
Beta-blockers in those with diabetes mellitus and frequent hypoglycaemic episodes  10(4.0%) 
 
Respiratory System 
Non cardio selective Beta-blocker with chronic obstructive pulmonary disease (COPD) 10 
(4.0%) 




The overall number of PIP identified by STOPP per patient can be viewed in 
Table 6.4 including percentages according to gender.  
 
TABLE 0-4 PATIENTS WITH PIP OVERALL AND BY GENDER 














 84 (32.0) 
 41 (16.6) 
   9 (3.6) 




  4 (3.9) 




  5 (3.4) 
  1 (0.7) 
 
 
6.4.3 START criteria 
 
A total of 161 PPOs were identified in 120 (48.6%) patients (Table 6.5). Of 
the 22 criteria in START, 14 (63.6%) were used to identify these PPOs. A total of 
83 (33.6%) patients had one PPO, 33 (13.4%) had two, and 4 (1.6%) had three. 
Of the 22 criteria in START, 14 (63.6%) were used to identify these (Table 6.5). 
The cardiovascular system accounted for the majority of the PPOs identified 
n=135 (83.9%) followed by the musculoskeletal system n=12 (4.9%) the CNS 
n=7 (2.8%) and respiratory system n=7 (2.8%). Of the 161 incidents identified by 
PPO 144 (89.4%) were attributed to five groups of medicines: statins (42.2%), 
angiotensin-converting-enzyme inhibitor (ACE inhibitor) (32%), aspirin (16.8%), 







TABLE 0-5 MOST FREQUENTLY ENCOUNTERED POTENTIAL PRESCRIBING OMISSIONS (PPO) ACCORDING 
TO START CRITERIA   








Warfarin in the presence of chronic atrial fibrillation 6 (2.4%) 
 
Statin therapy with a documented history of coronary, cerebral or peripheral 
vascular disease, where the patient’s functional status remains independent for 




Angiotensin Converting Enzyme (ACE) inhibitor with chronic heart failure 26 
(10.5%) 
 
Aspirin in the presence of chronic atrial fibrillation, where warfarin is 
contraindicated, but not aspirin 
 
4 (1.6%) 
Aspirin or clopidogrel with a documented history of atherosclerotic coronary, 




ACE inhibitors following acute Myocardial Infarction 6 (2.4%) 
 




Beta-blocker with chronic stable angina 2 (0.8%) 
 
 
Central Nervous System 
 
 
Antidepressant drug in the presence of moderate-severe depressive symptoms 
lasting at least three months 
 
6 (2.4%) 







Calcium and vitamin D supplement in patients with known osteoporosis 11 
(4.5%) 
Disease modifying anti-rheumatic drug (DMARD) with active moderate-severe 






Regular inhaled beta 2 agonist or anticholinergic agent for mild to moderate 
asthma or COPD 
6 (2.4%) 









A more concise overview of PIP and PPOs can be viewed in table 6.6 
 
TABLE 0-6 TOTAL NUMBERS OF POTENTIALLY INAPPROPRIATE PRESCRIPTIONS (PIP) AND 
POTENTIAL PRESCRIBING OMISSIONS (PPOS) 
PIP =204 
 
n (%) PPO =161 n (%) 
System  System  












































































6.4.4 Investigation of factors associated with potentiall y 
inappropriate medicines  
 
The results of the univariate and multivariate logistic regression analyses 
are presented in Table 6.7. In univariate analysis, there was a statistically 
significant association between number of prescribed medicines and having at 
least one PIP (p=0.002). Compared with patients with five prescribed medicines 
or fewer, patients with more than 10 prescribed medicines were more likely to 
have at least one PIP (OR: 5.89; 95% CI:1.94 to 17.92). No statistically significant 
associations were found between having at least one PIP and age group 
 
(p=0.948), gender (p=0.120) or activities of daily living group (p=0.202). In 
multivariate analysis after adjusting for age group, gender and activities of daily 
living group, the association between number of prescribed medicines and 
having at least one PIP remained (p=0.003). Compared with patients with five 
or fewer prescribed medicines, patients with more than 10 prescribed 
medicines were more likely to have at least one PIP (OR: 6.08; 95% CI:1.84 to 
20.12).  
 
TABLE 0-7 UNIVARIATE AND MULTIVARIATE LOGISTIC REGRESSION RESULTS FOR HAVING  




 OR (95% CI) 
 








1.01 (0.51 to 2.02) 




0.88 (0.42 to 1.87) 








0.65 (0.38 to 1.12) 
0.120  
1 (reference) 
0.62 (0.34 to 1.14) 
Barthel activities of daily 
living 
High dependency (0-4) 
Medium dependency (5-8) 
Low/medium dependency (9-
12) 




0.65 (0.27 to 1.54) 
1.51 (0.68 to 3.36) 
0.85 (0.40 to 1.80) 
0.202  
1 (reference) 
0.68 (0.28 to 1.68) 
1.51 (0.66 to 3.44) 
1.08 (0.48 to 2.44) 








2.80 (0.95 to 8.29) 




2.84 (0.90 to 8.97) 





6.4.5 Investigation of factors associated with potentia lly prescribing 
omissions (at least one PPO) 
 
The results of the univariate and multivariate logistic regression analyses 
for PPOs are presented in Table 6.8. No statistically significant associations 
were found between having at least one PPO (n=223) and age group, gender, 
activities of daily living group or number of prescribed medicines in either the 
univariate or multivariate analyses. 
 





 OR (95% CI) 
 









0.98 (0.49 to 1.95) 




0.95 (0.46 to 1.94) 








0.89 (0.52 to 1.51) 
0.658  
1 (reference) 
0.84 (0.47 to 1.49) 
Barthel activities of daily 
living 
High dependency (0-4) 
Medium dependency (5-8) 
Low/medium dependency 
(9-12) 





0.62 (0.26 to 1.50) 
1.55 (0.71 to 3.39) 




0.64 (0.26 to 1.56) 
1.56 (0.71 to 3.43) 
1.01 (0.46 to 2.23) 









1.34 (0.49 to 3.65) 




1.19 (0.41 to 3.43) 





6.4.6 Combining START/STOPP 
 
Combining START/STOPP criteria, 184 (74.5%) patients had at least one 
criterion of potentially inappropriate medicine. There was not a statistically 
significant association between the prescription of potentially inappropriate 
medicines and under-prescribing of medicines.  However, 72 (29.1%) patients 
had at least one PIP and 48 (19.4) had at least one PPO (STOPP vs START, 
p=0.129 Chi squared test).  
 
TABLE 0-9 STOPP AT LEAST ONE MEDICATION * START AT LEAST ONE MEDICATION CROSS 
TABULATION 




                                                        0=no 1=yes 
STOPP at least one medication              
                                                                       
0 no           Count          







 1 yes         Count 







Total                                                                    Count 












This is the first study to use STOPP/START criteria to evaluate NPs’ 
prescriptions. The findings report significant levels of potentially inappropriate 
prescribing to older people.  As there are no similar studies among NPs, the 
findings will be discussed in light of the published data examining the 
prevalence of PIP using STOPP criteria and PPOs using START criteria for 
patients in Irish nursing home care settings and hospitals (Byrne et al., 2008, 
Ryan et al., 2009c, Ryan et al., 2012, O'Sullivan et al., 2013). 
 
 
The PIP findings of 55% for NPs is slightly lower than previously published 
PIP rates of 59.8% (Ryan et al., 2012), 60% (Byrne et al., 2008) and 70.8% 
(O'Sullivan et al., 2013). The lower findings in this study may be attributed to 
the fact that nurse prescribers in the Irish setting have a more limited formulary 
than their medical counterparts from which to prescribe thereby potentially 
reducing the incidents in which PIP can occur. Having a collaborative practice 
agreement (CPA) has the potential to impact on criteria within STOPP/START 
for which NPs cannot prescribe.  Another potential reason for the lower rate of 
PIP is that nurse prescribers selected which patients were to be included in the 
study and so selection bias cannot be excluded from the interpretation of the 
findings.  
 
Tables 6.3 and 6.5 show that both sets of criteria identified an instance of 
PIP in approximately 54% of the population, with almost three quarters of 
those patients having at least one criterion of potentially inappropriate 
medicine defined by either set of criteria. The levels of PIP identified may be 
attributed to the complex level of chronic co-morbid illness in this section of 
the population that results in higher levels of polypharmacy (Ryan et al., 2012). 
It was noted in this study that an increase in the number of prescription 
medicines was associated with the occurrence of PIP using STOPP. Similar to 
rates described by Ryan et al. (2012) and O’Sullivan et al. (2013), patients with 
more than 10 prescribed medicines were more likely to have at least one PIP.  A 
number of studies have used the STOPP criteria to assess PIP prevalence 
nationally at primary, secondary and long term care.  The incidents of PIP 
identified range from 21% in primary care (Ryan et al., 2009c), to 35% in 
secondary care at the point of admission (Gallagher and O'Mahony, 2008b) and 
60% in long term care (Byrne et al., 2008).  This prevalence correlates with 
international published work that indicate as the complexity of care and level of 
patient frailty increases so too does the number of medications prescribed and 
level of patient co-morbidity that contribute to the prevalence of PIP (Buck et 
al., 2009, Conejos et al., 2010). Integrating an evaluation tool such as 
STOPP/START into the health service audits system could help identify issues 
 
and effect change that needs to be considered to ensure prescribing is 
appropriate and cost-effective. For instance a significant number of PIP 
identified in this study were medications acting on the CNS (n=84). This is an 
issue already identified by the Health Information Quality Authority (HIQA) who 
are at present targeting prescribing for the CNS in older patients in Irish nursing 
homes as a priority for improvement (HIQA, 2009). 
 
The STOPP criteria are designed to be used in conjunction with START 
criteria to ensure comprehensiveness of the screening process. As with the 
STOPP criteria the prevalence of PPOs is substantial in the older adult 
population (Hamilton et al., 2011b). However, there is limited evidence in the 
literature relating to the prevalence of PPO in older individuals as the majority 
of the literature has only been published in the last 6 years. These studies 
indicate that the rate of PPO cover a wide range from 11.2-74.0% (Gallagher et 
al., 2007, Ryan et al., 2009c, Gallagher, 2011, Dalleur, 2012).     
 
This study also revealed that the majority of patients (n=227) were taking 
five or more medications routinely which according to Viktil et al. (2007) 
exposes them to polypharmacy and increases the risk of ADEs (Barry, 2008).  To 
understand the impact of ADEs it was important to review the baseline 
diagnostic information over a three month period (Table 6.1).  This revealed the 
number of patients identified as having a diagnosis of falls was low under 
current diagnoses but the additional data gathered under baseline information 
disclosed a considerably higher proportion of patients having sustained a fall in 
that period. This finding requires additional research to understand if the falls 
are related specifically to ADEs. 
 
The median number of medications in the three studies conducted using 
STOPP/START in long-term care facilities in the Republic of Ireland is between 
eight (Ryan et al., 2012) and 11 (O'Sullivan et al., 2013) with the present study 
 
having a median of 10.  Current evidence-based guidelines that recommend 
several drugs in the treatment of a single condition make drug prescribing 
particularly challenging.  Steinman et al. (2006) discussed the relationship 
between inappropriate prescribing, medication underuse and the number of 
medicines used by older people in that patients with fewer than six regular 
medications were more likely to be missing a potentially beneficial medicine 
than to be taking a medication considered inappropriate.  Results however 
revealed there was no significant association between the prescriptions of 
potentially inappropriate medications and under-prescribing of indicated 
medicines STOPP vs START (p=0.129). Similar findings were reported by 
Gallagher et al. (2011). 
 
In this study, application of the START criteria identified a total of 161 
(48.5%) PPOs in a similar number of patients (Table 6.5). These findings are in 
line with the published data in the Irish setting whereby PPO rates of 44% 
(Gallagher and O'Mahony, 2008b) and 57.9% (Barry, 2008) have been reported. 
While the current study did not find any association between demographics 
and the occurrence of PPO, Barry and colleagues (2008) identified a higher 
probability of not receiving an appropriate medicine in female patients over 85 
years. The current study identified that  68 patients of the 120 identified by the 
START criteria did not receive the necessary statin therapy which may reflect an 
assumption that there is not sufficient time for the older person to benefit from 
the therapeutic intervention i.e. 5 yeas life expectancy. Reinforcing findings by 
Lang et al. (2010), the primary factor associated with the presence of START 
criteria (medicine under use) is a lack of medication knowledge concerning 
geriatric conditions in those caring for patients in long term care facilities.  In 
addition, a  number of studies have also reported that polypharmacy can result 
in the under-prescribing of clinically beneficial medications; this may be due to 
nurses having reservations about initiating additional medications to already 
potentially complex regimes (Cahir et al., 2010b). 
 
 
There continues to be a significant problem in relation to PIP and PPO in 
this vulnerable population that needs to be addressed. Explicit indicators 
identified in STOPP/START (Gallagher and O'Mahony, 2008a) are a powerful 
tool to address PIP at the point of issuing a prescription and help contain the 
increasing cost of medications for the health service (Gallagher, 2011). 
However, prescribing decisions in older people are often complex and 
STOPP/START is not a substitute for clinical judgment but encourages 
prescribers to consider medications as a possible cause for presenting 
symptoms. To date, there has not been no adverse reported incident to the 
Nurses and Midwives Board of Ireland regarding a nurse prescriber, which 
would suggest there are not serious issues with nurse prescribers in practice. 
The experience, training, and familiarity with the working environment of the 
nurse prescribers may also influence this situation.  Nonetheless, the 
researcher has to be mindful that there can be a cultural and organisational 
resistance to open disclosure of medication discrepancies due to associated 
legal ramifications (Forjuoh et al., 2005). 
 
 
6.7 Conclusion  
 
This section of the study highlights the rate of PIP and PPO in older patients 
who are prescribed medications by nurse prescribers across seventeen Irish 
long term care facilities. Over three quarters of the patients medications 
reviewed had at least one incident of PIP and/or PPO. The rates of PIP and PPO 
in patients aged ≥65 years prescribed for by NPs are in line with previously 
published data on prescribing by clinicians. These finding have a direct 
relevance for NPs working in older care settings given that recent data has 
shown a significant causal relationship between PIP and or PPO and ADEs 
(O'Sullivan et al., 2013). Considering the potential impact of using a medication 
 
evaluation tool in practice, the practical application of STOPP/START in daily 
practice is not yet established. However, the STOPP/START research group is 
currently developing an electronic version of STOPP/START criteria for this 
purpose. The aim of the project is to develop a highly-powered and efficient 
software engine (SENATOR) capable of individually screening the clinical status 
and pharmacological and non-pharmacological therapy of older people with 
multi-morbidity in order to define optimal drug therapy, highlight ADE risk, 
indicate best value drug brand for selection and provide advice on appropriate 
non-pharmacological therapy.  
 
In addition, further research is warranted to determine the utilisation of 






















In stage one of the research, participants were issued with feedback letters 
regarding PIP and PPO specific to their prescriptions which they had written.  
This section of Chapter 6 will investigate how the feedback letters from this 
evaluation tool were utilised, which, to date, is a significant element of the 




The aim of the research was to explore NPs’ views and experiences of 
inappropriate prescribing with specific reference to the utilisation of feedback 
generated following the application from the STOPP/START tool.  
 
6.10 Method  
 
To explore the NPs’ utilization of the feedback letters issued following 
application of the STOPP/START screening tool, a qualitative research approach 
was undertaken. This decision was based on the belief that human beings 
continuously interpret and make sense of their environment, and so 
researchers must take the meaning of events into account. The qualitative 
approach sought to understand the motivations and perceptions of the 
research participants allowing the researcher to gain rich knowledge about the 
participants, their emotions, perceptions and actions, focusing upon the lived 






Twenty five NPs working in care of the older adult that participated in 
Stage One of this research agreed to participate in Stage Two of the research.  
Access for the follow-up interviews was negotiated at the time of the 
quantitative data collection and took place approximately one month after the 
nurse prescribers received feedback letters generated from the application of 
the STOPP/START tool.  Two sites participated in a pilot of the interviews at 
which time it was evident that utilisation of the feedback letters were similar 
within the site because of collaboration. To avoid repetition of interview data 
which may give the impression of saturation being reached one nurse 
prescriber from each participating site n=15 was included in the interview 
process.     
 
6.10.2 Interviews  
 
 Qualitative semi-structured interviews were conducted over the 
telephone with NPs who participated in Stage One of the research.  The 
interviews were organised directly with the nurse prescriber at the time of 
screening (Stage One of the study) to take place one month following receipt of 
feedback letters generated by the application of the STOPP/START criteria to 
NPs prescriptions. It was deemed necessary to conduct telephone interviews 
for this section of the research because of a number of issues:  geographically it 
was not possible to re-visit each site for follow-up interviews because stage one 
of the data collection in one site often coincided with stage two the follow–up 
interviews in another site. Cost-effective issues were also a consideration for 
the researcher, securing time from work to re-visit the different sites including 
over-night accommodation was problematic. Furthermore, local considerations 
and workloads issues needed to be taken into account.  Telephone interviews 
therefore, facilitated flexibility to conduct interviews for participants during and 
outside of work hours.  
 
Pilot interviews were conducted with two NPs representing different 
nursing grades with prescribing authority and different sites to ensure the 
process to be followed was correct.  Prior to initiating telephone calls, a 
number of efforts were made to facilitate ease of communication with 
prospective interviewees. The pilot interviews facilitated testing to ensure 
appropriate structure and accurate preparation.  The process was divided into 

























TABLE 0-10 TELEPHONE INTERVIEW PROTOCOL 
 
Before the interview 
• Appropriate information was communicated to the potential participant 
and questions answered.  
• Interviews were scheduled with free time allocated by the researcher prior 
to and after the interview to accommodate any last minute change to 
arrangements because of clinical commitments or interruptions. 
• The interview protocol was pre-tested. 
• Audiotaping techniques were predetermined and tested. 
• Appropriate time was allocated for introductions and study overview. 
• Confidentiality was assured.  
• Results would be sent to each individual participant via email on 
completion. 
• Finally the process was piloted with a research student to ensure the 
process was smooth, and there were no technical problems.  
 
During the interview 
• Initial conversation was light to encourage the participant to relax. 
Introductions including career background, education and clinical interests 
of the researcher were discussed. An overview of the study was given and 
an explanation of how the present research contributes overall. 
Confidentiality was also reinforced.  
• Interview questions were structured to vary and allow for the participants 
opinion. 
• Themes of interest identified in earlier interviews informed the schedule in 
later interviews.  
• At the end of each interview any issues concerning information for a 
particular question was addressed with the participant and clarification or 
explanations sought regarding terminology etc. before moving forward. 
 
After the interview 
• Each interview was transcribed immediately following the interview while 
the researcher was still immersed in the essence of the interview. 
• Ample time was allocated for analysis.  
• Interviewees agreed to be contacted should validation of any issues in the 
interview transcripts be deemed necessary. 
 
Telephone interviews were commenced by following an interview schedule 
that began with some demographic questions and then focused the attention 
of the participant by asking ‘Can you tell me what you understand by the term 
inappropriate prescribing?’. However, the participants soon began to deviate 
from the topic and the researcher found it was important to utilise the 
 
interview schedule as the participants needed the prompts to maintain focus. 
Therefore, the schedule was followed closely yet, there was opportunity for the 
participant to give additional information at the end of the interview should 
they wish to do so. Maintaining focus on appropriate and inappropriate 
prescribing was important because of specific issue that stemmed from the 
STOPP/START criteria to establish how feedback was utilised needed to be 
addressed.  
Amendments made to the interview schedules following the pilot 
interviews were confined to clarity of language. The pilot exercise did however, 
confirm that a semi-structured interview approach was appropriate as it 
allowed the participants to move from one topic area to another in a natural 
way whilst the researcher was able to control the interview overall (Todd et al., 
2002). Nevertheless additional issues identified in the literature regarding non-
verbal communication needed to be considered when using telephone 
interviews. Mealer & Jones (2014) identified four types of non-verbal 
communication that need to be taken into account. 1) Porxemics – related to 
the way an individual communicates attitude and trust by controlling his/her 
personal space. 2) Kinesics is the use of posture gesture and facial expressions 
to communicate rapport and relationship among individuals. 3) Chronemics 
relates to the use of time such as the length of silence in a conversation and 
pacing of speech. 4) Paralinguistic communication is the way in which our voice 
communicates through its tone, speed, pitch and volume which also lends 
support to rapport during interviews as it can reinforce the message that the 
words convey.  The first two types of conversation are lost in telephone 
interviews which according to Novick (2008) is a disadvantage. However, 
Mealer & Jones (2014, p. 35) suggests that ‘the lack of visual cues allows for 
emotional distance, which is perceived as removing judgment and provides the 
subject with an environment to engage with their reality’. Additional research 
conducted by Novick (2008) and Drabble et al. (2015) identified specific 
strategies for success in conducting telephone interviews to include, cultivating 
rapport and maintaining connection; demonstrating responsiveness to 
 
interviewee content, concerns; and communicating regard for the interviewee 
and their contribution.   
Establishing contact and rapport - the researcher in conducting Stage One 
of the study had significant contact with the NPs which helped built a rapport. 
In addition, friendly informal conversation preceded the interview at the time 
the interviewee was given orientating information to help guide the participant 
through the interview.  
Demonstrating responsiveness to the interviewee content - specific 
strategies used in this area include active listening, supportive vocalisations and 
validation and clarification exchanges. Supportive vocalisation was used to 
convey presence by occasional interjecting phrases such as, ‘Please continue’, 
‘You mentioned…’, ‘Sure’, ‘Right’, ‘I know what you mean’, ‘Yes’. Clarification 
was addressed by paraphrasing participant’s statements. 
Communicating regard for the interviewee and their contribution - the 
interviewer also demonstrated attention by acknowledging disclosure with 
comments of appreciation while maintaining a non-judgmental tone at all 
times.  
Notes were taken during the interview to serve as a reminder of the 
nonverbal communication that was taking place extended such as pauses and 
change in tone. Note taking was facilitated by structuring the interview 
questions with comment boxes opposite for convenience (Appendix 16).   
 
The only amendment made to the interview schedules and process 
following the pilot interviews were confined to clarity of language.  On average, 
the interviews lasted 20-35 minutes and although guided by a predetermined 
set of questions, permitted the researcher the opportunity to probe the 
meaning of the experience for that individual, thus facilitating a deeper 
understanding of the experiences and thoughts of the participant.  
 
 
6.10.3 Ethics approval 
 
A research proposal was submitted (discussed in Section 6.3.2) and ethics 
approval for the research was granted from the Clinical Research Ethics 
Committee of the Cork Teaching Hospitals’ (Appendix 13).  
 
6.10.4 Data collection 
 
Telephone interviews were conducted one month following stage one of 
the research implementation of the screening tool STOPP and START from 
February to October 2014. From 17 sites, 15 interviews were conducted with 
NPs employed from staff nurse to advanced nurse practitioner level and having 
clinical experience of between one and six years participated in the quantitative 
section of the STOPP/START study. Participants in two sites were unavailable 
for interview due to an extended illness and maternity leave. 
At this stage of the research, participants were again given the opportunity 
to ask the researcher any questions. Consent was obtained verbally and 
contained all the elements of informed consent. Confidentiality was assured 
and the right to withdraw at any time during the investigation, without 
prejudice, was guaranteed. The interviews were digitally recorded and 
transcribed as soon as possible following the interview to ensure the 
experience as described by the participant was accurately captured.  
On completion of the research project, the data collected were archived 
according to University Regulations, and following a policy regarding paper and 
electronic disposal of data to which the study researchers adhered.   




6.10.5 Data analysis 
 
Data analysis was carried out using Colaizzi’s (1978) Procedural Steps which 
provided a framework in keeping with descriptive qualitative research to 
provide assistance in extracting, organizing, and analysing such narrative 
Meaning statements were clustered into common themes and referred to the 
original commentary for validation, thus ensuring that only the participant’s 
perception was captured. In following the principles of data reduction, all 
themes were included until a description of the experiences of the nurse 
prescribers as a whole was obtained. It was necessary to recognise overlapping 
themes and clarify others that were ambiguous by bringing them back to the 
participant for validation or further elaboration at a later date when necessary.  
By doing this, the interpretive research moves back and forth between two 
worlds: that of the understanding and practical dwelling of the participants, and 
the distancing and questioning world of the researcher.  Through analysis and 
interacting with the data, it is hoped to progress beyond the common sense 
understanding of the participants’ experience in the situation under study to a 




Three areas of interest were identified for discussion from exploration of 
the interview narrative: 
• Nurse prescribers experiences of inappropriate prescribing 
• Changing an inappropriate prescription 






6.11.1 Nurse prescribers’ perceptions of inappropriate prescribing  
 
NPs had a concise understanding of the term ‘inappropriate prescribing’, 
explanations which are summarised and presented in Table 6.11.  
 
TABLE 0-11 UNDERSTANDING OF THE TERM PIP (POTENTIAL INAPPROPRIATE PRESCRIBING). 
 
Drug duration too short/long 
Drug dosage incorrect 
No discontinuation date identified 
Prescriptions repeated without suitable review 
Interactions with other drugs 
Incomplete assessment  
Unsuitable combinations of drugs 
Incorrect maintenance drugs 
Unwanted side effects 
Under  and over prescribing  
High risk drugs unmonitored 
       Polypharmacy 
 
 
A broad range of issues were identified as contributing factors to PIP 
which, according to NPs, could be initiated by the  patient, the family or the 
healthcare professional. For instance, the well documented issues with 
polypharmacy may also be the result of patient and/or family assuming the role 
of prescriber. 
 
‘Sometimes patients will take medications from a relative because a 
drug worked for them or they combine over the counter medications 




If a family is unhappy with treatment for an older person or feel situations 
are unresolved, they often seek additional help and because of anxiety will visit 
several doctors for the same problem, especially if the patient has challenging 
behaviour and is difficult to manage at home.       
‘… when you have several doctors prescribing for the same patient 
some of them don’t understanding the root of the patient’s problem or 
communicate the changes made this can be a big problem for 
prescribers’….‘Families frequently request medications with lack of 




‘If the patient does not tell their family doctor they have been to see 
another doctor out of hours then the changes might not be picked up for 
some time – access to information is a problem’. 
(Participant 6) 
 
Participants identified a combination of age, multiple co-morbidities and 
poor history-taking as significant issues that contributed to the complexity of 
prescribing decisions in older people. Interventions to optimise prescribing 
appropriateness required support from suitable persons with knowledge to 
review prescriptions and were influenced strongly by the presence of a clinical 
pharmacist or access to a geriatrician.  
‘if pharmacists are involved in prescribing and undertaking reviews 





In addition, PIP was kept to a minimum if 
‘…GPs in the community worked closely with the community hospital 
and MDT including our geriatrician we had fewer problems’. 
(Participant 10) 
 
However, there were also issues identified within the nursing care facilities 
as contributing to PIP.  
‘Sometimes the use of antipsychotics and benzo’s (benzodiazepines) 
are staff rather than GP lead – staff shortages make it difficult to 
manage some patients’. 
(Participant 7) 
 
Having undertaken the prescribing programme, participants were acutely 
aware of the responsibility of prescribing medications and underpinning 
knowledge required. However, circumstances can sometimes contribute 
negatively to the prescribing process resulting in an inappropriate prescription.  
‘I suppose it (PIP) is something that would be on most prescriber’s 
minds. I feel confident enough but there is always the possibility of 
prescribing an inappropriate drug, dosage or frequency especially if I am 
busy and my assessment is rushed I try and make sure it does not 
happen but there is always the possibility’. 
(Participant 2) 
 
Participants’ concerns regarding PIP also extended to the management of 
patients’ medications from the wider perspective of changing conditions to 
ensure medications prescribed remain appropriate.   
 
‘I sometimes need to initiate reduction in dosages for the patient… 
but I would go back to my assessment and knowledge gained to do 
this’… ‘If the patient has too many underlying problems it is better to 





6.11.2 Changing a PIP 
 
Changing a PIP was either a simple or complex matter depending upon the 
acceptance of nurse prescribing in the clinical area in question.  
‘No problem, if I see a drug prescribed inappropriately there is no 




‘It depends on my relationship with the medic (doctor), some are 
very in favour of nurse prescribing whereas others want to control it’. 
(Participant 9) 
 
Even though the NPs appeared to be confident in altering a prescription 
many indicated that they would be cautious. One particular response within the 
clinical setting was more severe and debilitating for the NP and her practice. 
 ‘I once discontinued an antibiotic prescribed by the GP and had my 
knuckles wrapped because I had not consulted with him even though it 
was well documented that the patient was allergic to the drug …I was 
 
told not to prescribe for his patients again. The doctor in fact asked for 
restrictions to be put in place regarding my role, I haven’t prescribed in 
over a year now’. 
(Participant 5) 
 
Working from a CPA was considered somewhat restrictive if a PIP required 
attention. In clinical practice, NPs must work within the parameters of the 
agreed drugs list on the CPA. Therefore, nurse prescribers were not 
comfortable making alterations to drugs that were deemed inappropriate if 
outside the limit of their CPA.   
 
‘It would depend on the drugs listed on my CPA, if it is not listed I 
would not change it. If it was something simple I would not have a 




Reported confidence could also be viewed in terms of the CPA however, 
participants appeared to have outgrown the CPA which they now viewed as  
restrictive with some participants clearly stating that  
‘It’s wrong to leave an inappropriate drug on a medication chart and 
do nothing about it because I have to work within my CPA but I’m more 
competent than that’… ‘I will use the feedback letters (from 
STOPP/START) the next time my CPA is being reviewed’. 
(Participant 12) 
 
‘Nurse prescribing should be more independent, I find that my CPA is 





6.11.3 Utilisation of STOPP/START feedback 
 
Feedback letters given to the nurse prescribers following the application of 
the STOPP/START tool to their prescriptions were viewed in a very positive 
light.   
‘The STOPP/START feedback was good to discuss with the doctors it 
gives you real evidence’. 
(Participant 8) 
 
There was also a growing awareness by participants and the value that the 
screening tools feedback could play in improving collaborative care. 
‘Yes, I found them great to get feedback so honest. I like that I get 




‘Very good for guidance and alerting you to the most appropriate 
action see underlying problem and how it is being managed especially 
with PPI (proton pump inhibitors). Makes you think and be more aware  
 
 
of drugs. I use the feedback when discussing issues with the MDT’.  
(Participant 11) 
For staff who did not refer to screening tools routinely, they could also see 
the associated benefit.   
‘When I got the feedback letters it made me realise how powerful 
they (screening tools) can be.  I used the letters to get some of the 
patients medications changed and the doctors were responsive for the 




Participants were also creative in using the feedback as evidence of care 
and to advance and support ongoing issues in the clinical area that had 
previously been difficult to advance within the organisation.  
‘…the feedback from STOPP/START was used to highlight the 
importance of having a clinical pharmacist. Forty percent of our patient 
prescriptions were reviewed and when we had the evidence of the cost 
savings from the feedback letters our facility agreed to employ a clinical 
pharmacist three days a week’.  
(Participant 1) 
 
‘After the STOPP/START evaluation HIQA (Health Information 
Quality Authority) were with us we showed them the feedback letters as 




‘I think it’s great to assess prescribing using STOPP/START and have 
evidence for my audits’.  
(Participant 11) 
 
In general having an evaluation tool in place was viewed in a positive light 
however, there were concerns that an appropriate evaluation tool would be 
adopted  
‘Yes, I think the STOPP/START tool is easy to use; the problem here is 
that they are bringing in a system that is over complicated.  I would 
prefer the STOPP/START tool to work with’. 
(Participant 14) 
 
Reservations regarding the need for an evaluation tool centred on 
insufficient supporting systems in the clinical setting and having a patient-
focused approach to medications.  
‘…we would not have access to updated software.  I would like 
software to help with inappropriate prescribing’. 
(Participant 7) 
 
 ‘They are of benefit but I generally don’t refer to them I work with 
the patient ensuring they are well.  Listening to patient is the most 







Findings indicate that participants were knowledgeable regarding 
inappropriate prescribing and were positive regarding the feedback letters 
given following the STOPP/START medication evaluation. Previous research 
undertaken in this area concentrated on applying the STOPP/START tool mainly 
to prescriptions written by doctors. To date, a qualitative follow-up 
investigation has not been undertaken to explore the impact of the feedback 
given and if or how it was utilised. Therefore, information available in the 
literature on the topic to equate directly with the findings of this Chapter is 
limited. Consequently, results will be compared with the available data 
regarding PIP in older adult care and relevant issues identified by the 
participants.   
Participants revealed an insightful understanding of prescribing and that 
optimizing drug therapy for older adult patients was a challenging multifaceted 
process that should not be considered a straightforward procedure. The 
changes in age and multi co-morbidities identified by participants in relation to 
prescribing are issues discussed by Barry et al. (2008) who suggest that 
frequent exposure to medications in the older adult increases the risk of 
developing complications from drug therapy. However, participants also 
identified accurate assessment and history taking as potential additional 
contributing risk factors if not conducted properly in advance of undertaking 
the complexity of prescribing decisions in older people. This is, perhaps, due in 
part to the fact that the core element of the prescribing process centres on 
decision making which is considered ambiguous (Aronson, 2011) and varies 
considerably from one prescriber to another. Participants also highlighted the 
importance of the patient’s perspective on medicine-taking within the 
assessment process that needed to be determined in advance because a 
compromise was sometimes needed between the view of the prescriber and 
the patient’s informed choice to ensure medications were appropriate. The 
importance of this consensus is borne out in research undertaken by Frank et 
 
al. (2001) who states that 37 per cent of patients take drugs without their 
doctors’ knowledge, and 6 per cent of patients do not take medications 
prescribed by their doctors. In addition, if several different prescribers are 
involved in treatment, the risk of receiving an inappropriate drug combination 
is high and well established (Tamblyn et al., 1996) because the provider of 
prescriptions may not be fully informed.  Findings from this study identified 
that older patients were contributing unintentionally in the nurses view to the 
problem of inappropriate prescribing by self-medicating, failing to follow 
prescribed directions, failing to report all medications or over the counter 
products used and borrowing or trading medications with friends and family.  
 
PIP prescribing in older Irish people is a well-documented problem (Ryan et 
al., 2009c, Byrne et al., 2010a, O'Sullivan et al., 2013) that requires a 
collaborative approach to prescribing to ensure medications are appropriate for 
patients with complex drug regimens and multiple comorbidities.  Specifically 
the study confirmed that medication management in care of the older adult 
calls for a greater alignment between nurses’ and doctors’ prescribing 
processes if medication management is to improve. Having a two-tiered 
prescribing system in place fragments prescribing and could be viewed as 
contributing to the increasing medications problems experienced by the Health 
Service that now costs the government almost €2bn per year (Barry, 2013). 
Reflecting this collaboration, possibly the most beneficial modification to the 
clinical area secured by participants in this study was the addition of a clinical 
pharmacist to the team which according to Stuijt et al. (2008) and Kaczorowski 
et al. (2011) improves older patients' health care outcomes. 
 
Control of prescribing experienced by participants in the study was not 
reliant on actual authority but was exercised in a number of ways.  Firstly, 
participants recognised that nurses prescribed under restrictive conditions 
because of the CPA and confidence to change a PIP was heavily reliant on the 
 
relationship between the nurse prescriber and the doctor and whether or not 
the medication was identified on their CPA. Having rigorous controls in place 
for NPs raises the question, is it a tool that can be manipulated by the 
organisation for its own benefit or a role that keeps with a nursing vision of 
benefiting patients? At present the structures in place are at best, unproductive 
if each CPA does not accurately reflect the needs of the clinical area and the 
prescriber. It is suggested the governing body responsible for introducing the 
CPA needs to reflect on its value. Participants were in favour of having a CPA for 
the first 12-18 months to help with establishing confidence and competence, 
however, the majority of participants had moved beyond requiring this support 
and now found it cumbersome which detracted from the efficiency of their 
prescribing. Secondly, through the CPA, medical dominance was maintained 
over NP and, similar to work undertaken by Stein-Parbury & Liaschenko (2007), 
collaboration broke down when physicians overlooked nurses’ clinical 
assessment and concerns about a patient.  On the whole doctors’ primary work 
is concerned with the disease itself and its treatment whereas nurses’ work is 
often concerned with issues that are less physical and therefore poorly 
understood and perhaps less relevant to doctors.  However, the knowledge 
associated with prescribing is independent of this divide and should connect 
both nurse and doctors in a shared understanding of prescribing (Kroezen et al., 
2012).  
 
My work also found that feedback letters were valued by participants as a 
source of information to enhance and encourage good prescribing practice but 
also to support their position within the organisation. Having the information 
and rationale for change gave them the confidence to question medication 
regimes which they could now do from an evidence-based perspective. This, 
they felt, strengthened their position within the multidisciplinary team because 
they could now discuss relevant issues having appropriate background 
information and a proposed solution. The security of this knowledge also gave 
them more confidence presenting cases to the Drugs and Therapeutics 
Committee specifically in relational to advancing the medications listed on their 
 
CPA, that had in some cases been previously rejected. One particular site had 
four participants that equated to 40 patients’ prescriptions being reviewed. 
Having been unsuccessful in putting several proposals forward requesting the 
support of a clinical pharmacist for the hospital, the participants linked the 
feedback information to cost savings for the organisation and resubmitted their 
proposal. They were successful and the organisation now has a clinical 
pharmacist who can assist in a comprehensive appraisal of older patients’ 
medications and who is considered a valuable resource person.  According to 
Ansari (2010) clinical pharmacists have a major role to play in relation to 
prevention, detection, and reporting ADEs, considering that over 70% of the 
ADEs are avoidable (Howard et al., 2007). In addition, findings from Howard et 
al. (2007) found that common drug groups associated with preventable ADEs 
are similar to those identified in this study and identified in Table 6.6 (Stage 
One of STOPP/START study). The PIP medication groups in Table 6.6 could 
therefore be considered a priority when addressing polypharmacy for older 
adults after to inform the ineffective or unnecessary treatment. Working as a 
multidisciplinary team affords the skill range to meet the increasingly complex 
needs of older adult patients who require the different skills of different 
professionals. Finally, another participant presented her feedback letters and 
changes undertaken to the patient’s medication regimes to the Health 
Information Quality Authority (HIQA) as part of a national audit that included a 
review of medications. Discussion is underway to incorporate the STOPP/START 
tool into two clinical sites on a more permanent basis. 
 
STOPP/START should be considered a flexible tool to help balance safety 
and quality of prescribing with appropriate treatment of all co-morbidities 
(Gallagher and O'Mahony, 2008b). In some cases, what is considered 
inappropriate prescribing according to STOPP/START may be appropriate 
prescribing for an individual patient for various reasons. To address this, 
guidelines accompanying the STOPP/START tool clearly state that the tool does 
not replace the clinical judgment of the prescriber. To ensure continued clinical 
 
relevance and applicability, Version 2 of the STOPP/START criteria was 
published in October 2014 (O'Mahony et al., 2014). 
 
 
6.13 Conclusion  
 
This is the first studies in the Irish setting to investigate nurse prescribers’ 
views and experiences of PIP and receiving feedback using STOPP/START.  
Interventions that focused on optimising prescribing by addressing the issues 
related to the most common instances of PIP is important but understanding 
how the tool was used constructively in the clinical setting to improve 
relationships and establish hard evidence for change is vital for the future 
advancement of nurse prescribing.  
 
All of the participants welcomed the feedback letters following the 
STOPP/START evaluation and utilised them in various different ways: one 
particular site used the evidence in the feedback letters to support the 
introduction of a clinical pharmacist to the team. Other participants regarded 
the information in the feedback letters as valuable toward strengthening their 
position within the multidisciplinary team. Perhaps the most important 
outcome was the confidence the feedback letters gave the participants who 
challenged and changed medications regimes and presented cases, with self-
assurance, to the local Drugs and Therapeutics committee.  The letters also 
gave the participant a broader view of their CPA, which they felt was too 
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AND USING A PRESCRIBING 
EVALUATION TOOL 
 
Chapter 7 – investigates NPs’ perceptions of appropriate and inappropriate 
prescribing and their opinion of using a medication evaluation tool from an 
international perspective. Canadian nurse practitioners with prescriptive 
authority and previous experience of using a medication evaluation tool 
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7.1 Introduction  
 
Nurse practitioner has no universal definition (Worster et al., 2005) but it is 
generally accepted that nurse practitioners provide services to individuals and 
families across the lifespan and work in a variety of community-based settings 
(DiCenso et al. 2003, 2007). The title is frequently used to identify advanced 
practice nursing in Canada, the United States (US), Australia and the United 
Kingdom (UK). In Ireland, the position is referred to as an Advanced Nurse 
Practitioner (ANP). Historically, the nurse practitioner role was introduced in 
the US in the mid-1960s (McIntosh et al., 2003) and Canada in 1967 (DiCenso et 
al., 2003) to meet increasing health service needs, with the literature describing 
the first reported nurse practitioner’s role as ‘a contentious issue that produced 
a good deal of conflict and anxiety’ at the time (Schober and Affara, 2006 p. 
37). Today however, the role encompasses an evidence-informed holistic 
approach that emphasises health promotion and partnership development, 
that complements rather than replace other healthcare providers (Donald et 
al., 2010). More recent events of physician shortage, together with the aging 
population and the associated increase in healthcare demands that has exerted 
considerable pressure on the Canadian health care system (Gould et al., 2007b) 
and so nurse practitioners have become increasingly identified as a resource 
that can meet the ongoing health need of the Canadian population (Esmail, 
2011).  
Nurse practitioners’ prescriptive authority has therefore evolved in 
response to pressures from patients, physicians, changing policies and 
requirements relating to the effectiveness and efficiency of care (Latter and 
Courtenay, 2004, Kaplan and Brown, 2006). Prescribing authority for Canadian 
nurse practitioners is particularly important because health services cover large 
geographical regions that are remote, sparsely populated and where medical 
practitioners are not readily available (Forchuk and Kohr, 2009a). However, 
prescriptive authority for nurse prescribers in the Canadian context is complex 
and may vary due to provincial and territorial governance systems within the 
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country (Forchuk and Kohr, 2009b). This has resulted in each province and 
territory having its own approach to nurse practitioner positions with 
prescriptive authority closely linked to the development of the role within each 
province. The common ground being the requirement for additional education, 
training, and regulation to ensure that those functioning in the nurse 
practitioner role are able to provide safe care to the public (Donald et al., 
2010).  
Internationally over the past decade nurse practitioners have become part 
of  the long term care system (Jehan and Nelson, 2006, Stolee et al., 2006, 
Health Service Executive, 2008b) and are now caring for clients with higher 
prevalence of chronic illness, disability and dependency (Barry, 2009). However, 
advancing age and exposure to medications increases the risk of developing 
complications from drug therapy. Consequently, particular care must be taken 
when determining drugs and dosages for this section of the population to 
ensure prescribing is appropriate considering the long standing issues and 
number of older adult clients in receipt of medicines for chronic conditions in 
the Canadian health service (Sitar et al, 1995). While the benefits of 
pharmacotherapy for the older adult are potentially substantial, the process of 
choosing the appropriate medicine for the individual older adult patient may be 
complex. Changes in the patient’s medical status over time can cause long-term 
medicines to become unsafe or ineffective, therefore part of the nurse 
practitioner’s role is regular medication review to ensure continuing positive 
benefit for each medicine prescribed for the older adult. To ensure medication 
benefits are maintained several validated tools have been developed to help 
prescribers identify potential inappropriate prescribing in older adult care 
(Beers, 1997, Cantrill et al., 1998, Gallagher et al., 2008c). The significance of 
appropriate prescribing can be viewed in the context of the financial cost to the 
health service which has been identified by the Canadian Institute of Health 
Information (CIHI). In 2013, an estimated $34.5 billion was spent on drugs, the 
majority of which $29.3 billion (85.0%) was spent on prescribed drugs 
(Canadian Institute of Health Information, 2013). Within the priority research 
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area of Drug Policy, the Canadian Institute of Health Research has identified 
effectiveness, safety and adverse events as key areas to be addressed, their 
vision being to ‘transform from a reactive, one-size-fits all approach to a more 
personalized system of predictive, preventive, and precision healthcare that is 
tailored to a population or an individual’ (Canadian Institute of Health 
information, 2014, p. 64). Incorporating nurse practitioners to provide direct 
care by way of ‘initial diagnosis of problems/concerns, establishing of diagnosis 
following appropriate diagnostic tests if required and formulation of a 
management plan, which may include prescriptions of medications’ (Lowe et 
al., 2012) has the ability to provide personalised appropriate care the initiative 
requires. Furthermore, the competence of nurse practitioners to manage 
patient care in a comparable manner to physicians, with high levels of patient 
satisfaction, combined with increased advice on education and health 
promotion has been well reported in the international literature (Snowden and 
Martin, 2010, Courtenay et al., 2011, Bowskill et al., 2012, Latter et al., 2012, 
Ben Natan et al., 2013). However, the literature in relation to nurse 
practitioners understanding of appropriate or inappropriate prescribing is 
limited; leaving a void in the understanding of the impact nurse practitioners 
with prescriptive authority may have on patients’ drug regimes. The difficulty 
however, can be local governance policy that limits the number of products 
available in the prescribing formulary for nurse practitioners (Wilson and 
Bunnell, 2007) causing restrictions on prescribing that impact on their ability to 
prescribe appropriately. Therefore, it is important to gain a better appreciation 
of Canadian nurse practitioners’ understanding of appropriate and 
inappropriate prescribing and their views of using a prescription evaluation tool 
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The aim of the study was to explore Canadian nurse practitioners (with 
prescriptive authority) understanding of appropriate and inappropriate 




Similar to the qualitative descriptive methodology discussed in chapter 3 
(section 3.3) this study adopted a qualitative descriptive, approach to the 
research. Data were collected in May 2015 during a research travel bursary visit 
of four weeks to Dalhousie University, in Halifax, Using a descriptive 
phenomenology approach is the most appropriate way to develop an 
understanding of nurse practitioners’ experience of appropriate and 
inappropriate prescribing and the importance placed on a prescribing 





Participants in a Husserlian phenomenology study must have experienced 
the phenomenon and be able to articulate what it is like to have lived that 
experience (Lopez and Willis, 2004) of using a medication evaluation tool in 
practice. Therefore, a purposive sample of nurse practitioners with prescriptive 
authority working in older adult care in the greater Halifax region and the wider 
area of Nova Scotia, Canada were asked to participant. Sampling continued 
until no new themes emerged, this occurred after eight interviews. All 
participants except one were female having an educational level of either MSc 
or PhD, the participants also had experience as nurse practitioners with 
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prescriptive authority ranging from 2 to 14 years and clinical experience of 8 to 
28 years. All of the nurse practitioners interviewed were primary healthcare 
practitioners, with seven of them currently working in community health 




All eight participants were first contacted by the researcher via email to 
establish their interest in participating in the research. Positive responses were 
followed up with personal emails that included interview details and requesting 
that the participant identify a date and time suitable to carry out a telephone 
interview. Telephone interviews were necessary because of the diverse 
geographical location of participants across the state of Nova Scotia, Canada 
and the timeframe available to the researcher to collect the data. Interviews 
followed a semi-similar structure to the telephone interviews undertaken in 
Chapter 6 stage 2 (section 6.10.3) of the study to ensure appropriate structure 
and accurate preparation for the interviews, the process was divided into three:  
a) before, b) during and c) after the interview, details of which are set out in 
Table 6.10  
 
7.3.3 Data collection 
 
Interviews were conducted by telephone with each practitioner for 
approximately 25-35 min. A predetermined set of open questions were used to 
maintain focus on appropriate and inappropriate prescribing and the value of 
using a prescription evaluation tool (Appendix 16). This topic guide was 
developed by the author for a previous study using STOPP/START and piloted to 
ensure the guide maintained focus on appropriate and inappropriate 
prescribing. This structure provided an outline for the interview however, 
additional questions were allowed to emerge naturally from the dialogue. Due 
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to the lack of visual cues the researcher took notes as a reminder of the non-
verbal communication such as pauses or hesitations that took place during the 
interview and to facilitate transcription.  
The interviews were digitally recorded and transcribed immediately 
following the interview to ensure the experience as described by the 
participant was accurately captured. Using the telephone for data collection 
interviews may also reduce some forms of response bias (facial expressions) as 
the interviewer and participant are potentially less affected by each other's 
presence. This, in turn, may increase the level of comfort for both parties and 
result in a more relaxed interview (Smith, 2005).  
 
7.3.4 Ethics considerations 
 
Ethical approval was not granted for data collection in Canada by the 
Clinical Research Ethic Committee Cork (Appendix 17). Access to potential 
participants for the study in Canada was facilitated by the Pharmacy 
Department at Dalhousie University who arranged the appropriate meeting and 
introduction to the Senior Advanced Nurse Practitioner in Nova Scotia to 
discuss the study and potential participants. Before the interview process 
commenced, research participants were given the opportunity to ask the 
researcher questions regarding the study. Verbal consent was obtained and the 
possibility of re-negotiating consent was also discussed. Confidentiality was 
assured and the right to withdraw at any time during the investigation, without 
prejudice, was guaranteed.  
 
7.3.5 Data analysis 
 
Data analysis was carried out using Colaizzi’s (1978) Procedural Steps which 
provided a framework in keeping with qualitative descriptive research (see 
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table 4.3).  Similar to the structures undertaken in chapter 4, meaning 
statements were clustered into common themes and again referred back to the 
original commentary for validation, thus ensuring that only the participant’s 
perception was captured.  
 In following the principles of data reduction all themes were included until 
a textural-structural description of the experiences of the nurse prescribers as a 
whole was obtained. It was necessary to recognise overlapping themes and 
clarify others that were ambiguous by bringing them back to the participant for 
validation or further elaboration, when necessary.  In doing this, the 
interpretive research moved back and forth between two worlds: that of the 
understanding and resourceful dwelling of the participants, and the distancing 
and questioning world of the researcher.  Through analyses and interaction 
with the data, it is hoped to progress beyond the common sense understanding 
of the participants’ experience in the situation under study to a level of 
interpretation and critique (Benner, 1994).  
 
7.4 Results  
 
Following analysis of the narrative data, findings were grouped under the 
following headings for reporting: 
• Level of confidence and competence described by nurse practitioners in 
their role as prescriber. 
• Understanding and consequences of inappropriate prescribing. 
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7.4.1 Confidence and competence 
 
Participants acknowledged that having prescribing rights had improved 
their self-esteem, and autonomy in practice. When asked specifically to rate 
their confidence in prescribing on a scale of 1-10, 1 being the least and 10 the 
most confident the majority of participants rated themselves between 8 and 
10. These participants were well established having the most experience in 
their specialty area, kept up to date and understood their professional 
boundaries. However, one participant did not share this view awarding 
themselves a 6. This participant had the least experience having qualified as a 
nurse prescriber two year previously and attributed this to not having had the 
opportunity to prescribe as part of the education process. 
You know I found when you get in a course you can teach about the 
disease and learn about a particular drug but we don’t know how to 
prescribe or how to titrate or discontinue it (medication) really I find you 
learn by using the drug or talking to colleagues…I didn’t know how to, 
start it (prescribing) and I always ‘start low and go slow’. But what is low 
and what is slow?’ 
(Participant 2) 
 
Additional issues concerning confidence and competence surfaced when 
asked if there was anything they should know more about when prescribing for 
older adults. CPD was identified by all participants as important to maintain 
awareness of medication issues and better placing them to question or 
challenge medication changes or adjustments required. 
‘I won’t prescribe anything new unless I have absolute 
understanding of what patients are on and taking in addition, like 
herbal, over the counter or any complementary therapies…because a lot 
of them don’t even think that an enteric coated aspirin they take for 
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heart disease is even a medication because they don’t get a prescription 
for it… patients adding over the counter medications can be a big 
problem’ 
 (Participant 7) 
 
Accurate assessment was also identified as important for competent 
prescribing. However, several participants highlighted that developing nursing 
expertise in a particular area can focus your knowledge so finely that limitations 
can occur.  
‘I’m comfortable assessing my patients, my background is renal but 
my patients don’t just come with renal problems they have vascular 
problems, diabetes the whole list. I’m not an expert in some of those 
other areas’.  
(Participant 6) 
 
Participants felt that their role was not to primarily generate prescriptions 
instead they were keen to communication and interact with patients as part of 
an accurate assessment and competent prescribing process.  Understanding 
the characteristics of the patient’s requirements, strengths and weaknesses 
that facilitated a more holistic approach to prescribing was identified as 
important.  
‘Having a conversation is important because you can have patients 
with strange reactions to their medicines and if you don’t explore it 
properly you won’t know. I find that sometimes the gaps I identify during 
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7.4.2 Understanding and consequences of inappropriate prescribing  
 
The level of understanding regarding inappropriate prescribing was broad 
and has been condensed into the main areas identified in table 7.1.  
 
TABLE 0-1 DESCRIPTION OF INAPPROPRIATE PRESCRIBING 
1. Medications not appropriate for the client in terms of diagnosis or health 
status at the moment. 
2. Prescribing without a good cause or reason. 
3. Making a choice of medications for patients that either don’t follow best 
practice or are not in the patient’s best interest. 
4. Prescribing outside my scope of practice. Wrong dose for the wrong 
patient. 
5. Medications prescribed that are not clinically relevant. 
6. Prescribing something that is not based on evidence based rationale from 
a clinical assessment point of view that fits the actual condition.  
7. Prescribing a medication that may not be warranted or effective.  
8. Wrong medication for the wrong patient. 
 
Although not referred to directly, prescribing by omission was addressed 
indirectly within answers questions.   
 
It is an established fact that medication use increases with advancing age. 
This in turn requires that prescribing for older people represents a range of 
options and values that attempt to optimize prescribing quality for individual 
patients.  
‘Prescribers do not use frailty as a predictor when prescribing. A lot 
of the medication of older folk are family driven because they want Mom 
or Dad or whoever to have the same level of care that they have not 
recognising the physiological changes that occur with aging may not 
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Also depending on the level of care, therapies can be viewed from different 
perspectives. 
‘Sometimes treatment in hospitals would be a little more aggressive 
than what we would consider appropriate in primary care’. 
(Participant 7) 
 
All participants identified they had a substantial role to ensure medicines 
were appropriate. Specifically, interactive approaches were used to combat 
problems. 
‘I have a direct involvement because I am educating the residents 
myself and nursing staff plus allied staff. I also review charts as part of 
the process.  
(Participant 4) 
 
‘I have direct involvement in making sure medications are 
appropriate we do hundreds of med reviews every year and we do med 
reconciliation also. I explain to the families and staff the physical and 
medications review results’.  
(Participant 3) 
 
Participants linked proper assessment to appropriate prescribing through 
individualised care assessment thereby, ensuring the drug–patient interaction 
is implicitly included in the prescriptive process.   
‘I’ve seen families who were primary care givers for older adults 
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which were actually side effects of medications when assessed’. 
(Participant 7) 
Several characteristics of ageing and geriatric medicine affect medication 
prescribing for older adult people and render the selection of appropriate 
pharmacotherapy a challenging and complex process that may not result in the 
desired effect. 
 
‘I really don’t think there is a black and white answer to prescribing 
sometimes the patient does not keep up to date with the changes to 
medications it’s not always about the medicines sometimes its human 
error that causes the problems. We try to do our best, but sometimes 
problems just happen’.  
(Participant 4) 
 
Inappropriate prescribing remains a problem in day-to-day practice and 
despite increased awareness; the dynamic nature of the problem requires 
updating solutions that address constant changing patterns.  
‘I try to focus on what I do well… and individualise care to reduce risk’ 
(Participant 6) 
 
For prescribing in general it is important that the patient has trust in the 
prescriber. Trust is also essential for establishing collegial relationships with 
other healthcare professionals and patients.  
‘There is human error in everything we do. What people deserve to 
know is whether it was an error or an omission and the biggest thing 
people want to know is what are we going to do differently, or if we are 
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Participants were confident that the consequences of inappropriate 
prescribing could be addressed 
‘I think it would be education for all involved but there is a barrier to 
that because it costs money’ 
(Participant 2) 
 
‘So in order to make change we really have to have a complete 
culture shift and make the prescribers and the whole system aware that 
seniors require unique care and they are uniquely different form the 
adult population when it comes to prescribing’.  
(Participant 4) 
 
‘I’m the only nurse practitioner within a huge facility (485 beds) in 
my opinion there is work for three in the facility then we could cover and 
support each other and share the workload and have cover at the 
weekends. Yes we need more prescribing nurse practitioners’. 
(Participant 3) 
 
Address polypharmacy we’ve been talking about it for years but we 
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Polypharmacy was identified as very common among older adults and is 
often adopted as a strategy to address symptoms, reducing disease-related 
problems and improving quality of life in the older adult. 
‘When we look at underlying causes for problematic symptoms it is 
sometimes due to too many drugs. We have to strip them back to the 




Polypharmacy may also be the result of patient and/or family assuming the 
role of prescriber. 
If over the counter drugs are added (to the medication regime) the 
patients may present to us with problems that can be difficult to figure 
out. Education is important and even salads in the summer for someone 
on warfarin can cause problems’ 
(Participant 8) 
 
It is unrealistic to expect that the majority of clinicians have enough 
knowledge about drug-related appropriateness and interactions when 
prescribing for older people with multi-morbidity to avoid errors. However, 
participants felt that they could err on the side of caution.  
‘If there is ever a problem I write my cell number on all my 
prescriptions so if the pharmacist ever has a question they can contact 
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The most effective benefits of prescriptive drug therapy for older adults can 
only be derived if drugs are prescribed and used appropriately. Participants 
voiced that combining expert opinions was also an option.  
‘…attention to detail is required and if I have a problem I will take it 
to my collaborative practice partner to discuss. I work in a collaborative 
team so I don’t work in isolation it’s always good to have colleague 
around for advice.  
(Participant 6)  
 
 
7.4.3 The role screening tools play in prescribing for older people.  
 
All participants had experience of using a prescribing appropriate 
evaluation tool and were familiar with the STOPP/START evaluation tool in 
particular. 
‘I used the STOPP/START criteria in my work and clearly identified 
areas where there is inappropriate prescribing and the need for re-
evaluation depending on the stage of life’. 
(Participant 4) 
 
Time appeared to be an issue when applying a screening tool with some 
participants identifying it as cumbersome to apply in the clinical setting.  Many 
practical issues were raised. 
‘I can really see the benefit of using a medication evaluation tool 
especially if we had the database that you (the researcher) use. It would 
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and applying the criteria manually is just not practical’.  
(Participant 3) 
 
‘I think it would play an important role especially if the nurses and 
doctors were using the same computer based system. We would follow 
the same structure and have a better result for the patient using the 
evaluation tool’. 
(Participant 2)  
 
Participants’ concerns regarding PIP also extended to the management of 
patients’ medications from the wider perspective of changing conditions to 
ensure medications prescribed remain appropriate.   
‘I love the STOPP/START tool because the research is there in the 
literature and so easy to share the information and findings. They make 
us think about leaving people on medications for extended periods of 
time simply because they saw a cardiologist 15 years ago’. 
(Participant 3) 
 
Other participants could see possibilities beyond the initial identification of 
PIP. 
‘They are not necessarily looking at just prescribing but gathering 
data on your patient about their diagnosis, past history, medications, lab 
tests and activities of daily living a concise history and assessment on 
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All participants were knowledgeable regarding inappropriate prescribing 
and had information about or worked with a prescribing evaluation tool in the 
past. As with previous research, participants highly rated the use of a 
prescribing medication evaluation tool, understanding that medication 
appropriateness can be measured by evaluating the content or quality of a 
prescribing decision and or the outcome of that decision (O'Connor et al., 
2012).  Even though there was a number of prescribing evaluation tools 
available for detecting inappropriate prescribing, the participants had a very 
good working knowledge of the STOPP/START criteria.  This was attributed to 
the ongoing research using the STOPP/START criteria undertaken by the 
Pharmacy Department in Dalhousie University, Halifax, in collaboration with the 
School of Pharmacy in University College Cork, Ireland.   
 
All participants endorsed regular reviews of older adults prescriptions, a 
practice that is supported by the literature to reduce medications prescribed 
(Loganathan et al., 2001). Nurse practitioners were aware of the issues 
surrounding the aging population in their region especially the growing number 
of older adults that face challenging treatment decisions. This trend makes it 
even more critical to develop interventions that can improve the decision-
making process to ensure appropriate medications are prescribed (Tariman et 
al., 2012). In order to facilitate good decision making and depending on 
cognitive awareness of patient’s nurse practitioners included families when 
necessary through organised family conferences. Including the family in the 
assessment process opened communication to ensure that patients concerns 
and wishes regarding medications and treatments are elicited and understood. 
This is an important additional component of managing medications 
considering physicians’ and patients’ perspectives on treatment and associated 
decisions can sometimes differ. Such differences were identified by Kutner et 
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al. (2000) who recognised physicians rank co-morbid conditions and the 
medical literature as important factors in treatment decision-making, while 
patients rank family preference, family burden, and physician’s opinion as 
important factors in making treatment decisions.  Nurse practitioners with 
prescriptive authority are adequately placed in practice to promote informed 
treatment choices that are consistent with the patients’ personal preference 
and based on informed decision making. Nonetheless, the balance is fine 
between medications that improve quality of life for the older adult and 
medication related problems that place them at risk (Rocchiccioli et al., 2007).  
 
Nurse practitioners identified that selecting appropriate medications for 
use in older adult patients is often complicated by multiple illnesses and 
multiple medications. The potential is high for drug-drug and drug-disease 
interactions which the nurse practitioner must bear in mind when choosing a 
medication or assessing its effectiveness or side effects (Herr, 2002). The 
primary factor associated with medicine under use was a lack of knowledge. In 
particular lack of access to the expert knowledge of a geriatrician impact on 
medications concerning geriatric conditions in those caring for older adult 
findings similar to Lang et al.  (2010).  Even though participants indicated that 
specialisation improved their knowledge, it was focused on a specific condition 
or system depending on nurse practitioners area of expertise. This posed a 
considerable challenge for nurse practitioners, because patients who usually 
presented with problems require a wider understanding of individual diagnosis 
and differential diagnosis in order to make appropriate medication decisions for 
them. To ensure patients with multiple problems were appropriately assessed 
the nurse prescriber utilised the expertise of the multidisciplinary team which 
according to the literature ‘utilises individuals from different disciplines working 
in a team toward a common goal’ (Thylefors et al., 2005 p. 112). Such 
collaboration has led to improved client outcomes such as decreased hospital 
admissions and timely interventions for older adults (Arbon et al., 2008, Health 
Service Executive, 2010). However, participants also expressed the importance 
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of combining multidisciplinary care with a medication evaluation tool especially 
STOPP/START was significant because of its correlation with ADEs (Hamilton et 
al., 2011a).  
 
Much attention has been paid to over-prescribing for older adults 
nonetheless participants recognised that under-prescribing of appropriate 
medications was also a concern. This is a seriously misdirected practice 
according to Rochon (2015) because seeking to simply limit the overall number 
of drugs prescribed to older adults in the name of improving quality of care is 
incorrect practice. Therefore, a medication evaluation tool used in practice 
needs to encompass the appropriateness of prescribing which according to 
Spinewine et al. (2007) embraces three values, 1) the preferences of the 
patient, 2) the scientific and technical rationale of prescribing; and 3) the 
interests of the community.  However, quantifying what the patient wants and 
serving the best interests of the community can be quite challenging as they 
can be influenced by societal, economic and family factors (Lam and Cheung, 
2012).  
 
The literature reveals that numerous studies using STOPP/START criteria 
have been conducted in various patient-care settings to assess prescribing 
appropriateness (Gallagher and O'Mahony, 2008b, Ryan et al., 2009c, Cahir et 
al., 2010b, Gallagher, 2011, Ryan et al., 2012, O'Sullivan et al., 2013). However, 
when using a prescribing evaluation tool, it is important to consider that explicit 
criteria such as that of STOPP/START do not take into account all factors that 
define high quality health care for the individuals. The START screening tool for 
PPOs does not allow for factors such as life expectancy, time needed to derive 
clinical benefit and patient preference as legitimate reasons for under-
prescribing (Spinewine et al., 2007). It is the nurse practitioners responsibility to 
understand the burden of comorbid disease and patient preference which are 
then taken into account and required to reconcile decisions with the evaluation 
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tool. Applying the STOPP/START evaluation tool may require flexibility, in some 
cases, what is considered inappropriate according to STOPP/START may not be 
appropriate for an individual patient for various reasons (Jansen and Jacobus, 
2012). To address this, guidelines accompanying the STOPP/START evaluation 
tool clearly state that the tool does not replace the clinical judgment of the 
prescriber (Gallagher and O'Mahony, 2008b). There were however, concerns 
expressed about inconsistent implementations of the evaluation tools and the 
time required to evaluate patient’s medications. According to Ryan et al. 
(2009c) this issue was recognised by the research group in the School of 
Pharmacy, University College Cork and University Hospital Cork who began 
developing a database to facilitate the use of STOPP/START criteria in day-to-
day clinical practice. Furthermore, in 2013 the research group was funded to 
develop a Software ENgine for the Assessment & optimization of drug and non-
drug Therapy in Older peRsons (SENATOR) a highly-powered and efficient 
software engine capable of individually screening the clinical status and 
pharmacological and non-pharmacological therapy of older adults with 
multimorbidity. The significance of this software to nurse practitioner and other 
prescribers is that it can define optimal drug therapy, highlight adverse drug 
reaction risk, indicate best value drug brand for selection and provide advice on 
appropriate non-pharmacological therapy.  A very valuable tool considering the 
majority of older adults with multimorbidity are managed by healthcare 
professionals that are not specially trained in geriatric medicine and 
rehabilitation and may not have access to a geriatrician or specialised nurse 
practitioner to help with assessments.   
 
In this study, nurse practitioners’ knowledge and experience was 
recognised by other health care professionals as supportive within their 
practices. In addition, the value of nurse practitioners was also considered 
important because of connection with a range of services and clinical networks 
that have been emphasised in the literature as primary, speciality and acute 
services (Conger and Plager, 2008). Participants in this study did not take for 
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granted the referring diagnosis of the GP or hospital department but showed 
initiative and integrity and acted on their advanced knowledge and experience 
to independently assess their patients. The nurse practitioner then had the 
confidence and ability to bring a range of clinicians together to develop a 
package of care that was focussed on the individual patient needs. Utilising this 
approach helps the nurse practitioner to look beyond the initial clinical 
problems that presented to focus on the more holistic plan of care for each 
patient and provide staff with support and motivation, as described by 
Garrubba et al. (2011). However, building such an integral service required 
healthcare professionals to broaden their professional standards. According to 
Veysey et al. (2005), this process requires training, discussion, collaboration, 
and a shared assessment and treatment plan. The fact that the nurse 
practitioners mentor and are champions for change within organisations is 
significant for the future development of best practice in elderly care. 
 
The importance of CPD and remaining up to date was an issue identified by 
all participants that required additional support.  Positive comments were 
tempered with a belief that too many demands placed on the nurse 
practitioner encroach unacceptably on the opportunity to undertake CPD. 
Specifically, heavy workload and absence of colleagues to cover the work 
(‘backfill’) prevent uptake of CPD, issues already identified in the literature by 
Gould et al. (2007a). Whilst it was acknowledged that a certain amount of 
learning was achieved ‘on the job’, it was repeatedly put forward in the 
interviews that formal education and training was necessary to supplement and 
enhance such learning. Considering the predicted changes of increasing 
complexity in elderly care (Canadian Nurses Association, 2008) it is essential 
that nurse practitioners engage with CPD and are supported throughout their 
careers to maintain and develop the knowledge and skills to respond effectively 
to the needs of patients, service users and the wider public (Taylor et al., 2010). 
Especially when viewed in the context of changing demographic patterns of 
disease in countries across the world and the subsequent impact on health 
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service delivery, preparatory education can only ever be an initial grounding for 




Nurse practitioners have derived both personal and professional benefits 
from prescribing and feel better equipped to make decisions and challenge 
changes if necessary. The potential for prescribing nurse practitioners to 
contribute positively to address the issues with increasing healthcare demands 
and associated problems and to improve quality of care in the Canadian health 
system is substantial given their understanding regarding appropriate and 
inappropriate medication management.   
Nurse practitioners in Nova Scotia, Canada are both competent and 
confident prescribers and have integrated prescribing effectively within their 
respective roles. In addition, recognition of their role and contribution to the 
wider healthcare team is acknowledged but there are still some cautious 
responses from a number of doctors in practice.  Another tangible issues 
identified is the importance and support required for ongoing CPD. More 
specifically CPD was identified as a substantial prerequisite for maintaining 
knowledge and keeping up-to-date with the ever changing pharmaceutical 
industry and medications available in practice. Management strategies 
employed in practice were communication, collaboration and collegial 
relationships to effectively safeguard medications prescribed and reviewed as 
appropriate for the older adult population. However, the issues surrounding 
the consequences of inappropriate prescribing were more complex requiring an 
organisational approach to the interactive management of medications 
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CHAPTER 8 DISCUSSION 
 
Chapter 8 – collates the issues, findings and relevant important information 


















There is general consensus both nationally and internationally among 
demographers that improvements in life expectancy will continue for the 
foreseeable future (CSO, 2014). In Ireland at present older individuals account 
for a large portion of the population with numbers expected to almost double 
in the next 40 years. The most significant increase within this timeframe will 
occur in those aged 80 years and above with numbers increasing from 128,000 
to 484,000 (CSO, 2014).  This life expansion will undoubtable be helped by 
medicine which will allow people to live longer however, they will do so with 
needs, difficulties, disabilities and illnesses. Such changes challenge all of us to 
re-think models of care delivery, and poses real challenges to health services to 
ensure that the highest quality of clinical care is guaranteed (Phelan and 
McCormack, 2012). Therefore, many countries are transferring tasks, such as 
the prescribing of medicines, from doctors to nurses in order to improve 
healthcare quality, efficiency and effectiveness (Buchan and Calman, 2000, 
Sibbald et al., 2004, McKee et al., 2006). The evolving role of the nurse is also at 
the forefront of service development in Ireland.  For example the HSE 
Corporate Plan (2015-2017) specifically refers to the development of a national 
coordinated plan to include the continued expansion of nurse and midwifery 
led services based on population need and taking account of efficiencies 
(Health Service Executive, 2015a).  This thesis widely acknowledged the 
contribution of NPs and the important role they now play in service 
development in Ireland.  The role of the NP is clearly an important element of 
future healthcare (Health Service Executive, 2015a) however this thesis 
demonstrated that some aspects of nurse prescribing requires change to 
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8.2 Core findings 
 
 The Irish foundational structures of nurse prescribing from the educational 
requirements, registration, and assessment criteria are similar to that of 
the UK and Canada. 
 
 Evidence form the literature suggests that the impact of nurse prescribing 
on clinical practice is positive from a patient, healthcare professional and 
organisational perspective. A significant number of nurse prescribers are 
unwilling to register as nurse prescribers following completion of the 
education programme. The organisational support for nurse prescribing 
needs to improve if the initiative is to continue evolving. 
 
 The nurse prescribing role is ambiguous because it does not have a specific 
role description to embed the initiative in practice and is now regarded as 
an add-on to an already busy workload. 
 
 The data collected through the MDS are restricted, incomplete and 
inaccurate especially pertaining to nurse prescriber’s workloads which 
have significantly increased.  In addition, the MDS has also contributed to a 
two-tiered prescribing system in Ireland making nurse prescribing more 
labour intensive to complete than their medical counterparts.   
  
 
 The competence and confidence levels of nurse prescribers in Ireland are 
comparable to their counterparts in the UK and Canada. Similar issues 
regarding continuing professional development were identified in all 
countries. 
 
 The collaborative practice agreement is proving to be restrictive in practice 
and reaffirms that overall responsibility for nurse prescribing remains with 
the doctor because their signatures are required to complete this 
document.  
 
 The STOPP/START evaluation tool has the potential to improve safety and 
quality of prescribing that has an immediate effect on patient care. 
Although the incidents of potentially inappropriate prescribing for nurses 
prescribers appears high the results are slightly lower than previous 






8.3 The impact of nurse prescribing in practice  
 
There are several aspects of the study findings which hold relevance 
towards existing nurse prescribing evidence. The literature review (Chapter 3) 
re-affirms that nurse prescribing is beneficial for the patient (Courtenay et al., 
2010b, Drennan et al., 2011), the organisation (Carey et al., 2009b, Darvishpour 
et al., 2014) and the healthcare professional (Dunn et al., 2010, Dobel-Ober et 
al., 2013) and is viewed as one of the most stimulating initiatives by the nursing 
profession in the recent advancements of nursing. In Chapters 4, 5 and 6 it is 
evident that nurses clearly understand the requirements of the prescribing role 
at different levels of care delivery which makes better use of their skills. 
Nevertheless, the degree to which this has been described and acknowledged 
has not been fully supported at organisational level for the initiative to evolve 
as planned. Perhaps one of the most important concerns that require 
immediate attention is the data generated by the prescribing process because 
of the integral connection it has to clinical decision making, nursing research, 
professional development, and operational effectiveness. At present, nurse 
prescribing data published are incomplete and inaccurate causing frustration 
for the nurse prescriber on two levels that of under representing workloads and 
lack of communication (active involvement in decision making). Chapter 5 
establishes that NPs recognise the integral connection of prescribing data to 
evidence-based practice, findings similar to those of Cashin et al. (2009), 
Courtney et al. (2011), Drennan et al. (2011) and Coull et al. (2013). Improved 
communication between the HSE and NPs is necessary to capitalise on this 
insight in order to reduce the risk of poorly structured plans for nurse 
prescribing in the future. Lack of consultation/communication regarding 
mandatory requirements in the form of the MDS had proven to be burdensome 
for NPs who find they are working with repetitive processes that impede their 
practice. Chapter 4 revealed that initially the NPs response to the MDS was 
limited compliance but due to continued lack of communication between the 
HSE and the NPs, the response has increased to non-compliance and in some 
cases escalated even further reducing their willingness to engage with the 
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nurse prescribing process. Also compounding this issue is the generation and 
publication of incomplete reports and audits from the MDS at a national level 
(Health Service Executive, 2014c). This has further contributed to the lack of 
confidence in the system and has resulted in the gradual withdrawal of NP 
involvement with the data in practice (table 5.8). Considering the negativity 
now associated with MDS the NPs had the ability to look beyond the problems 
encountered with the system, to view contributions from prescribing data as 
having value for nurse prescribing if collated and reported with accuracy. 
However, this would require a restructuring of the MDS to ensure appropriate 
data was captured and connectivity of the database be improved. Thereby 
allowing nurse prescribing data to be managed more effectively and with clarity 
to influence nursing practice about a range of strategic issues such as quality 
and patient safety, finance, human resources, risk management and national 
services plans (Moen and Mæland-Knudsen, 2013, Cusack et al., 2014). 
 
 Restructuring of the MDS is required to ensure NPs are active participants 
in the data gathering and utilisation of the system moving away from the 
undervalued passive role they now hold. Draft recommendations from a recent 
and as yet unpublished review (September 2015) of nurse prescribing have 
suggested removing the national mandatory requirement for NPs to input all 
prescriptions to the MDS. The review also suggested that MDS be considered as 
a template for electronic prescribing (Health Service Executive, 2015a). This 
final recommendation should be discussed more extensively with NPs in 
practice, outside of the nurse prescribing representatives on the review 
committee to establish if working from an imperfect system is an appropriate 
start point for electronic prescribing. If nurse prescribing is to maintain 
continued clinical significance, changes should be driven from the perspective 
of all concerned; patients, NPs and the organisation and not controlled by the 




A more revealing insight is disclosed in chapter 6 (Stage 2) of the Thesis 
regarding many of the issues highlighted by nurse prescribers as obstacles to 
the advancement of the nurse prescribing initiative. In addition, to increased 
workloads, medical dominance, restrictive CPA, and fluctuating degrees of 
support from colleagues and the organisation were also identified as an 
impediment to the role advancement. These findings are supported by Earle et 
al. (2011a), Bowskill et al. (2012) and Carey et al. (2013). Although workload 
issues also featured prominently in Chapter 4 information was limited to the 
Irish nurse prescriber’s perspective in this section. The issue of workloads was 
further investigated to incorporate the views of both Irish and UK nurse 
prescribers in Chapter 5 (Table 5.4 together with Figures 5.2 and 5.3) with the 
unrecognised ‘hidden workload’ identified as the biggest concern for both Irish 
and UK nurse prescribers.  
 
 Irish nurses that undertake the role of nurse prescribing do so without 
adjustment to their already busy clinical workload requiring the NP to negotiate 
their new role within the current system. Success as a nurse prescriber 
therefore depends not only on their prescribing skills but also on how they 
manage their time, prioritise workloads and effective merging of their 
prescribing and nursing roles.  Compounding this issue there is no job 
description associated with nurse prescribing to help the NP negotiate the 
difficult task of integrating their new role in practice. Nurses repeatedly 
identified the benefits of the nurse prescribing role throughout this Thesis in 
Chapters 4, 5, 6 and 7 however, they struggle with the nursing and prescribing 
role an issue identified by (Bowskill et al., 2012) that is not clearly defined. This 
role ambiguity was also trying for NPs because the role was described as not 
embedded in practice but was regarded as an ‘add on’ to an already busy 
workload. Furthermore, a wider issue associated with this add on role was the 
perceptions of other staff who did not understand the responsibilities 
associated with the prescribing role and sometimes viewed prescribing as 
taking time away from patient care and clinical work rather than 
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complementing the care delivery of the unit/ward as a whole. This issue was 
addressed in Chapters 4, and 5 which revealed that the clinical aspects of nurse 
prescribing required adequate time and resources to be invested at practice 
level which was outside the remit of the NP.    
 
Irish NPs also verbalised that the CPA and its role in practice needs to be 
reviewed.  The issues identified concerning CPAs were restrictive prescribing, and 
delays in processing the CPA both initially and on renewal of the document.  
Although the CPA is specific to Irish nurse prescribing, similar limits on 
prescribing exist in The Netherlands, Spain, Australia, Georgia and Missouri in 
the USA (Kroezen et al., 2012) using formularies. Even though the NP has 
accountability for their prescribing decision, engaging in permission seeking to 
complete their CPA acknowledged that overall responsibility for the patient 
remained with the doctor.  Similar to findings by Bowskill et al. (2012) who 
suggested that engaging in such behaviour permits the NP to exhibit 
professional respect and avoid any potential conflict of agreement about the 
division of labour with the doctor to secure their prescribing position within the 
team. In addition this thesis revealed that cooperation and support between 
nurses and doctors allowed them to move from a compliant relationship 
towards one of collaboration but difficulties did arise in the workplace when 
prescribing for the same patient. Nonetheless, nurse prescribing makes care 
slightly more complex, which required that those involved be conscious of the 
fact that this increases the need for consultation between physicians and 
nurses. In particular, the qualitative interviews (Chapters 4 and 6) were useful 
for exploring some of the possible factors that influenced perceptions of 
control. 
 
Specifically, discontinuation of inappropriate medications was identified as 
an issue if the medication in question was not identified on the CPA. This has 
led to a two-tiered approach to prescribing (Chapter 5) in the Irish setting 
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causing conflict between the nurses’ perceived role and the role the 
organisation imposes on them. The inflexibility of the CPA was addressed by 
NPs by not adding new drugs or simply not prescribing and transferring the 
responsibility for prescribing to junior doctors who do not experience similar 
restrictions with prescribing. A more effective way of addressing these issues 
could be the establishment of a national medicines formulary for use by all 
prescribers that would contribute to an overall governance framework for 
medicines management activities. Having a national formulary to replace the CPA 
would also address the two tiered prescribing system now in place and allow 
prescribing by NPs and medical practitioners that is evidence based and cost 
effective. 
 
Given the autonomy to choose independent prescribing nurse prescribers 
have shown a preference to limit the CPA to a one year period at which time 
there was a consensus that confidence and competence had developed 
sufficiently to allow for independent prescribing and continued use of the CPA 
proved restrictive. Thus, defeating the essence of nurse prescribing which 
allows nurse to take on a more rounded complete role that facilitates better 
patient care.  Having a CPA can be argued that the medical profession have 
authorised, coached and overseen the development of non-medical prescribing 
in practice. Using such structures has advantages which include progress 
reviews and demonstration of critical understanding.  However, findings in 
Chapters 4 and 7 identify formularies as cumbersome and needing regular 
review to take into account prescribers needs and continued competence 
development. In addition, over-reliance on protocols or personal formularies 
(CPA) has the potential to decrease opportunity to independently prescribe in 
practice a situation that will eventually impact on confidence levels and the 




Based on the sample of nurse prescribers in this thesis, Irish nurse 
prescribers are as confident in their ability to prescribe as their counterparts in 
the UK and Canada (Chapters 5 and 7). Self-reported confidence and 
competence is measured specifically in relation to the Irish/UK nurse 
prescribers in Chapter 5. Through applying the same topic guide to Irish and 
Canadian nurse prescribers in (Chapters 6 and 7), knowledge in relation to 
appropriate and inappropriate prescribing and the use of a medication 
evaluation tool is also comparable. The role is set to expand further and nurses 
need to be aware of phrases such as, ‘extended or expanded scope of nursing 
practice’ that could be argued includes camouflaged medical care (Lyon, 2005). 
Recent developments in Ireland, that has put the health service under pressure 
to retain doctors (Humphries et al., 2015) which has resulted in the associated 
shouldering of medical responsibility by other healthcare professionals 
including nurses, is of note here. 
 
Both Irish and Canadian cohorts of prescribers identified similar issues in 
relation to optimising prescribing and recognised the feedback from the 
application of the STOPP/START criteria as enriching their confidence to discuss 
medication issues within the care team. Patient assessment and regular 
medication reviews were considered the cornerstone of the prescribing process 
by both cohorts. Canadian nurse prescribers had the element of medication 
review well established and utilised doctors, clinical pharmacists and nurses in 
the process. In the Irish setting the medication review process although 
recognised as important was not as well established in the clinical sites that 
participated in this research and in addition lacked input from a pharmacist at 
the point of prescribing.  A missed opportunity considering the emphasis placed 
on the importance of medications management by the health service and 
associated financial output. Encouragingly, there is increased involvement of 
geriatricians and clinical pharmacists in a limited number of sites which is in 




There was evidence of increased confidence displayed by the NPs following 
receipt of the medication evaluation tool feedback which gave them the 
underpinning information required to challenge or question medication and 
prescriptive decisions in practice (Chapter 6).  Having the appropriate 
knowledge promotes an environment whereby nurses and doctors collaborate 
more efficiently on medication management through questioning and 
discussion as opposed to imposed restrictions on prescribing privileges.  
 
Perhaps the introduction of nurse prescribing to the Irish healthcare setting 
in 2007 was somewhat ill timed. Considering the first NPs finished the 
education programme in September 2007 and entered the work force at the 
start of the recession and introduction of the moratorium by the HSE in 2008. 
This challenging and rapidly changing environment of health service reform, 
austerity and political change, put particular pressures not only on service 
managers but also on front line delivery staff. During this very difficult period 
prescribers continued to evolve in practice, they adapted, reconfigured or 
replace specific fundamentals (Chapter 4 - findings) to meet the changes 
imposed on them by the health service or organisation. These adjustments 
impacted on professional engagement in decision-making behaviours and 
practice and guidance was shaped more by workplace policies, values, norms 
and resources than by scientific evidence for the nurse prescribing initiative. 
This situation has resulted in limited opportunity and support for prescribers to 
make sense of and learn from their collective experiences and knowledge 
during this time (Chapters 4, 5 and 6). The thesis has also given us an 
understanding of what NPs require from the HSE to meet their commitment to 
the prescriptive process in practice (Chapter 5). In addition, to supportive 
organisational structures access to relevant CPD is also essential (Chapters 4, 5, 
6 and 7).  Having such support  would help overcome the barriers appearing in 
the form of reduced applications for the education programme and lack of 
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commitment to register as a prescriber once the education programme has 
been completed. CPD for nurse prescribers is relevant from the perspective of 
the individual, organisation and profession.  However, the added dimension of 
having CPD requirements imbedded in the Nurses Act (2011) firmly transfers 
the responsibility for CPD to the individual that may or may not have support 
from the organisation in which they work. The difficulty in arranging 
appropriate CPD for NPs is 1) the diversity of specialties associated with the 
role and 2) the pharmacology knowledge associated with that specialty.  The 
present system in place of attendance at study days, conferences and 
presentation only addressed CPD at a basic level and not the specifics of what is 
required by NPs. The difficulties of structuring appropriate CPD is making it 
specific to each NPs area of practice that to date has proven to be expensive 
and labour intensive to formulate. 
 
The issue of non-registered 337 NPs (Health Service Executive, 2015) that 
have completed the education programme also needs to be addressed.  Having 
qualified and remaining unregistered perhaps needs to be viewed in the 
context of fitness to register and practice. Considering the importance placed 
on CPD by registered practicing NPs to maintain competence a timeframe 
should be place on non-registered NPs within which they must register to 
ensure safety. 
 
An overall impression from the findings in this thesis suggest that 
management of nurse prescribing by the HSE and hospital organisations is 
viewed from two perspectives that of a tool that can be manipulated by the 
organisation when suitable, or a role that keeps with a nursing vision of 
benefiting patients. Evidence of this coincidental finding can be seen in the 
broader understanding of nurse prescribing in practice Chapter 4 that becomes 
more focused in Chapter 5 which reveals the confidence and competence of 
NPs and additional supports required to advance the initiative. Chapter 6 
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refines the reality of nurse prescribing in practice through the application of the 
STOPP/START criteria to NPs’ prescriptions and the qualitative element of the 
study that shows the role of NPs in practice and the alternation of the initiative 













Figure 8.1 Nurse prescribing a Tool or a Role  
 
Further research is required to address this coincidental finding and its 





Overview and MDS 
(implications in practice) 
 
Irish / UK 
Questionnaire 
(development of confidence and 
competence, future support required)  
Application of 
STOPP/START to Nurse 
Prescribing using a validated 
framework 
(initiative fluctuates between a 
tool and a role) 
228 
 
8.4 Prescriptive process  
 
Economic aspects of prescribing have become increasingly important in 
healthcare systems with finite resources and increasing medicine costs. The 
prescribing process can offer important data in relation to the costs of training 
together with prescribing trends and expenditures. 
 
The application of the STOPP/START criteria (Chapter 6) to the role 
(prescriptions) of NPs has demonstrated the importance of such data revealing 
that NPs PIP rates in this sample although high are consistent with previous 
research undertaken in the area (Ryan et al., 2012, O'Sullivan et al., 2013). Prior 
to undertaken this research nurse prescribers did not have evidence regarding 
PIP and without this evidence were reluctant to alter prescriptions with 
confidence. More specifically, without a medication evaluation process there is 
an absence of association on how medications impact on morbidity, mortality 
and quality of life. However, the distinct way in which nurse prescribers utilised 
the feedback and implemented the majority of the recommendations resolved 
this disassociation and revealed increased awareness.  Prescribers’ genuine 
interest in the role was apparent when the NPs within clinical settings peer-
reviewed the feedback letters given to them following the application of the 
STOPP/START evaluation tool.  This was evident from the pilot interviews 
(Chapter 6 Stage 2) undertaken in one site where the nurse prescribers 
reviewed the feedback as a group and utilised the information collectively.  
 
STOPP/START has a potential contribution to make in terms of issues such 
as shared decision making, working as a team, improved safety and quality of 
prescribing that has an immediate and positive effect on patient care. Similar 
findings were identified in the Canadian setting (Chapter 7) implying that the 
STOPP/START criteria may provide an effective framework for assessment of 
PIP and PPOs in older adults for nurse prescribers. In particular, their position is 
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strategic in the clinical setting between the resources of medication 
requirements and the logistics of medication management for the patient and 
organisation.  
 
As with any new role difficulties have been identified requiring further 
management and structuring of its integration. Nurse prescribing looks set to 
play a part in continuing to transform our health services in the future because 
of the identified improve health-care efficiencies and reduce costs of health-
care delivery directly related to date.  
 
8.4.1 Potentially inappropriate prescribing  
 
This thesis indicates that the rate of potentially inappropriate prescriptions 
in the South of Ireland is substantial (Chapter 6). Across the seventeen Irish 
long term care facilities included in the study, 55% of the patients medications 
reviewed had at least one incident of PIP. However, the findings are consistent 
with previous studies undertaken in the Irish setting (Byrne et al., 2010b, Ryan 
et al., 2012, O'Sullivan et al., 2013). These finding have a direct relevance for 
nurse prescribers working in this setting given that recent data have shown a 
significant causal relationship between PIP and or PPO and ADEs (O'Sullivan et 
al., 2013). Application of the STOPP/START screening tools to prescribing 
decisions may reduce unnecessary medication, related adverse events, 
healthcare utilisation and cost. 
 
The most common PIP medications were those associated with the CNS 
(41.2%) i.e. benzodiazepines, neuroleptics, opioids and antidepressants. A 
number of studies have raised concerns relating to the appropriateness of 
benzodiazepines in older individuals. Despite these documented risks of falls, 
confusion, as well as psychological and physical dependency (Gallagher et al., 
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2008, Ryan et al., 2009a, Ryan et al., 2009c), benzodiazepines continue to be 
prescribed for older individuals, nationally and internationally across all settings 
of healthcare (Parr et al., 2009, Ryan et al., 2009c). Additionally mediations 
relating to the gastrointestinal system followed closely at 37.7% (proton pump 
inhibitors) that were mostly prescribed at the wrong dosage for maintenance 
therapy. The last significant group were the cardiovascular system but at a 
much lower figure of 8.8%.   These figures need to be considered in context as 
older patients admitted to hospital are sicker and frailer than those in the 
community.  
 
Reducing PIP in older people will require implementation of more robust 
methods of medication reviews to routinely assess drug effectiveness, dosage, 
duration, interactions and adverse effects. There is a need therefore to install 
PIP prevention measures for patient in long term care facilities, as a means of 
preventing ADEs and minimising avoidable expenditure on medications.  
Although mooted in the literature since 2009, the practical application of 
STOPP/START in daily general practice has not yet been established. However, 
the study highlights that the STOPP/START criteria could be used to develop a 
prescribing intervention led by nurses who have constant and close contact 
with patients to significantly reduce PIP and in addition associated health care 
utilisation costs. The cost of PIP was not considered in this study but a previous 
national study estimated the cost of PIP to be in excess of €45 million using a 
subset of 30 STOPP criteria (Cahir et al., 2010b) 
 
8.4.2 Potential prescribing omissions  
 
PPO is another important aspect of PIP that often goes under-reported 
considering   a recent randomised controlled trial demonstrated that the 
application of the STOPP criteria significantly improved medication 
appropriateness when compared with the usual pharmaceutical care in 400 
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hospital inpatients (Gallagher et al., 2011). However, one research article in the 
Irish healthcare setting reports on PPO in older adults identifying a prevalence 
of 42.2% (Ryan et al., 2012). This thesis identified PPOs at 48.5% (Chapter 5) of 
patients who had one or more clinically indicated medicines omitted from their 
regular prescriptions without a valid reason and PPO previously reported for 
older hospitalised patients in the literature of 11.2-72.7 (Barry et al. 2008, 
Gallagher et al. 2011. Dalleur et al. 2012).  The majority of these omissions 
involved statins, ACE inhibitors, aspirin and calcium with vitamin D3 
supplements (Table 5.6). These drugs are generally well tolerated in older 
people however the prescribers may be of the view that the practical value of 
the medication is limited given that the life expectancy in many of the patients 
is shorter than the average time for clinical benefit.   
 
8.4.3 E-Pharm Assist CDSS System 
 
The E-Pharm-Assist CDSS system standardised the data collection and 
review process within this thesis, while also allowing the researcher access to 
additional clinically relevant information such as drug-drug interactions, hepatic 
and renal dosage adjustment at the point of review. Nurse prescribers were 
very interested in the system and could see the value of having such a tool 
available to them in practice. At present, for NPs addressing PIP and PPO in frail 
older people is a considerable challenge and time-consuming process that the 
prescriber may not have the skills to undertake with confidence. The 
commercial version of the CDSS system SENATOR will significantly assist all 
prescribers with the practical application of STOPP/START in everyday use in 
order to optimise drug therapy as a routine. The SENATOR project is focused on 
developing software that can individually screen the clinical status and 
pharmacological and non-pharmacological therapy of older people with 
multimorbidity in order to define optimal drug therapy, highlight adverse drug 
reaction (ADR) risk, indicate best value drug brand for selection and provide 
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advice on appropriate non-pharmacological therapy. Valuable feedback, 
previously unavailable to prescribers can now be delivered in an electronic 
format and in a timely manner changing the dynamics of how prescribing is 
approached in practice for the countries involved. Clinical trials are underway 
at present with a much anticipated data system to be available in 2017.  
 
 
8.5 Reflection on using a mixed method design using the SPEC 
guidelines 
 
The SPEC guidelines were used to identify the value added components of 
using a mixed method research design details of which are set out in Table 8.1  
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S: Building on the strengths of single research designs to overcome 
weaknesses.   
In stage one and two of the research, data were collected sequentially 
commencing with the interviews aimed at identifying what nurse prescribers 
considered to be the impact of the minimum data set in practice. Findings from 
these interviews informed the improvement of the questionnaire in stage two of 
the research, the Irish/UK questionnaire. I was able to explore issues concerning 
competence development, independence of prescribing, hidden workloads and 
relevant value of nurse prescribing to the practice setting. However, no research 
had been conducted on whether nurse prescribing was appropriate or 
inappropriate or how the process compared with their medical counterparts who 
had been assessed using STOPP/START. Stage three and four of the research 
allowed me to generalise results between nurse prescribers and doctors, and the 
research undertaken also included a qualitative element where previous studies 
had been limited to quantative research only (Table 2.1). Mixed method research 
enabled in-depth identification and exploration if nurse prescribing in practice 
that allowed generalisation of results to the relevant population. 
  Using mixed methods research, both quantitative and qualitative, in my Thesis 
added value as the strengths and weakness of each method were realised. This 
allowed comparison and interrogation of findings throughout the different stages 
of the research which sharpened the overall understanding and integrity of 
results.  
 
 P: Comprehensive and complete picture of the phenomenon 
To understand the impact of nurse prescribing on practice and to ensure a fair 
evaluation, multiple sources of evidence were gathered. This evidence was 
gathered from interviews, surveys, and documents that included both nursing and 
medical notes. As the researcher, I was able to carry out a focused evaluation 
based on the comprehensive data gathered from multiple sources. Mixed 
methods research enabled a complete picture to be constructed using quantative 
234 
 
and qualitative data, and this could only be achieved by comparing outcomes 
gathered in each approach. This comparison would not have been as inclusive or 
complete with a standalone research method, as it was the combining of data that 
enabled the holistic picture of nurse prescribing in practice to emerge. 
 
 E: Building research capacity and expertise  
This was a challenging study that required knowledge and guidance in 
quantitative, qualitative and mixed method designs. A number of challenges have 
been highlighted in the research identified under E in Table 8.1 
The supervision support for this thesis required methodological expertise across 
methods which were essential for rigor. While it was the responsibility of the PhD 
student to gather, structure and analyse the data; guidance though discussion and 
debate from the supervision team facilitated understanding of the data enabling 
the integration of the components of the study.  
The added value of mixed methods research in this section was the expansion of 
my research knowledge. However, to build capacity and explore complex nurse 
prescribing issues in the future requires wider collaboration.   
 
 C: Convincing and powerful results for funders and policy makers 
The range of evidence from the nurse prescribers was substantial but the power 
of the findings came from the integration of the data collected. Outcomes 
gathered from each method of collecting data were matched across the five 
stages of the study to give strength to the outcomes. Integrating the findings from 
both a qualitative and quantitative perspective gave evidence to policy makers 
regarding the results of the research which, to date, has been used in a national 
review of the currently used minimum dataset. Therefore, it is important to frame 
recommendations in a way that would be most relevant to future Health Service 





The researcher identified limitations that impacted upon the reporting of 
study results or would impact on other researchers should any individual want to 
replicate any aspect of this study. The limitations identified in this study will be 
discussed relevant to each chapter. 
Chapter 3 although database and manual searching was protracted and 
extensive for the systematic review, the majority of relevant studies identified for 
inclusion in the review were conducted in the UK. This could be interpreted as a 
limitation however, the research process is not only to discover new knowledge 
but to also to confront assumptions to explore what we don't know. For instance 
the views of NPs themselves, although useful, need to be balanced with the views 
of the medical profession and/or other healthcare professionals. 
Chapter 4 as a qualitative study on the minimum data set (MDS), 
acknowledges that the findings may not reflect the views of all nurse prescribers. 
However, there is confidence that the sample included enough variation in 
participant roles and settings to provide a comprehensive picture of nurse 
prescribing phenomena under investigation. Nurse prescribers who agreed to be 
involved may have done so because they have particular concerns and issues with 
the MDS.  
While efforts were made to maximise recruitment for the study in chapter 5 , 
it could have been strengthened if more nurse prescribers in both Ireland and the 
UK had been recruited. I cannot ignore the possibility of bias, in particular 
responder bias, mostly due to selective participation by respondents who are 
interested and/or more positive about the subjects of nurse prescribing. Thus the 
participants may not be representative of the population of NPs in both countries. 
Despite the limitations there has been no comparative analysis between NPs in 
Ireland and the UK to date. Therefore, the authors are confident that the sample 
provides enough variation to give an initial overview of the parallels between both 




 In chapter 6 Stage 1 selection bias may have been introduced as NPs 
selected the ten patients for inclusion in the study. However, it should be 
noted that a variety of cases in terms of medical conditions and medications 
were identified. While this study identified PIP, it did not study whether this 
resulted in ADEs to the patients. In addition, there were a significant number 
of patients categorised according to the Barthel score as poorly mobile 
(Table 6.1). Prescribing drugs that effected balance and mobility may not 
have warranted the same concerns as for the mobile patients which may 
have resulted in a higher PIP rate. Data collected was mostly by extraction 
form case notes and in some instances discussion with NPs therefore the 
precise reason for PIP in this study could not always be clarified with 
precision.  
 In chapter 6 Stage 2 the reduced sample size of NPs from 40 to 25 in a 
restricted geographical area of Ireland limits the generalisability of the 
findings. Similar to stage one of this research limitations identified for this 
section of the study included generalisability of the findings considering the 
limited geographical location of the HSE South. Conducting follow up 
interviews by telephone may have had limitations.  However, due to time 
constraints, ongoing data collection, geographical spread of participants and 
the cost involved, it appeared to be the best option. It also ensured, given 
the nurses busy schedules, all follow-up interviews were conducted one 
month following the application of the STOPP/START criteria to nurses’ 
prescriptions. The clinical and financial benefits from routine application of 
STOPP/START criteria to prescriptions in care of the older adult are as yet 
unknown. Further research is required to establish if there is a tangible 
benefit to introducing such an initiative into practice. 
 
In Chapter 7 a possible limitation is the low number and source of the 
participants drawn from a specific area in Canada, who are not necessarily 
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representative of all Canadian nurse practitioners, restricting the study’s 
generalisability to other areas or countries. In addition, recruitment of 
participants for this study was the responsibility of the senior nurse practitioner 
for the Nova Scotia Region, Canada. All of the participants had previously heard 
about STOPP/START criteria, because of involvement with research in the 
clinical practice, which is not representative of the general nurse practitioner 
population. The sample size of eight although small is acceptable for qualitative 





Nurses appear to be very confident and competent in their prescribing 
considering the restrictions placed on Irish nurse prescribers by the Nurses and 
Midwives Board of Ireland (formally ABA) and the Office of Nurses and 
Midwives Services Department. Perhaps a cautious approach to nurse 
prescribing was warranted initially however, there has not been one adverse 
reported incident to the Nurses and Midwives Board of Ireland regarding a 
nurse prescriber therefore it is timely that structures in place are reviewed and 
revised or removed accordingly. Of note throughout this thesis is NPs have 
repeatedly shown an in-depth understanding and commitment to the nurse 
prescribing process including an understanding of their limitations. NPs 
structures in place requiring review to improve relevance to practice are:  
1) The MDS and its contribution to the overall process of nurse prescribing is 
required, especially the connectivity of the database and how it can be 
restructured to facilitate cross-referencing for similar specialties or prescribers 
with similar issues regarding a particular medication.  Having a data gathering 
system in place is very valuable but not when it stops the nurse from 
prescribing or it contributes to a two tiered prescribing system between the 
nurses and doctors.   
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2) The CPA needs to be removed or restructured and used for a timeframe so 
that it supports the development of confidence and competence for new nurse 
prescribers. Removing the CPA would give nurses better access to medications 
similar to their UK counterparts which in turn facilitates better involvement 
with the prescribing process and multidisciplinary team approach to care. To 
date, nurses have been cautious in identifying medications for their first CPA 
perhaps an indication of their caution when it comes to prescribing in general 
that is evident to date of no reported incidents to NMBI regarding nurse 
prescribers.  
3) Documentation regarding prescribing needs to be reviewed for 
appropriateness and duplication eliminated.  
4) Professional barriers between nurses and physicians i.e. physicians may be 
less likely to accept recommendations made by the nurse still exist but appear 
to be improving the more doctors are exposed to nurse prescribing.  However, 
if nurses have evidence from the application of a medication evaluation tool 
regarding medications to be commenced, changed or discontinued then there 
appears to be a better acceptance of the partnership in prescribing.   
5) Nurse prescribers refusing to register once the education programme has 
been successfully completed have grown in numbers. Nurse prescribing is a 
very responsible role to undertake and nurse prescriber’s need such 
responsibility acknowledged through appropriate evaluation of workloads and 
remuneration for the additional responsibilities this is supported by the strong 
response to these issues Chapter 6.  
6) The importance of incorporating a medication evaluation tool in practice 
cannot be overstated considering the predicted Irish population trends for the 
next 20 years of a 300% increase in the population ≥ 65 years.  Using a 
medication evaluation tool to regularly review medications for PIPs and or PPOs 
in older adult care has the potential to improve care cost effectiveness in the 
health service.  Although not available as yet SENATOR will be an impressive 
resource to support and improve appropriate prescribing for nurse prescribers 
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in practice. However, it is important to remember that although the CDSS 
enables the user to perform a detailed review of medications in a timely 
fashion its effectiveness is dependent on data input. Therefore, CDSS is 
designed to complement not replace clinical judgment.  
7) A more structured approach to CPD to ensure practice is relevant and up to 
date is required. 
8) A timeframe for registration needs to be in place to ensure nurses that have 




8.7 Further research 
 
• Research is required into what appears to be the interchangeable use of 
NP as a tool or a role by the HSE and/or hospital organisation. 
• Further research is required if the data management system is to be 
streamlined and restructured for efficient use. All consultations in 
research/evaluations and not just those that end in a medication being 
prescribed.   
• Information on trust in nurse prescribers working relationships is very 
limited this warrants further investigation. 
• A number of nurse prescribers approached to participate in the research 
could not do so because they had not registered with the Nursing and 
Midwifery Board of Ireland. Further investigation is required to 
understand why nurse prescribers that have successfully completed the 
education programme do not register with the governing body to 
prescribe in practice.  
• Structured collaborative research is required to assess nurses’ 
implementation of prescribing process nationally and requirements to 
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Appendix 1 - Introduction to Nurse Prescribing Publication (Chapter 1)
Introducing nurse prescribing: 
an Irish perspective
Rena Creedon and Elizabeth O’Connell
Abstract
This article outlines the introduction 
of nurse prescribing to the Irish 
setting by reviewing the changes 
made to the legislation and the 
roles played by An Bord Altranais 
(the regulatory body for the 
nursing profession in Ireland), the 
Health Service Executive, and the 
University in delivering the education 
programme. The future of nurse 
prescribing and implications for 
practice is also addressed.
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The introduction of nurse and midwife prescribing to Ireland in 2007 by 
the Minister of Health and Children is a 
signifi cant initiative in the Irish Health 
Service which has implications not only 
for nurses and midwives, but for the 
health service system as a whole, and 
patients and service users in particular. 
Nurse and midwifery prescribing, it was 
hoped, would lead to better integrated 
care for patients, improved delivery in 
the acute sector and earlier intervention 
in the community and primary care 
settings. Th is article will illustrate how 
collaboration between regulatory bodies, 
health service providers and higher 
education institutions has led to the 
registration of the fi rst Irish nurse and 
midwife prescribers in March 2008 and 
discuss the future of nurse prescribing 
in Ireland.
to the administration or application 
of non-prescribed drugs by nurses 
and midwives. In response, An Bord 
Altranais and the National Council for 
the Professional Development of Nursing 
and Midwifery jointly established ‘Th e 
Review of Nurses and Midwives in 
the Prescribing & Administration of 
Medicinal Products Project’ in September 
2001. Th is review took place over a 
3.5-year period concluding in a fi nal 
report in 2005 that  examined expansion 
of practice by nurses and midwives 
specifi cally in relation to prescribing and 
medication management. Th e Steering 
Committee of this project was comprised 
of representatives from An Bord 
Altranais, the National Council for the 
Professional Development of Nursing and 
Midwifery and the Department of Health 
and Children. Other areas of nursing 
and midwifery were represented, as were 
patient and service user groups, the 
medical and pharmaceutical professions, 
various agencies and nursing unions. 
Background
Th e present focus on nurse prescribing 
in Ireland has emerged from two 
documents: Report of Th e Commission 
on Nursing —A Blueprint for the Future 
(Department of Health and Children 
(DoHC), 1998) and Review of Scope 
of Practice for Nursing and Midwifery 
(An Bord Altranais, 2000). During the 
consultative process employed for both 
of these reports, it emerged that nurses 
or midwives might need to administer 
non-prescribed drugs or medicated 
dressings in the interests of the patient, 
but in the absence of medical support 
(An Bord Altranais, 2000). In 1999 
the prevailing circumstance therefore 
resulted in constraints to delivering 
optimal patient care in a coherent and 
effi  cient way. In cognisance of this 
situation, it was recommended that An 
Bord Altranais (the regulatory body 
for the nursing profession in Ireland) 
urgently review the guidelines in relation 
Nurse and midwife prescribing was introduced to Ireland in 2007.
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Th eir over-riding consideration for the 
extension of prescribing rights to nurses 
and midwives was to improve services to 
patients and deploy the education 
and expertise of nurses and midwives 
more effi  ciently.
Th e project included a review of 
international developments in nurse and 
midwife prescribing which summarised 
international research studies on the 
subject and identifi ed the benefi ts for 
patients and service users as:
n Appropriate and safe prescribing
n Patient satisfaction
n Convenience and greater accessibility 
for patients
n Nurses as providers of information
n patients having improved compliance 
with their medications
n Fewer pharmacological interventions 
considered
n Appropriate clinical decision making
n Cost eff ectiveness.
In November 2006, the DoHC, with 
the approval of the Minister, established 
a Resource and Implementation Group 
on Nurse and Midwife Prescribing 
(RIG). Th is committee initially advised 
on the regulations to be draft ed and 
then focused on overseeing the ongoing 
development of nurse and midwife 
prescribing at a national level until 
December 2008. 
Overview of legislation 
framework
To facilitate nurse and midwife 
prescribing, changes to the legislation 
were required. Th e Minister for Health 
and Children was instrumental in 
introducing primary legislation to 
allow prescriptive authority for nurses 
and midwives (Government of Ireland, 
2006). Th e Minister’s rationale for the 
extension of prescriptive authority to 
nurses and midwives was to improve 
services to patients, reduce health service 
delays and deploy the education and 
expertise of nurses and midwives more 
effi  ciently. Th is was supported by strong 
international evidence from the USA, 
with over 30 years’ experience in nurse 
prescribing, and the UK with practice in 
this area since 1987. Subsequently, on 
1 May 2007 the Minister for Health and 
Children signed into law:
n Th e Irish Medicines Board 
(Miscellaneous Provisions) Act 2006 
(Commencement) Order 2007.
n Th e Medicinal Products (Prescription 
and Control of supply) (Amendment) 
Regulations 2007.
n Th e Misuse of Drugs (Amendment) 
Regulations 2007. 
Education programme
A pilot education programme for nurse 
and midwife prescribing commenced 
in the Royal College of Surgeons 
Ireland (RCSI) at the end of March 
2003 and concluded in September 
2003. However, although the pilot 
educational programme was successful, 
empowering legislation and clinical 
areas were not suffi  ciently developed 
for the full implementation of nurse/
midwife prescribing at this time. It was 
not until April 2007 that the present 
nurse and midwife prescribing education 
programme was commenced. In its 
development and delivery, the education 
programme builds on the established 
regulatory documents from An Bord 
Altranais, the National Council for the 
Professional Development of Nursing 
and Midwifery and relevant current 
legislation pertaining to medicinal 
products. It is currently off ered as a 
stand-alone programme by the School 
of Nursing, Royal College of Surgeons, 
Dublin and the Catherine McAuley 
School of Nursing and Midwifery, 
University College Cork. Th e purpose 
of this education programme for 
prescriptive authority is to ensure that 
upon successful completion the nurse/
midwife is equipped with the knowledge, 
skills and competence to prescribe safely 
and eff ectively. 
Th e education programme is designed 
in response to a direct request from the 
Health Service Executive and An Bord 
Altranais which may change in the future 
depending on best practice.
The role of the Health 
Service Executive (HSE)
Following the introduction of legislation 
to allow prescriptive authority for nurses 
and midwives in May 2007, the remit of 
RIG was to oversee the introduction of 
the initiative. With guidance provided by 
RIG, the role of the HSE included 
the following:
n Development and implementation of 
a plan to roll out nurse and midwife 
prescribing
n Identifi cation of clinical governance 
structures to support appropriate and 
safe nurse and midwife prescribing
n Evaluation of nurse and midwife 
prescribing from a service perspective 
within two years and development of a 
structure for ongoing evaluation
n Implementation of an inclusive 
communication strategy in partnership 
with the Department of Health and 
Children, An Bord Altranais and the 
National Council for the Professional 
Development of Nursing and 
Midwifery.
Essential criteria were identifi ed 
which had to be met by all Health 
Service Providers (HSPs) in order to 
participate in the prescribing initiative. 
Participating HSPs are required to have 
organizational policies which support the 
safe management of nurse prescribing 
and access to a Drugs and Th erapeutics 
Committee. Th ey are also required to 
develop robust collaborative practice 
agreements in collaboration with a 
named medical practitioner as well as a 
mechanism to audit and evaluate nurse 
and midwife prescribing practices. 
The role of An Bord 
Altranais
An Bord Altranais is the regulatory body 
for the nursing profession in Ireland 
(www.nursingboard.ie). It has played 
a key role in the regulation, education, 
clinical governance and professional 
guidance in the area of prescriptive 
authority for nurses and midwives. Th e 
publication of Nurses’ Rules (An Bord 
Altranais, 2007a) established for nurse 
and midwife prescriber is a new division 
of the Register. It also provided for 
approval of Higher Education Institutes 
(HEIs) and HSPs to collaboratively 
deliver education programmes to prepare 
nurse and midwife prescribers for 
their expanded role. Th e development 
of the Decision-Making Framework 
for Nurse and Midwife Prescriptive 
Authority (An Bord Altranais, 2007b) 
provided guidance for HSPs in regard 
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to the context and appropriateness of 
prescribing to their service needs while 
the Practice Standards for Nurses and 
Midwives with Prescriptive Authority 
(An Bord Altranais, 2007c) gave 
professional guidance on prescriptive 
authority and medication management. 
Finally, a guideline for the development 
of Collaborative Practice Agreements 
was provided for with the publication of 
Th e Collaborative Practice Agreement for 
Nurses and Midwives with Prescriptive 
Authority (An Bord Altranais, 2007d). 
Th e introduction of this document has 
restricted prescribing in Ireland from 
what initially was described as an open 
formulary to that of a limited formulary, 
one which is controlled by the drug 
and therapeutic committee within each 
clinical organization. However, this is 
not as restrictive as the supplementary 
prescribing that was initially introduced 
in the UK. 
Evaluation
Th e combined information from both 
the audit (An Bord Altranais, 2009) and 
the HSE evaluation (HSE, 2009) will 
be used to inform future changes to 
the curriculum content and assessment 
system together with organizational 
structures in the clinical setting and 
ongoing professional development 
requirements.
Future of nurse 
prescribing and 
implications for practice
Th e DoHC has conducted a national 
evaluation of the nurse prescribing 
programme from an educational and 
clinical perspective with a report due 
to be published in August 2009 (An 
Bord Altranais, 209; HSE, 2009). As part 
of the evaluation, students have been 
asked to evaluate the course content and 
delivery since its inception in April 2007.  
Informal student feedback regarding 
nurse prescribing to date identifi es the 
relationship between the nurse and 
the patient in providing reassurance, 
continuity of care, information, 
provision of health promotion, and being 
approachable (unpublished observations, 
University College Cork, 2007; 2008; 
2009) as the most positive aspects of 
nurse prescribing. Th is mirrors the 
fi ndings of international research where 
nurse prescribers have been identifi ed as 
safe and eff ective practitioners resulting 
in increased patient satisfaction (Shum 
et al, 2000; Pritchard and Kendrick, 
2001) and a more cost-eff ective service. 
However, concerns also exist regarding 
the acceptance of nurse prescribing in 
the clinical setting a situation that was 
previously studied in the US (Bryant 
and Clark-Graham, 2002) and Sweden 
(Wilhelmesson and Foldevi, 2003) 
and which found that some doctors 
were reluctant to accept non-medical 
prescribing, despite evidence that 
nurse prescribers are able to provide 
safe, eff ective prescribing care that is 
popular with service users. Despite these 
diffi  culties, nurse prescribing is extending 
(While and Biggs, 2004) and looks set 
to play a pivotal part in modernizing 
health services in Ireland. Discussions 
held with the various stakeholders 
during the evaluation undertaken by 
An Bord Altranais (2009) identifi ed 
that the success of nurse prescribing is 
largely dependent on the acceptance, 
support and understanding of doctors, 
some of whom have taken a cautious 
stance. Some students feel that the title 
of the programme, Certifi cate in Nurse 
Prescribing, is somewhat misleading for 
clinicians and may be a contributory 
factory in their cautious attitude in 
that it suggests an insuffi  cient level of 
qualifi cation for such a responsible role. 
In light of this, the current title of the 
programme is under review by 
the University.
Perhaps an important observation for 
future policy makers and nurse leaders 
in this area is the importance of engaging 
with medical colleagues in planning 
and supporting nurse prescribing. 
Th e nurse prescribers must also take 
responsibility for consolidating their 
new role by being assertive in raising 
awareness among colleagues of their 
potential and skills while continuing to 
build positive working relationships for 
the benefi t of their patients. Th e picture 
emerging from practice today is that 
there are a number of benefi ts from nurse 
prescribing which include time saving 
and convenience, a belief that patients 
receive better information from nurses 
about prescriptions, earlier intervention 
and a more holistic approach to care.  
Nurse prescribers also experience an 
increased sense of satisfaction, status 
and autonomy, as well as improved 
relationships with pharmacists and 
doctors (An Bord Altranais, 2009). 
Although nurses’ evaluation of nurse 
prescribing has generally been positive, 
some concerns have been identifi ed 
by mental health nurses, paediatric 
nurses and community nurses. Th ese 
concerns include lack of remuneration, 
adherence to a medical model, use 
of unlicensed medications, lack of 
organizational support, and not having 
clearly defi ned access to drug and 
therapeutic committees, in particular 
for community-based nurses. Although 
community based nurses are the group 
best positioned to really see the impact 
of nurse prescribing in Ireland, it is too 
soon to identify the full impact on this 
group of care recipients. Although nurses 
are being encouraged and liberated 
to work effi  ciently and autonomously, 
they are also in confl ict with inadequate 
resources. Th e community nurse 
prescribers clearly recognize the need to 
enhance existing services by improving 
access, reducing patient journeys and 
delays, and ensuring that the focus 
should always be on improving the 
patient experience. Th ere is growing 
support from community based doctors 
who have worked with nurse prescribers, 
but they need to be encouraged to talk 
about their experiences to increase 
support in the current economic climate. 
At present, the HSE is experiencing 
severe budgetary constraints and is 
looking for alternative ways of providing 
service to patients. However, at the local 
macro level of service planning, nurse 
prescribing may not be a priority because 
of a failure to understand its impact. 
From the information captured in the 
An Bord Altranais report (2009) and the 
HSE evaluation (2009) it is clear that the 
extension and further implementation 
of nurse prescribing is a way forward 
to provide these quality services at 
community level and throughout 
the HSE. 
Nurse prescribers see themselves 
as having increased knowledge that 
contributes to the wider health care 
team, however, to consolidate this, 
contribution protected study time 
and access to continuing professional 
development is required (An Bord 
Altranais, 2007). Similar concerns were 
found in the UK by Latter et al (2007), 
whose study highlighted that 95% of 
nurse prescribers engaged in self-directed 
informal professional development. Th is 
concern stems from the fact that the Irish 
Nurses Act of 1985 does not identify 
ongoing professional development as 
a requirement for maintaining best 
practice, appropriate care delivery and 
re-registration. However, nurse educators 
in Ireland are acutely aware of this 
situation and are providing post graduate 
programmes to address this defi ciency. 
Th e high uptake of such courses indicates 
that nurses in general are aware of the 
importance of ongoing professional 
development and the impact it has on 
confi dence and practice. Th is view is 
supported by Courtenay et al (2007) 
when they say ‘access to continuing 
professional development has been 
shown to increase confi dence levels in 
nurse prescribers’. 
To avoid misunderstanding of the 
newly qualifi ed nurse prescriber’s role 
amongst healthcare providers, education 
of the multidisciplinary team is also 
vital. Verbal feedback from the An Bord 
Altranais report (2009) highlights that 
newly qualifi ed nurse prescribers have 
a vital role in consolidating their new 
position as they are partly responsible for 
defi ning the scope of their new role and 
how they plan to implement it.  
An Bord Altranais is reviewing the 
Nurses’ Act (1985), which is due to 
be published later this year. Because 
nurse prescribing is still new to the 
Irish setting, newly qualifi ed nurse 
prescribers will again have an important 
role to play in determining their 
specifi c professional development needs 
through ongoing research and audit. 
One nurse prescriber suggested that 
it was possible to keep updated for a 
short time only by self-motivation and 
the use of journals, but that an offi  cial 
professional development course was 
needed to fully address their needs. Th is 
was reinforced by another participant 
who clearly stated, ‘that the nurse 
prescribers are in a better position now 
as newly qualifi ed specialist practitioners 
having successfully completed the nurse 
prescribing education programme to 
critically analyse the research fi ndings 
off ered by pharmaceutical representatives 
(Programme evaluation UCC, 2009) in 
order to make an informed decision. 
However, with constant changes in the 
pharmaceutical arena this position of 
security could be short lived. 
Conclusions
From an international perspective, and 
considering the implementation of 
several diff erent models of prescribing 
worldwide, nurse prescribing has 
been evaluated positively to date (An 
Bord Altranais, 2005a,b). Th e An 
Bord Altranais report of 2009 and the 
HSE evaluation of nurse prescribing 
(2009) have identifi ed strengths and 
weaknesses in the education and 
prescribing process that can be addressed 
through collaboration with the various 
stakeholders. As questions arise regarding 
this new nursing role, research is needed 
to provide robust evidence about the 
eff ectiveness, safety and satisfaction 
of nurse prescribing. To ensure that 
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Newly qualifi ed nurse prescribers have a vital role in consolidating their new position as they are partly responsible for defi ning 
the scope of their new role and how to implement it.
progress continues, support from the 
Department of Health together with the 
multidisciplinary team is vital to the 
continued success of nurse prescribing. 
Th e organization has the specifi c role 
of ensuring structures are in place 
and access to appropriate committees 
is facilitated. Th e organization is also 
required to help the nurse prescriber 
with ongoing professional development 
by providing protective time to attend 
study days or specifi cally designed 
programmes. Addressing these issues 
as they arise in collaboration with the 
various stakeholders will help consolidate 
nurse prescribing in Ireland in keeping 
with international best practice.
With the early introduction of the Irish 
budget in October 2008, the subsequent 
revision of the budget in March 2009 
and the further introduction of a 
mini-budget, funding for the majority 
of postgraduate nursing education 
programmes has been withdrawn 
although nurse prescribing and the 
public health programme continues to 
be funded. However, providing funding 
may not be suffi  cient to ensure that 
nurse prescribing education programmes 
continue. Staff  also need support at an 
organizational level. Economists have 
informed the Government that the 
modern Irish economy needs to rely 
increasingly on human ingenuity, and 
agile, frequent innovations to improve its 
present economic situation (Irish Times, 
2009). Nurse prescribing can contribute 
signifi cantly to the improvements 
required in the health care system and 
help it to move forward in these diffi  cult 
times. Nurse prescribing has already 
had a signifi cant impact on medical and 
hospital costs in Ireland, and it is hoped 
that the Department of Health through 
its discussions and the fi ndings of the 
recent evaluations (An Bord Altranais, 
2009), will continue to recognize the 
benefi ts of nurse prescribing and support 
its development over the diffi  cult 
economic period ahead. 
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Key points
n The introduction of nurse and midwife prescribing to Ireland in 2007 by the 
Minister of Health and Children is a signifi cant initiative in the Irish Health 
Service which has implications not only for nurses and midwives, but for the 
health service system as a whole, and patients and service users in particular.
n Nurse prescribing has already had a signifi cant impact on medical and 
hospital costs in Ireland. 
n Although nurses’ evaluation of nurse prescribing has generally been positive, 
some concerns have been identifi ed by mental health nurses, paediatric 
nurses and community nurses.
n These concerns include lack of remuneration, adherence to a medical model, 
use of unlicensed medications, lack of organizational support, and not having 








Appendix 2 - Explanation and application of Caldwell’s Framework 




















Caldwell et al. 2011 framework is supported firstly by identifying common 
features of the research design framework and secondly a detailed explanation 
of each step of the evaluation process.  
Common features  
 
Quantitative Qualitative 
Research design          Philosophical background 
Experimental hypothesis          Research design 
Operational definitions          Concepts 
Population          Context 
Sample          Sample 
Sampling          Sampling 
Validity/reliability of data     
collection 
         Auditability of data collection 
Data analysis 
         Credibility/confirmability of data 
analysis 
Generalizability          Transferability 
 
Guidelines that provide an extended explanation of each item 
Details of these explanations are set out below including how the questions 
specifically relevant to qualitative and quantitative are structured. 
Does the Title reflect the content?   The title should be informative and 
reflect the focus of the study. It should allow the reader to easily interpret the 
content of the study. An inaccurate or misleading title can confuse the reader.  
Are the authors credible?   Researchers should hold appropriate academic 
qualifications and be linked to a professional field relevant to the research. 
Does the abstract summarize the key components?   The abstract should 
provide a short summary of the study. It should include the aim of the study, 
outline of the methodology and the main findings. The purpose of the abstract 
is to allow the reader to decide if the study is of interest to them. 
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Is the rationale for undertaking the research clearly outlined?  The author 
should present a clear rationale for the research, setting it in context of any 
current issues and knowledge of the topic to date. 
Is the literature review comprehensive and up-to-date?   The literature 
review should reflect the current state of knowledge relevant to the study and 
identify any gaps or conflicts. It should include key or classic studies on the 
topic as well as up to date literature. There should be a balance of primary and 
secondary sources. 
Is the aim of the research clearly stated?   The aim of the study should be 
clearly stated and should convey what the researcher is setting out to achieve. 
Are all ethical issues identified and addressed?   Ethical issues pertinent to 
the study should be discussed. The researcher should identify how the rights of 
informants have been protected and informed consent obtained. If the 
research is conducted within the NHS then there should be indication of Local 
Research Ethics committee approval. 
Is the methodology identified and justified?   The researcher should make 
clear which research strategy they are adopting, i.e. qualitative or quantitative. 
A clear rationale for the choice should also be provided, so that the reader can 
judge whether the chosen strategy is appropriate for the study. 
At this point the researcher look specifically at the questions that apply to 
the paradigm appropriate to the study they are critiquing. To complete their 
critique, the final questions students need to address are applied to both 











Does the title reflect the content? 
 ↓  
 Are the authors credible?  
 ↓  
Does the abstract summarise the key points? 
 ↓  
Is the rational for undertaking the research  
clearly underlined? 
 ↓  
Is the literature review comprehensive  
and up-to- date? 
 ↓  
Is the aim of the research clearly stated? 
 ↓  
Are all ethical issues identified and addressed? 
 ↓  
Is the methodology identified and justified? 
   
Quantitative   Qualitative 
↓  ↓ 
Is the study design clearly identified, and is 
the rationale for choice of design evident? 
 Are the philosophical background and study 
design identified and the relational for choice of 
design evident?  
↓  ↓ 
Is there an experimental hypothesis clearly 
stated?  
Are the key variables clearly defined  
 Are the major concepts identified? 
↓  ↓ 
Is the population identified?  Is the context of the study outlined? 
↓  ↓ 
Is the sample adequately described and 
reflective of the population? Is the method of 
data collection valid and reliable? 
 Is the selection of participants described and 
sampling method identified?  
Is the method of data collection auditable? 
↓  ↓ 
Is the method of data analysis valid and 
reliable? 
 Is the method of data analysis credible and 
confirmable? 
    
Are the results presented in a way that is appropriate? 
↓ 
Are the results 
generalizable? ← 
Is the discussion 
comprehensive   
→Are the results 
transferable? 
↓ 
Is the conclusion comprehensive? 
 
Are the results presented in a way that is appropriate and clear?   
Presentation of data should be clear, easily interpreted and consistent. 
Is the discussion comprehensive?   In quantitative studies the results and 
discussion are presented separately. In qualitative studies these maybe 
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integrated. Whatever the mode of presentation, the researcher should 
compare and contrast the findings with that of previous research on the topic. 
The discussion should be balanced and avoid subjectivity. 
Is the conclusion comprehensive? Conclusions must be supported by the 
findings. The researcher should identify any limitations to the study. There may 
also be recommendations for further research, or if appropriate, implications 
for practice in the relevant field. 
 
Diagrammatic Framework 
A diagrammatic framework indicates the pathways that are central to both 







Appraisal results for individual reviews using the Caldwell Framework (Caldwell et al. 2011) 
Questions 1-18 based on the Caldwell Framework 
Studies 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Total 
Banicek 2012 2 1 1 2 1 2 1 1 0 1 1 1 1 1 1 1 1 1 20 
Black 2013 2 1 2 1 1 2 1 1 1 2 2 1 1 2 2 1 2 2 27 
Bowskill et al. 2012 2 2 2 2 1 2 1 1 1 1 2 1 2 2 2 2 2 2 30 
Carey et al. 2009 2 2 2 2 2 2 2 1 2 1 2 1 2 2 2 2 2 2 33 
Carey et al. 2010 2 2 2 2 2 2 2 1 2 1 2 1 2 2 2 2 2 1 32 
Carey et al. 2013 2 2 2 2 2 2 1 1 2 2 2 1 2 2 2 2 2 1 32 
Carey et al. 2014 2 2 2 2 1 2 1 2 2 1 2 1 2 2 2 2 2 1 31 
Cashin et al. 2009 1 2 2 2 1 2 1 1 1 0 2 1 1 1 2 2 2 1 25 
Cooper et al. 2013 2 2 1 2 2 2 0 1 2 1 2 2 2 0 2 2 2 1 28 
Coull et al. 2013 2 2 1 2 2 1 1 1 1 1 1 1 2 1 2 1 2 1 25 
Courtney et al. 2010 2 2 2 1 1 2 0 2 2 1 2 2 1 2 2 2 2 1 29 





1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18  Total 
Darvishpoor et al. 
 
2014 2 2 2 2 2 2 0 2 2 0 2 2 2 2 2 2 2 2 32 
Dhalivaali  
 
2011 2 1 2 1 2 2 1 1 1 0 2 2 2 0 1 2 2 2 26 
Dobler-Ober et al.  
 
2013 1 2 1 2 2 1 0 1 2 0 2 2 2 1 2 2 2 1 26 
Drennan et al.  
 
2011 2 2 2 2 2 2 2 1 2 2 2 2 2 2 2 2 2 1 34 
Dunn et al.  
 
2010 1 2 1 1 1 2 1 1 2 0 2 1 1 2 2 2 2 2 26 
Earle et al.  
 
2011a 1 2 1 2 1 2 1 2 2 1 2 1 2 1 2 2 2 1 28 
Earle et al.  
 
2011b 2 2 1 2 1 2 1 1 2 0 0 1 2 1 2 2 2 1 25 
Fisher  
 
2010 2 2 1 2 2 1 1 2 2 1 2 1 2 1 2 2 2 1 29 
Gielen et al.  
 
2014 2 2 2 2 2 2 0 2 2 1 2 2 2 2 2 2 2 2 33 
Green et al.  
 
2009 2 2 2 1 1 2 0 2 2 0 2 1 2 2 2 2 2 1 28 
Hobson et al. 
 
2010 2 1 2 2 2 2 0 2 2 1 2 1 2 2 2 2 2 1 30 
Jones et al.  
 
2010 2 2 2 2 2 2 1 1 2 0 2 1 2 2 2 2 2 2 31 
Kroezen et al.  
 
2012 2 2 2 2 2 2 0 2 2 2 2 2 2 2 2 2 2 2 34 
Kroezen et al.  2013 2 2 2 2 2 2 1 1 2 2 2 2 2 2 2 2 2 2 34 
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NOTES   Individual items 1-18 as defined by Caldwell et al. 201, 2 = Yes compliant with Caldwell et al. 2011,  1 = partially compliant with Caldwell et al. 2011 item            
0=  Non-compliant with Caldwell et al. 2011. Question Key  Note: Caldwell criteria: (1) title reflects content, (2) authors credible, (3) key points summarised in abstract, (4) 
rationale outlined, (5) comprehensive up-to-date literature review, (6) aim clearly stated,  (7) ethical issues identified, (8) methodology identified and justified, (9) 
philosophical background and rationale for study design identified, (10) major concepts identified, (11) is the context of the study outlined,  (12) selection participants and 
sample method identified, (13) data collection auditable, (14) method of data analysis credible and confirmable, (15) results presented appropriately and clear,  (16) are 
results transferrable, (17) is the discussion comprehensive, (18) is the conclusion comprehensive.   
 
Kroezen et al.  
 
2014 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 1 35 
Studies 
 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18  Total 
Latter et al.  
 
2012 2 2 2 2 2 2 0 1 2 1 2 2 2 2 2 2 2 2 32 
Naughton et al.  
 
2012 2 2 2 2 2 2 1 1 2 1 2 2 2 2 2 2 2 2 33 
Natan et al.  
 
2012 2 2 2 1 2 2 0 2 2 0 2 2 2 1 2 2 2 2 30 
Rana et al.  
 
2009 2 2 1 2 2 2 1 1 2 0 2 1 2 2 2 2 2 2 30 
Ross& Kettles  
 
2012 2 2 1 1 2 1 2 2 2 1 2 2 1 2 2 2 2 1 30 
Scrafton et al.  
 
2012 2 2 2 1 1 2 1 2 2 1 2 2 1 2 2 2 2 2 31 
Snowden et al. 
 
2010 1 2 1 1 2 2 1 1 1 0 2 1 1 1 2 2 2 1 24 
Stenner et al.  
 
2012 2 2 2 2 2 2 1 1 2 1 2 1 2 2 2 2 2 2 32 
Weglicki et al. 
 
2014 2 2 2 2 2 2 1 2 2 1 2 2 2 2 2 2 2 1 33 
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The impact of nurse prescribing 
on the clinical setting
P rescribing medications has traditionally been thedomain of doctors, but nurse prescribing has beenintroducedinresponsetochangingserviceneedsandthe increasing specialisation of nurses and midwives




as formalising the ‘informal’ prescribing that nurses already
undertake(Nolanetal,2001).Theinternationalexperienceof
Rena Creedon, Stephen Byrne, Julia Kennedy and Suzanne McCarthy
nurseprescribers(NPs)hasdemonstratedtheassociatedbenefits
in terms of increased patient satisfaction and concordance
withmedicationregimes(Berryetal,2008),cost-effectiveness
(Drennanetal,2009)andincreasednurseconfidence(Courtenay




aspects of nurse prescribing (Russell et al, 2003; Courtenay
et al, 2010). The role of NPs continues to grow in the
healthcaresettinginternationally,increasinginbothprominence
and significance (Cipher et al, 2006). However, international
differencesbetweenlegislativeproceduresandtheprofessional
bodies responsible for the regulationofNPshave resulted in
theimplementationofseveralmodelsofprescribingworldwide
(Nursing and Midwifery Board of Ireland, 2005; Kroezen et




involvement in the process—thenurse has full accountability
and responsibility for the diagnosis and prescribing for that
patient. In contrast, nurse supplementary prescribing is based
on a voluntary prescribing partnership between the doctor
and thenurse that facilitates thenurse to prescribe anydrug







doctor. Medications include over-the-counter drugs, wound
dressings and applications. Specific international variations of
nurse prescribing models were identified by Kroezen et al
(2012)(Table 1).
Irrespective of the prescribing model used, nurse
prescriberscontinuetopublicisethatextendingprescribing
rights has allowednurses tomake better use of their skills
(WilhelmessonandFoldevi,2003;Drennanetal,2009),gain






withchanges in societalvaluesandtechnology. In theUK,
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Abstract
Aim: To investigate the impact nurse prescribing has on the 
organisation, patient and health professional, and to identify factors 
associated with the growth of nurse prescribing. Methods: Systematic 
search and narrative review. Data obtained through CINAHL, PubMed, 
Science direct, Online Computer Library Centre (OCLC), databases/
websites, and hand searching. English peer-reviewed quantitative, 
qualitative and mixed-method articles published from September 
2009 through to August 2014 exploring nurse prescribing from the 
perspective of the organisation, health professional and patient were 
included. Following a systematic selection process, studies identified 
were also assessed for quality by applying Cardwell’s framework.
Results: From the initial 443 citations 37 studies were included in 
the review. Most studies were descriptive in nature. Commonalities 
addressed were stakeholders’ views, prescribing in practice, jurisdiction, 
education and benefits/barriers. Conclusions: Prescriptive authority for 
nurses continues to be a positive addition to clinical practice. However, 
concerns have emerged regarding appropriate support, relationships 
and jurisdictional issues. A more comprehensive understanding of 
nurse and midwife prescribing workloads is required to capture the 
true impact and cost-effectiveness of the initiative.
Key words: Non-medical prescribing ■ Independent prescriber 
















independentprescribing rights tootherprofessions suchas
pharmacists, optometrists, physiotherapists and podiatrists
(PharmaceuticalJournal,2013).
Current studies have indicated that the introduction of
nurseprescribinghasblurredprofessionalboundarieswith
jurisdictional responsibility for prescribing between the
medical and nursing profession now unclear (Bowskill et
al, 2012;Kroezen et al, 2013;Natan et al, 2013;Kroezen
et al, 2014). The consequence of these changes has an
impactonthepatient(Courtenayetal,2011),organisation
(Banicek, 2012) and health professional (Latter et al,
2012).However, additional concerns have been identified
regardingtherapeuticrelationships,roleconflict,andlackof
support,whichimpactontheprogressofnurseprescribing
(Ross and Kettles, 2012). Building on a literature review
conductedin2009andpublishedintwopartsbythefirst
author and colleagues (Creedon et al, 2009; O’Connell
etal,2009) it isnowtimelytosystematically identifyand





patient and health professional perspective and identify
possiblefactorsthatmayimpactoncontinuedgrowth.
Method
A systematic search and narrative review was undertaken.
Givensuchabroadquestion, this reviewtypecombines the
search strategies and inclusion/exclusion criteria associated
withsystematicreviewsaswellastheanalyticalsynthesisofa
criticalreview(Twycrossetal,2015)toprovide‘bestevidence
synthesis’ (Grant and Booth, 2009). Multiple study designs
are incorporated in the review rather than focusing on a
single study design with the intention of providing a more
complete picture of the research on the topic. Its primary
purpose is to offer the reader a comprehensive background




databases and websites were searched: CINAHL, PubMed,
Online Computer Library Centre (OCLC) and Science
Direct. Websites included were the Irish Department of
Health (health.gov.ie), the English Department of Health
(http://tinyurl.com/c8cqtdj) and Google Scholar (www.
scholar.google.com). The search terms (prescribing OR
‘prescriptive authority’) AND (nurse OR nursing OR
non-medical) were repeated across the databases. Articles
selectedwere dated fromSeptember 2009 toAugust 2014
withnorestrictiononthetypeofpatientgroupforwhom
medicationswereprescribed.Furtherstudieswereincluded
if they had a comparative design, e.g. comparing nurse
prescribingwith physician prescribing or comparing nurse





qualitative,quantitativeormixedmethod innature and that
hadnurses,healthprofessionalsandserviceusersasparticipants
ofresearchundertakenintheareaofnurseprescribing.Articles






programmes with no research design were not included. 
Figure 1showstheprocessofidentifyingandselectingstudies
forinclusioninthereview
Data extraction and synthesis 
Dataextracted fromeach study took the following format:
study, country, study design, aim, sample (participants and
Table 1: Use of formularies, group protocols, clinical management plans (CMPs) 






Alaska (USA) IP IP
Alberta (Canada) IP
Finland IP  SP
Georgia (USA) SP
Ireland IP
Missouri (USA) SP SP
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setting), data collection method, main results and quality




jurisdiction, and remuneration. Information was tabulated
allowing identification of prominent themes and offering
structuredwaysofdealingwiththedataineachitem.




using specific items based on the methodology and
provides a list of criteria forqualitative, quantitative and
mixed-methodresearchtoassistthereaderinassessingthe
reliabilityofthestudytoitsstateddesignanddetermine
the dependability of the results (Twycross et al, 2015).
Theitemsincludesuchelementsas:isthereahypothesis?
arekeyvariables defined? is the selectionof participants
described and sample method defined? and are major
concepts defined?.Although initially the framework did
notproduceasinglenumericalscoretorepresentquality,
for the purpose of this review the Caldwell framework
consistingof18questionswasawardedanumericalvalue
(Bettany-Saltikov,2012).Theapplicationofeachquestion
in Caldwell’s framework had three possible answers; an
answerofno=0,partly=1,andyes=2,withthemaximum
value any study could achievebeing36.On completion
ofthisprocessallstudiesscoredbetween20and35points.
Studieswerenotexcludedbasedontheassessmentquality
as preconceptions can be inherent in a wide range of
researchdesignsincludedinthereview.
Findings
The literature originated from Britain, Scotland,Australia,
TheNetherlands,Israel,IranandIreland.Alldataextracted
from the studies were based on the results and discussion
sections,notthestudyconclusion.Outcomeswereclassified
accordingtothecategoriesidentified.Categorieswerethen




Of the 37 studies reviewed 31 included data on prescribing
in practice, frequently from the viewpoint of prescribers and
clients.SevenstudiesincludeddataaboutCPD,fourdirectlyand
three indirectly.Five studies reportedon issuesof jurisdiction
with two focusing specifically on this issue. Although there
werenostudiesthatreportedpreciselyonfinancialissues,four
mentionedfinancialincentivesassignificant.
There were a mixture of quantitative (n=15), qualitative
(n=20) and mixed methods (n=2) studies sourced using a
rangeofdatacollectionmethods.
Prescribing in practice 
Eventhoughnursesprescribemedicinesonanindependent
or supplementary basis, their scope of practice varies
considerably depending on whether or not protocols,
formularies or clinical management plans are in place
and how restrictive they are.The model of prescribing
applieddirectlyimpactsontheextenttowhichNPsmake
use of their prescriptive authority in everyday practice
(Kroezen et al, 2014). Although the majority of studies
referred to issues about prescribing in practice, seven
focused specifically on this area. Overall, findings agreed
thatnurseprescribingincreaseseffectivenessandautonomy
in practice, which in turn raises many issues concerning
confidence,workload(Earleetal,2011a),accesstoongoing
orspecialisttraining(Stenneretal,2012;Careyetal,2013),




aninformalwaythatisagreeabletobothnursesanddoctorsFigure 1. Flow diagram showing how relevant studies were identified for the narrative review
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Unable to obtain further 
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There was a strong feeling that service development must
takeintoaccounttheadditionalworkinvolvedinprescribing.
Having the ability to prescribe increased workloads for
the NPs (Earle et al, 2011a) who appear to struggle with
balancing their new role, particularly where boundaries of
thenursingworkandprescribingrolesareunclear(Bowskill
et al, 2012). Earle et al (2011a) suggest that this can be






negatively in terms of prescribing itself, numbers accessing
training and the ability to demonstrate the effectiveness of
nurseprescribing(Scraftonetal,2012).Workforceplanning
in some instances did not support funding arrangements
and agreements were not always in place to support nurse
prescribing,therebycreatingpotentialinequalitiesinservice
provisionforpatients(Careyetal,2014).
Continuing professional development 
NPs expressed anxiety that they were not‘keeping up to
date’.Therewasalsoafearofmakingincorrectdecisionsif
theycouldnotrecalltheorylearnedduringtheprescribing
course (Weglicki et al, 2014). This anxiety and lack of
confidence by nurses in their prescribing ability poses a
significant challenge for CPD. Contrasting professional
backgrounds,individualskill levels,workplaceexpectations
and demands are some of the concerns to be addressed
when focusing onCPDneeds for nurse prescribers. Four
studies reported specifically on CPD for NPs (Courtenay
andGordon,2009;Greenetal,2009;CareyandCourtenay,
2010;Weglickietal,2014).Thenumberislowconsidering
the importance placed on CPD by governing bodies and
organisations to ensure NPs’ knowledge remains current.
However,additionalstudiesincludedCPDintheirfindings
ordiscussionasanimportantelementofnurseprescribing
tobe addressed (Scraftonet al, 2012;Stenner et al, 2012).
The pace of change in the area of prescribing presents





and workload patterns (Courtenay and Gordon, 2009). In
addition, pressure to satisfy mandatory updates (Green et al,
2009); lack of organisational support (Carey and Courtenay,
2010);patientsafety,workforceplanningandeducationofline
managers, support from employer or the professional body,
reducededucationbudgets,anxietyandlackofconfidencein
non-medicalprescribing, and individual skill levels (Weglicki
et al, 2014) all impact on CPD. From a more encouraging
perspective,studiesalsoidentifiedpositiveoutcomesofCPD:
consolidation of learning, information on new skills, an




reduced anxiety (Weglicki et al, 2014).Themainbarriers to
CPD were consolidated by Stenner et al (2012) as financial
andtime/staffshortage,availabilityoftrainingatanappropriate
levelandlackoforganisationalsupportforroledevelopment.
Pharmacology knowledge is the most important CPD
need identified by nurse prescribers, a situation that Carey
and Courtenay (2010) acknowledged as warranting further
investigation.However,additionalstudiesidentifiedassessment






Until recently the domain of prescribing was exclusive
to the medical profession. The expansion of prescriptive
authority has affected professional boundaries and in some
relationshipstherehasbeenastrugglefordominance(Fisher,
2010). This affects the relationship between the nursing
and medical professions and jurisdictional control over
prescribing(Kroezenetal,2014).Theattitudesofdoctorsto
theinitiative—inparticular,withseniordoctorsbeingmore
supportive of the role than junior doctors—may represent
concernsabouttheirfuturerole(Ranaetal,2009).However,






blurredboundaries by addressing the issues through formal
workplace policies (Kroezen et al, 2013) that require clear
organisational structures (Earle et al, 2011b). For NPs the
acquisitionofprescribingrightsisnotconsideredachallenge
tomedicinebut the‘evolution’ofnursing tomeetpractice
demands (Kroezen et al, 2013). Only in the UK, where
nursesprescribe independently fromthenational formulary,
isjurisdictionoverprescribingconsideredequaltothatofthe
medicalprofession(Kroezenetal,2012).
Prescribing arrangements and treatment protocols 





and thepatient’ (Kroezenet al,2012).The impactofnurse
prescribingonprofessionalrelationshipsmaydifferdepending
on whether supplementary or independent prescribing is
practised. Continued medical authority is expected with
supplementary prescribing given that the doctor makes
the initial diagnosis and is involved in agreeing a clinical
managementplan for thepatient (Cooperet al,2013).The
independentprescribingmodelismoreautonomousallowing
















and responsibility for thediagnosis andprescribing for that
diagnosis.Independentprescribingthereforeposesadifferent













et al, 2009). In reality, nurses struggle with balancing their
role as prescriber and nurse and may harbour resentment




qualifications unrelated to prescribing qualifications.A lack
ofpayincentivewasalsorecognisedbyEarleetal(2011a)as
anissuethatmayslowthedevelopmentofnurseprescribing.
Factors relating to the patient
Thepatients’perspectiveofnurseprescribingwasatthecore
of six studies; two studiesused the term‘viewsofpatients’,





accessibility, timeliness, knowledge, safety, holistic care
approachandagoodrelationshipwiththenurse.However,
an interesting concern identified by Dhalivaal (2011) and
Banicek (2012) was patients’ apprehension in relation to
thequalifications and trainingofnurseprescribers.This is
significant because patients’ confidence is inspired by the
nurse’s level of knowledge (Cashin et al, 2009;Courtenay
et al, 2011;Drennanet al, 2011;Coull et al, 2013)which




who they perceived as having more extensive knowledge
due to their lengthy training (Courtenayetal,2011)with
somepatientscontinuingtothinkthattheroleofthenurse
is tohelp thephysician (Natanet al, 2013). Initial patient
impressions changed and became more positive the more
exposure patients have to nurse prescribers, according to
Natanetal(2013).Overall,findingsindicatedthatpatients
welcomedtheadditionoftheNPtothehealthcareteam.
Factors relating to the health professional 
Development of confidence and competence in practice
were significant factors identifiedby thehealthprofessional
(Cashinetal,2009;SnowdenandMartin2010;Dunnetal,
2010;Dobel-Ober et al, 2013). In particular, Snowden and
Martin (2010)emphasised thatconfidenceandcompetence
isdependentonknowledgeofpharmacologyandthequality
of the therapeutic relationship. Cashin et al (2009) found
thatthroughtheprovisionofpatientinformation,education,
discussion,andassistingclientsinmakinginformeddecisions,
confidence and competence were also advanced. Many
countries use formularies to support nurse prescribers’
confidence. However, when using formularies the health
professionalmayfindthemcumbersomeandregularreview
is required to take into account prescribers’ needs and
confidence development (Dobel-Ober et al, 2013). In
addition, Dunn et al (2010) cautioned over-reliance on
protocolsorpersonal formularies forhealthprofessionals,as
theymaydecreaseopportunities to independentlyprescribe





Factors relating to the organisation 
Lack of support within the organisation was identified as
threefold:lackofsupervision,lackofsupportwithintherole,
andlackofsupportfromotherhealthprofessionals(Rossand
Kettles, 2012). In addition, organisational implementation of
practiceprotocolswasidentifiedasrestrictiveandshouldnotbe
confusedwithbestpractice(Dunnetal,2010).Organisational





better patient satisfaction, cost-effectiveness, and streamlining
of staff skills (Carey et al, 2009; Darvishpour et al, 2014).
Patient benefits that improve organisational effectiveness are
convenience,betterpatient education, enhancedpatient care,
easieraccesstodrugs,reducedwaitingtimes,safety,improved
satisfaction and compliance, skill mix and flexible working
(Carey et al 2009;Ross andKettle, 2012;Darvishpour et al,
2014).Theorganisationalsoprofitsfromthehealthprofessional
perspective with increased clinical competence, recognition
of abilities, professional autonomy, accountability, increased








were acknowledged by Coull et al (2013). In addition, Ross






















concerns related toprescribing thathavebeen identified as
barriers or potential barriers to prescribing. For instance,
remuneration was identified by Ross and Kettles (2012) as
a continuing barrier for nurses considering that additional
responsibility and increased workload did not equate to
financialreward.Todate,thissituationhasnotchangedwith
Careyetal(2014)highlightingthatstructuralreorganisation
in the health service is now looking at GPs and managers
gaininggreatercontroloveralreadystretchedresources.
Discussion
Despite differences in prescriptive authority for nurse
prescribing indifferent countries, a reviewof the literature
shows many similarities in relation to the benefits that it
providesforpatients,carers,nurses,doctors,theorganisation
andtheoveralldeliveryofhealthcare.Compellingadvantages
for nurse prescribing across healthcare settings include the
nurse prescribers’ awareness of patient needs, giving more
options for patients, giving complete episodesof care, time
saving, early intervention, use of advanced practice skills
and cost saving for the healthcare system.The advantages
come hand in hand with the concerns about patient care,
inappropriateprescribing,interprofessionalrelationships,cost
ofCPDand the jurisdictionof prescribing. It is important
to note that studies included in this review meet specific




from the UK perspective, which is very progressive in
advancingnurseprescribing.OthercountriessuchasAustralia,
FinlandandCanadawithlargergeographicalareashaveNP




Impact of nurse prescribing on health professionals
Nurse prescribing is viewed as a valuable addition to
existing roles, and expansion of prescribing rights was




lightly but was welcomed, as long as it was for patient
benefitandnotjusttofillgapsleftbystaffingshortfalls.The
main factors identified that facilitatedeffectiveprescribing
inpracticeincludeteamworkandpeeranddoctorsupport
that is accessible and positive regarding nurse prescribing.
When present, such support can facilitate prescribing but
when absent, they limit nurse prescribing.Therefore, the
education ofmedical practitioners on prescribing and the
role of the NPs is of paramount importance to ensure a
collegialrelationship.Addressingthisissueateducationlevel
maybeanoptionforthefuture.Usinganinterdisciplinary
educational approach to preparing both doctors and
nurses for prescribing would improve relationships and
understandingofbothroles.
The views of NPs themselves, although useful, are over-
reported, with limited research into the views of the
medical profession or other health professionals evident.
Supplementary prescribing was credited with improved
understanding between the professions because the doctor
takes responsibility for the diagnosis; but this is dependent
on individual attitudes. Rana et al (2009) stressed the
importance of health trusts (organisations) in assisting the
transitiontowardnewrolesforprescriberswiththeintention
of reducing conflict.A comparison of nurses’ and doctors
prescribing practices would also be useful to compare the
decision-makingprocessbybothnursesanddoctors,ideally
incorporating patient outcomes and cost-effectiveness of
prescribingoutcomesintheclinicalsetting.
Impact of nurse prescribing on the organisation
The healthcare environment has changed significantly over
the last decade, driven by changing demographics and
epidemiology,withorganisationsnowincreasinglyrequiring
the services of NPs to help provide a streamlined and
timely service for patients. Clinical governance and overall
organisational support have been identified repeatedly as
importantfactorsforthesuccessofnurseprescribing.Having
organisational structures inplace also supportsNPs to fully
integrate into the healthcare team. In addition, current
knowledgeisanessentialelementforNPstoworkaspartof
thehealthcare teambecauseprescribingknowledgeextends
beyond the act of consultations for issuing prescription to
also encompass education, titration and discontinuation of
medication. Inadequate support in the face of heavy work
commitments reduces the opportunity for development
(Greenetal,2009).Havingaccesstoasupportiveenvironment
encouragesNPstoattendupdatesandcreatesopportunities
for networking between the different healthcare settings.
However, a clear evaluation framework is required to
obtainarobustpictureoftheCPDthatworksforNPs.The
challenge of providing appropriate CPD for experienced
nurse prescribers is pharmacology education, which, if
appropriately focused, relates to their specialty making it
applicable to a small number of prescribers.This focused
educationcreateschallengesforprovidersofCPDwhomay
finditdifficulttodeliveratanaffordablecost.Inaddressing










situations.The progressive dynamic nature of NP requires
sharedresponsibilitywithhealthserviceproviderstodevelop
robust systems to support competence, assurance and safe
clinical governance. This requires that the health service
expands its narrow view of prescribing, which tends to be
focusedonaconsultationthatresultsinamedicationbeing
prescribed (Health Service Executive, 2014). Education,
















environment of today’s health service. Understanding the
truecost-effectivenessof theNPs’contributionswithin the
organisation could facilitate the redirection of partial funds
to address issues such as protected study time and financial
supportthathindertheaccessofCPD.
The issueof remuneration,or lackof,wasmentioned in
several papers and could be identified as a barrier to the
implementationofnurseprescribing.Thismayexplainwhy
nurses do not prescribe although remuneration does not
factorhighlyinreportedfindingsonthetopic.Nevertheless,
itdoes seemunrealistic toexpectnurses toundertake such
a skilled independent role that is cost-effective for the
organisationwithoutrecompense.
Impact of nurse prescribing on the patient
Improved speed and convenience of access to medicines
have been consistently reported as key benefits of NP by
patients(Drennanetal,2009).IncreasingthenumberofNPs
has a twofold effect: improved patient access to services and
relievedpressureondoctorstherebypreservinglimitedmedical
resources for the most seriously ill patients. However, these





thepatient’s levelof satisfaction.Patientsarehighly satisfied




and more likely to include them in discussion about their
medications.This approach to prescribing makes it easier
forpatients to share information, askquestions, andaddress
problemsandasaresulttheyunderstandtheirconditionand
treatmentbetter.Inpromotingagoodprescribingrelationship
withthepatient, it is important toavoidconfusionbecause
there may be limitations imposed on prescribing certain
medicationsdependingonthecountry inwhichtheNPis
practising.This can present problem when treating patient
withmultiplecomorbidities.Toovercomethis,NPsmustbe
clearwithpatientsaboutwhattheycanandcannotprescribe














Health professionals need to maintain awareness of the






Their preference forCPD relates to specific pharmacology
educationrelatingtotheirspeciality.
From an organisational perspective the review provides
evidence that NPs improves the quality of care patients
receiveandcontributestoanimprovedservicethatisflexible
and accessible. However, a lack of commitment from the
organisationtonurseprescribingneedstobeaddressedfrom
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Question set for the MDS study 
Overarching question 
1. What is your experience of the using MDS in practice?
Participants did not need additional prompting after asking the first question. 
They self-selected the important issues to be discussed which included all of 
the additional areas identified below. Question were utilised from this list on 
occasion to ensure clarity.  
Additional questions if required 
2. Do you record all your prescriptions written in the MDS?
3. Do you input prescription information to the minimum data
immediately after writing each prescription or at another time?
4. Do you record prescription information in any way other than the MDS?
5. Do you utilise the information in the MDS?
6. Considering the HSE uses the information in the MDS to produce a bi-
annual report on prescribing activity, do you think the MDS captures
your prescribing work load?






























Participants Name:                 _________          Clinical Specialty:    
Title of Study: What impact does the minimum data set have on the process of 
prescribing in the clinical setting? 
Researcher:  Rena Creedon, PhD student, School of Pharmacy, University College 
Cork.  
Telephone 021-4901495   E Mail: r.creedon@ucc.ie 
 
You are being asked to participate in a research study.  The researcher is a PhD student 
in the School of Pharmacy, University College Cork and through the use interviews 
aims to explore the experiences of nurse prescribers in the clinical settings.  In order to 
decide whether or not you want to be a part of this research study, you should 
understand enough about its risks and benefits to make an informed judgment.  This 
process is known as informed consent.  This consent form gives detailed information 
about the research study, which will be discussed with you.  Once you understand the 
study, you will be asked to sign this form if you wish to participate. 
The purpose of this study is to explore the impact the minimum data set has on the 
prescribing process in the clinical setting. Interviews will be set up to explore the views and 
experiences of nurse prescribers with the minimum data set. We do not foresee any risk 
for you in taking part in this study. The results will however help to establish a structure on 
the information generated by you when prescribing.   
Participation in the study is purely on a voluntary basis.Results of the study will be 
shared with the participants and practice development coordinators in each 
participating organization. The results will also be published in the PhD thesis, academic 
journals and presented at conferences. 
 
AGREEMENT TO CONSENT 
The research project has been fully explained to me.  I have had the opportunity to ask 
questions concerning any and all aspects of the project.  I am aware that participation 
is voluntary and that I may withdraw my consent at any time.  I am aware that my 
decision not to participate or to withdraw will not restrict me.  Confidentiality of 
records concerning my involvement in this project will be maintained in an appropriate 
manner.  When required by law, the records of this research may be reviewed by 
government agencies and sponsors of the research. 
I understand that the sponsors and investigators have such insurance as is required by 
law in the event of injury resulting from this research. 
I, the undersigned, hereby consent to participate as a subject in the above described 
project conducted at the Cork Teaching Hospitals.  I have received a copy of this 
consent form for my records.  I understand that if I have any questions concerning this 
research, I can contact the researcher listed above.  If I have further queries 
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concerning my rights in connection with the research, I can contact the Clinical 
Research Ethics Committee of the Cork Teaching Hospitals, Lancaster Hall, 6 Little 
Hanover Street, Cork. 
After reading the entire consent form, if you have no further questions about giving 
consent, please sign where indicated. 
 
Researcher _____________________       Participant  ______________________ 






















Exploring the Clinical Experience of Nurse Prescribers 
(Information sheet for participants) 
 
Purpose of the Research 
The purpose of this study is to explore the experiences of nurse prescribers in the clinical 
setting and to examine and interpret the reality of non-medical prescribing and the resulting 
data generated from the MDS process. By expanding the nature and way data is gathered and 
structured there is the potential to facilitate continuing professional development, research, 
patient care, and organizational processes such as quality assurance, audits, risk management 
and policies.   
Research Procedure 
Focus groups will be set up to explore the views and experiences of nurse prescribers 
prescriptive process and the data that is generated in the clinical setting.  Focus groups will be 
conducted with the participants at a convenient time so that minimal disruption is experienced.  
It is estimated that the interviews will last 45-60 minutes and will be tape-recorded. You will be 
free to raise questions at any stage throughout the focus group session. 
Confidentiality 
Your participation in the research is confidential.  Outside of the focus group only the 
researchers will know you participated. All data gathered during the study will remain strictly 
confidential you will be allocated a pseudonym if you agree to participate in the research. Any 
personal details will not be identifiable and the researchers will be the only persons with access 
to the data.  Discussion of the data will be limited to people associated with the research.   
Research Timeframe 
The research will be conducted over a six month period September 2010 to April 2011. A 
summary of the findings will be made available to each participant on completion. 
Contact Information 
In case you may have any questions or concerns regarding the study or its conduct, in the 
first instance pleased contact the researcher is listed below 
Email r.creedon@ucc.ie 
Office telephone    021- 4901495 
or alternatively Dr. Michael Hyland Chairperson of the Ethics Committee 021-4901901 
 
Researchers 
Professor Julia Kennedy Principle Researcher, School of Pharmacy, University College Cork. 
Dr. Suzanne McCarthy, PhD Supervisor, School of Pharmacy, University College Cork. 
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Internationally, several health-care systems now permit prescribing by non-medical health professionals, offer-ing potential benefits in terms of increasing patients’ 
continuity of care and access to medicines, better utilisation 
of economic and human resources, reduction in patient 
waiting times and less fragmented care (Cooper et al, 2008; 
Jones et al, 2010; Coull et al, 2013). Prescribing medica-
tions has traditionally been the domain of doctors, but 
nurse and midwife prescribing (NMP) has been introduced 
in response to changing service needs and the increasing 
specialisation of nurses and midwives as they expand and 
advance their scope of practice (McKenna, et al, 2008; 
Kroezen et al, 2012). However, international differences 
between legislative procedures and the professional bodies 
responsible for the regulation of nursing practice has result-
ed in the implementation of several models of prescribing 
worldwide (An Bord Altranais, 2005; Kroezen et al, 2013).
NMP was introduced to the Republic of Ireland in 
April  2007 and follows the model of independent nurse 
prescribing that utilises a limited formulary extending to 
those medicinal products normally used in a named clini-
cal area. More specifically, the identified medications are 
‘listed in a collaborative practice agreement and approved 
by the collaborating medical practitioner and authorised 
by The Director’ (Health Service Executive (HSE), 2012). 
Encouragingly, NMP in Ireland has continued to grow 
nationally over the past 5 years, with the role of the nurse 
prescriber in health-care settings increasing in prominence 
and significance in keeping with international develop-
ment (Cipher and Hooker, 2006; Latter et al, 2010). As a 
result, nurse prescribing is generating an ever-increasing 
amount of rich clinical and patient information that needs 
appropriate management and analysis. Collecting and utilis-
ing nurse prescribing data correctly is, therefore, of major 
significance (Munsch, 2002).
Data generated by NMP in Ireland is monitored 
using data recorded in the National Nurse and Midwife 
Prescribing Minimum Data Set (MDS), which was funded 
and introduced to Ireland by the Health Service Executive 
(HSE) in February 2008 (Adams et al, 2010). The MDS is 
composed of the 12 items that are set out in Box 1.
The MDS is an electronic system that was specifically 
developed to collect nurse prescribing data and is a web-
based application used for retrospective recording of pre-
scribing information. The main purpose of the system is to 
allow (HSE, 2008):
‘Each individual nurse and/or midwife prescriber 
to report on the number of prescriptions written by 
them and for which principal clinical indication 
over any specified time period’.
Each registered nurse prescriber in clinical practice is 
required to use the system, the benefits of which are set out 
in Box 2 (HSE, 2008).
The system was designed to allow for the immediate 
answering of questions in relation to the prescribing practice 
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‘either by using standard reports or the search and export 
functions’ (HSE, 2008). However, one of the primary bar-
riers to the effective use of health information technology 
(HIT) remains its successful adoption and implementation 
(Sequist et al, 2008). Technology may, however, have limited 
effectiveness because the management of clinical data for 
supporting patient care/direction is a complex endeavour 
that is highly dependent on appropriate management and 
accurate input of information to the system developed 
(Bose, 2003). Lapane et al (2008) highlight the importance 
of careful attention to the detail of implementing HIT, 
including active promotion of the benefits of these tech-
nologies, setting the ‘appropriate sensitivity and specificity’ 
of the interventions and incorporating them into workflow 
and clinical activities. Such data can be useful to address 
the increasing consumer demands for quality care services 
that are cost effective. These data also guide health services 
towards the potential of HIT to help ‘lower health care cost, 
improve efficiency, quality and safety of medical care’ (Jamal 
et al, 2009). These optimistic expectations are predicated 
based on the substantial role HIT already plays in improv-
ing health care internationally, along with evidence from 
research undertaken (Ortiz and Clancy, 2003; Chaudhry et 
al, 2006; Bates and Britton, 2010).
In November 2011, anecdotal evidence came to light at 
a meeting with An Bord Altranais that the MDS was hav-
ing a negative impact on prescribing in the clinical setting 
and that many sites had stopped inputting data while others 
were inputting limited data to the system across the HSE 
South region.
Aim
The aim of this study was to investigate and enhance 
understanding of nurse prescribers’ experiences of using the 
MDS in clinical practice. Secondly, the study aimed to assess 
the accuracy of the MDS as a collection tool.
Method
Design
A qualitative approach was taken to allow exploration 
and examination of the nurse prescriber’s experience of 
the MDS. To achieve this, a phenomenological approach 
(Munhall, 2012) was selected using the interpretive para-
digm as an appropriate tool for data collection and analysis. 
The use of a single, broad, open-ended question was 
believed to provide a good starting point, but additional 
questions were allowed to emerge naturally from the dia-
logue. This permitted the researcher the opportunity to 
probe the meaning of the experience for that individual, 
thereby facilitating a deeper understanding of the experi-
ences, thoughts and emotions of the participant.
Ethical considerations
A full research proposal was submitted for examination 
by the Regional Clinical Research Ethics Committee, 
Cork. The study met the research governance criteria and 
approval to undertake the study was granted.
Participants
Purposive sampling was used to recruit participants who had 
experience of the phenomenon of interest in order that a rich 
and dense text might be generated (van Manen, 1990). The 
participants were reached using the practice development 
coordinators across a number of organisations in the HSE 
throughout the south of Ireland. The participants were both 
male and female, of varying ages, from different clinical back-
grounds, and holding positions from staff nurse to advanced 
nurse practitioner that permitted an in-depth understanding 
Box 1. Composition of the Minimum Data Set
1. Prescribing site











Source: Health Service Executive (2008: 61)
Box 2. Benefits of the Minimum Data Set
w Accessibility in any location with web access
w The system is centrally administered and funded, thereby ensuring that 
there are no additional requirements on local information communication 
technology departments
w Security and confidentiality of the system
w Ability to retrieve any aspect of the information entered in the system 
using the search function
w Ability to run standard reports on prescribing activity over a given 
time period
w Transparency and comparability in relation to activity of prescribers
w Functionality to prepare, print, export, save or email reports immediately 
when required
w Capacity to export information, pre-formatted for analysis and research
w A key resource for registered nurse prescribers to demonstrate their con-
tinuing competence within their area of prescriptive authority
w An important mechanism for clinical supervision among registered nurse 
prescribers and the interdisciplinary team
w Access to resources (journal articles and texts related to prescribing) 
including links to key websites
w A tool for use as the basis for undertaking an audit of prescribing activity
w Links to other registered nurse prescribers and the Office of the Nursing 
Services Director through the noticeboard section of the system















of the lived experience of inputting data to the MDS in 
clinical practice.
Data collection
The interviews were conducted between February and 
April 2012 with nurse prescribers who met the inclusion 
criteria (Box 3). Data saturation occurred in 10 interviews.
Prior to the interviews, all participants were pro-
vided with information sheets detailing the purpose and 
nature of the research and had the opportunity to ask 
the researcher any questions. All participants approached 
agreed to participate in the research. Consent was obtained 
and the possibility of renegotiating consent was discussed. 
Confidentiality was assured and the right to withdraw at 
any time during the investigation, without prejudice, was 
guaranteed. The interviews were digitally recorded and 
later transcribed to ensure the experience as described by 
the participant was accurately captured. The strength of 
emotion regarding some issues was identified by noting 
recurrence of key statements and themes.
Data analysis 
Data analysis was carried out using Colaizzi’s (1978) pro-
cedural steps, which provided a framework in keeping with 
phenomenological research. Meaning statements were 
clustered into common themes and again referred back 
to the original commentary for validation, thereby ensur-
ing that only the participant’s perception was captured. 
Following the principles of data reduction, all themes 
were included until a textural-structural description of 
the experiences of the nurse prescribers as a whole was 
obtained. To address rigour, the findings were presented in 
a report for the participants to examine. Transcripts, codes 
and themes were reviewed by two researchers with any dif-
ferences resolved by re-analysing transcripts and discussion. 
Results
Of the 10 participants interviewed, two were male and 
eight were female, holding positions of staff nurse, midwife, 
clinical nurse specialist and advanced nurse practitioner. 
Prescribing experience ranged between 2 and 5 years.
Three main themes emerged from the analysis of the 
data, each of which is elaborated on individually. While 
the themes are distinctive and demonstrate that the nurse 
prescribers recognise and identify benefits and challenges 
to inputting data, they also had reservations about the 
effectiveness of the MDS and its use in the clinical setting. 
Theme 1: communication
The most immediately apparent issue for all participants 
was a perception that communication between the HSE 
(decision-makers) and the nurse prescribers (participants) 
was inadequate. In particular, nurse prescribers explained 
how the lack of communication regarding the MDS 
caused frustration because the challenges experienced with 
inputting data in the clinical setting were not acknowl-
edged or recognised. The situation is further compounded 
by the fact that when the HSE introduced the MDS in 
2008, nurse prescribers were clearly informed that the 
initiative would be revisited after 1  year. When this did 
not transpire, participants sought guidance from colleagues 
within the health service: 
‘I was under the impression from the first ... 
nurse prescribing course that it would be a year 
that we would have to input the information 
on the MDS then it would be reviewed ... and 
I or my colleagues never heard anything about 
it being reviewed since then … So, I stopped 
inputting data in 2010. I did contact the HSE 
via email and tried to make phone contact but 
I got no reply. …. The nurse practice develop-
ment coordinator fed it back nationally that 
there were issues with the Minimum Data Set 
and prescribers in her site were stopping input-
ting data for that reason … we heard nothing’.         
(Nurse Prescriber 1)
‘I made phone calls and sent emails to the HSE 
regarding issues I had with the MDS but I got 
no reply … I just didn’t have the time to keep 
contacting them’. (Nurse Prescriber 6)
In addition, the lack of response to emails and phone 
queries by the HSE raised even more questions from the 
nurse prescribers:
‘Why be monitored so closely … we are autono-
mous in our practice and we are able to make 
decisions that we can stand by and there are no 
mistakes being made by nurse prescribers?’
(Nurse Prescriber 8)
Failure by the HSE to respond to direct queries by the 
participants is interpreted as the HSE having a limited 
understanding of the nurse prescriber’s role and addi-
tional workload. The task of reporting on each prescrip-
tion written by inputting the information into the MDS 
is questioned by the majority of participants regarding 
its value and accuracy considering four of the partici-
pants do not input any data and five of the participants 
only input data on a proportion of prescriptions writ-
ten. In fact, nurse prescribers voiced concerns that the 
end user and technology did not interact to achieve a 
common goal:
‘I discussed it [the MDS] with colleagues and 
other advanced nurse practitioners—everybody 
had the same gripe, that it was of little value to 
the clinical area and patient’.
(Nurse Prescriber 2)
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Box 3. Inclusion/exclusion criteria of the study
Inclusion criteria
Selecting participants are nurses who have completed the nurse prescribing 
programme, are registered with An Bord Altranais and are now prescribing 
medications independently in the clinical setting
Exclusion criteria
Nurses who have undertaken the nurse prescribing programme but who 















‘Prescribing is really valuable to my work … I 
absolutely don’t input data to the MDS and I 
cannot say it’s even accurate, or up to date. I think 
the last time I inputted data on it was nearly 
8  months ago … I know from talking to other 
nurse prescribers I am not the only one not input-
ting data’. (Nurse Prescriber 7)
It was important for nurse prescribers to trust and have 
confidence in the nurse prescribing structures (particularly 
communication) managed by the HSE. As the role of nurse 
prescribing develops, it has become clear to participants 
that the absence of established structures for exchanging 
information constitutes a one-way communication struc-
ture that does not facilitate the communication of clinical 
issues which impacts on nurse prescribing and the HSE as 
a whole in practice:
‘The MDS is causing a terrible bottleneck … 
the unfortunate thing about it is that it is 
actually affecting patients and prescribing’.
(Nurse Prescriber 6)
Theme 2: workload and time
Having the time to prescribe was a concern for all partici-
pants because of the impact of the moratorium on recruit-
ment introduced by the HSE in 2009. Resulting problems 
identified by the participants include frontline disorder, staff 
shortages, rising patient waiting lists, ward and bed closures, 
and increased trolley numbers in emergency departments. 
The research participants’ views suggest that they have to sat-
isfy unrealistic expectations by coping with an unacceptable 
working environment to meet the HSE’s financial targets. 
Assessing and meeting the more complex health needs of 
patient medication requires time. Participants reported dif-
ficulties because of increasing reductions in staffing levels and 
time available to complete their work in the clinical setting:
‘When I do prescribe it’s time is an issue … I 
can’t spend a whole lot of time with the patient 
because the next patient is waiting’.
(Nurse Prescriber 2)
‘If I have 10  minutes to spare, inputting data 
to the MDS is not a priority by no means’.  
(Nurse Prescriber 3)
The components of stress and workload balance high-
lighted by participants tend to relate to excessive work, 
rather than challenging care situations. The participants’ 
cognizance of their workloads was defined in terms of time 
spent on conducting assessment, administration issues (doc-
umentation) and patient communication and education. 
Several issues were identified as increasing workload prob-
lems; however, the single most highlighted issue was dupli-
cation of documented information regarding prescribing:
‘There is a lot of repetition—like, I would have 
to document in the medication chart first, then the 
nursing notes, then the medical notes and by the 
time you get to the MDS it comes down to whether 
or not I have time to input data’.
(Nurse Prescriber 3)
‘The MDS is not a true representation of the pre-
scriptions written here so we keep our own records 
of prescribing … I don’t like the MDS because I 
don’t use the information for anything’.
(Nurse Prescriber 3)
Because of time and workload constraints, narrow 
parameters of the data system and incomplete entry of data 
to the MDS, prescribers now identify the MDS as inac-
curate and time consuming with little benefit for practice, 
patients or audit purposes. This situation has resulted in the 
development of separate audit structures being put in place 
depending on the local requirements.
‘The database provides you with none of the qual-
ity indicators I feel support best practice in relation 
to prescribing … I use an auditing tool we devised 
here in the hospital for auditing my prescribing 
now—not the MDS’. (Nurse Prescriber 2)
‘Whatever data is pulled off it, if it is looking 
at reflection of numbers of nurses prescribing I 
can tell you now it is not accurate … the data is 
absolutely skewed and flawed … I do not use it for 
auditing.’ (Nurse Prescriber 7)
‘The data on the MDS is flawed and does not 
capture information on diagnosis, comorbidities, or 
drug interaction and should not be used for reports 
or research’. (Nurse Prescriber 8)
At present, nurse prescribers feel there is limited under-
standing of the nurse prescriber’s role and the additional 
workload of the prescribing process that is taken on in 
addition to an already full clinical workload. While some 
participants felt that having a means of identifying when 
nurse prescribers were becoming overburdened was impor-
tant, others felt that there was the additional element of 
valuable data loss that contributed to the negative reaction 
to the MDS that needed to be addressed:
‘It is totally of no use to me personally and I 
suppose ... this sounds awful but we often wonder 
what it’s for—I wonder what it’s for—but I do feel 
there is valuable data that needs to be captured and 
used more appropriately’. (Nurse Prescriber 7)
Now that participants are experiencing the MDS as an 
obstacle with little perceived value, their motivation appears 
to be challenged:
‘I think the MDS is overkill and is not of any 
benefit to the prescriber or patient … if I didn’t 
have the MDS in place I would be more inclined 
to prescribe for patients’. (Nurse Prescriber 6)
Negative comparisons were also made between the pre-
scribing process in place for nurses and those for doctors. 
Six respondents felt it was more time efficient to get the 
doctor to prescribe:
‘The main problem I have is the time it takes 
and … doctors don’t have to do it [input data] 
so I just ask them to prescribe—it’s easier’. 
(Nurse Prescriber 8)

















In general, participants’ attitudes to nurse prescribing were 
very positive. They agreed that having prescribing rights 
improved continuity of care and delivery time for patients. 
However, the impact on their own workload did cause 
them concern:
‘The extra work prescribing generates is always in 
the back of my mind … and controls my decision 
to prescribe or not—yes, it’s a big element of my 
decision to prescribe’. (Nurse Prescriber 5)
The same participant avoided prescribing complex medi-
cations or taking on high-risk patients because of increased 
workload:
‘It’s stopping patient care and that’s not what nurse 
prescribing was about in the first place. The MDS 
is defeating the purpose of prescribing for me’.  
(Nurse Prescriber 5)
Nurse prescribers understood the prescribing processes, 
which are controlled by the use of standards, policies and 
improved patient outcomes:
‘With nurse prescribing organisational policy in 
place we are within our own comfort zone and 
have the knowledge base … that’s good’.
(Nurse Prescriber 4)
However, they expressed concern regarding the lack of 
representation from the clinical areas. In particular, partici-
pants felt that nurse prescribers’ views on structures in place 
and relevance of these structures to patients and practice 
was central to the future development as nurse prescrib-
ing was becoming a stressful experience in some clinical 
situations. 
‘I am very happy to prescribe, I am very happy to 
do the assessments; I just find the MDS is a com-
plete waste of my time, I find it very stressful … 
and you see there is no benefit in it for me.’
(Nurse Prescriber 10)
Participants found it difficult to align their thoughts 
and actions with the expectations and change experiences 
within the HSE because of its state of continuous flux. In 
fact, each nurse prescriber’s unique understanding of what 
change is or represents seems to add to the formulation of 
attitudes and reaction to change in the clinical setting:
‘Prescribing can be very frustrating because it’s 
such a good course and you learn so much…in 
fact, it is the best course I have ever done … it’s 
just so frustrating when you can’t use it more…
it [the MDS] even stops you from extending 
your CPA [collaborative practice agreement]’. 
(Nurse Prescriber 6)
‘I get very stressed out about it’;I worry about 
not filling it, I just do not…absolutely not have 
any time in my working week even to consider 
putting data into the MDS’. (Nurse Prescriber 7)
Participants felt that role overload and expansion of 
duties without clear description was causing problems 
for them as prescribers. The extra time that it takes to 
write the prescription and subsequent documentation 
does have its costs to patients, and participants would 
like to see role expansion and increased workload off-
set with sufficient support. In addition, participants felt 
that they were in a good position to identify and help 
resolve underlying systemic issues and offer suggestions 
for possible resolution to issues encountered with the 
MDS. However, the MDS appears to be creating a 
negative attitude to prescribing because the partici-
pants cannot see the benefit of results considering the 
time that is required to input the data onto the system.
‘I thought the MDS was to be in place for 
1  year and then it would be reviewed, but 
that was 5  years ago … like any new ini-
tiative there are things that work and things that 
don’t, but no one came back to the prescribers 
using the system to find out what they were’.  
(Nurse Prescriber 6)
‘I would say having the right to prescribe is very 
beneficial but the MDS stops me from prescrib-
ing’. (Nurse Prescriber 2)
‘Nurse prescribing is the greatest thing I have 
experienced in years and years ... it’s brilliant 
… but I have so many issues with the MDS’.  
(Nurse Prescriber 10)
Discussion
Findings indicate that participants believe prescriptive rights 
for nurses is of significant benefit in the health service—
results that are comparable to those identified in other set-
tings where nurses prescribe medicines (Avery et al, 2004; 
Latter et al, 2005; Courtenay and Berry, 2007; Stenner and 
Courtenay, 2008; Courtenay et al, 2010; Bowskill et al, 
2012). However, findings also provide insight into some of 
the concerns and anxieties nurse prescribers have regarding 
data recording. Factors identified that contribute to these 
anxieties and concerns are:
w The MDS and its perceived value
w Communication
w Staffing levels
w Time and workload.
NMPs viewed the task of inputting data to the MDS as 
having limited outcomes and being a deterrent to prescrib-
ing. This situation may be better understood in the context 
of the HSE National Implementation Report (HSE, 2014), 
which states that ‘1067 nurses and midwives have been 
funded’ to undertake the nurse prescribing programme to 
date. However, the numbers of registered nurse prescribers 
in the country as of March 2014 is ‘678’, equating to 63.5% 
of the nurses and midwives that have been funded and 
have completed the education programme. The National 
Implementation Report also uses the MDS to report on nurse 
prescribing productivity nationally. Considering the source 
of the data, the findings from this research would dispute 
the accuracy of the figures published, which are, in fact, a 
serious under-reporting of the actual prescribing under-
taken. In addition, our results find that the database does 
NURSE PRESCRIBING















not capture important information on diagnosis, patient 
age, comorbidities, drug interactions or discontinuation of 
drugs that could be cross-referenced to inform practice and 
policy. Participants acknowledged this from their concern 
that the database end-user and technology does not interact 
to achieve a common goal. Perhaps the independent lists 
contained in the database and identified by O’Halloran 
(2010) as not being structurally designed to generate que-
ries need to be addressed before the database can produce 
information that is valuable in the clinical setting. Nurse 
prescribers have moved beyond the simplistic presentation 
of prescribing data in the National Implementation Report 
(HSE, 2014) to understanding that recorded prescribing 
data is information that is be valuable to inform their 
decision-making and guide quality improvement.
‘Workarounds’
Perceived and real inefficiencies in the MDS have encour-
aged the nurse prescribers to use ‘workarounds’ (Lawlor et al, 
2011). These are locally constructed paper-based alternatives 
that meet their clinical needs and goals more efficiently and 
effectively. While the ‘workarounds’ may benefit the nurse 
prescriber, they are also a manifestation of incompatibility with 
the MDS and clinical requirements. Resolving competing 
demands by managing nurse prescribing data using ‘worka-
rounds’ creates new pathways of documentation that must 
now be cross-referenced with the MDS to fully understand 
the challenges of nurse prescribing in practice. The dramati-
cally reduced HSE staffing levels (by 5197 nurses in the last 
5  years) (O’Regan, 2014) further support concerns regard-
ing unacknowledged workloads. These figures together with 
the results of this study imply that clinical workloads have 
been increased substantially since the introduction of nurse 
prescribing to the clinical setting without consideration for 
altering existing arrangements or roles. Difficulties in adapting 
to such demands on time in the clinical setting are appearing, 
with nurse prescribers reducing the numbers of prescriptions 
written, asking the doctor to prescribe, not expanding their 
collaborative practice agreement to add new drugs or simply 
not prescribing. While participants believe that prescribing 
is very beneficial, the difficulties identified have caused stress 
for the nurse prescriber. This is now becoming an inhibiting 
factor to the initiative, making it unattractive, problematic and 
leading to a non-supportive attitude (Vakola and Nikolaou, 
2005). However, participants are also aware that smart use of 
prescribing data and information is an important component 
of creating a responsive system that contributes positively to 
the nurse prescribing initiative and provides opportunity to 
improve health in terms of both quality and cost. Having 
access to good data that is accurate, reliable and consist-
ent reflects what is really happening in practice with nurse 
prescribing. Interpretation of this data then determines the 
most appropriate interventions to address the issues/problems 
identified in the study. Participants revealed an insightful 
understanding of the nurse prescribing processes and are well 
placed to select the most appropriate interventions to establish 
implementation strategies in collaboration with the HSE to 
improve workload issues in the clinical setting.
The evidence from this research finds that the MDS is 
designed to meet different needs from those of the local 
clinical areas, making it difficult to implement. This in 
turn results in reduced productivity and access to nurse 
prescribing information that is a critical component of 
future patient care and safety. The task for the HSE is to 
re-evaluate the design of the MDS to ensure the benefits 
significantly outweigh the disadvantages clearly communi-
cated by the research participants.
Conclusion
Nurse prescribers recognise the integral connection of 
nurse prescribing data to evidence-based practice and the 
role both those components play in clinical decision mak-
ing, professional development, operational effectiveness 
and, ultimately, the patient–nurse relationship. If the MDS 
is to remain in place, it needs to be reviewed and restruc-
tured to ensure it facilitates NMP rather than causing 
an obstruction.
Due to the moratorium on national recruitment, an 
insufficiency of staff numbers has become a hindering fac-
tor for service delivery. The paradox for nurse prescribers at 
present is that, on one hand, they are a service that is valued 
by patients and, on the other, they are a disenfranchised, 
overworked and undervalued group of staff. The role of the 
nurse prescriber is clearly an important element of future 
health care, and issues surrounding workload management 
and communication need to be addressed by the HSE 
to guarantee appropriate and accurate management of 
nurse prescribing and the data generated. Research is also 
required to understand the reluctance of newly qualified 
nurse prescribers to register for practice.
As demonstrated by international research, in the long 
term, time and resources will need to be invested by the 
health service to address the issues identified by participants 
in this research. BJCN
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Dear Nurse Prescriber, 
I am conducting research for my PhD in the area of nurse prescribing. The aim 
of the research is to undertake a ‘Comparative Analysis of Nurse Prescribing’ 
and in light of this the opinion of nurse prescribers in the UK is very valuable.   
The questionnaire is designed to address various areas of prescribing in order 
to gather the necessary data in order to undertake an international 
comparative analysis of nurse prescribing.  In particular I am interested in: 
your opinion of prescriptive authority and how prescribing supports you 
in practice 
your role as a nurse prescriber and the support you require 
your prescribing workload how it is identified and recorded 
your professional development needs as a nurse prescriber 
I would be most grateful therefore if you could take time (10 mins) to complete 
the questionnaire which is contained on the link below. 
https://www.surveymonkey.com/s/UKnurseprescribingquestionnaire 
When the questionnaire is completed click done and it will automatically return 
for analysis which is anonymous.   





Nurse prescribing programme Coordinator, 












Screening Tool of Older People’s potentially inappropriate Prescriptions. 
The following prescriptions are potentially inappropriate in persons aged  
65 years of age 
A.  Cardiovascular System 
1.  Digoxin at a long-term dose > 125µg/day with impaired renal function (increased 
risk of toxicity). 
2.  Loop diuretic for dependent ankle oedema only i.e. no clinical signs of heart failure 
(no evidence of efficacy, compression hosiery usually more appropriate). 
3.  Loop diuretic as first-line monotherapy for hypertension (safer, more effective 
alternatives available). 
4.  Thiazide diuretic with a history of gout (may exacerbate gout).  
5.  Non-cardioselective beta-blocker with Chronic Obstructive Pulmonary Disease 
(COPD) (risk of bronchospasm). 
6.  Beta-blocker in combination with verapamil (risk of symptomatic heart block). 
7.  Use of diltiazem or verapamil with NYHA Class III or IV heart failure (may worsen 
heart failure). 
8.  Calcium channel blockers with chronic constipation (may exacerbate constipation).  
9.  Use of aspirin and warfarin in combination without histamine H2 receptor 
antagonist (except cimetidine because of interaction with warfarin) or proton 
pump inhibitor (high risk of gastrointestinal bleeding).  
10.  Dipyridamole as monotherapy for cardiovascular secondary prevention (no 
evidence for efficacy). 
11.  Aspirin with a past history of peptic ulcer disease without histamine H2 receptor 
antagonist or Proton Pump Inhibitor (risk of bleeding). 
12. Aspirin at dose > 150mg day (increased bleeding risk, no evidence for increased 
efficacy). 
13. Aspirin with no history of coronary, cerebral or peripheral arterial symptoms or 
occlusive arterial event (not indicated). 




15.  Warfarin for first, uncomplicated deep venous thrombosis for longer than 6 
months duration (no proven added benefit). 
16.  Warfarin for first uncomplicated pulmonary embolus for longer than 12 months 
duration (no proven benefit). 
17.  Aspirin, clopidogrel, dipyridamole or warfarin with concurrent bleeding disorder 
(high risk of bleeding). 
 estimated GFR <50ml/min. 
 
B.  Central Nervous System and Psychotropic Drugs 
1.  Tricyclic antidepressants (TCA’s) with dementia (risk of worsening cognitive 
impairment). 
2.  TCA’s with glaucoma (likely to exacerbate glaucoma). 
3.  TCA’s with cardiac conductive abnormalities (pro-arrhythmic effects). 
4.  TCA’s with constipation (likely to worsen constipation). 
5.  TCA’s with an opiate or calcium channel blocker (risk of severe constipation). 
6.  TCA’s with prostatism or prior history of urinary retention (risk of urinary 
retention). 
7.  Long-term (i.e. > 1 month), long-acting benzodiazepines e.g. chlordiazepoxide, 
fluazepam, nitrazepam, chlorazepate and benzodiazepines with long-acting 
metabolites e.g. diazepam (risk of prolonged sedation, confusion, impaired 
balance, falls). 
8.  Long-term (i.e. > 1 month) neuroleptics as long-term hypnotics (risk of confusion, 
hypotension, extra-pyramidal side effects, falls). 
9.  Long-term neuroleptics (> 1 month) in those with Parkinsonism (likely to worsen 
extra-pyramidal symptoms) 
10.  Phenothiazines in patients with epilepsy (may lower seizure threshold). 
11.  Anticholinergics to treat extra-pyramidal side-effects of neuroleptic medications 
(risk of anticholinergic toxicity). 
12.  Selective serotonin re-uptake inhibitors (SSRI’s) with a history of clinically 
significant hyponatraemia (non-iatrogenic hyponatraemia <130mmol/l within the 
previous 2 months). 
13.  Prolonged use (> 1 week) of first generation antihistamines i.e. diphenydramine, 
chlorpheniramine, cyclizine, promethazine (risk of sedation and anti-cholinergic 
side effects).  
 
C.  Gastrointestinal System 
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1.  Diphenoxylate, loperamide or codeine phosphate for treatment of diarrhoea of 
unknown cause (risk of delayed diagnosis, may exacerbate constipation with 
overflow diarrhoea, may precipitate toxic megacolon in inflammatory bowel 
disease, may delay recovery in unrecognised gastroenteritis). 
 
2.  Diphenoxylate, loperamide or codeine phosphate for treatment of severe infective 
gastroenteritis i.e. bloody diarrhoea, high fever or severe systemic toxicity (risk of 
exacerbation or protraction of infection) 
3.  Prochlorperazine (Stemetil) or metoclopramide with Parkinsonism (risk of 
exacerbating Parkinsonism). 
4.  PPI for peptic ulcer disease at full therapeutic dosage for > 8 weeks (earlier 
discontinuation or dose reduction for maintenance/prophylactic treatment of 
peptic ulcer disease, oesophagitis or GORD indicated).  
5.  Anticholinergic antispasmodic drugs with chronic constipation (risk of 
exacerbation of constipation). 
 
D.  Respiratory System 
1.  Theophylline as monotherapy for COPD. (safer, more effective alternative; risk of 
adverse effects due to narrow therapeutic index) 
2.  Systemic corticosteroids instead of inhaled corticosteroids for maintenance 
therapy in moderate-severe COPD (unnecessary exposure to long-term side-effects 
of systemic steroids). 
3.  Nebulised ipratropium with glaucoma (may exacerbate glaucoma). 
 
E.  Musculoskeletal System 
1.  Non-steroidal anti-inflammatory drug (NSAID) with history of peptic ulcer disease 
or gastrointestinal bleeding, unless with concurrent histamine H2 receptor 
antagonist, PPI or misoprostol (risk of peptic ulcer relapse). 
2.  NSAID with moderate-severe hypertension (moderate: 160/100mmHg – 
179/109mmHg; severe: ≥180/110mmHg) (risk of exacerbation of hypertension). 
3.  NSAID with heart failure (risk of exacerbation of heart failure). 
4.  Long-term use of NSAID (>3 months) for relief of mild joint pain in osteoarthritis 
(simple analgesics preferable and usually as effective for pain relief) 
5.  Warfarin and NSAID together (risk of gastrointestinal bleeding). 
6.  NSAID with chronic renal failure (risk of deterioration in renal function).  
estimated GFR 20-50ml/min. 
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7.  Long-term corticosteroids (>3 months) as monotherapy for rheumatoid arthritis or 
osteoarthritis (risk of major systemic corticosteroid side-effects). 
8.  Long-term NSAID or colchicine for chronic treatment of gout where there is no 
contraindication to allopurinol (allopurinol first choice prophylactic drug in gout) 
 
F.  Urogenital System 
1.  Bladder antimuscarinic drugs with dementia (risk of increased confusion, 
agitation). 
2.  Bladder antimuscarinic drugs with chronic glaucoma (risk of acute exacerbation of 
glaucoma). 
3.  Bladder antimuscarinic drugs with chronic constipation (risk of exacerbation of 
constipation). 
4.  Bladder antimuscarinic drugs with chronic prostatism (risk of urinary retention). 
5.  Alpha-blockers in males with frequent incontinence i.e. one or more episodes of 
incontinence daily (risk of urinary frequency and worsening of incontinence). 
6.  Alpha-blockers with long-term urinary catheter in situ i.e. more than 2 months 
(drug not indicated). 
 
G.  Endocrine System 
1.  Glibenclamide or chlorpropamide with type 2 diabetes mellitus (risk of prolonged 
hypoglycaemia). 
2.  Beta-blockers in those with diabetes mellitus and frequent hypoglycaemic 
episodes i.e.  1 episode per month (risk of masking hypoglycaemic symptoms). 
3.  Oestrogens with a history of breast cancer or venous thromboembolism (increased 
risk of recurrence) 
4.  Oestrogens without progestogen in patients with intact uterus (risk of endometrial 
cancer). 
 
H.  Drugs that adversely affect those prone to falls (≥ 1 fall in past three months) 
1.  Benzodiazepines (sedative, may cause reduced sensorium, impair balance). 
2.  Neuroleptic drugs (may cause gait dyspraxia, Parkinsonism). 
3.  First generation antihistamines (sedative, may impair sensorium). 
4.  Vasodilator drugs known to cause hypotension in those with persistent postural 




5.  Long-term opiates in those with recurrent falls (risk of drowsiness, postural 
hypotension, vertigo). 
 
I.  Analgesic Drugs 
1.  Use of long-term powerful opiates e.g. morphine or fentanyl as first line therapy 
for mild-moderate pain (WHO analgesic ladder not observed). 
2.  Regular opiates for more than 2 weeks in those with chronic constipation without 
concurrent use of laxatives (risk of severe constipation). 
3.  Long-term opiates in those with dementia unless indicted for palliative care or 
management of moderate/severe chronic pain syndrome (risk of exacerbation of 
cognitive impairment). 
 
J.  Duplicate Drug Classes 
Any regular duplicate drug class prescription e.g. two concurrent opiates, NSAID’s, 
SSRI’s, loop diuretics, ACE inhibitors (optimisation of monotherapy within a single 
drug class should be observed prior to considering a new class of drug). This 
excludes duplicate prescribing of drugs that may be required on a prn basis e.g. 
inhaled beta2 agonists (long and short acting) for asthma or COPD, and opiates for 

















Screening Tool to Alert doctors to Right i.e. appropriate, indicated 
Treatments. 
The following medications should be considered for people  65 years of age 
with the following conditions, where no contraindication to prescription exists.  
 
A.  Cardiovascular System 
1.  Warfarin in the presence of chronic atrial fibrillation. 
2.  Aspirin in the presence of chronic atrial fibrillation, where warfarin is 
contraindicated, but not aspirin. 
3.  Aspirin or clopidogrel with a documented history of atherosclerotic coronary, 
cerebral or peripheral vascular disease in patients with sinus rhythm. 
4.  Antihypertensive therapy where systolic blood pressure consistently >160 mmHg. 
5.  Statin therapy with a documented history of coronary, cerebral or peripheral 
vascular disease, where the patient’s functional status remains independent for 
activities of daily living and life expectancy is > 5 years. 
6.  Angiotensin Converting Enzyme (ACE) inhibitor with chronic heart failure. 
7.  ACE inhibitor following acute myocardial infarction. 
8.  Beta-blocker with chronic stable angina. 
 
B.  Respiratory System 
1.  Regular inhaled beta 2 agonist or anticholinergic agent for mild to moderate 
asthma or COPD. 
2.  Regular inhaled corticosteroid for moderate-severe asthma or COPD, where 
predicted FEV1 <50%. 
3.  Home continuous oxygen with documented chronic type 1 respiratory failure (pO2 









C.  Central Nervous System 
1.  L-DOPA in idiopathic Parkinson’s disease with definite functional impairment and 
resultant disability. 
2.  Antidepressant drug in the presence of moderate-severe depressive symptoms 
lasting at least three months. 
 
D.  Gastrointestinal System 
1.  Proton Pump Inhibitor with severe gastro-oesophageal acid reflux disease or 
peptic stricture requiring dilatation. 
2.  Fibre supplement for chronic, symptomatic diverticular disease with constipation. 
 
E.  Musculoskeletal System 
1.  Disease-modifying anti-rheumatic drug (DMARD) with active moderate-severe 
rheumatoid disease lasting > 12 weeks. 
2.  Bisphosphonates in patients taking maintenance oral corticosteroid therapy. 
3.  Calcium and Vitamin D supplement in patients with known osteoporosis 
(radiological evidence or previous fragility fracture or acquired dorsal kyphosis). 
 
F.  Endocrine System 
1.  Metformin with type 2 diabetes +/- metabolic syndrome (in the absence of renal 
impairment). 
2.  ACE inhibitor or Angiotensin Receptor Blocker in diabetes with nephropathy i.e. 
overt urinalysis proteinuria or micoralbuminuria (>30mg/24 hours) +/- serum 
biochemical renal impairment. 
3.  Antiplatelet therapy in diabetes mellitus if one or more co-existing major 
cardiovascular risk factor present (hypertension, hypercholesterolaemia, smoking 
history). 
4.  Statin therapy in diabetes mellitus if one or more co-existing major cardiovascular 
risk factor present. 
























































Application of STOPP/START (Screening Tool of Older Persons’ 
Prescriptions/Screening Tool to Alert to Right Treatment) to nurse prescribing. 
  
PATIENT NAME:    DATE OF REVIEW: 
DATE OF BIRTH:    CONSULTANT:  
MRN:  
 
The nurse prescriber for the above patient has consented to participate in the 
study ‘An exploration of nurse prescribing using the STOPP START Screening Tool’. 
Following the application of the STOPP START Screening Tool to the prescriptions 




1.benzodiazepines (sedative, may cause reduced sensorium, impair balance)- 
2. long-term (i.e. > 1 month) neuroleptics as long-term hypnotics (risk of 
confusion, hypotension, extra-pyramidal side effects, falls)- 
START 
1. Angiotensin Converting Enzyme (ACE) inhibitor with chronic heart failure. 
 






         
Rena Creedon    Prof. Stephen Byrne/Dr. Suzanne McCarthy 
PhD Student School of Pharmacy PhD supervisors 


























Review of patient medications: 
At admission the study patients demographic, current and past medical history 
and biomedical information were extracted from the patients’ medical and 
nursing notes and entered into the specially developed electronic data 
collection form. This database was developed by the pharmacy research group 












Barthel Index:  
The Barthel Index consists of 10 elements that assess an individual's daily 
function, specifically their activities of daily living and mobility. The index 
primarily issues relating to feeding, mobilising, grooming, transfer, toilet use, 
bathing, going up and down stairs, dressing and level of bowel and bladder 
continence. The system incorporates a computerised Barthel Index, the user 
answers the specific questions relating to the Barthel index and the system 








The medications are coded at the point of data entry using a modified version 
of the ATC codes (D-ATC codes). As the medications are entered, the system is 
designed to give the user the ability to simultaneously check specific 
indications, dosages, side effects, cautions and contra-indications etc. in a 
specially designed drug information tab, which updates based on specific drug 
selected by the user. The information in this drug information tab was 





The conditions/ disease states are also coded at the point of entry based on a 
modified version of the ICD-10 codes (D-ICD-10). The medications are entered 
into an auto/predict- text box and a free text box. The D-ICD-10 codes are 
based on the ICD-10 codes and the most common described disease 
descriptions used in practice. On repeat usage new D-ICD-10 codes will be 
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generated based on new descriptions or abbreviated descriptions of diseases 
and conditions. However eventually this should theoretically reach saturation.    
 
 
STOPP Intervention 2008: 
The system is designed to screen for the medications related to the STOPP 
criteria, based on a subset of STOPP D-ATC filter codes. These medications are 
filtered out and the user can then select the individual medications to see its 
corresponding STOPP criteria. The user can then record the relevant instances 













The system is designed to screen for conditions relating to the START criteria, 
based on a subset of the START D-ICD-10 filter codes and screen for 
medications relating to the START criteria, based on a subset of the START D-
ATC filter codes. These conditions that are filtered out and the user can select 
the specific conditions to see the corresponding START criteria. The user can 
then record the relevant instances of potential prescribing omissions (PPOs) 












Intervention Notes  
Notes were also recorded throughout the data collection process to ensure 















INTERVIEWS QUESTIONS STOPP/START. 
 
Before I commence the interview can I please confirm that you are still willing 
to participate in this interview regarding inappropriate prescribing? 
Thank you for agreeing to participant and let me reinforce that the interview is 
confidential.  All information from this interview will be anonymised before 
analysis. There will not be any consequences to what you tell me and there will 
be no blame attributed to you or anyone else. There is no right or wrong 
answer to the questions, just give as much detail as you can. It will probably 
take 20 minutes.  
Are you happy for me to proceed with the interview? 
 
1. DEMOGRAPHIC QUESTIONS: 
 Nurses grade     
 Years of experience  as a 
nurse- Nurse prescriber-  
 
 Do you have qualification 
in geriatric care?    
 
 Undergraduate / 
postgraduate?    
 
 
2 CAN YOU TELL ME WHAT YOU UNDERSTAND BY THE TERM 
INAPPROPRIATE PRESCRIBING? 
 Can you give an example?     
 Drugs with wrong/no 
indication? 
 
 Prescribing of a drug or 
drug class that are likely to 
exacerbate a clinical 
problem – ADE? 
 
 Drug that is unnecessarily 
expensive? 
 
 Prescribed for too short 
or too long period of 
time?  
 
 Underuse of medications  
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or under prescribing 
 Failure to prescribe for 




3. WHAT PORTION OF OLDER PEOPLE (65 YEARS OR OLDER) ARE PRESCRIBED 
AT LEAST ONE INAPPROPRIATE MEDICINE? 
 On admission     
 During their stay in hospital     
 On discharge     
 
4. DO YOU THINK THE LEVEL OF INAPPROPRIATE PRESCRIBING IS A PROBLEM 
AMONGST OLDER PATIENTS?  
 Primary care     
 Secondary care     
 Tertiary care     
 
5. WHAT DO YOU THINK CONTRIBUTES TO INAPPROPRIATE PRESCRIBING IN 
OLDER PEOPLE? 
 Age   
 Polypharmacy  
 Comorbidities  
 Multiple doctors / 
prescribers    
 
 History of falls    
 Other    
 
 
6. DO YOU THINK THERE IS ANYTHING IN PARTICULAR YOUR SHOULD 
KNOW MORE ABOUT WHEN PRESCRIBING FOR OLDER PEOPLE? 
 Clinical knowledge     




7. COULD YOU TELL ME WHAT YOU UNDERSTAND BY THE TERM ADVERSE 
DRUG ACTION? 
 What class of drugs are likely to be 
problematic in older patients?   
 
 What percentage of older patients 
would you say experience an 
adverse drug event?    
 
 
8. ON A SCALE OF 1 TO 10 HOW WOULD YOU RATE YOUR CONFIDENCE IN 
PRESCRIBING FOR OLDER PEOPLE, 1 BEING NOT CONFIDENT AT ALL AND 
10 BEING VERY CONFIDENT?      
 What parts of the prescribing 
process would you be least 
confident about?     
 
 Deciding on the drug?    
 Appropriateness of drug?     
 Dose?     
 Duration?     
 Discontinuation?  
 
9. WHAT WOULD YOU SAY THE POTENTIAL CONSEQUENCES OF 
INAPPROPRIATE PRESCRIBING ARE? 
 For Patient?     
 You?     
 Job?       
 Colleagues?     
 Patient’s family?     
 
10.  DO YOU THINK THE POSSIBILITY OF PRESCRIBING AN INAPPROPRIATE 
MEDICINE IS SOMETHING THAT IS ON THE PRESCRIBERS MIND ON A DAY-TO-





11.   AS A PRESCRIBER, HOW WOULD YOU DESCRIBE YOUR OWN ROLE IN 
ENSURING MEDICINES PRESCRIBED FOR OLDER PEOPLE ARE APPROPRIATE? 
 Directly involved?     
 Not much input?     
 Reviewing charts?     
 
12.  WOULD YOU FEEL COMFORTABLE CHANGING AND INAPPROPRIATE 
PRESCRIPTION IF IT WAS HIGHLIGHTED TO YOU, IF NOT, WHY NOT? 
 If you had prescribed something and 
it was highlighted to you?    
 
 If you noticed something else 
someone had prescribed?    
 
 Have you changed 
inappropriate prescriptions in 
the past?    
 
 What would warrant you 
changing a prescription?    
 
 
13.   FROM YOUR EXPERIENCE WOULD YOU SAY ENVIRONMENTAL CONTEXT 
IMPACTS ON PRESCRIBING? DOES THIS INCREASE THE CHANCE OF 
INAPPROPRIATE PRESCRIBING? 
 Time constraints?     
 Multi-tasking?      
 Are the necessary 
resources/structures available to 
assist you?    
 
 
14.   TO WHAT EXTEDT DO THE VIEWS/ACTIONS OF YOUR COLLEAGUES 
AFFECT YOUR PRESCRIBING? 
 
 
15.   DO YOU THINK YOUR EMOTIONS EVER IMPACT ON PRESCRIBING? DOES 





16.   DO YOU THINK THERE IS A PARTICULAR WAY OF WORKING OR STEPS 
THAT COULD BE TAKEN TO ENCOURAGE APPROPRIATE PRESCRIBING IN 
OLDER PATIENTS?  
 
 
17.   IF SOMETHING COULD BE DONE TOMORROW TO ADDRESS 
INAPPROPRIATE PRESCRIBING, WHAT DO YOU THINK WOULD NEED TO BE 
DONE DIFFERENTLY AND WHO WOULD NEED TO DO IT? 
 Do you think it can be easily 
achieved?    
 
 What barrier do you see to 
implementing this?    
 
 
18.   WHAT ROLE DO YOU THINK SCREENING TOOLS PLAY IN PRESCRIBING 
FOR OLDER PATIENTS? 
 Are you aware of the tools BEERS, 
STOPP/START    
 
 Do you refer to them?    
 
19. DO YOU FIND SCREENING TOOLS BENEFICIAL?  
 Yes 




20.   IS THERE ANYTHING ELSE YOU WOULD LIKE TO ADD? 
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ABSTRACT
Background and Objective: Over the past two decades nurse practitioners’ prescriptive authority, has evolved specifically in
response to pressures from patients’ physicians, changing policies and preoccupation with the effectiveness and efficiency of care.
However, little is known of the nurse practitioners’ understanding of appropriate and inappropriate prescribing and their views of
using a prescribing evaluation tool in practice to ensure prescribing is optimal and can support national change. The aim of this
research is to explore Nova Scotia nurse practitioners (with prescriptive authority) understanding of inappropriate prescribing and
their experience of using a prescribing evaluation tool.
Methods: This qualitative study used a phenomenology research design. A series of semi-structured telephone interviews were
held with a purposive sample of nurse practitioners with prescriptive authority. Interviews were tape recorded and transcribed
verbatim. Data were analysed using Colaizzi’s framework method.
Results: The study identified four recurrent themes: competence and confidence, understanding inappropriate prescribing,
consequences of inappropriate prescribing and the role screening tools play in prescribing.
Conclusions: The potential for prescribing nurse practitioners to contribute positively to address the issues with increasing
healthcare demands and associated problems and to improve quality of care in the Canadian health system is substantial given
their insight to medication management.
Key Words: Nurse practitioner, Prescribing, Inappropriate prescribing, Prescribing evaluation tool, Quality care
1. INTRODUCTION
Nurse practitioner has no universal definition[1] but it is gen-
erally accepted that nurse practitioners provide services to
individuals and families across the lifespan and work in a va-
riety of community-based settings.[2, 3] The title is frequently
used to identify advanced practice nursing in Canada, the
United States (US), Australia and the United Kingdom (UK).
In Ireland, the position is referred to as an Advanced Nurse
Practitioner (ANP). Historically, the nurse practitioner role
was introduced in the US in the mid-1960s[4] and Canada
in 1967[2] to meet increasing health service needs, with the
literature describing the first reported nurse practitioner’s
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role as “a contentious issue that produced a good deal of
conflict and anxiety” at the time.[5] Today however, the
role encompasses an evidence-informed holistic approach
that emphasises health promotion and partnership develop-
ment, that complements rather than replace other healthcare
providers.[6] More recent events of physician shortage, to-
gether with the aging population and the associated increase
in healthcare demands that has exerted considerable pressure
on the Canadian health care system[7] and so nurse practition-
ers have become increasingly identified as a resource that can
meet the ongoing health need of the Canadian population.[8]
Nurse practitioner’s prescriptive authority has therefore
evolved in response to pressures from patients, physicians,
changing policies and requirements relating to the effective-
ness and efficiency of care.[9, 10] Prescribing authority for
Canadian nurse practitioners is particularly important be-
cause health services cover large geographical regions that
are remote, sparsely populated and where medical practition-
ers are not readily available.[11] However, prescriptive author-
ity for nurse prescribers in the Canadian context is complex
and may vary due to provincial and territorial governance
systems within the country.[11] This has resulted in each
province and territory having its own approach to nurse prac-
titioner positions with prescriptive authority closely linked to
the development of the role within each province. The com-
mon ground being the requirement for additional education,
training, and regulation to ensure that those functioning in
the nurse practitioner role are able to provide safe care to the
public.[6]
Internationally over the past decade nurse practitioners have
become part of the long term care system[12–14] and are now
caring for clients with higher prevalence of chronic illness,
disability and dependency.[15] However, advancing age and
exposure to medications increases the risk of contact with
a potentially inappropriately prescribed medication and de-
velopment of complications from drug therapy. More specif-
ically, the literature describes inappropriate prescribing as
encompasses the use of medicines that pose more risk than
benefit to patients, the use of medicines that have clinically
significant drug-drug and drug-disease interactions, and im-
portantly, the under-use of beneficial medicines.[16] Con-
sequently, particular care must be taken when determining
drugs and dosages for this section of the population to en-
sure prescribing is appropriate considering the long stand-
ing issues and number of older adult clients in receipt of
medicines for chronic conditions in the Canadian health ser-
vice.[17] While the benefits of pharmacotherapy for the older
adult are potentially substantial, the process of choosing the
appropriate medicine for the individual older adult patient
may be complex. Changes in the patient’s medical status
over time can cause long-term medicines to become unsafe
or ineffective, therefore part of the nurse practitioner’s role
is regular medication review to ensure continuing positive
benefit for each medicine prescribed for the older adult. To
ensure medication benefits are maintained several validated
tools have been developed to help prescribers identify poten-
tial inappropriate prescribing in older adult care.[16, 18, 19] The
significance of appropriate prescribing is best viewed in the
context of the financial cost to the health service which has
been identified by the Canadian Institute of Health Informa-
tion (CIHI). In 2013, an estimated $34.5 billion was spent on
drugs, the majority of which $29.3 billion (85.0%) was spent
on prescribed drugs.[20] Within the priority research area
of Drug Policy, the Canadian Institute of Health Research
has identified effectiveness, safety and adverse events as key
areas to be addressed, their vision being to “transform from
a reactive, one-size-fits all approach to a more personalized
system of predictive, preventive, and precision healthcare
that is tailored to a population or an individual”.[21] Incor-
porating nurse practitioners to provide direct care by way
of “initial diagnosis of problems/concerns, establishing of
diagnosis following appropriate diagnostic tests if required
and formulation of a management plan, which may include
prescriptions of medications”[22] has the ability to provide
personalised appropriate care the initiative requires. Fur-
thermore, the competence of nurse practitioners to manage
patient care in a comparable manner to physicians, with high
levels of patient satisfaction, combined with increased advice
on education and health promotion has been well reported
in the international literature.[23–27] However, the literature
in relation to nurse practitioners understanding of appropri-
ate or inappropriate prescribing is limited; leaving a void
in our understanding of the impact nurse practitioners with
prescriptive authority may have on patients’ drug regimes.
The difficulty however, can be local governance policy that
limits the number of products available in the prescribing
formulary for nurse practitioners[28] causing restrictions on
prescribing that impact on their ability to prescribe appropri-
ately. Therefore, it is important to gain a better appreciation
of Canadian nurse practitioners’ understanding of appropri-
ate and inappropriate prescribing and their views of using a
prescription evaluation tool in practice to ensure prescribing
is optimal and can support the planned national change.
Aim
The aim of this research is to explore Nova Scotia nurse
practitioners (with prescriptive authority) understanding of
inappropriate prescribing and their experience of using a
prescribing evaluation tool.
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2. METHOD
This study adopted a Husserlian, or descriptive, phenomenol-
ogy approach to the research. Data were collected in May
2015 during a research travel bursary visit to Dalhousie Uni-
versity, in Halifax. Using a descriptive phenomenology ap-
proach is the most appropriate way to develop an under-
standing of nurse practitioners’ experience of appropriate
and inappropriate prescribing and importance placed on a
prescribing evaluation tool as interpreted by nurse practition-
ers who have lived the experience. An important component
of Husserlian phenomenology is the belief that it is essential
for the researcher to shed all prior personal knowledge to
grasp the essential lived experiences of those being studied.
2.1 Participants
Participants in a Husserlian phenomenology study must have
experienced the phenomenon and be able to articulate what it
is like to have lived that experience[29] of using a medication
evaluation tool in practice. Therefore, a purposive sample
of nurse practitioners with prescriptive authority working
with older adult care in the greater Halifax region and the
wider area of Nova Scotia, Canada were asked to participant.
Sampling continued until no new themes emerged, this oc-
curred after eight interviews. All participants except one was
female, experience as nurse practitioners with prescriptive
authority ranged from 2 to 14 years. All of the nurse prac-
titioners interviewed were primary healthcare practitioners,
with seven of them currently working in community health
centres and one in private practice supported by a health care
team.
2.2 Interviews
Participants were first contacted by email to establish their
interest in participating in the research. Positive responses
were followed up with personal emails that included inter-
view details and requesting that the participant identify a
date and time suitable to carry out a telephone interview.
Telephone interviews were necessary because of the diverse
geographical location of participants across the state of Nova
Scotia, Canada and the time frame available to the researcher
to collect the data. Interviews followed a structured process
to ensure appropriate structure and accurate preparation for
the interviews, the process was divided into three: a) before,
b) during and c) after the interview, details of which are set
out in Table 1.
Table 1. Telephone interview protocol
 
 
Before the interview 
 Appropriate information was communicated to the potential participant and questions answered.  
 Interviews were scheduled with free time allocated by the researcher prior to and after the interview to accommodate any last 
minute change to arrangements because of clinical commitments or interruptions. 
 The interview protocol was pre-tested. 
 Audiotaping techniques were predetermined and tested. 
 Appropriate time was allocated for introductions and study overview. 
 Confidentiality was assured.  
 Results would be sent to each individual participant via email on completion. 
 Finally the process was piloted with a research student to ensure the process was smooth, and there were no technical problems. 
During the interview 
 Interview style was clearly identified.  
 Initial conversation was light to encourage the participant to relax. Introductions including career background, education and 
clinical interests of the researcher were discussed. An overview of the study was given and an explanation of how the present 
research contributes overall. Confidentiality was also reinforced.  
 Interview questions were structured to vary and allow for the participants opinion. 
 Themes of interest identified in earlier interviews informed the schedule in later interviews.  
 At the end of each interview any issues concerning information for a particular question was addressed with the participant and 
clarification or explanations sought regarding terminology etc. before moving forward. 
After the interview 
 Each interview was transcribed immediately following the interview while the researcher was still immersed in the essence of 
the interview. 
 Ample time was allocated for analysis.  
 Interviewees agreed to be contacted should validation of any issues in the interview transcripts be deemed necessary. 
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2.3 Data collection
Before the interview process commenced, research partici-
pants were given the opportunity to ask the researcher ques-
tions regarding the study. Verbal consent was obtained and
the possibility of re-negotiating consent was also discussed.
Confidentiality was assured and the right to withdraw at
any time during the investigation, without prejudice, was
guaranteed.
Interviews were conducted by telephone with each practi-
tioner for approximately 25-35 mins. A predetermined set
of open questions were used to maintain focus on appropri-
ate and inappropriate prescribing and the value of using a
prescription evaluation tool. This topic guide was developed
by the author for a previous study using STOPP/START and
piloted to ensure the guide maintained focus on appropriate
and inappropriate prescribing. This structure provided an
outline for the interview however, additional questions were
allowed to emerge naturally from the dialogue. Due to the
lack of visual cues the researcher took notes as a reminder of
the non-verbal communication such as pauses or hesitations
that took place during the interview to facilitate transcription.
The interviews were digitally recorded and transcribed im-
mediately following the interview to ensure the experience
as described by the participant was accurately captured. Us-
ing the telephone for data collection interviews may also
reduce some forms of response bias (facial expressions) as
the interviewer and participant are potentially less affected
by each other’s presence. This, in turn, may increase the
level of comfort for both parties and result in a more relaxed
interview.[30]
2.4 Ethical considerations
A research proposal was submitted and approved by the
Clinical Research Ethics Committee of the Cork Teaching
Hospitals and University College Cork to undertake the re-
search.
2.5 Data analysis
Data analysis was carried out using Colaizzi’s (1978) Pro-
cedural Steps[31] which provided a framework in keeping
with phenomenological research. Meaning statements were
clustered into common themes and again referred back to the
original commentary for validation, thus ensuring that only
the participant’s perception was captured.
In following the principles of data reduction all themes were
included until a textural-structural description of the expe-
riences of the nurse prescribers as a whole was obtained. It
was necessary to recognise overlapping themes and clarify
others that were ambiguous by bringing them back to the
participant for validation or further elaboration, when nec-
essary. In doing this, the interpretive research moved back
and forth between two worlds: that of the understanding and
resourceful dwelling of the participants, and the distancing
and questioning world of the researcher. Through analyses
and interaction with the data, it is hoped to progress beyond
the common sense understanding of the participants’ experi-
ence in the situation under study to a level of interpretation
and critique.[32]
3. RESULTS
Following analysis of the narrative data, findings were
grouped under the following headings for reporting:
• Level of confidence and competence described by
nurse practitioners in their role as prescriber.
• Understanding and consequences of inappropriate pre-
scribing.
• The role screening tools play in prescribing for older
people.
3.1 Confidence and competence
Participants acknowledged that having prescribing rights had
improved their self-esteem, and autonomy in practice. When
asked specifically to rate their confidence in prescribing on
a scale of 1-10, 1 being the least and 10 the most confi-
dent the majority of participants rated themselves between
8 and 10. These participants were well established having
the most experience in their specialty area, kept up to date
and understood their professional boundaries. However, one
participant did not share this view awarding themselves a 6.
This participant had the least experience and attributed this
to not having had the opportunity to prescribe as part of the
education process.
“You know I found when you get in a course
you can teach about the disease and learn about
a particular drug but we don’t know how to pre-
scribe or how to titrate or discontinue it (medi-
cation) really I find you learn by using the drug
or talking to colleagues. . . I didn’t know how to,
start it (prescribing) and I always ‘start low and
go slow’. But what is low and what is slow?”
(Participant 2)
Additional, issues concerning confidence and competence
surfaced when asked if there was anything they should know
more about when prescribing for older adults. CPD was iden-
tified by all participants as important to maintain awareness
of medication issues and better placing them to question or
challenge medication changes or adjustments required.
“I won’t prescribe anything new unless I
have absolute understanding of what patients
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are on and taking in addition, like herbal
over the counter or any complementary ther-
apies. . . because a lot of them don’t even think
that an enteric coated aspirin they take for heart
disease is even a medication because they don’t
get a prescription for it. . . patients adding over
the counter medications can be a big problem.”
(Participant 7)
Accurate assessment was also identified as important for
competent prescribing. However, several participants high-
lighted that developing nursing expertise in a particular area
can focus your knowledge so finely that limitations can occur.
“I’m comfortable assessing my patients, my
background is renal but my patients don’t just
come with renal problems they have vascular
problems, diabetes the whole list. I’m not an
expert in some of those other areas.” (Participant
6)
Participants felt that their role was not to primarily generate
prescriptions instead they were keen to communication and
interact with patients as part of an accurate assessment and
competent prescribing process. Understanding the character-
istics of the patient’s requirements, strengths and weaknesses
that facilitated a more holistic approach to prescribing was
identified as important.
“Having a conversation is important because
you can have patients with strange reactions to
their medicines and if you don’t explore it prop-
erly you won’t know. I find that sometimes the
gaps I identify during conversation give me the
most information.” (Participant 7)
3.2 Understanding and consequences of inappropriate
prescribing
The level of understanding regarding inappropriate prescrib-
ing was broad and has been condensed into the main areas
identified in Table 2.
Table 2. Description of inappropriate prescribing
 
 
1) Medications not appropriate for the client in terms of diagnosis or health status at the moment. 
2) Prescribing without a good cause or reason. 
3) Making a choice of medications for patients that either don’t follow best practice or are not in the patient’s best interest. 
4) Prescribing outside my scope of practice. Wrong dose for the wrong patient. 
5) Medications prescribed that are not clinically relevant. 
6) Prescribing something that is not based on evidence based rationale from a clinical assessment point of view that fits the actual 
condition.  
7) Prescribing a medication that may not be warranted or effective.  
8) Wrong medication for the wrong patient. 
 
Although not referred to directly prescribing by omission
was addressed indirectly when answering questions.
It is an established fact that medication use increases with
advancing age. This in turn requires that prescribing for older
people represents a range of options and values that attempt
to optimize prescribing quality for individual patients.
“Prescribers do not use frailty as a predictor
when prescribing. A lot of the medication of
older folk are family driven because they want
Mom or Dad or whoever to have the same level
of care that they have not recognising the physi-
ological changes that occur with aging may not
make those medications appropriate.” (Partici-
pant 4)
Also depending on the level of care, therapies can be viewed
from different perspectives.
“Sometimes treatment in hospitals would be a
little more aggressive than what we would con-
sider appropriate in primary care.” (Participant
7)
All participants identified they had a substantial role to en-
sure medicines were appropriate. Specifically, interactive
approaches were used to combat problems.
“I have a direct involvement because I am ed-
ucating the residents myself and nursing staff
plus allied staff. I also review charts as part of
the process.” (Participant 4)
“I have direct involvement in making sure medi-
cations are appropriate we do hundreds of med
reviews every year and we do med reconciliation
also. I explain to the families and staff the physi-
cal and medications review results.” (Participant
3)
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Participants linked proper assessment to appropriate prescrib-
ing through individualised care assessment thereby, ensuring
the drug–patient interaction is implicitly included in the pre-
scriptive process.
“I’ve seen families who were primary care
givers for older adults struggling to manage with
what appeared to be deteriorating conditions
which were actually side effects of medications
when assessed.” (Participant 7)
Several characteristics of ageing and geriatric medicine af-
fect medication prescribing for older adult people and render
the selection of appropriate pharmacotherapy a challenging
and complex process that may not result in the desired effect.
“I really don’t think there is a black and white an-
swer to prescribing sometimes the patient does
not keep up to date with the changes to medica-
tions it’s not always about the medicines some-
times its human error that causes the problems.
We try to do our best, but sometimes problems
just happen.” (Participant 4)
Inappropriate prescribing remains a problem in day-to-day
practice and despite increased awareness the dynamic na-
ture of the problem requires updating solutions that address
constant changing patterns.
“I try to focus on what I do well. . . and individu-
alise care to reduce risk.” (Participant 6)
For prescribing in general it is important that the patient has
trust in the prescriber. Trust is also essential for establishing
collegial relationships with other healthcare professionals
and patients.
“There is human error in everything we do.
What people deserve to know is whether it was
an error or an omission and the biggest thing
people want to know is what are we going to
do differently, or if we are going to do anything
differently. That’s how we tend to manage most
everything here.” (Participant 5)
Participants were confident that the consequences of inappro-
priate prescribing could be addressed.
“I think it would be education for all involved
but there is a barrier to that because it costs
money.” (Participant 2)
“So in order to make change we really have to
have a complete culture shift and make the pre-
scribers and the whole system aware that seniors
require unique care and they are uniquely differ-
ent form the adult population when it comes to
prescribing.” (Participant 4)
“I’m the only nurse practitioner within a huge
facility (485 beds) in my opinion there is work
for three in the facility then we could cover and
support each other and share the workload and
have cover at the weekends. Yes we need more
prescribing nurse practitioners.” (Participant 3)
“Address polypharmacy we’ve been talking
about it for years but we are only starting to
take some action now.” (Participant 1)
Polypharmacy was identified as very common among older
adults and is often adopted as a strategy to address symptoms,
reducing disease-related problems and improving quality of
life in the older adult.
“When we look at underlying causes for prob-
lematic symptoms it is sometimes due to too
many drugs. We have to strip them back to the
essential drugs so that the team can get in and
treat the patient in a meaningful way.” (Partici-
pant 5)
Polypharmacy may also be the result of patient and/or family
assuming the role of prescriber.
“If over the counter drugs are added (to the
medication regime) the patients may present to
us with problems that can be difficult to figure
out. Education is important and even salads in
the summer for someone on warfarin can cause
problems.” (Participant 8)
It is unrealistic to expect that the majority of clinicians have
enough knowledge about drug-related appropriateness and
interactions when prescribing for older people with multi-
morbidity to avoid errors. However, participants felt that
they could err on the side of caution.
“If there is ever a problem I write my cell num-
ber on all my prescriptions so if the pharmacist
ever has a question they can contact me directly
to discuss any possible error.” (Participant 5)
The most effective benefits of prescriptive drug therapy for
older adults can only be derived if drugs are prescribed and
used appropriately. Participants voiced that combining expert
opinions was also an option.
“. . . attention to detail is required and if I have a
problem I will take it to my collaborative prac-
tice partner to discuss. I work in a collaborative
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team so I don’t work in isolation it’s always
good to have colleague around for advice.” (Par-
ticipant 6)
3.3 The role screening tools play in prescribing for older
people
All participants had experience of using a prescribing
appropriate evaluation tool and were familiar with the
STOPP/START evaluation tool in particular.
“I used the STOPP/START criteria in my work
and clearly identified areas where there is in-
appropriate prescribing and the need for re-
evaluation depending on the stage of life.” (Par-
ticipant 4)
Time appeared to be an issue when applying a screening tool
with some participants identifying it as cumbersome to apply
in the clinical setting. Many practical issues were raised.
“I can really see the benefit of using a medi-
cation evaluation tool especially if we had the
database that you (the researcher) use. It would
save us time and we would get immediate results.
Using STOPP/START and applying the criteria
manually is just not practical.” (Participant 3)
“I think it would play an important role espe-
cially if the nurses and doctors were using the
same computer based system. We would follow
the same structure and have a better result for the
patient using the evaluation tool.” (Participant
2)
Participants’ concerns regarding potential inappropriate pre-
scribing (PIP) also extended to the management of patients’
medications from the wider perspective of changing condi-
tions to ensure medications prescribed remain appropriate.
“I love the STOPP/START tool because the re-
search is there in the literature and so easy to
share the information and findings. They make
us think about leaving people on medications for
extended periods of time simply because they
saw a cardiologist 15 years ago.” (Participant 3)
Other participants could see possibilities beyond the initial
identification of PIP.
“They are not necessarily looking at just pre-
scribing but gathering data on your patient about
their diagnosis, past history, medications, lab
tests and activities of daily living a concise his-
tory and assessment on each patent documented
and easily accessible.” (Participant 8)
4. DISCUSSION
All participants were knowledgeable regarding inappropri-
ate prescribing and had information about or worked with
a prescribing evaluation tool in the past. As with previous
research, participants highly rated the use of a prescribing
medication evaluation tool, understanding that medication
appropriateness can be measured by evaluating the content
or quality of a prescribing decision and or the outcome of
that decision.[33] Even though there was a number of pre-
scribing evaluation tools available for detecting inappropriate
prescribing, the participants had a very good working knowl-
edge of the STOPP/START criteria. This was attributed to
the ongoing research using the STOPP/START criteria under-
taken by the Pharmacy Department in Dalhousie University,
Halifax, in collaboration with the Pharmacy Department in
University College Cork, Ireland.
All participants endorsed regular reviews of older adults pre-
scriptions, a practice that is supported by the literature to
reduce medications prescribed.[34] Nurse practitioners were
aware of the issues surrounding the aging population in their
region especially the growing number of older adults that face
challenging treatment decisions. This trend makes it even
more critical to develop interventions that can improve the
decision-making process to ensure appropriate medications
are prescribed.[35] In order to facilitate good decision making
and depending on cognitive awareness of patient’s nurse prac-
titioners included families when necessary through organised
family conferences. Including the family in the assessment
process opened communication to ensure that patients con-
cerns and wishes regarding medications and treatments are
elicited and understood. This is an important additional com-
ponent of managing medications considering physicians’ and
patients’ perspectives on treatment and associated decisions
can sometimes differ. Such differences were identified by
Kutner et al.[36] who recognised physicians rank co-morbid
conditions and the medical literature as important factors in
treatment decision-making, while patients rank family pref-
erence, family burden, and physician’s opinion as important
factors in making treatment decisions. Nurse practitioners
with prescriptive authority are adequately placed in practice
to promote informed treatment choices that are consistent
with the patients’ personal preference and based on informed
decision making. Nonetheless, the balance is fine between
medications that improve quality of life for the older adult
and medication related problems that place them at risk[37] .
Nurse practitioners identified that selecting appropriate medi-
cations for use in older adult patients is often complicated by
multiple illnesses and multiple medications. The potential is
high for drug-drug and drug-disease interactions which the
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nurse practitioner must bear in mind when choosing a medi-
cation or assessing its effectiveness or side effects.[38] The
primary factor associated with medicine under use was a lack
of health literacy concerning geriatric conditions in those car-
ing for older adults’ findings similar to Lang et al.[39] Even
though participants indicated that specialisation improved
their knowledge, it was focused on a specific condition or sys-
tem depending on nurse practitioners area of expertise. This
posed a considerable challenge for nurse practitioners, be-
cause patients who usually presented with problems require a
wider understanding of individual diagnosis and differential
diagnosis in order to make appropriate medication decisions
for them. To ensure patients with multiple problems were
appropriately assessed the nurse prescriber utilised the ex-
pertise of the multidisciplinary team which according to
the literature “utilises individuals from different disciplines
working in a team toward a common goal”.[40] Internationally
such collaboration has led to improved client outcomes such
as decreased hospital admissions and timely interventions
for older adults.[41, 42] However, participants also expressed
the importance of combining multidisciplinary care with a
medication evaluation tool especially STOPP/START was
significant because of its correlation with adverse drug events
(ADEs).[43]
Much attention has been paid to over-prescribing for
older adults nonetheless participants recognised that under-
prescribing of appropriate medications was also a concern.
This is a seriously misdirected practice according to Ro-
chon[44] (2015) because seeking to simply limit the overall
number of drugs prescribed to older adults in the name of
improving quality of care is incorrect practice. Therefore, a
medication evaluation tool used in practice needs to encom-
pass the appropriateness of prescribing which according to
Spinewine et al.[45] embraces three values: 1) the preferences
of the patient; 2) the scientific and technical rationale of pre-
scribing; and 3) the interests of the community. However,
quantifying what the patient wants and serving the best inter-
ests of the community can be quite challenging as they can
be influenced by societal, economic and family factors.[46]
The literature reveals that numerous studies using
STOPP/START criteria have been conducted in various
patient-care settings to assess prescribing appropriate-
ness.[47–52] However, when using a prescribing evaluation
tool, it is important to consider that explicit criteria such as
that of STOPP/START do not take into account all factors
that define high quality health care for the individuals. The
START screening tool for potential prescribing omissions
(PPOs) does not allow for factors such as life expectancy,
time needed to derive clinical benefit and patient preference
as legitimate reasons for under-prescribing.[45] It is the nurse
practitioners responsibility to understand the burden of co-
morbid disease and patient preference which are then taken
into account and required to reconcile decisions with the
evaluation tool. Applying the STOPP/START evaluation tool
may require flexibility, in some cases, what is considered
inappropriate according to STOPP/START may not be ap-
propriate for an individual patient for various reasons.[53] To
address this, guidelines accompanying the STOPP/START
evaluation tool clearly state that the tool does not replace the
clinical judgment of the prescriber.[50] There were however,
concerns expressed about inconsistent implementations of
the evaluation tools and the time required to evaluate pa-
tient’s medications. According to Ryan et al.[48] this issue
was recognised by the research group in the School of Phar-
macy, University College Cork and University Hospital Cork
who began developing a database to facilitate the use of
STOPP/START criteria in day-to-day clinical practice. Fur-
thermore, in 2013 the research group was funded to develop
a Software ENgine for the Assessment & optimization of
drug and non-drug Therapy in Older peRsons (SENATOR)
a highly-powered and efficient software engine capable of
individually screening the clinical status and pharmacolog-
ical and non-pharmacological therapy of older adults with
multimorbidity. The significance of this software to nurse
practitioner and other prescribers is that it can define optimal
drug therapy, highlight adverse drug reaction risk, indicate
best value drug brand for selection and provide advice on
appropriate non-pharmacological therapy. A very valuable
tool considering the majority of older adults with multimor-
bidity are managed by healthcare professionals that are not
specially trained in geriatric medicine and rehabilitation and
may not have access to a geriatrician or specialised nurse
practitioner to help with assessments.
In this study, nurse practitioners’ knowledge and experience
was recognised by senior doctors as supportive within their
practices. In addition, the value of nurse practitioners was
also considered important because of connection with a range
of services and clinical networks that have been emphasised
in the literature as primary, speciality and acute services.[54]
Participants in this study did not take for granted the refer-
ring diagnosis of the GP or hospital department but showed
initiative and integrity and acted on their advanced knowl-
edge and experience to independently assess their patients.
The nurse practitioner then had the confidence and ability
to bring a range of clinicians together to develop a package
of care that was focussed on the individual patient needs.
Utilising this approach helps the nurse practitioner to look
beyond the initial clinical problems that presented to focus
on the more holistic plan of care for each patient and pro-
vide staff with support and motivation.[55] However, building
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such an integral service required healthcare professionals to
broaden their professional standards. This process requires
training, discussion, collaboration, and a shared assessment
and treatment plan.[56] The fact that the nurse practitioners
mentor and are champions for change within organisations
is significant for the future development of best practice in
elderly care.
The importance of continuing professional development
(CPD) and remaining up to date was and issue identified
by all participants that required additional support. Posi-
tive comments were tempered with a belief that too many
demands placed on the nurse practitioner encroach unac-
ceptably on the opportunity to undertake CPD. Specifically,
heavy workload and absence of colleagues to cover the work
(backfill) prevent uptake of CPD, issues already identified in
the literature.[57] Whilst it was acknowledged that a certain
amount of learning was achieved “on the job”, it was re-
peatedly put forward in the interviews that formal education
and training was necessary to supplement and enhance such
learning. Considering the predicted changes of increasing
complexity in elderly care[58] it is essential that nurse practi-
tioners engage with CPD and are supported throughout their
careers to maintain and develop the knowledge and skills to
respond effectively to the needs of patients, service users and
the wider public.[59] Especially when viewed in the context
of changing demographic patterns of disease in countries
across the world and the subsequent impact on health service
delivery, preparatory education can only ever be an initial
grounding for nurse practitioners.
Limitations
This study has the limitations specifically related to the use of
the qualitative methodology. Among its limitations is the low
number and source of the participants drawn from a specific
area in Canada, who are not necessarily representative of all
Canadian nurse practitioners, restricting the study’s generali-
sation to other areas or countries. In addition, recruitment of
participants for this study was the responsibility of the senior
nurse practitioner for the Nova Scotia Region, Canada. All of
the participants had previously heard about STOPP/START
criteria, because of involvement with research in the clinical
practice, which is not representative of the general nurse prac-
titioner population. The sample size of eight although small
is acceptable for qualitative research and reached saturation
point.
5. CONCLUSION
Nurse practitioners have derived both personal and profes-
sional benefits from prescribing and feel better equipped to
make decisions and challenge changes if necessary. The
potential for prescribing nurse practitioners to contribute
positively to address the issues with increasing healthcare
demands and associated problems and to improve quality
of care in the Canadian health system is substantial given
their understanding regarding appropriate and inappropriate
medication management.
Nurse practitioners in Nova Scotia, Canada are both compe-
tent and confident prescribers and have integrated prescribing
effectively within their respective roles. In addition, recog-
nition of their role and contribution to the wider healthcare
team is acknowledged but there are still some cautious re-
sponses from a number of doctors in practice. Another tangi-
ble issues identified is the importance and support required
for ongoing CPD. More specifically CPD was identified as
a substantial prerequisite for maintaining knowledge and
keeping up-to-date with the ever changing pharmaceutical
industry and medications available in practice. Management
strategies employed in practice were communication, collab-
oration and collegial relationships to effectively safeguard
medications prescribed and reviewed as appropriate for the
older adult population. However, the issues surrounding
the consequences of inappropriate prescribing were more
complex requiring an organisational approach to the interac-
tive management of medications prescribed and reviewed to
ensure maximum benefit.
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